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Abstract 
The central purpose of this thesis is to test the utility of ant-microbe 
associations for discovering antifungal compounds with novel molecular (sub-) 
structures. Novel antifungals displaying reduced adverse side-effects, increased 
water-solubilities, and/or strong fungicidal properties would be helpful in medical 
science for responding to the rising prevalence of human mycoses and for 
solving problems with adverse side-effects in currently used antifungal drugs. 
Host-symbiont systems may represent a source of bacterial species that, due to 
their co-evolved association with hosts, have evolved antifungals differing in 
their molecular structures from antifungals of well-explored environmental 
sources.  
To test the suitability of ant-microbe symbioses for discovering novel 
antifungals, I characterise ectosymbiotic bacteria and antifungal metabolites in 
three ant-associated niches: Acromyrmex octospinosus worker ants, fungal 
cultivars of Allomerus decemarticulatus and A. octoarticulatus, and Tetraponera 
penzigi worker ants and their putative fungal cultivar. I find that the A. 
octospinosus and T. penzigi niches hosted multiple bioactive actinobacteria 
including Streptomyces, Pseudonocardia, Nocardiopsis, and 
Saccharopolyspora.  
A Streptomyces strain from the Acromyrmex octospinosus niche was 
shown to produce the structurally unmodified antifungals candicidin and 
antimycin, which is suggestive of bacterial recruitment from environmental 
sources. Antimycin consisted of two sets of six molecules varying in number of 
attached CH2 groups. Both sets differ in polarity and fragmentation pattern. Only 
one set of antimycins inhibited the growth of Candida albicans, and this set 
revealed tandem-LCMS analogies with an antimycin A1-A4 standard.  
A Pseudonocardia strain from the same A. octospinosus niche was found 
to produce a partially novel (to science) and potentially water-soluble nystatin-
like antifungal, which is suggestive of host-symbiont coevolution. These findings 
indicate that the host ant is able to use multiple-drug therapy in the form of 
antifungal cocktails to tackle resistance evolution in fungal pathogens. 
Overall, this research demonstrates that ant-microbe associations provide 
new opportunities for finding abundant bioactive bacteria and novel antibiotics. 
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Chapter 1) Introduction 
1.1 Antifungals and their application 
Only a small proportion of fungal genera includes species that are 
pathogenic to humans, animals, and plants (De Lucca 2007, Richardson 2003). 
However, these species impose a large and increasing burden to society by 
harming the health of humans, their domestic animals, and their crops. This 
burden can be quantified by the prevalence of fungal infections (mycoses) in 
humans. For example, Slavin et al. (2004) studied the occurrence in Australia of 
life-threatening human mycoses caused by opportunistic fungi in the genera 
Aspergillus and Candida. In contrast to primary fungal pathogens, which attack 
healthy humans, opportunistic fungal pathogens attack weakened hosts, 
especially those that are immunocompromised (e.g. AIDS) or very ill (e.g. 
cancer) (Slavin et al. 2004). Surveying data of the National Hospital Morbidity 
Database, between 1995-1999, the authors found that the total cost of 
hospitalisation during the study period of patients diagnosed with aspergillosis 
was AUS$ 42.8 million (equals £ 26.9 or  33.6 million; calculated May 30, 
2012, 10:03 UTC) and of patients with candidiasis was AUS$ 520.5 million 
(equals £ 326.5 or  408.6 million; calculated May 30, 2012, 10:03 UTC). The 
number of people affected by these diseases is on the rise; for example, over 
the study period the annual growth of hospitalisation due to aspergilloides and 
candidiases was 13.8% and 3.5%, respectively. 
One important and widely used clinical intervention for lowering the 
economic and human burden of mycoses is the application of antifungal 
substances. However, the set of currently used antifungal compounds suffers 
from several problems: difficulty of application, pathogen resistance, and 
adverse side-effects in patients. Therefore, there is a need to discover new 
antifungal antibiotics. The goal of this thesis is to assess the utility of a novel 
niche, ant-microbe associations, for the discovery of novel antifungals. In the 
introduction, I first briefly review mechanisms of antifungal action, fungal 
resistance mechanisms to antifungals, and some of the problems with currently 
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used antifungals, which together demonstrate why we need to find new 
antifungal compounds. I then briefly relate some of the history of antifungal 
prospecting and the use of insects as novel niches for antifungal discovery. 
Finally, I outline the plan of my thesis. 
1.1.1 Mechanisms of antifungal action 
As suggested by their name, antifungals are antibiotics that disrupt vital 
functions in fungal cells, possessing fungistatic (growth inhibiting) and/or 
fungicidal (killing) properties. Such substances are used for the treatment of 
fungal infections in humans. Antifungal drugs can be characterised by their 
mechanism of action on the fungal pathogen, which describes how the 
antifungals inhibit fungal cells on a molecular level. The molecular targets of 
some medically important antifungal classes include RNA/DNA, the cell wall, 
and the cell membrane. 
Molecular target: RNA/DNA. 5-fluorocytosine is an antifungal substance 
that develops its potency when entering fungal cells and being transformed into 
5-fluorouracil and the follow-up metabolites 5-fluorouridine triphosphate and 5-
fluorodeoxyuridine monophosphate (Waldorf and Polak 1983, Polak 1990, 
Georgopapadakou 1998, Odds et al. 2003). These processes are mediated by 
the enzymes cytosine permease, cytosine deaminase, and uracil 
phosphoribosyl transferase. While 5-fluorouridine triphosphate is incorporated 
into fungal RNA, where it interferes with protein synthesis, and 5-
fluorodeoxyuridine monophosphate inhibits thymidylate synthase, which disrupts 
DNA synthesis.  
Molecular target: the cell wall. Fungal cell walls, among others, consist of 
(1,3)--glucan and chitin, of which the first forms the main component and the 
second is thought to increase stability (Levitz 2010). Echinocandins and 
nikkomycins are classes of antifungals that interfere with cell wall synthesis. 
Echinocandins interrupt the functioning of (1,3)--glucan synthase that 
polymerises uridine diphosphate glucose molecules to -glucan, which leads to 
osmotic lysis (Georgopapadakou 1998, Kontoyiannis and Lewis 2002). 
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Nikkomycins inhibit chitin synthase (i.e. Chs3) that polymerises UDP-N-
acetylglucosamine to chitin, leading to a weakening of the fungal cell wall and 
death (Georgopapadakou 1998). 
Molecular target: the cell membrane. The phospholipid bilayer of the fungal 
cell membrane contains ergosterol, which is the fungal equivalent of cholesterol 
in human cells. Various classes of antifungals, including allylamines, azoles, 
morpholines, and polyenes affect different stages of the ergosterol biosynthesis 
and membrane functioning. For example, the polyene antifungals amphotericin 
B, nystatin, and candicidin target ergosterol molecules in fungal cells. Like all 
phospholipids, the chemical structure of these antifungal substances has a polar 
head and an apolar tail; this allows them to bind ergosterol hydrophobically, 
integrate into the membrane bilayer, and form membrane-spanning pores that 
increase membrane permeability, and thereby reduce fungal survival (Gray et 
al. 2012). Compounds of the remaining classes interfere with various enzymes 
involved in ergosterol biosynthesis (e.g. squalene epoxidase, lanosterol-14 
demethylase, 7-8 isomerase), processing the acetyl-coenzyme A-derived 
intermediate squalene to lanosterol and ultimately to ergosterol 
(Georgopapadakou 1998).  
1.1.2 Resistance mechanisms to antifungals 
Despite these multiple modes of antifungal action, and because fungal 
pathogens are diverse and continuously evolving, many pathogens show innate 
(primary) or acquired (secondary) resistance to known antifungal compounds.  
Resistance to 5-fluorocytosine. Filamentous fungi often lack enzymes 
responsible for the uptake and processing of 5-fluorocytosine (Odds et al. 
2003). This makes them innately resistant to this antifungal since the active 
metabolites 5-fluorouridine triphosphate and 5-fluorodeoxyuridine 
monophosphate, which disrupt protein and DNA synthesis, are not formed. The 
yeast Candida albicans belongs to a set of organisms that is susceptible to 5-
fluorocytosine but can acquire resistance when developing defects in the 
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enzyme uracil phosphoribosyl transferase, which is involved in the processing of 
5-fluorocytosine (Vanden Bossche 1997). 
Resistance to echinocandins. The strength of the echinocandin antifungal 
caspofungin varies across fungal species; for example, it shows a strong 
inhibitory activity against many Candida species, slows down the growth of 
Aspergillus spp., and is inactive against Cryptococcus neoformans (Hector 
2005). The resistance of certain Candida albicans strains towards this antifungal 
likely stems from a mutation in the gene encoding the (1,3)--D-glucan synthase 
(Baixench et al. 2007), which produces glucan, the main component of fungal 
cell walls. 
Resistance to polyenes and azoles. Fungi with an acquired resistance to 
the polyene antifungal amphotericin B are uncommon, since the antifungal is 
potently disrupting cell functioning without having to enter fungal cells; 
nevertheless, polyene resistance in Candida, among others, derives from 
mutations in ergosterol biosynthesis genes resulting in an alteration of the 
ergosterol content in fungal membranes (reviewed in: Masia Canuto and 
Gutierrez Rodero 2002, Kontoyiannis and Lewis 2002), and thus a diminished 
potential for pore formation. Interestingly, treatment of fungal pathogens with 
azoles reduces the concentration of membrane-bound ergosterol, and hence 
the susceptibility to polyenes.  
Candida spp. that are resistant to azoles have been found to exhibit 
multiple resistance mechanisms (reviewed in Masia Canuto and Gutierrez 
Rodero 2002). These include mutation and/or overexpression of the gene 
encoding lanosterol-14 demethylase, which is a molecular target of azoles, as 
well as up-regulation of multidrug efflux transporter genes and reduction of 
fungal membrane permeability to reduce the accumulation of antifungal 
molecules within fungal cells.  
1.1.3 Problems with currently used antifungals 
Not only can fungal pathogens evolve resistance to antifungal compounds, 
it is inherently difficult to treat fungal infections because many antifungals are 
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weakly absorbed by the host body, metabolised by the host to inactive 
molecules, and/or irregularly distributed over body tissues (reviewed in Hector 
2005), all of which prevent antifungals from achieving minimum inhibitory 
concentrations at sites of fungal infection. Furthermore, because of the close 
phylogenetic affinity of animals to fungi, relative to bacteria, antifungals are 
notorious for producing damaging side-effects in animal hosts. For example, 
because of its affinity for ergosterol, amphotericin B also binds to cholesterol 
and forms pores in animal cell membranes (Kaneshiro et al. 2000, Baginski et 
al. 2002), which results in so many adverse side-effects that the drugs 
nickname is amphoterrible.  
Such side-effects limit the use of standard strategies that have been 
developed for overcoming or preventing the evolution of resistance in fungal 
infections, such as applying high doses, varying the antifungal used over time, 
or simultaneously exposing the pathogen to multiple antifungals at once. In 
short, even relative to antibacterials, for which there is already a shortage of 
effective compounds (Butler and Buss 2006), there is a great need for new 
antifungals, which explains strong pharmaceutical interest in finding ways to 
discover unknown antifungals, especially those with novel sub-structures that 
show improved lethality toward fungal pathogens, while exhibiting stronger 
affinities to fungal target molecules to reduce side-effects. To achieve this goal, 
antifungal drug discovery and development explores natural, semi-synthetic, 
and synthetic molecules. Natural-product antifungals are unmodified bioactive 
compounds; semi-synthetic and synthetic ones refer to structurally modified 
natural products and chemically synthesised bioactive molecules, respectively. 
This thesis concentrates on the discovery of new natural-product antibiotics.  
1.2 Sources of new natural-product antifungals 
Miyadoh (1993) studied the origin of antibiotics that were published in the 
Journal of Antibiotics (1984-1993) and in patent applications (1983-1992). The 
author found that around 70% of antibiotic compounds were produced by 
actinomycetes, 20% by fungi, and only 10% by other bacteria. The name 
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actinomycetes refers to bacteria in the phylum Actinobacteria that 
morphologically resemble fungal mycelia in their production of filaments. 
Actinobacteria are common soil organisms, characterised by DNA with a high 
guanine and cytosine content. Miyadoh (1993) also found that antibiotics with an 
actinomycete origin were mainly produced by Streptomyces (68%), with smaller 
contributions from the bacterial genera: Nocardia, Saccharopolyspora, 
Nocardiopsis, Amycolatopsis, and Pseudonocardia. The statistics for antifungal 
compounds are comparable to the ones for antibiotics in general in that 
actinobacteria represent the largest group of producers (60%); fungi (32%) and 
other bacteria (8%) represent smaller producer groups. This shows that 
(actino)bacteria represent an important source of novel metabolites with 
potentially favourable pharmaceutical properties. Some researchers have tried 
to increase the exploitation of this source by studying cryptic or silent 
pathways in known antibiotic-producers (Hertweck 2009). Bacteria often have 
more genes encoding antibiotic compounds than are transcribed under 
laboratory conditions. Some cryptic antibiotic biosynthesis genes can be 
switched on by growing the producing bacteria on specific media, under specific 
temperature regimes, or in the presence of chemical inducers. For instance, the 
chemical substance sodium butyrate is known to influence the (de)acetylation of 
histones in eukaryotic cells, around which the DNA is packed. The acetylation of 
histones lowers DNA binding and hence allows an increased transcription of 
genes (Hertweck 2009), including antibiotic biosynthesis genes. Sodium 
butyrate appears to influence DNA binding of histone-like proteins in bacteria as 
well and has been reported to increase antifungal production in certain bacteria 
(Martin and McDaniel 1976, Moore et al. 2012). 
Other researchers have focused on screening novel or under-explored 
environmental niches to discover unknown bacteria and novel biosynthesis 
genes. One interesting set of novel niches is symbioses of bacteria with 
animals, fungi, and plants. Symbioses are long-term associations between 
different species, and symbioses that result in fitness benefits to both species 
are called mutualisms. The most common form of mutual benefit occurs when 
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physically larger partners (hosts) provide housing and food to smaller partners 
(symbionts), which in turn provide specialised services or compounds. For 
example, termites disperse to patches of dead wood, and the protozoan 
symbionts of termite guts produce enzymes that can digest cellulose, which 
feeds both the termites and its symbionts (Poinar 2009).  
Symbiotic mutualisms involving microbes may be of particular 
pharmaceutical interest; firstly, hosts may provide living conditions to their 
symbionts that differ markedly from host-unassociated, potentially well-explored, 
and more accessible habitats that have been extensively surveyed by antibiotics 
researchers (Schmidt 2008, Piel 2009, Seipke et al. 2011c). Secondly, 
symbionts and hosts are likely to have coevolved, and bacterial metabolites 
therefore have evolved to serve hosts needs. For instance, symbionts have 
been reported to provide their hosts with a large diversity of small nutritional and 
non-nutritional molecules, serving diverse ecological functions in the hosts 
defence, predation, and health-care (Schmidt 2008, Seipke et al. 2011c). Both 
factors may increase the genetic and molecular novelty of the bacterial 
metabolites, compared to compounds that have been characterised to date. 
Additionally, it is possible that the symbiotic niche has selected for antifungals 
that are less harmful to the animal hosts, while still being effective against fungal 
pathogens. Below, I briefly survey the large diversity of pharmaceutically 
exploitable host-symbiont systems by providing key examples spanning three 
kingdoms; however, the focus is on the chemical exchange between insects and 
bacteria since this is the major topic of this thesis.  
1.2.1 Fungus-bacteria mutualism  
The mutualism between the fungal host Rhizopus microsporus and 
bacterial symbionts in the genus Burkholderia has been investigated by Partida-
Matinez and Hertweck (2005). The fungus is known to attack rice seedlings, 
causing root swellings, and to kill plant tissue. Both mutualistic partners benefit 
from the bacterial production of rhizoxin. This secondary metabolite is able to 
disrupt plant cell division by binding -tubulin; the killed plant tissue serves as 
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food for the fungus and also supports the growth of the bacterium. Previously, 
rhizoxin-production has been attributed to the fungus; however, the authors 
showed that the bioactive metabolites are of bacterial origin and that the 
microbes are hosted endosymbiotically. 16S rDNA of the Burkholderia
symbionts and ketosynthase genes, encoding parts of the polyketide synthase 
that is involved in rhizoxin metabolism, could be traced in symbiont-containing 
R. microsporus strains but were absent from non-rhizoxin producing fungi. 
Furthermore, the bacterial symbiont could be isolated and introduced into a 
symbiont-free host, which thereafter re-established rhizoxin production. Due to 
its cytocidal effects, rhizoxin has been studied for its antitumor properties.               
1.2.2 Plant-bacteria mutualism  
Marine algae have been studied as a source for novel bacterial antibiotics 
(Armstrong et al. 2001, Penesyan et al. 2009). For example, the alga Delisea 
pulchra has been shown to host a diverse community of episymbiotic bacteria 
(Penesyan et al. 2009). These have been suggested to contribute in preventing 
the establishment of biofouling, describing the growth of epiphytic organisms on 
the plant surfaces. Penesyan et al. (2009) found the bacterial community of D. 
pulchra to consist of 79% Gamma-Proteobacteria, 13% Alpha-Proteobacteria, 
4% Bacteroidetes, and 4% Firmicutes; most of the isolated Gamma-
Proteobacteria belonged to the genus Microbulbifer. The bacterial isolates were 
tested positively for inhibition of diverse mammalian pathogens, including Gram-
positive (Streptococcus suis, Staphylococcus aureus) and Gram-negative 
(Neisseria canis) bacteria, as well as against a fungal pathogen (Candida 
albicans). One explanation for the secretion of antibacterials and antifungals is 
to prevent bacterial competitors from colonising the algal surface tissue 
(Armstrong et al. 2001, Penesyan et al. 2009), and these compounds may be 
exploitable pharmaceutically. 
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1.2.3 Animal-bacteria mutualism  
1.2.3.2 Solitary wasps: Philanthus triangulum 
The European beewolf Philanthus triangulum hosts mutualistic 
Streptomyces bacteria (Kaltenpoth et al. 2005). The life-cycle of this solitary 
wasp includes a phase during which its larvae develop underground. Fertilised 
females excavate tunnel-like cavities in the soil, into which they place paralysed 
prey insects (i.e. honeybees), which serve as food resources for the developing 
beewolf larvae.  
The females inoculate the brood chambers with secretions from their 
antennae, which contain Streptomyces bacteria. The bacteria are subsequently 
taken up by the larval offspring and applied to their cocoons when pupating. The 
bacteria are thought to protect the pupae from bacterial and fungal infections, 
originating from the soil and/or from the prey carcasses. The presence of the 
bacterial symbionts increases the survivorship of the beewolf offspring 
(Kaltenpoth et al. 2005), as shown in a test where only one of fifteen (6.7%) 
Streptomyces-deprived beewolf larvae survived to pupation, whereas 15 out of 
18 (83.3%) control larvae that had access to the bacterial symbiont survived.  
The bacterial symbionts produce antibiotics (Kroiss et al. 2010). In 
particular, the bacterial solutions applied to the brood cells contain streptochlorin 
(C11H7N2OCl, 218.0 amu), as well as piericidin A1 (C25H37NO4, 415.3 amu), B1
(C26H39NO4, 429.3 amu), and A5 (C26H39NO4, 429.3 amu). Furthermore, cocoon 
extracts have been shown to contain these and five other piericidin derivates, 
including glucopiericidin A (C31H47NO9, 577.3 amu). These antibiotics are not 
novel but were unknown to insect systems. Piericidin A1 and B1 were the most 
abundant substances. The authors isolated streptochlorin, piericidin A1 and B1, 
as well as glucopiericidin A; they challenged the substances against a diverse 
set of fungi (e.g. general and entomopathogenic fungi) and bacteria. Piericidin 
A1 inhibited the growth of eight test organisms; streptochlorin and piericidin B1
were more specific in their antibiotic action but particularly strong in inhibiting 
fungi that showed resistance towards piericidin A1.  
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1.2.3.3 Solitary wasps: Sceliphron caementarium and Chalybion californicum 
Another example is given by the mud dauber wasps Sceliphron 
caementarium and Chalybion californicum (Poulsen et al. 2011), which also 
house mutualistic Streptomyces bacteria. S. caementarium builds its nest 
chambers from mud. There, foundresses deposit eggs and paralysed arthropod 
prey (e.g. spiders) that serve as food for the wasp larvae. C. californicum 
parasitises S. caementarium by emptying and ovipositing into nest chambers 
previously occupied by S. caementarium. Both the soil and prey represent 
potential sources of harmful fungi and bacteria. 
Streptomyces bacteria can be found on the integuments of both species 
and possess antibacterial and antifungal properties (Poulsen et al. 2011). To 
date, no integumental structures have been identified in the insects to support 
ectosymbiotic bacteria; hence, the bacterial isolates could be only contaminants 
from the soil. Nevertheless, cuticular washes from 33 wasps have been shown 
to contain a variety of 24 bacterial morphotypes (Poulsen et al. 2011).   
Liquid growth cultures of 15 strains were analysed metabolomically, 
resulting in the discovery of 11 antibiotic substances. These metabolites were 
produced by 10 of the 15 bacterial strains, including the well-known compounds: 
streptazoline (e.g. C11H13NO3, 207.229 amu, CAS: 80152-07-4); streptazon B 
(e.g. C10H11NO, 161.203 amu, Reaxys ID: 8682540); bafilomycin A1 (e.g. 
C35H58O9, 622.84 amu, CAS: 88899-55-2) and B1 (e.g. C44H65NO13, 815.999 
amu, Reaxys ID: 20434788); antimycin A1 (e.g. C28H40N2O9, 548.634 amu, CAS 
116095-18-2), A2 (e.g. C27H38N2O9, 534.607 amu, CAS 118890-43-0), A3 (e.g. 
C26H36N2O9, 520.58 amu, CAS 116095-17-1), and A4 (e.g. C25H34N2O9, 506.553 
amu, CAS 117603-45-9); daunomycin (e.g. C27H29NO10, 527.528 amu, Reaxys 
ID: 18461908); mycangimycin (e.g. C20H24O4, 328.408 amu, CAS: 1093661-81-
4); as well as the novel compound: sceliphrolactam (e.g. C28H35NO6, 481.589 
amu, CAS: 1267888-95-8). During colony bioassays, the 15 bacterial isolates 
were tested against a set of 16 fungal strains, including entomopathogens, and 
against one another. A complex pattern of bacterial and fungal inhibition was 
found. For example, bacteria producing different antifungals inhibited the same 
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fungal strain, and strains of the same fungal species showed different 
susceptibilities to the same bacterial strain. The secretions also inhibited 
bacteria; however, inhibition patterns were even more variable. Poulsen et al. 
(2011) carried out the bioassays with bacterial colonies instead of isolated 
antibiotics; therefore, it cannot be excluded that the bacteria produced multiple 
antibiotic substances on agar plates.  
1.2.3.4 Southern pine beetles: Dendroctonus frontalis 
Secretions from bacterial symbionts are also used for protecting food 
resources in insect fungicultural systems. Insect fungiculture is common, and 
known to occur in ants, termites, beetles, and gall midges (Kaltenpoth et al. 
2009). For example, the southern pine beetle Dendroctonus frontalis cultivates 
mutualistic fungi of the species Entomocorticium sp. and Ceratocysfiopsis 
ranaculosus (Klepzig et al. 2001). Female beetles chew galleries in the inner 
bark and phloem of living pine trees into which they oviposit and inoculate their 
fungal cultivars. Typically, pure fungal cultures of either species are carried by 
the females in integumental pouches, so-called mycangia. The fungal hyphae 
appear to serve as food for the developing larvae (Klepzig et al. 2001). The 
activities of the adults and offspring destroy the phloem and lead to tree death. 
In addition, the females often vector a third fungus, Ophiostoma minus, which 
hitchhikes on their exoskeleton. The parasite has been suggested to compete 
with the fungal mutualists for phloem space. In vitro, this fungus is able to 
readily overgrow Ceratocysfiopsis ranaculosus but is less likely to overgrow
Entomocorticium sp. (Klepzig et al. 2001). Due to this, and because of 
representing a richer nutritional substrate for the larvae, it has been suggested 
that the beetle offspring may be better off when surrounded by latter.  
Bacteria of the genus Streptomyces, found in the females mycangium and 
inside the fungal cultivar, are thought to defend the fungal cultivar against O. 
minus (Scott et al. 2008). In particular, red and white bacterial morphotypes 
have been isolated from female beetles. In agar plate bioassays, these were 
challenged against the fungal mutualist Entomocorticium sp. and the fungal 
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parasite O. minus. The red morphotype was able to inhibit the growth of the 
fungal parasite, whereas the white morphotype was not; both bacterial 
morphotypes only slightly inhibited the growth of the fungal mutualist (Scott et 
al. 2008, Oh et al. 2009). In consequence, the bacterial symbionts have been 
proposed to benefit the beetle fungiculture. In a chemical analysis, the red 
morphotype was shown to produce a novel antibiotic with the name 
mycangimycin (e.g. C20H24O4, 328.408 amu, CAS: 1093661-81-4).  
In summary, host-symbiont systems represent promising and under-
explored environmental niches for finding new, potentially coevolved, bacteria 
with novel antibiotic biosynthesis genes of potential pharmaceutical importance. 
1.3 Outline of this study    
In this study, four ant species (Hymenoptera, Formicidae), Acromyrmex 
octospinosus (Myrmicinae), Allomerus decemarticulatus and A. octoarticulatus
(Myrmicinae), and Tetraponera penzigi (Pseudomyrmecinae), were investigated 
regarding their associations to bioactive bacteria that could provide their 
(putative) hosts with potentially novel and pharmaceutically exploitable 
antifungal metabolites. The following is an overview of the main results.  
Chapter 2, titled Acromyrmex octospinosus ant-associated bacteria, 
describes the composition of the bacterial microbiome on the cuticles of A. 
octospinosus worker ants. A. octospinosus is known to cultivate the fungus 
Leucoagaricus gongylophorus (Agaricales, Agaricaceae), which produces 
nutritive food bodies (gongylidia) to provide the ants with food. In particular, this 
association is obligate since the queen and larvae of Acromyrmex exclusively 
feed on gongylidia. The health of the fungal cultivar is endangered by diverse 
non-cultivar fungi. Among those, fungi in the genus Escovopsis, are common, 
virulent, and specialised. The health of the fungal cultivar has been shown to 
partly depend on antifungal metabolites of bacterial symbionts. To date, 
bioactive Pseudonocardia, Streptomyces, and Amycolatopsis bacteria have 
been isolated from the cuticles of attine workers (Currie et al. 1999b, Currie et 
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al. 2003, Kost et al. 2007, Haeder et al. 2009, Oh. et al. 2009, Sen et al. 2009), 
and bioactive Streptomyces and Burkholderia bacteria have been isolated from 
fungal cultivars of attine ants (Haeder et al. 2009, Santos et al. 2004). 
Furthermore, these bacterial symbionts have been shown to produce diverse 
antifungal metabolites, including candicidin, actinomycin (D and X2), antimycin 
A1-A4, valinomycin, and the novel antifungal dentigerumycin (Haeder et al. 2009, 
Schoenian et al. 2011, Oh. et al. 2009).  
In addition to the potential for bioprospecting of novel antibiotics, the attine 
system provides an interesting evolutionary dilemma. How does antibiotic 
defence, provided by the ant-associated bacteria, remain effective against 
Escovopsis and other non-cultivar fungi over ecological and evolutionary time-
spans? So far, two hypotheses have been proposed: firstly, metabolites of 
vertically transmitted and coevolved, attine-associated Pseudonocardia
symbionts may be in an evolutionary arms race with resistance mechanisms in 
Escovopsis (Currie et al. 1999b, Currie et al. 2003, Mueller 2012). Secondly, 
resident attine-associated Pseudonocardia strains may be exchanged for or 
augmented by actinobacteria with effective antifungal metabolites (Zhang et al.
2007, Mueller et al. 2008, Mueller 2012), potentially recruited from the soil 
environment; this environmental recruitment might occur at all times or in 
response to exposure to resistant Escovopsis strains. A different version of the 
second hypothesis is that antifungal cocktails, produced by mixed communities 
of bacteria not only provide protection against a variety of harmful non-cultivar 
fungi, including Escovopsis, but also slow-down the evolution of resistance in 
single parasite strains. The first empirical support for environmental recruitment 
and mixed bacterial communities came from Kost et al. (2007), who showed that 
Acromyrmex ants, in addition to Pseudonocardia, also associate with 
Streptomyces. As a further step to test the hypothesis that antifungal cocktails 
help A. octospinosus prevent the rise of pathogen resistance, this chapter 
focuses on identifying the bioactive bacterial microbiome of worker ants in 
Acromyrmex octospinosus.  
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The data presented in this chapter show that diverse genera of Gram-
positive bacteria can be isolated from the cuticles of A. octospinosus workers. 
Selected isolates, including Pseudonocardia, Streptomyces, and Nocardiopsis
strains, as well as their growth culture media, were challenged in bioassays 
against Candida albicans and three Escovopsis strains. Representatives of all 
tested bacterial genera were shown to inhibit at least one of the test fungi. The 
data thus confirm the potential of Pseudonocardia and Streptomyces as 
mutualistic partners, but further studies are needed to characterise the 
ecological role of Nocardiopsis in the A. octospinosus symbiosis. A portion of 
these results was published by Barke et al. (2010) in BMC Biology. In this 
paper, the hypothesis is tested that the observed variety of bacterial symbionts, 
indeed translates into a diversity of antifungal metabolites. In particular, two 
antifungal metabolites are described that are metabolised by two worker ant-
associated bacterial species, one Pseudonocardia and one Streptomyces, 
which in Chapter 2 were shown to originate from the same ant colony and to 
inhibit diverse test fungi. The data demonstrate that the putatively coevolved 
Pseudonocardia strain can produce a novel variant of the polyene antifungal 
nystatin and that the apparently environmentally recruited Streptomyces strain 
can produce the well-known compound candicidin. Hence, a diversity of 
bacterial symbionts indeed translates into a diversity of antifungal metabolites, 
which may explain the long-term fungicultural success of A. octospinosus.  
In an invited auto-commentary on Barke et al. (2010), Barke et al. (2011) 
place the vertical transmission and environmental recruitment hypotheses into 
general mutualism theory, explaining how the first invokes partner fidelity 
feedback and the second invokes partner choice; the auto-commentary forms 
the discussion of Chapter 2. 
Chapter 3, titled Antifungals of an Acromyrmex octospinosus ant-
associated Streptomyces strain, demonstrates that the Streptomyces strain 
that had previously been shown to produce candicidin (Barke et al. 2010) can 
also produce antimycins, which is another class of antifungals. For the 
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purification and identification of the non-candicidin antifungal, the bacterium was 
grown in a liquid growth culture. Apolar molecules, which characterise many 
antifungals, were extracted from the growth supernatants with butanol. The 
extract was purified in bioassay-guided normal- and reversed-phase column 
fractionations. The compound masses of the parent ions in the double-purified 
extract were detected by mass spectrometry. These compounds were identified 
by determining their masses/formulae and the masses/formulae of their sub-
structures (i.e. daughter ions), generated during MS2 analyses.   
The data, presented in this chapter, show that the double-purified extract 
from the growth cultures, in addition to candicidin, also contains antimycin. In 
particular, two sets of six antimycin molecules could be detected, corresponding 
to diverse antimycins that differ in polarity and mass by the attachment of CH2
groups. A tandem-LCMS analysis confirmed analogies between the second 
compound set and an antimycin A1-A4 standard. The data illustrate that even 
single bacterial associates are able to provide their ant hosts with multiple 
antifungal metabolites, increasing the compound diversity of antifungal cocktails. 
This work was published as part of Seipke et al. (2011a).   
Chapter 4, titled Allomerus decemarticulatus and A. octoarticulatus
cultivar-associated bacteria, describes the presence of bacteria in the fungal 
cultivar of Allomerus ants. Here, the idea of investigating new environmental 
niches for unknown bacterial symbionts is applied to the ant genus Allomerus, 
which has never been studied this way. A. decemarticulatus and A. 
octoarticulatus ants are hosted by the myrmecophytic trees Hirtella physophora
and Cordia nodosa, respectively, in exchange for protection against herbivores. 
The ants are known to maintain a fungal monoculture in the order 
Chaetothyriales (Ruiz-González et al. 2010). The fungus is thought to stabilise 
trap constructions, built out of carton and other detritus by the ants on host-tree 
branches, to capture insect prey. Spores of diverse, and potentially harmful, 
non-cultivar fungi have been isolated from the traps (Ruiz-González et al. 2010), 
that if left unattended, could render the traps useless. Here, the hypothesis is 
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tested that cultivar-associated bacterial symbionts may promote the health of 
the fungal mutualist. Recall that in the Acromyrmex system, cultivar-associated 
Burkholderia and Streptomyces bacteria have been suggested to defend the 
fungal mutualist against non-cultivar fungi (Santos et al. 2004, Haeder et al. 
2009). The focus here is on the Allomerus fungal cultivar, not on the ants 
themselves, because the latter are not known to possess integumental 
structures to house bacterial symbionts.  
The data presented in this chapter show that diverse genera of Gram-
positive and Gram-negative bacteria can be isolated from the cultivar traps. 
Selected isolates, including Streptomyces and Nocardia strains, and their 
growth cultures, were challenged in bioassays against Candida albicans and 
two non-cultivar fungi that also were isolated from the cultivar traps. Under 
laboratory conditions, none of the bacterial isolates inhibited the test fungi. 
Addition of the chemical inducer sodium butyrate did cause two Streptomyces
strains to inhibit Candida, but only weakly. These results are, at most, only 
weakly consistent with the hypothesis that cultivar-associated bacteria promote 
the health of the fungal cultivar in this mutualism. 
Chapter 5, titled Tetraponera penzigi ant- and cultivar-associated 
bacteria, describes microbes that were isolated from T. penzigi worker ants 
and their putative fungal cultivar. The ants are hosted by the myrmecophyte 
Acacia drepanolobium as host defence against herbivory. T. penzigi ant-
inhabited domatia have been found to consistently contain hyphal growth of a 
fungus in the genus Chaetomonium, which might feed T. penzigi in some way. 
Here, I test the hypothesis that, analogous to the fungal cultivar of previous 
chapter, this putatively cultivated fungus is protected against potentially harmful 
non-cultivar fungi by worker ant- and cultivar-associated bacteria. 
The data provided in this chapter show that diverse genera of Gram-
positives and Gram-negatives can be isolated from the worker ants and their 
putative fungal cultivar. Selected bacteria, including Streptomyces and 
Saccharopolyspora strains, as well as their culture supernatants were 
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challenged in bioassays against Candida albicans and three non-cultivar fungi, 
isolated from the fungal cultivar. Both Streptomyces and Saccharopolyspora
strains strongly inhibited the growth of test fungi. Hence, the data suggest that 
the metabolites of ant- and cultivar-associated bacteria in this system may 
indeed promote the health of the putative fungal cultivar. The Tetraponera-
bacteria association therefore becomes a new and promising candidate for the 
discovery of novel antibiotics.     
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Chapter 2) Acromyrmex octospinosus ant-associated bacteria                     
2.1 Introduction 
2.1.1 Mutualistic partners 
The origin of attine ants (Hymenoptera, Formicidae, Attini) dates back 
around 50 million years ago (Schultz and Brady 2008). Since then, the tribe 
Attini, which is endemic to the New World, has diversified into more than 230 
species and thirteen genera. The so-called lower attines include the genera 
Mycocepurus, Myrmicopcrypta, Apterostigma, Mycetophylax, Mycetarotes,
Mycetosoritis, Cyphomyrmex, and Mycetagroicus; the higher attines include 
the genera Sericomyrmex, Trachymyrmex, Acromyrmex, Pseudoatta, and Atta 
(Schultz and Brady 2008, Solomon et al. 2011). Attine species differ enormously 
in their biogeography, ecology, and associations to fungi. For example, despite 
all being known to cultivate fungi for food  hence the common name fungus-
growing ants  their cultivars differ among others in identity and growth 
requirements (e.g. substrate). Schultz and Brady (2008) distinguish five types of 
attine fungiculture, including lower agriculture, coral fungus agriculture, yeast 
agriculture, higher agriculture, and leaf-cutter agriculture. Higher agriculture is 
carried out by the higher attines Sericomyrmex and Trachymyrmex; and leaf-
cutter agriculture is carried out by the higher attines Atta and Acromyrmex that 
are commonly referred to as leaf-cutting ants or leaf-cutter ants. The genera 
Atta, comprised of 15 species, and Acromyrmex, comprised of 24 species, 
cultivate the basidiomycetous fungal species Leucoagaricus gongylophorus
(Agaricales, Agaricaceae). For brevity, L. gongylophorus will henceforth be 
referred to as the cultivar. Atta and Acromyrmex, and also certain 
Trachymyrmex species (Schultz and Brady 2008), collect large volumes of plant 
leaves and flowers, masticate them to make nutrients more available, and use 
them as substrate for their cultivar. L. gongylophorus, which seems not to occur 
outside of the mutualism, converts the plant material into hyphal-tip swellings, 
called gongylidia (Schultz and Brady 2008). These contain high concentrations 
of lipids and carbohydrates, and are selectively harvested by the worker ants to 
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feed the larvae and queen. The worker ants supplement their own diets with 
plant secretions. Furthermore, the ants propagate and protect their cultivar; for 
example, the cultivar is propagated vertically, from parent to daughter colonies, 
by newly emerging and dispersing queens (gynes). These carry a small 
inoculum of the fungal resident in their mouth pocket (infrabuccal pocket). After 
nest initiation, the cultivar is taken care of by the gynes; in more established 
nests, this responsibility is taken over by the worker ants. 
2.1.2 Fungal parasites 
Leaf-cutter ant colonies maintain single strains of their L. gongylophorus
cultivar. The potential disadvantage of relying exclusively for food on a 
genetically depauperate and vertically transmitted fungal monoculture is that the 
fitness of the ants crucially depends on the health of the cultivar, but the entire 
cultivar could be destroyed by just a single pathogen species or genotype, if the 
pathogen is able to overcome the cultivars defences, including the cultivars 
own antifungal compounds (Wang et al. 1999). In addition, any given lineage of 
the mutualistic fungus has a reduced capacity to evolve novel resistance 
mechanisms and/or antifungal molecules, as the only source for novel genetic 
variation is mutation, as opposed to sex and recombination. In contrast, the 
genetic diversity of harmful and/or competing non-cultivar fungi, as well as the 
genetic variability and potential of single fungal pathogens to evolve new 
virulence mechanisms, are maintained at high levels by both mutations and 
sexual reproduction.   
  Specialised and unspecialised non-cultivar fungi are indeed common in 
attine nests. Of those, fungi in the genus Escovopsis (Hypocreales, 
Hypocreaceae) appear to be common, virulent, and specialised. For example, 
Currie et al. (1999a) analysed the presence of non-cultivar fungi in gardens of 
201 colonies of eight attine genera, including Atta and Acromyrmex. 39.7% of 
2,480 garden pieces were infected with non-cultivar fungi, and 26.0% of the 984 
infectants belonged to the genus Escovopsis. In a study by Rodrigues et al. 
(2008), 37 nests of ten Acromyrmex species were investigated for non-cultivar 
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fungi. A total of 33 fungal species of 16 genera could be isolated from the nests; 
most prevalent were the genera Cunninghamella, Escovopsis, Fusarium, Mucor, 
Penicillium, and Trichoderma. Fusarium oxysporum and Escovopsis weberi
were the most common species, occurring in 40.5% and 27% of the nests, 
respectively. However, in contrast to Escovopsis, fungi in the genus Fusarium
can also be found outside of the symbiosis (Rodrigues et al. 2008).  
Furthermore, the virulence of Escovopsis stems from its ability to feed on 
the ant-cultivar by degrading its hyphae and obtaining its nutrients without the 
need to penetrate the fungus, making it a contact necrotroph (Reynolds and 
Currie 2004). Also, Escovopsis may overgrow cultivar gardens or form 
permanent infections. The latter have been shown to severely reduce garden 
biomass and worker production in colonies of Atta colombica (Currie 2001).  
In addition, Escovopsis seems to be horizontally transmitted; Escovopsis is 
absent from fungal inocula carried by the gynes of Atta columbica, it is also 
absent from young colonies that have not started collecting leaf-material, but it 
is present in around 60% of 1-2 year-old nests (Currie et al. 1999a). Attine nests 
therefore likely experience a constant influx of virulent and genetically variable 
Escovopsis strains. 
2.1.3 Exploitation control of non-cultivar fungi 
An array of exploitation control mechanisms has been identified that 
reduce the likelihood of successful infection by Escovopsis and other 
pathogenic and parasitic fungi. These control mechanisms include the 
separation of cultivars into distinct and remote underground nest chambers, the 
use of garden platforms to isolate initial nests from the soil (Fernández-Marín et 
al. 2007), the cleaning of contaminants from the leaf-material (Mangone and 
Currie 2007), the production of antifungals by the cultivated fungus itself (Wang 
et al. 1999), and the production of antifungal compounds by cultivar-associated 
bacteria (Santos et al. 2004, Haeder et al. 2009). These control mechanisms 
filter out many susceptible strains of non-cultivar fungi, but obviously do not 
guarantee a full protection against all non-cultivar strains and species. In 
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particular, sets of cultivar-specific Escovopsis strains seem to be able to 
generate successful infections in attine gardens. For example, Gerardo et al.
(2006) suggest that specific associations between Escovopsis strains and 
clades of the mutualistic fungus, grown by attine ant Apterostigma, can be 
explained by chemotaxic attraction and antibiotic susceptibility.  
Attine ants that obligately depend on their fungal mutualist for food should 
be selected to eliminate cultivar-specific Escovopsis strains from the nest. 
Higher attines remove and kill fungal intruders by grooming spores of non-
cultivar fungi, weeding infected garden material, applying bioactive metapleural 
gland secretions, and using antifungal secretions of cuticular bacteria. The 
prevalence of these control mechanisms differs among attine genera and 
castes. For example, the attine genera Atta and Sericomyrmex, which do not 
show any (visible) growth of cuticular bacteria, confront Escovopsis infections 
and general contaminations behaviourally and with secretions from their 
metapleural glands. Fernández-Marín et al. (2009) report increased grooming 
activities, using metapleural gland secretions, after experimental infections of 
their nest with Escovopsis. In contrast, the attine genera Acromyrmex and 
Trachymyrmex (but also diverse lower attines), use secretions of bacterial 
symbionts to target Escovopsis. They down-regulate metapleural gland 
grooming and up-regulate bacterial coverages after experimental nest infections 
with Escovopsis (Fernández-Marín et al. 2009). 
The behavioural and chemical defence strategies of Acromyrmex ants are 
caste-specific (Poulsen et al. 2002). Older major workers collect plant material; 
minor workers and young major workers tend the garden, care for the brood, 
and prepare the leaf-material collected by older nestmates. The fungal gardens 
are structured by the degradation status of the plant material into a top part, 
containing the highest proportion of plant material and unspecialised infectants, 
and a bottom part containing the highest proportion of cultivar biomass and 
Escovopsis parasites. With their relatively large metapleural glands, minor 
workers at the top limit the influx of non-cultivar fungi on the fresh leaf-material. 
Metapleural gland secretions of Acromyrmex octospinosus contain a chemical 
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cocktail that has broad-spectrum bioactivity (Ortius-Lechner et al. 2000). 
Interestingly, although the metapleural gland secretions do not harm Escovopsis
hyphae, the secretions do kill its spores (Bot et al. 2002). Thus, minor workers 
can provide some defence against the specialist parasite Escovopsis as long as 
it enters nests in its spore stage. In contrast, young major workers at the bottom 
do not possess such large metapleural glands but do maintain a high 
abundance of cuticular bacteria, whose antifungal secretions kill Escovopsis
even in hyphal state (e.g. Currie et al. 1999b, Currie et al. 2003, Kost et al. 
2007, Haeder et al. 2009, Oh. et al. 2009, Sen et al. 2009, Barke et al. 2010). 
One of the still unresolved fundamental questions regarding this three-part 
mutualism is what the identity and composition of the bacterial symbionts is. 
From 1999 onwards, numerous papers, mainly published by Cameron Currie 
and colleagues (e.g. Currie et al. 1999b), propagated the view that single attine 
colonies symbiotically associate with single lineages of bacteria in the genus 
Pseudonocardia (Actinomycetales, Pseudonocardiaceae) (N. B. papers of 
Currie et al. published in 1999-2003 referred to the genus Streptomyces; this 
was later corrected by the authors to Pseudonocardia, Currie et al. 2003). In 
return for antifungals, the bacteria benefit from nutrients via secretions from 
gland cell-associated tubercles (Currie et al. 2006). In this scenario, vertical 
transmission leads to host-symbiont coevolution, in which the fitness of both are 
highest if bacterial antifungals kill current Escovopsis attackers; to retain 
antifungal efficacy and ensure long-term fungicultural successes, the bacterial 
metabolites provided to the host, must show structural innovations to meet 
reduced parasite resistances (Currie et al. 1999b, Currie et al. 2003). 
More recently, attine colonies have been found to associate with bacterial 
communities, including diverse actinobacteria, rather than to associate with 
single Pseudonocardia lineages. In the above view, the newly discovered 
ectosymbionts would be described as contaminants rather than beneficial 
symbionts. In order to refute this assumption, it needs to be demonstrated that 
associations to non-Pseudonocardia strains are common and that their 
antifungals kill Escovopsis  also in the field. To date, Gram-positive 
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Pseudonocardia, Streptomyces (Actinomycetales, Streptomycetaceae), and 
Amycolatopsis (Actinomycetales, Pseudonocardiaceae) bacteria have been 
isolated from attine ants (Currie et al. 1999b, Currie et al. 2003, Kost et al. 2007, 
Haeder et al. 2009, Oh. et al. 2009, Sen et al. 2009, Barke et al. 2010). Also, 
Gram-positive Streptomyces and Gram-negative Burkholderia (Burkholderiales, 
Burkholderiaceae) bacteria have been isolated from attine cultivars (Santos et 
al. 2004, Haeder et al. 2009). However, non-actinobacteria have been largely 
neglected in favour of Pseudonocardia- and Streptomyces-like actinobacteria 
that are well-known for their capability to produce novel drugs (Miyadoh 1993).  
Non-Pseudonocardia actinobacterial symbionts have been shown to 
produce antifungals that inhibit Escovopsis (Kost et al. 2007, Haeder et al. 2009, 
Sen et al. 2009, Barke et al. 2010). For example, Sen et al. (2009) tested ten 
Pseudonocardia and two Amycolatopsis strains, isolated from the attine genera 
Trachymyrmex, Cyphomyrmex, and Mycocepurus, against 23 fungal strains. 
The fungal opponents included saprotrophs (e.g. Cyphellophora), endophytes 
(e.g. Alternaria), entomopathogens (e.g. Beauveria), fungal cultivars (i.e. 
Leucocoprinus), and nest parasites (i.e. Escovopsis). The bacterial strains 
inhibited 56.3-72.7% of the test fungi, including the fungal mutualists and 
Escovopsis parasites, indicating a secretion of metabolites with broad-spectrum 
antifungal properties. Because the bacterial metabolites also inhibit the growth 
of the fungal cultivar, the bacterial secretions have to be applied carefully, not to 
harm the fungal mutualist. How antifungals can be applied discretely has been 
described for Trachymyrmex zeteki (Little et al. 2006). Gram-positive bacteria 
not only occur on the integuments of T. zeteki worker ants but also in their 
infrabuccal pockets. It is unknown whether the bacterial mutualists are cultivated 
inside the infrabuccal pocket or continuously replenished from the cuticle. 
Nevertheless, this is the place where the worker ants store infected garden 
material and spores of non-cultivar fungi that they collect during grooming and 
weeding. According to the authors, the treated pocket material rarely contains 
viable Escovopsis spores. Furthermore, Schoenian et al. (2011) have reported 
the presence of Streptomyces-antifungals on the cuticles of A. echinatior. 
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Due to the discovery of bioactive bacterial communities on ants and in 
attine colonies, as described above, of nest-unassociated bacteria being able to 
inhibit Escovopsis (Kost et al. 2007), and of nest-associated and 
environmentally collected Pseudonocardia strains being phylogenetically related 
(Mueller et al. 2010, Mueller et al. 2012), integumental bacteria have been 
proposed to be environmentally recruited rather than coevolved (Barke et al.
2011, Mueller et al. 2012). Furthermore, Acromyrmex ants are even able to 
distinguish between Pseudonocardia strains of closely related Acromyrmex
species, which would allow them to exchange resident ectosymbionts (Zhang et 
al. 2007). This line of thinking suggests an alternative hypothesis of how 
resistance evolution in Escovopsis can be prevented; mixed bacterial 
communities of recruited bacteria may produce antifungal cocktails, which may 
not only target a range of non-cultivar fungi but also slow down the evolution of 
resistance in current individual fungal strains.   
2.2 Aims 
In Chapter 2, and a paper by Barke et al. (2010), experiments are 
described to test the hypothesis that antifungal cocktails of mixed bacterial 
communities allow Acromyrmex octospinosus to defend their fungal mutualist 
against non-cultivar fungi. In the chapter, the bioactive actinobacterial 
microbiome of A. octospinosus workers was investigated in a culture-dependent 
way. The recovered cuticular bacteria were genetically identified, and their 
potential as mutualists was confirmed in bioassays by challenging the bacteria 
and their growth cultures against various test fungi, including the medically 
important yeast Candida albicans and Escovopsis spp. nest parasites. In Barke 
et al. (2010), the question is examined whether the diversity of cuticular bacteria 
indeed translates into a diversity of antifungal compounds.    
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2.3 Materials and Methods 
2.3.1 Sampling host ants 
Worker ants of three Acromyrmex octospinosus colonies, A, B, and C, 
were obtained from a supplier of insects in Essex, United Kingdom 
(www.martingoss.co.uk). The ant colonies were collected near the 
Blanchisseuse Road, around 6.4 km north of Arima, Trinidad (Fig. 2.1). 
Photographs of a typical ant nest, the fungal cultivar, and a worker ant are 
shown in figure 2.2; the colour of the fungal garden is composed of white 
cultivar hyphae on a brown background of masticated leaf-material. The 
sampled colonies, including the queen, different worker castes (minor and major 
workers), and the fungal garden were transported by the supplier from Trinidad 
to the United Kingdom. There, the colonies remained in captivity for around 12 
weeks before sub-
samples of the nests 
were sent to the 
University of East Anglia 
(UEA). The sub-samples 
consisted of some 
garden material and 60, 
86, and 68 garden-associated worker ants in the three colonies respectively 
(Table 2.1). The ants were placed individually into sterile 1.5 ml Eppendorf 
tubes.  
2.3.2 Isolation of ant-associated bacteria  
Ectosymbiotic bacteria were isolated from the cuticles of the worker ants in 
a category 2 microbiological laboratory at the University of East Anglia. The 
isolations were carried out using sterile technique. For example, sensitive parts 
of the work were done in a safety cabinet or next to a Bunsen burner, equipment 
was sterilised (e.g. forceps, glass spreaders, Eppendorf tubes), and isolation 
media and liquids were autoclaved.  
Table 2.1 Acromyrmex octospinosus worker ants. 
From Martin Goss (www.martingoss.co.uk) worker 
ants of three ant colonies were purchased 
originating from Trinidad.
Sampling location Worker ants               Colony
Blanchiseusse Road, Trinidad 1-60 (60 Ants) A
Blanchiseusse Road, Trinidad 76-161 (86 Ants) B
Blanchiseusse Road, Trinidad 271-338 (68 Ants) C
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Figure 2.1 (A-C) Origin of Acromyrmex octospinosus worker ants. Three ant 
colonies (including queen, worker ants, and fungal cultivar) were collected near 
the Blanchisseuse Road, north of the city Arima, Trinidad. The colonies were 
sub-sampled in the United Kingdom for worker ants and supplied by Martin 
Goss (www.martingoss.co.uk) to the University of East Anglia. 
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The bacterial isolates were grown on hydrolysed chitin (HC) or mannitol 
soy-flour (MS) agar plates (Table 2.2). Fresh agar plates were prepared by 
enriching 100 ml batches of autoclaved medium (50 oC) with 1 ml of nystatin (5 
mg (Sigma N3503) in 1 ml dimethyl sulfoxide) and 1 ml of cycloheximide (5 mg 
(Fisher 35742-0050) in 1 ml of 100% ethanol) solutions to prevent fungal spores 
of cuticular origin from overgrowing bacterial colonies; the medium was then 
spread over four Petri dishes. The bacterial ectosymbionts were isolated from 
workers by streaking and washing. Streaking describes the transfer of cuticular 
bacteria to agar plates by scraping the ventral and dorsal sides of the ants over 
agar plates.  
Figure 2.2 Acromyrmex and Atta leaf-cutter ants. (A) Nest chamber of an 
Acromyrmex sp. field colony. (B) Fungal cultivar Leucoagaricus gongylophorus. 
(C) Acromyrmex worker ant. The integument of this worker lacks an obvious 
white coating consisting of ectosymbiotic bacteria. (D) Ant highways through a 
lawn. The paths here were built by Atta, a sister genus of Acromyrmex, to 
transport collected leaf-material back to the nest. Both ant genera use freshly 
cut plant-material for fungiculture. 
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Table 2.2 Media for cultivation of fungi and bacteria. 
Medium Ingredients
Weight (g), 
volume (ml), 
percent (%)
Hydrolysed crab shell chitin 3.0 g
Agar 20.0 g
Tap water 1000 ml
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Distilled water 1000 ml
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Agar 15.0 g
Distilled water 1000 ml
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Agar 5.0 g
Distilled water 1000 ml
Organic soy-flour 20.0 g
Mannitol 20.0 g
Agar 20.0 g
(+SB, 150mM sodium butyrate) (16.5 g)
Tap water 1000 ml
Organic soy-flour 20.0 g
Mannitol 20.0 g
(+SB, incl. 150mM sodium butyrate) (16.5 g)
Tap water 1000 ml
Glucose 20.0 g
Instant mashed potato (smash) 5.0 g
Agar 20.0 g
Distilled water 1000 ml
Dextrose 40.0 g
Peptone 10.0 g
Agar 20.0 g
Distilled water 1000 ml
Tryptone soya broth (Oxoid) 30.0 g
Distilled water 1000 ml
Yeast extract 3.0 g
Peptone 5.0 g
Malt extract 3.0 g
Glucose 10.0 g
Distilled water 1000 ml
TSB 50 %
YEME 50 %
Mannitol soy-flour (MS) broth 
Potato dextrose agar (PDA) 
Hydrolysed chitin (HC) agar
Lennox broth (LB) soft agar 
Mannitol soy-flour (MS) agar 
Lennox broth (LB) agar
Lennox broth (LB)
Sabouraud agar                            
(pH=5.6)
Yeast extract-malt extract 
(YEME)
TSB/YEME
Tryptone soya broth (TSB)
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Washing describes the transfer of ectosymbiotic bacteria into 20% of 
aqueous glycerol (2G) by placing a worker ant in 500 µl of 2G and vortexing it 
for at least 10 seconds to detach cuticular bacteria. The washes of some ants 
were diluted ten times, and 100-200 µl of the (diluted) wash were used for 
inoculating agar plates. The original wash was preserved at -20 oC. In particular, 
all of the 60 worker ants of sub-sample A were streaked; five ants with a visible 
bacterial coating were additionally washed. All 86 workers of colony B were 
washed. The wash of all samples was additionally diluted ten times. Lastly, 54 
of the 68 workers of colony C were washed, and the remainder was streaked.  
Inoculated agar plates were incubated at room temperature (21-28 oC). 
Actinobacterial morphotypes were purified from agar plates containing mixed 
bacterial communities by repeatedly picking and propagating individual colonies 
to fresh MS agar plates. The propagation plates contained the same antifungal 
concentrations as described above and were incubated at 30 oC. In total, 16 
actinobacterial lineages were purified, each of which received an individual ID, 
consisting of the prefix E and a number (2-17). These were maintained on agar 
plates (4 oC) and in glycerol.  
Bacterial glycerol stocks were prepared by transferring cell material of 
individual source colonies to equivalent MS agar plates containing nystatin and 
cycloheximide. The cell material was spread across the whole surface of the 
target plates. Then the plates were incubated at 30 oC to promote abundant 
growth and sometimes spore production. The spores of spore-producing 
bacterial lineages were collected by scrubbing the surface of the bacterial lawns 
with sterile cotton buds and 1.5 ml of 2G. Cell material was collected from 
bacterial strains that did not produce any spores. Here, the surface of the agar 
plates was scrubbed with sterile cotton buds and 1.5 ml of 2G. The glycerol 
stocks were preserved at -20 oC. 
2.3.3 Procurement of fungal symbionts 
The fungal mutualist L. gongylophorus was kindly provided by Ulrich 
Mueller from the University of Texas (www.sbs.utexas.edu/muelleru/). Several 
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Escovopsis strains were purchased from the Fungal Biodiversity Centre 
(www.cbs.knaw.nl), a culture collection in Utrecht, the Netherlands. Included 
was an Escovopsis weberi strain from a Brazilian ant nest (EWB, CBS 810.71); 
an E. weberi strain from a Colombian ant nest (EWC, CBS 110660) and an E. 
aspergilloides strain from a Trachymyrmex ruthae nest (EA, CBS 423.93). The 
fungi were maintained on MS agar, potato dextrose agar (PDA), and Sabouraud 
agar (Table 2.2). Fresh agar plates were prepared in the same way as the 
bacterial isolation plates, but the antifungals were replaced with antibacterials. 
In particular, 1 ml of filter-sterilised carbenicillin (5 mg (Fisher BPE2648-5) in 1 
ml dH2O) and 1 ml of filter-sterilised streptomycin (5 mg (Fisher BPE910-50) in 1 
ml dH2O) solutions were added to 100 ml of medium. The medium was either 
equally sub-divided over four Petri dishes for short-term cultivation purposes or 
added to Bijouxs for long-term storage of the fungal strains. Bijouxs are plastic 
containers enclosed by screw caps; due to their cylindrical shape, the agar can 
form slopes offering increased surface areas for fungal growth. Agar plates and 
Bijouxs were inoculated by transferring fungal hyphae from source plates; the 
fungal inocula were grown at room temperature or at 30 oC.  
2.3.4 Light microscopy  
Stereomicroscope photographs of the bacterial isolates and fungal strains 
were taken in the Henry Wellcome Laboratory for Cell Imaging 
(www.uea.ac.uk/bio/biobmi) with a Zeiss SV11 M2 Bio Quad stereomicroscope 
and an AxioCam HRc CCD camera. To keep the entire surface of the bacterial 
colonies in focus, young and thus mostly flat colonies were used. Nonetheless, 
magnifications were adjusted to suit the size differences between bacterial 
species. Photographs of the bacterial colonies and fungal hyphae were taken at 
magnifications of 2.0, 3.2, 4.0, 5.0, and 6.6X. Scale bars of 1-2 mm were added 
to the pictures with AxioVision software (Carl Zeiss, Welwyn Garden City, UK).  
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2.3.5 Extraction of genomic DNA  
DNA was extracted from fungal and bacterial samples for genetic 
identification. The DNA of L. gongylophorus and Escovopsis EWB, EWC, and 
EA were extracted from the fungal hyphae (Table 2.3). A loop of hyphal material 
was added to Eppendorf tubes, containing glass beads and 800 µl of ice-cold 
TGE buffer (Table 2.4). Also, DNA was extracted from growth cultures of the 
bacterial isolates E2-E17 (Table 2.3).  
The cultures were obtained by growing the bacteria in closed-up glass 
containers (universals) containing 10 ml liquid TSB/YEME (Table 2.2). The 
universals also contained springs to prevent cell clustering and to increase the 
oxygen concentration of the medium. The medium was either inoculated with 50 
µl of the glycerol stocks or with a toothpick tip full of bacterial cells of single 
source colonies. The universals were grown overnight in a shaker incubator 
(200 rpm, 30 oC), and cells were harvested by centrifugation (4000 rpm, 5 
minutes, 4 oC). After discarding the supernatants, the pellets were re-suspended 
in 800 µl of ice-cold TGE buffer. The solutions were placed into 2.0 ml 
Eppendorf tubes containing a small layer of glass beads.  
Table 2.3 Origin of fungal and bacterial symbionts.  
Sample type Name Sample origin Host type Host colony Host ant
Fungal cultivar L. gongylophorus Ulrich Mueller (University of Texas) - - -
Non-cultivar fungus E. weberi EWB (CBS810.71) CBS Fungal Biodiversity Center - - -
Non-cultivar fungus E. weberi EWC (CBS110660) CBS Fungal Biodiversity Center - - -
Non-cultivar fungus E. aspergilloides EA (CBS423.93) CBS Fungal Biodiversity Center - - -
Bacterial isolate E2 Blanchiseusse Road, Trinidad Worker ant C 328
Bacterial isolate E3 Blanchiseusse Road, Trinidad Worker ant A 41
Bacterial isolate E4 Blanchiseusse Road, Trinidad Worker ant C 308
Bacterial isolate E5 Blanchiseusse Road, Trinidad Worker ant C 315
Bacterial isolate E6 Blanchiseusse Road, Trinidad Worker ant C 315
Bacterial isolate E7 Blanchiseusse Road, Trinidad Worker ant C 311
Bacterial isolate E8 Blanchiseusse Road, Trinidad Worker ant C 319
Bacterial isolate E9 Blanchiseusse Road, Trinidad Worker ant B 126
Bacterial isolate E10 Blanchiseusse Road, Trinidad Worker ant C 315
Bacterial isolate E11 Blanchiseusse Road, Trinidad Worker ant B 119
Bacterial isolate E12 Blanchiseusse Road, Trinidad Worker ant B 84
Bacterial isolate E13 Blanchiseusse Road, Trinidad Worker ant A 18
Bacterial isolate E14 Blanchiseusse Road, Trinidad Worker ant C 308
Bacterial isolate E15 Blanchiseusse Road, Trinidad Worker ant C 329
Bacterial isolate E16 Blanchiseusse Road, Trinidad Worker ant C 320
Bacterial isolate E17 Blanchiseusse Road, Trinidad Worker ant B 109
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Fungal and bacterial samples were bead-beaten (6x30 seconds, 6 m/s). 
Before, during, and after bead-beating sessions, the samples were stored on ice 
for a minimum of 5 minutes, which is expected to reduce DNA degradation due 
to overheating and DNase activity. The solid remains in the samples were then 
separated from the DNA containing supernatants in a benchtop centrifuge 
(13,200 rpm, 1 minute). The supernatants were transferred to fresh 1.5 ml 
Eppendorf tubes and 0.5 ml of phenol:chloroform:isoamyl alcohol (25:24:1) were 
added. Then the tubes were vortexed for 1 minute and centrifuged (13,200 rpm, 
5 minutes) to separate the aqueous supernatant from the phenol-chloroform. 
The upper (aqueous) layer was transferred to fresh microcentrifuge tubes. The 
washing procedure was repeated until the aqueous layer and phase boundary 
were clear and thus free of proteins. Depending on the expected DNA 
concentration, the purified supernatants were either washed one time with 0.5 
ml chloroform:isoamyl alcohol (24:1), to remove phenol traces, or were ethanol 
precipitated. For ethanol precipitation, 1 ml of 100% ethanol was added to the 
cleaned supernatant and mixed by inverting the tube several times. The DNA 
was then pelleted in a benchtop centrifuge (13,200 rpm, 5 minutes). The DNA 
pellet was washed a second time with 200 l of 70% ethanol. The ethanol was 
again removed by repeated centrifugation (13,200 rpm, 2 minutes), and the tube 
was left for several minutes in the safety cabinet for a final drying step. Then the 
dry DNA pellet was re-suspended in 50 l of sterile dH2O. 
Table 2.4 Solutions for DNA extractions and gel electrophoresis. 
Solution Ingredients Volume (µl), concentration (mM)
Tris Base 90 mM
Boric Acid 90 mM
EDTA 2 mM
Tris 50 mM
EDTA 10 mM
Ladder Invitrogen (Cat.No.15615-016) 100 µl
Dye 200 µl
Distilled water 700 µl
Tris/Borate/EDTA (TBE) buffer 
1 kb DNA ladder
Tris/Glycine/EDTA (TGE) buffer 
(pH=8.0)
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2.3.6 Amplification and purification of diagnostic genes 
The fungal and bacterial DNA extracts were used for the amplification of 
diagnostic genes by polymerase chain reaction (PCR). The sample-specific 
reaction mixtures and thermocycles are presented in table 2.5. Fragments of the 
fungal (ITS region) and bacterial (16S SSU) rDNA genes were amplified using 
the primer sets ITS1-FITS4 and 5151492, respectively (Table 2.6). The PCR 
reactions were analysed by running 5 µl sub-samples on diagnostic 
electrophoresis gels, containing agarose, Tris/Borate/EDTA (TBE) buffer (Table 
2.4), and ethidium bromide. The PCR products were separated at 100 V; the 
quality (band strength) and correctness (band position) of the amplicons were 
compared under UV light to a 1 kb ladder (Table 2.4).  
Polymerase chain reactions can result in the amplification of multiple 
genes, and hence reaction mixtures may contain a variety of amplicons. 
Amplicons with the correct sizes were selectively recovered from the reactions 
by separating the remainder of the reaction mixtures (35 µl) on purification 
agarose gels. Under low UV light conditions, amplicons with the correct lengths 
were cut out of the gel and placed individually into Eppendorf tubes. 500 µl of 
QG buffer from the Qiagen Gel Extraction Kit (www.qiagen.com) were added to 
the tubes, which then were incubated at 50 oC for 10 minutes to completely 
dissolve the agarose and release the DNA. 200 µl of isopropanol was added to 
the mixture. Then the DNA was loaded on a QIAGEN QIAquick spin column.  
Table 2.5 (A-B) PCR mixture and thermocycles for the partial 
amplification of fungal (ITS region) and bacterial (16S SSU) rDNA 
genes. 
A B
PCR mixture Volume
dH2O 23.0 µl
GoTaq buffer (incl. loading buffer) 8.0 µl
GoTaq MgCl (25 mM) 2.4 µl
DMSO (100%) 2.0 µl
Bioline dNTP's (10 mM) 1.0 µl
Forward primer (25 µM) 1.0 µl
Reverse primer (25 µM) 1.0 µl
DNA 1.0 µl
GoTag polymerase 0.6 µl
Total 40.0 µl
Temperature Minutes Temperature Minutes
1 94 oC 4:00 94 oC 12:00
2 95 oC 0:30 94 oC 1:00
3 53 oC 1:00 45 oC 0:45
4 72 oC 1:00 72 oC 1:30
5
6 72 oC 10:00 72 oC 20:00
7 end end
Go 34x to step 2 
Fungi BacteriaStep
Go 29x to step 2 
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The filter bound DNA was washed with 0.5 ml QG buffer and 0.75 ml PE 
buffer to remove traces of agarose and salts from the DNA, respectively. The 
PE buffer was then removed completely by repeated centrifugation and the DNA 
was eluted from the filter with 30 l of EB buffer.   
2.3.7 Sequencing and BLAST-matching  
The purified amplicons were sequenced with the sample-specific forward 
primers, ITS1-F and 515, under conditions presented in table 2.7. The 
sequenced PCR products were analysed by The Genome Analysis Centre 
TGAC (www.jicgenomelab.co.uk) using ABI 3730XL sequencers (Life 
Technologies). The sequences were quality-checked and truncated with 
FinchTV (www.geospiza.com/Products/finchtv.shtml). Then the reads were 
matched to the BLAST database of the National Center for Biotechnology 
Information (NCBI, http://blast.ncbi.nlm.nih.gov/Blast.cgi). In particular, the 
BLASTn search compared the sample reads to database sequences in the 
Table 2.6 Primer sets for the partial amplification of fungal (ITS region) and 
bacterial (16S SSU) rDNA genes. 
Name Sequence Reference Gene Amplicon length
ITS1-F 5'-CTTGGTCATTTAGAGGAAGTAA-3' Gardens and Bruns (1993)
ITS4 5'-TCCTCCGCTTATTGATATGC-3' White et al . (1990)
515 5'-GTGCCAGCMGCCGCGGTAA-3' Turner et al.  (1999)
1492 5'-GGTTACCTTGTTACGACTT-3' Turner et al. (1999)
18S rDNA ± 600 bp
16S rDNA ± 1000 bp
Table 2.7 (A-B) Reaction mixture and thermocycles for the 
sequencing of PCR amplicons. 
A B
Sequencing mixture Volume
dH2O 5.5 µl
5x sequencing buffer 1.5 µl
Forward primer (3.2 µM) 1.0 µl
DNA 1.0 µl
Enzyme E3.1 1.0 µl
Total 10.0 µl
Step Temperature Minutes
1 96 oC 1:00
2 96 oC 0:10
3 50 oC 0:05
4 60 oC 4:00
5
6 60 oC 0:10
7 end
Go 25x to step 2
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nucleotide collection (nr/nt), optimising for highly similar sequences (megablast).     
2.3.8 Colony bioassays  
A selection of twelve actinobacterial isolates (E2-E4, E6, E8-E15) was tested 
with colony bioassays against Candida albicans (CA6, Table 3.2) and 
Escovopsis spp. (EWB, EWC, EA). The selected bacteria all belong to genera 
that are well-known for their antibiotic production, and will henceforth be referred 
to as NNSPS strains. This acronym is based on the initial letters of the genera 
Nocardia, Nocardiopsis, Streptomyces, Pseudonocardia, and 
Saccharopolyspora (Nocardia and Saccharopolyspora were isolated in Chapters 
4 and 5 from Allomerus and Tetraponera, respectively).   
2.3.8.1 Bioassays against Candida  
The NNSPS strains were challenged in colony bioassays against Candida 
CA6, which was kindly provided by Neil Gow from the University of Aberdeen, 
United Kingdom. The yeast was maintained on agar plates containing 
carbenicillin- and streptomycin-enriched Lennox broth (LB) agar (Table 2.2), as 
described for the media of the filamentous fungi.  
Universals containing 10 ml of TSB/YEME and a spring were inoculated 
with 30 µl of the bacterial glycerol stocks. The cultures were grown on a shaker 
incubator for the accumulation of sufficient biomass (280 rpm, 30 oC). The 
length of the incubation period was strain-specific since some strains (i.e. 
Pseudonocardia) grew more slowly. The cell material was harvested by 
centrifugation (4000 rpm, 5 min) and the supernatant was removed. To 
investigate the effect of sodium butyrate on the production of bioactive 
metabolites, the bacteria were grown on two sets of MS agar plates containing 
no antibiotics. The medium of one set was enriched with 150 mM of sodium 
butyrate; the medium of the other set did not contain the additive. A 
standardised inoculum of the bacterial cell pellet was point-inoculated into the 
centre of the bioassay plates and incubated for thirteen days at 21 oC. 
Uninoculated agar plates and dishes with Streptomyces lividans colonies, with 
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and without sodium butyrate, served as a negative control. One day before the 
plates were due to be overlaid with Candida, Candida was grown in universals 
containing 10 ml of Lennox broth and incubated in a shaker incubator at 37 oC 
(280 rpm) (Table 2.2).  
In order to overlay the bioassay plates, which were pre-warmed to 30 oC, 1 
ml of the Candida culture was added to universals containing 5 ml of Lennox 
broth (LB) soft agar (50 oC, Table 2.2). The soft agar was poured over the 
bioassay plates and contacted the bacterial colonies but was never poured over 
colonies to prevent the spread of bacterial cells and the growth of daughter 
colonies. The agar plates were incubated for 2 days at 26 oC to give Candida
sufficient time for growing and developing a whitish appearance, which 
facilitated scoring the presence or absence of inhibition zones via contrasts with 
the brown colour of the medium. Inhibition zones are characterised by the lack 
of fungal growth around bacterial colonies, due to the presence of bacterial 
antifungals in the surrounding medium. 
2.3.8.2 Bioassays against Escovopsis EA, EWB, EWC   
The selected bacteria were also tested against Escovopsis spp. (EA, EWB, 
EWC). For the bioassays, 100 ml of TSB/YEME were inoculated with 50 µl from 
the bacterial glycerol stocks. The flasks were incubated in a shaker incubator to 
accumulate sufficient biomass (180 rpm, 30 oC). As mentioned above, some 
strains grew more slowly than others and therefore strain-specific incubation 
periods were used. The cells were harvested by centrifugation (5 minutes, 4000 
rpm, 4 oC), and supernatants were discarded. Standardised fractions of the cell 
pellets were point-inoculated to the centre of MS agar plates, containing no 
antibiotics (and no sodium butyrate). The plates were incubated for 10-14 days 
at 21 oC. When the bacterial colonies grew to an average diameter of 1.3 cm 
(0.9-1.8 cm), Escovopsis was introduced at the edge of the bioassay plates; 
negative control plates, not containing any bacteria, were also inoculated with 
hyphal material. The plates were incubated at 21 oC. Under a stereomicroscope, 
the distance between the fungal growth front and the bacterial colony was 
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measured (test plates), or between the fungal opponent and the centre of 
control plates. The distances were measured every second day for a maximum 
of 22 days. Bioassays against EWB and EWC numbered 6-12 replicates and 
those against EA numbered 3-15 replicates.  
2.3.9 Supernatant bioassays  
Candida CA6 and Escovopsis EWC were also challenged against culture 
supernatants of the NNSPS strains (E2-E4, E6, E8-E15). Supernatant bioassays 
were conducted to discover whether the bacteria secrete their antifungals into a 
liquid environment.  
2.3.9.1 Obtaining supernatants    
Mannitol soy-flour (MS) broth (Table 2.2) was used as liquid environment 
to test antifungal production. The bacterial isolates were grown in flasks 
containing a spring and 50 ml of MS broth. The flasks were inoculated with 30 µl 
from the bacterial glycerol stocks. As negative controls, one flask remained 
uninoculated, and another flask was inoculated with spores of S. lividans. The 
experiment was carried out in duplicate with one set of growth media containing 
150 mM of sodium butyrate and the other set without. Inoculated flasks were 
incubated in a shaker incubator for 14 days (30 oC, 250 rpm). Possibly due to 
the small inoculation volume (and/or low spore/cell concentrations in the 
glycerol stocks), a longer incubation period was needed to accumulate bacterial 
cells and sometimes observe a colour change. The supernatants were 
harvested by centrifuging out much of the cell material and insoluble medium 
(30 minutes, 4000 rpm, 4 oC). After this treatment, the supernatants of the 
coloured growth cultures retained their colouration, which can possibly be 
attributed to secreted (non)bioactive metabolites. For carrying out bioassays, 
small sub-samples of the supernatants were centrifuged a second time with a 
benchtop centrifuge (5 minutes, 13,200 rpm). The supernatants were then filter-
sterilised with 0.2 µm filters.  
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2.3.9.2 Bioassays against Candida  
The sterile supernatants, with and without sodium butyrate, were tested 
against Candida CA6. Two sets of paper filter disks, with a diameter of 0.9 cm, 
were each inoculated with 100 µl from the supernatants and the negative control 
liquids. Sterile Petri dishes containing LB agar were coated with 400 µl of a one-
day-old C. albicans culture, grown in 10 ml of Lennox broth at 37 oC. When the 
disks and plates were dry, the filters were attached to the Candida lawn with 60 
µl of dH2O. The presence or absence of inhibition zones was scored after the 
plates were incubated at 26 oC for two days.   
2.3.9.3 Bioassays against Escovopsis EWC   
The same sterile growth supernatants, lacking sodium butyrate and 
previously being bioassayed against Candida, were tested here against 
Escovopsis EWC. As a negative control, the corresponding supernatant from an 
uninoculated batch of MS broth was used. Paper filter disks, with a diameter of 
4 cm, were loaded each with 2 ml of the supernatants. Compared to the smaller 
filter disks for the Candida bioassays, comparably large filter disks were used 
for the bioassays against Escovopsis, since size had to be adjusted to account 
for the length of the hyphae of the filamentous fungus. With 200 µl of dH2O, the 
dry disks were attached to MS agar plates, containing no antibiotics. Thereafter, 
the fungal strains were introduced by transferring a standardised inoculum of 
hyphal material to the edge of the bioassay plates. The plates were incubated at 
26 oC until the filter disks were either contacted by the fungi or clearly avoided.  
2.4 Results 
2.4.1 Isolation and microscopy of ant-associated bacteria  
The bioactive bacterial microbiome of Acromyrmex worker ants was 
studied in a culture-dependent way by isolating ectosymbiotic bacteria from the 
cuticles of worker ants. The workers originated from three ant colonies (A, B, C), 
collected in Trinidad, and imported to the United Kingdom. Sub-samples of 
these colonies were sent to the UEA around 12 weeks post-collection. The sub-
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samples contained 60, 86, and 68 worker ants and some garden cultivar. The 
reason for using workers from the cultivar garden was to increase the likelihood 
for young major workers with abundant cuticular bacteria. The ectosymbiotic 
bacteria were removed from the cuticles of the individuals by washing and 
streaking. The majority (65%) of the 214 worker ants was washed in 2G. 
Because microbial cultures were not obviously dense on the cuticle, the wash of 
most ants was used undiluted for inoculations of HC and MS agar plates; only a 
fraction of the washes (86 out of 140 washes) was additionally diluted ten times. 
Ectosymbiotic bacteria from the remaining 35% of the 214 workers were 
isolated by streaking their ventral and dorsal sides over agar plates with the 
same media. The nutrient content of the media was chosen to be low in order to 
decrease the likelihood of fast-growing bacteria out-competing and/or inhibiting 
the growth of slow-growing ones, thereby increasing plate biodiversity.  
Most, if not all, isolation plates harboured a community of bacteria, 
including Gram-positive and Gram-negative morphotypes. Actinobacteria were 
isolated from the mixed bacterial communities by repeated propagation of single 
colonies to fresh MS agar plates. This medium was chosen because 
morphotypes in general were less distinguishable on HC than on MS agar. The 
focus was placed on actinobacteria due to their well-known association with 
attine ants and because this taxon contains many antibiotic-producing bacterial 
genera. Due to the qualitative character of the isolation method, morphotypes 
were not selected twice. Therefore, no conclusions can be made about the 
distribution and abundance of individual strains on the cuticles of the worker 
ants. Furthermore, bacterial species may be lost on isolation plates due to the 
culturing conditions, such as temperature, humidity, and ingredients of the 
isolation media. The purified bacterial lineages were preserved in 2G. Not all 
actinobacterial isolates produced spores, even after extended incubation times. 
Hence, glycerol stocks contained both spores of spore-producing lineages and 
cell material of strains that did not produce spores. Due to their role in the 
bacterial reproduction, spores are more resistant to environmental stresses than 
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regular cells and thus are expected to be more suitable for long-term storage in 
glycerol; however, cell survival was checked regularly. 
Sixteen bacterial morphotypes (E2-E17) were purified from the isolation 
plates. Figure 2.3 shows stereomicroscope photographs of the bacterial 
isolates. The secondary metabolites of some bacteria accumulated as 
transparent or coloured droplets on the colony surface.  
2.4.2 Procurement and microscopy of fungal symbionts 
The fungal parasites were obtained from ant colonies other than the ones 
used for the bacterial isolations. The garden material of colonies A-C, obtained 
along with the worker ants, was plated out on agar plates containing different 
fungal isolation media (data not shown). The agar plates were then screened for 
Escovopsis; however, other non-cultivar fungi rapidly overgrew the fungal 
inocula instead. Hence, Escovopsis was obtained from the Fungal Biodiversity 
Centre. The same Escovopsis strains were also used by Kost et al. (2007), CBS 
810.71, Schoenian et al. (2011), CBS 110660, and Haeder et al. (2009), CBS 
110660 and CBS 423.93, to carry out fungal bioassays.  
The Escovopsis strains originated from different attine genera and 
geographical distributions. In particular, Escovopsis weberi EWB and EWC were 
isolated from attine nests (genus not identified) in Brazil and Colombia, 
respectively; E. aspergilloides (EA) was isolated from a Trachymyrmex nest. 
Multiple Escovopsis strains were chosen to account for the possibility that attine 
ants may maximise their bacterial defence by continuously adjusting their 
symbionts to changing cultivar specific Escovopsis invaders. In this case, 
bioassay challenges between bacterial symbionts and alien Escovopsis strains 
could lead to suboptimal matches in antifungal effectiveness and fungal 
susceptibility. In other words, testing bacterial symbionts against various (nest-
unrelated) Escovopsis strains may increase the likelihood of finding a 
susceptible strain. On MS agar, Escovopsis EWC and EA showed consistent 
and dense growth patterns; in contrast, Escovopsis EWB often grew patchily. 
The fungal cultivar L. gongylophorus was obtained from Ulrich Mueller.  
Chapter 2) Acromyrmex octospinosus ant-associated bacteria
41
Figure 2.3 Microscopy photographs of 16 bacterial isolates (E2-E17). The 
bacteria were isolated from the cuticles of Acromyrmex octospinosus worker 
ants and belong to the actinobacterial genera Streptomyces (E2, E6, E8, E9, E10, 
E13, E14, E15), Pseudonocardia (E4, E12), Nocardiopsis (E5, E11, E16, E17), and 
Tsukamurella (E7). Despite of morphologically resembling Streptomyces, strain 
E3 genetically matches Streptomyces and Nocardia sequences of the NCBI 
database. An overview of the bacterial origin and details on their genetic identity 
are provided in tables 2.3 and 2.8, respectively. A selection (NNSPS strains) of 
twelve bacteria (E2-E4, E6, E8-E15), belonging to antibiotic-producing genera, are 
bioassayed against various test fungi.  
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Stereomicroscope pictures of Escovopsis and a regular photograph of the 
fungal cultivar are shown in figure 2.4. 
2.4.3 Amplification, purification, sequencing, and BLAST-matching of 
diagnostic genes from genomic DNA extracts 
Genomic DNA was extracted from the fungal mutualist (L. gongylophorus), 
the fungal parasites (Escovopsis EWB, EWC, EA), and the bacterial isolates 
(E2-E17) (Table 2.3). The ITS region of the fungal rDNA gene was sequenced 
Figure 2.4 Fungal symbionts of attine ants. (A-C) Fungal 
parasites obtained from the Fungal Biodiversity Centre 
(www.cbs.knaw.nl). In sequence, the pictures show 
Escovopsis weberi (EWB) from a Brazilian ant nest, 
Escovopsis weberi (EWC) from a Colombian ant nests, and 
Escovopsis aspergilloides (EA) from a Trachymyrmex ruthae
nest. Escovopsis is known to feed on the hyphae of the fungal 
cultivar. (D) The Acromyrmex ant-associated fungal cultivar 
Leucoagaricus gongylophorus, provided by Ulrich Mueller from 
the University of Texas. An overview on the fungal origin, and 
details on their genetic identity, is provided in tables 2.3 and 
2.8.
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partially. The ITS sequence of L. gongylophorus is 280 bp in length and shows 
BLAST analogies with L. gongylophorus (AY642813, Table 2.8). The ITS reads 
of Escovopsis EWB, EWC, and EA are respectively 604 bp, 593 bp, and 613 bp 
in length. The sequences of both E. weberi strains match Escovopsis
(FJ948131, Table 2.8). In contrast, the one of E. aspergilloides matches a 
Trametes trogii entry (HM989941, Table 2.8), which might be explained by a 
limitation of corresponding sequences in the NCBI database. The 
Supplementary Information A1 provides a detailed listing of the sequencing data.  
In addition, a fragment of the 16S rDNA gene was sequenced from the 
genomes of the bacterial isolates. The bacterial sequences are on average 750 
bp (608-897 bp) in length. Based on NCBI database searches, the strains can 
be sub-divided into four actinobacterial genera including Nocardiopsis, 
Pseudonocardia, Streptomyces, and Tsukamurella. Strains E2, E6, E8, E9, E10, 
E13, E14, and E15 match Streptomyces; the sequence of strain E3 relates to 
database entries of both Streptomyces and Nocardia (but morphologically 
resembles Streptomyces), strains E4 and E12 are in the genus Pseudonocardia; 
strains E5, E11, E16, and E17 belong to a group of Nocardiopsis bacteria; and E7
is a Tsukamurella strain (accession nos. in Table 2.8). It is interesting to note 
that, in contrast with the vertically transmitted ant-associate Pseudonocardia, 
bacterial morphotypes in the genus Streptomyces are more numerous and also 
can be isolated from all of the ant colonies (A-C). A detailed listing of the 
sequencing data is shown in the Supplementary Information A1. 
2.4.4 Colony bioassays  
Streptomyces E2, E3, E6, E8, E9, E10, E13, E14, and E15; Pseudonocardia E4
and E12; and Nocardiopsis E11 (NNSPS strains) were tested for their ability to 
inhibit the medically important yeast Candida CA6 and nest parasites 
Escovopsis EWB, EWC, and EA. 
Table 2.8 Genetic identity of fungal and bacterial symbionts. Details on their origin and an overview of the sequencing data are 
presented in table 2.3 and in the Supplementary Information A1, respectively. 
Sample type Name PCR                     primers
Sequencing 
primer
Sequence 
length Genus Closest relative (accession)
Max 
score
Total 
score
Query 
coverage E value
Max 
ident
Fungal cultivar L. gongylophorus ITS1-FITS4 ITS1-F 280 bp Leucoagaricus Leucoagaricus gongylophorus isolate I internal transcribed spacer 1, partial sequence (AY642813.1) 496 496 100% 4.00E-137 98%
Non-cultivar fungus E. weberi EWB ITS1-FITS4 ITS1-F 604 bp Escovopsis Escovopsis  sp. TF2CWG 18S ribosomal RNA gene, partial sequence (FJ948131.1) 702 702 100% 0 88%
Non-cultivar fungus E. weberi EWC ITS1-FITS4 ITS1-F 593 bp Escovopsis Escovopsis  sp. TF2CWG 18S ribosomal RNA gene, partial sequence (FJ948131.1) 695 695 100% 0 88%
Non-cultivar fungus E. aspergilloides EA ITS1-FITS4 ITS1-F 613 bp Trametes Trametes trogii  isolate TEM H2 18S ribosomal RNA gene, partial sequence (HM989941.1) 1127 1127 100% 0 99%
Bacterial isolate E2 5151492 515 750 bp Streptomyces Streptomyces  sp. S1(2010) 16S ribosomal RNA gene, partial sequence (HM179225.1) 1386 1386 100% 0 100%
Streptomyces Streptomyces  sp. SA36 16S ribosomal RNA gene, partial sequence (GU294698.1) 1308 1308 100% 0 100%
Nocardia Nocardia  sp. JJE-2 16S ribosomal RNA gene, partial sequence (GU132484.1) 1308 1308 100% 0 100%
Bacterial isolate E4 5151492 515 707 bp Pseudonocardia Pseudonocardia  sp. P1(2010) 16S ribosomal RNA gene, partial sequence (HM179227.1) 1306 1306 100% 0 100%
Bacterial isolate E5 5151492 515 608 bp Nocardiopsis Nocardiopsis sp. JJF-6 16S ribosomal RNA gene, partial sequence (GU132509.1) 1118 1118 100% 0 99%
Bacterial isolate E6 5151492 515 725 bp Streptomyces Streptomyces  sp. S3(2010) 16S ribosomal RNA gene, partial sequence (HM179228.1) 1339 1339 100% 0 100%
Bacterial isolate E7 5151492 515 762 bp Tsukamurella Tsukamurella  sp. C35 16S ribosomal RNA gene, partial sequence (GU183394.1) 1408 1408 100% 0 100%
Bacterial isolate E8 5151492 515 830 bp Streptomyces Streptomyces  sp. S4(2010) 16S ribosomal RNA gene, partial sequence (HM179229.1) 1533 1533 100% 0 100%
Bacterial isolate E9 5151492 515 760 bp Streptomyces Streptomyces  sp. FXJ8.036 16S ribosomal RNA gene, partial sequence (HQ622492.1) 1404 1404 100% 0 100%
Bacterial isolate E10 5151492 515 697 bp Streptomyces Streptomyces  sp. FXJ8.063 16S ribosomal RNA gene, partial sequence (HQ622509.1) 1288 1288 100% 0 100%
Bacterial isolate E11 5151492 515 701 bp Nocardiopsis Nocardiopsis  sp. SA6 16S ribosomal RNA gene, partial sequence (GU997639.1) 1295 1295 100% 0 100%
Bacterial isolate E12 5151492 515 825 bp Pseudonocardia Pseudonocardia  sp. P2(2010) 16S ribosomal RNA gene, partial sequence (HM179232.1) 1524 1524 100% 0 100%
Bacterial isolate E13 5151492 515 780 bp Streptomyces Streptomyces  sp. S7(2010) 16S ribosomal RNA gene, partial sequence (HM179233.1) 1441 1441 100% 0 100%
Bacterial isolate E14 5151492 515 656 bp Streptomyces Streptomyces  sp. BK166 partial 16S rRNA gene, strain BK166 (FR692106.1) 1212 1212 100% 0 100%
Bacterial isolate E15 5151492 515 783 bp Streptomyces Streptomyces sp. S9(2010) 16S ribosomal RNA gene, partial sequence (HM179235.1) 1447 1447 100% 0 100%
Bacterial isolate E16 5151492 515 897 bp Nocardiopsis Nocardiopsis sp. 13634A 16S ribosomal RNA gene, partial sequence (EU741113.1) 1652 1652 100% 0 99%
Bacterial isolate E17 5151492 515 817 bp Nocardiopsis Nocardiopsis  sp. JJF-6 16S ribosomal RNA gene, partial sequence (GU132509.1) 1509 1509 100% 0 100%
E3 Bacterial isolate 708 bp5155151492
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2.4.4.1 Bioassays against Candida  
The NNSPS isolates were challenged against Candida CA6 on agar plates 
that were or were not enriched with (150 mM) sodium butyrate; these were 
overlaid with soft agar containing the yeast. Streptomyces E8, E9, and E6
produced secondary metabolites that inhibited Candida on agar plates without 
sodium butyrate (Fig. 2.5A). Streptomyces E8 and E9, and Pseudonocardia E4, 
inhibited Candida on sodium butyrate-containing agar plates (Fig. 2.5B). The 
results indicate that only a minority of bacterial isolates is able to inhibit the 
growth of Candida in vitro, and confirm that sodium butyrate can stimulate 
antifungal production in certain bacteria (i.e. E4). It is possible that using a lower 
concentration of sodium butyrate might have more effectively stimulated 
antifungal production by the other bacterial strains because the concentration 
used seemed to prevent Streptomyces E6 from growing and producing bioactive 
metabolites. 
2.4.4.2 Bioassays against Escovopsis  
The NNSPS strains were also tested on agar plates against Escovopsis
spp. (EWB, EWC, EA). The time-series graphs of figure 2.6 show the average 
distances (+/- s.e.) between the fungal growth front and bacterial colonies as a 
percentage of the starting distance on day zero. A numerical representation of 
the data and photographs of representative replica bioassay plates are given in 
table 2.9 and figure 2.7, respectively.  
At the end of the experiment (day 22), one of the bacterial strains 
(Nocardiopsis E11) was not overgrown by Escovopsis EA, relating to one of 15 
replica plates; the replica plates of all other strains were all overgrown by the 
parasitic fungus (Fig. 2.6A). However, the average size of the inhibition zones in 
bioassay plates of Nocardiopsis E11 was only 0.01 cm (Table 2.9).  
In comparison, Escovopsis EWB was more susceptible to some of the 
bacterial metabolites as indicated by generally less S-shaped curves in the 
graph (Fig. 2.6B).  
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Figure 2.5 (A) Candida (CA6) colony bioassays of NNSPS 
isolates (E2-E4, E6, E8-E15). An uninoculated agar plate (C- No 
bacterium) and one with a S. lividans colony (C- S. lividans) were 
included as negative controls. Streptomyces E8, E9, and E6
(orange font) are secreting effective antifungals into the medium 
surrounding the colony, resulting in inhibition zones with no or 
reduced fungal growth. 
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Figure 2.5 (B) Candida (CA6) colony bioassays of NNSPS 
isolates (E2-E4, E6, E8-E15). An uninoculated agar plate (C- No 
bacterium) and one with a S. lividans colony (C- S. lividans) were 
included as negative controls. Here, the agar plates were 
enriched with 150 mM of sodium butyrate. Streptomyces E8 and 
E9, as well as Pseudonocardia E4 (orange font) are inhibiting
Candida. 
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In particular, replica plates of Streptomyces E6 (0.12 cm), E9 (0.02 cm), 
and E13 (0.15 cm), Pseudonocardia E4 (0.03 cm), as well as Nocardiopsis E11
(0.31 cm) were not overgrown by the fungus (Table 2.9). The most inhibitory 
bacterial strain was Nocardiopsis E11, since 75% of its replica colonies remained 
uncontacted by Escovopsis EWB, leading to a final mean distance between 
bacterial and fungal opponents of 0.31 cm.  
In contrast with EA and EWB, Escovopsis EWC was more susceptible to 
the bacterial metabolites (Fig. 2.6C). On average, 95% of the replica colonies of 
Streptomyces E2, E3, E6, E8, E9, E10, E13, and E14, Pseudonocardia E4, and 
Nocardiopsis E11, were not contacted by fungal hyphae after 22 days (Table 
2.9). The bioassay plates of the remaining strains, Streptomyces E15 and 
Pseudonocardia E12, were all overgrown by the parasitic fungus. Among the 
successful strains, Streptomyces E8, E9, and E13, as well as Nocardiopsis E11
showed the largest mean inhibition zones, spanning 1.17 cm, 1.12 cm, and 1.05 
cm, as well as 1.92 cm, respectively. In contrast, Streptomyces E3 produced the 
smallest inhibition zones of only 0.22 cm.  
In summary, the metabolites of some NNSPS strains indeed possess 
antifungal activity against Escovopsis spp., but two of the fungal test strains 
(EWB, EA) were mostly resistant to the compounds.  
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Figure 2.6 Escovopsis (EA, EWB, EWC) colony bioassays of NNSPS isolates 
(E2-E4, E6, E8-E15). The bacteria were inoculated into the centre of agar plates 
containing no sodium butyrate, and the fungi were grown from the edge. The X-
axes show the time over a period of 22 days; the Y-axes show the distance 
between the fungi and bacterial colonies as a percentage of the starting 
distance, averaged across replica plates (± s.e.). Slopes that are shallower than 
the control therefore indicate fungal inhibition. However, bacterial strains are 
only termed successful (marker displayed), if at least one of its replica colonies 
is not overgrown and the mean distance value at the end of the experiment 
remained larger than zero. A numerical representation of these data is given in 
table 2.9. (A) Bioassays against Escovopsis EA. This fungus is highly resistant 
to any of the bacterial secretions, and exhibiting S-shaped growth curves. Most 
successful is Nocardiopsis E11, showing a mean final distance of 0.01 cm. (B)
Bioassays against Escovopsis EWB. Various bacterial strains are successful 
against this fungus (E4, E6, E9, E11, E13). Again most successful is Nocardiopsis
E11; 75% of its replica colonies are not overgrown by the fungus, resulting in a 
mean final distance of 0.31 cm. (C) Bioassays against Escovopsis EWC. Ten 
out of twelve bacterial isolates are successfully inhibiting the growth of this 
fungus; among the successful strains are Nocardiopsis E11 (1.92 cm) as well as 
Streptomyces E8 (1.17 cm), E9 (1.12 cm), and E13 (1.05 cm).  
Table 2.9 Numerical representation of the colony bioassay results of figure 2.6. The NNSPS strains are challenged against 
Escovopsis EA, EWB, and EWC. Successful bioassay performances are highlighted with red boxes. 
No. replica 
plates
No. success-
ful plates
Success 
rate (%)
Mean 
distance (cm)
No. replica 
plates
No. success-
ful plates
Success 
rate (%)
Mean 
distance (cm)
No. replica 
plates
No. success-
ful plates
Success 
rate (%)
Mean 
distance (cm)
E2 3 0 0.0% 0.00 6 0 0.0% 0.00 6 6 100.0% 0.57
E3 3 0 0.0% 0.00 6 0 0.0% 0.00 6 4 66.7% 0.22
E4 4 0 0.0% 0.00 7 1 14.3% 0.03 7 7 100.0% 0.46
E6 3 0 0.0% 0.00 6 1 16.7% 0.12 6 6 100.0% 0.77
E8 3 0 0.0% 0.00 6 0 0.0% 0.00 6 5 83.3% 1.17
E9 3 0 0.0% 0.00 6 1 16.7% 0.02 6 6 100.0% 1.12
E10 3 0 0.0% 0.00 6 0 0.0% 0.00 6 6 100.0% 0.72
E11 15 1 6.7% 0.01 12 9 75.0% 0.31 12 12 100.0% 1.92
E12 4 0 0.0% 0.00 7 0 0.0% 0.00 7 0 0.0% 0.00
E13 3 0 0.0% 0.00 6 1 16.7% 0.15 6 6 100.0% 1.05
E14 3 0 0.0% 0.00 6 0 0.0% 0.00 6 6 100.0% 0.60
E15 3 0 0.0% 0.00 6 0 0.0% 0.00 6 0 0.0% 0.00
C- 6 0 0.0% 0.00 9 0 0.0% 0.00 12 0 0.0% 0.00
E. weberi (EWB) E. weberi (EWC)E. aspergilloides (EA)
Strain
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Figure 2.7 (A) Escovopsis (EA) colony bioassays, as described 
in figure 2.6. Replica colonies not overgrown by the test fungus 
are shown for successful bacterial strains and overgrown colonies 
for unsuccessful strains. Due to the microscopic size of the fungal 
hyphae, the fungal growth front is largely unrecognisable on the 
pictures, and thus successful strains are highlighted with orange 
font.
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Figure 2.7 (B) Escovopsis (EWB) colony bioassays, as described 
in figure 2.6. Replica colonies not overgrown by the test fungus 
are shown for successful bacterial strains and overgrown colonies 
for unsuccessful strains. Successful strains are highlighted with 
orange font. 
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Figure 2.7 (C) Escovopsis (EWC) colony bioassays, as described 
in figure 2.6. Replica colonies not overgrown by the test fungus 
are shown for successful bacterial strains and overgrown colonies 
for unsuccessful strains. Successful strains are highlighted with 
orange font. 
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2.4.5 Supernatant bioassays 
The NNSPS isolates (E2-E4, E6, E8-E15) were also tested for their ability to 
secrete antifungal metabolites into a liquid environment, with and without 
enrichment by sodium butyrate. The culture media were challenged against 
Candida CA6 and Escovopsis EWC, which is the most susceptible of the three 
Escovopsis strains (Fig. 2.6C). 
2.4.5.1 Bioassays against Candida  
Culture media from Streptomyces E8 and E9 alone inhibited Candida, with 
and without sodium butyrate (Fig. 2.8A-F). Recall that Streptomyces E8 and E9
also inhibited the yeast during colony bioassays both in the presence and 
absence of sodium butyrate (Fig. 2.5A-B).  
Figure 2.8 Candida (CA6) supernatant bioassays testing the bioactivity of 
NNSPS (E2-E4, E6, E8-E15) growth cultures. As negative controls, a growth 
culture of S. lividans (C- S. lividans) and an uninoculated batch of medium (C-
No bacterium) were included. One set of media contained 150 mM sodium 
butyrate and another one did not. The supernatants were inoculated onto paper 
filter disks and attached to Candida-coated agar plates. (A-C) The supernatants 
of Streptomyces E8 and E9 (red font), grown in the absence of the inducer, are 
inhibiting Candida. (D-F) In the presence of sodium butyrate, the liquid growth 
media of Streptomyces E8 and E9 (red font) are inhibiting Candida.     
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Unlike the Petri dish bioassays, in which Streptomyces E6 in the absence 
of sodium butyrate and Pseudonocardia E4 in its presence (Fig. 2.5A-B) were 
able to inhibit Candida, none of their growth supernatants inhibited Candida
(Fig. 2.8A,D). 
Surprisingly, the supernatant of S. lividans (negative control) also inhibited 
Candida when sodium butyrate was added to the medium (Fig. 2.8F). Since the 
supernatants of most test strains, as well as the supernatant of the other 
negative control, which was completely uninoculated, did not show any effect on 
Candida, the bioactivity of S. lividans is most parsimoniously attributed to the 
uncharacterised products of S. lividans, rather than to the medium.   
2.4.5.2 Bioassays against Escovopsis  
Similar to the results with Candida, supernatants of only Streptomyces E8
and E9 successfully inhibited the growth of Escovopsis (Fig. 2.9). 
2.5 Discussion 
The data presented in this chapter confirm the recent observation that 
Acromyrmex spp. worker ants associate with a diversity of bacterial 
ectosymbionts (e.g. Kost et al. 2007, Haeder et al. 2009, Barke et al. 2010). In 
this study, bacteria of the genera Pseudonocardia, Streptomyces, Tsukamurella, 
and Nocardiopsis were isolated from A. octospinosus worker ants. In contrast to 
the genera Pseudonocardia and Streptomyces, bacteria in the genus 
Nocardiopsis have never been reported as symbionts of this ant genus before; 
hence, future studies will be needed to establish the ubiquity and importance of 
this association.  
A selection of the bacterial isolates was challenged on agar plates against 
the medically important yeast Candida albicans and three Escovopsis strains 
(EA, EWB, EWC). Streptomyces E8, E9, and E6, inhibited Candida. Diverse 
Streptomyces, Pseudonocardia, and Nocardiopsis strains inhibited the growth of 
Escovopsis EWB, EWC, and EA; particularly strong were combinations of 
Streptomyces E8, E9, and E13, as well as Nocardiopsis E11 with Escovopsis
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Figure 2.9 Escovopsis (EWC) supernatant bioassays testing the 
bioactivity of NNSPS (E2-E4, E6, E8-E15) growth cultures. The 
supernatant of an uninoculated batch of medium (C- No 
bacterium) was included as a negative control. Only the 
supernatants of Streptomyces E8 and E9 (orange font), soaked 
onto paper filter disks and containing no sodium butyrate, are 
inhibiting the test fungus.  
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EWC. The bioassay results of Nocardiopsis E11 (Table 2.9) illustrate that 
different fungal strains, even of the same species (i.e. Escovopsis weberi), 
experience different levels of stress upon being exposed to the same bacterial 
metabolites. In general, metabolites that have fungicidal effects on one test 
fungus may have only fungistatic or no inhibitory effects on another test fungus. 
Decreased susceptibilities in resistant strains may for example be explained by 
modifications in, or a reduction of, fungal target molecules. In contrast, observed 
differences between replica plates, in which a bacterial strain is challenged 
against a single test fungus, do not originate from susceptibility differences. 
These may rather be explained by intrinsic variabilities in the growth pattern of 
Escovopsis or by slight differences in the number of inoculated cells resulting in 
slight variations in the amounts of secreted antifungals. Consequently, the 
bioassay results in which a single Nocardiopsis E11 colony (out of 15 replica 
colonies) remained free of Escovopsis EA hyphae (Table 2.9) can be explained 
by a generally high fungal resistance that due to the above reasons has not 
resulted in pathogen contact within the period of the experiment.    
Perhaps surprisingly, the best-studied attine-symbiont, Pseudonocardia, 
showed weaker inhibitory properties against the test fungi than did many of the 
Streptomyces and Nocardiopsis strains. The difference in inhibitory strength 
between Pseudonocardia and Streptomyces symbionts has previously been 
recognised by Haeder et al. (2009). Of the bacteria that successfully inhibited 
fungi in the agar plate bioassays, only Streptomyces E8 and E9 also produced 
antifungal compounds in liquid medium. This trait makes these two strains 
suitable candidates for antifungal isolation and identification. 
To induce the bacterial isolates to produce cryptic antifungals under 
laboratory conditions, the microbes were additionally grown on agar plates 
containing the chemical inducer sodium butyrate. Pseudonocardia E4 was 
successfully induced to secrete antifungals. In contrast, Streptomyces E8 and E9
exhibited similar levels of antifungal inhibition in both the presence and absence 
of sodium butyrate, although bioassays alone are not enough to detect changes 
in the composition of the compounds produced. There is still a need to optimise 
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sodium butyrate concentrations, as illustrated by the growth inhibition of 
Streptomyces E6 when grown with a standard concentration of 150 mM of 
sodium butyrate. 
Possible sources of errors inherent to the culture-dependent method used 
in this chapter are the following. In contrast to 454 sequencing approaches, 
culture-dependent methods may fail to detect unculturable and/or rare bacteria 
in microbial communities of ectosymbionts, as a result of unfavourable growth 
media or competition with other bacteria. Furthermore, selection of bacterial 
morphotypes focused on actinobacteria, which are well-known for their 
association to attine ants, but this resulted in neglecting other potentially 
mutualistic bacteria. In addition, the culture-dependent method does not allow 
quantitative estimates of the dominance and distribution of bacterial strains, 
meaning that few conclusions can be made about their importance to the 
mutualism.  
With these caveats in mind, the data presented in this chapter show that A. 
octospinosus ants host a diverse community of bioactive bacteria that may offer 
a variety of pharmacologically interesting antifungal metabolites, which might 
provide antifungal inhibition benefits to the host ants. 
2.5.1 Implications for mutualism theory 
The diverse community of bacteria associated with A. octospinosus is 
shown to express itself in the ability to produce a diversity of antifungals, 
forming a so-called antifungal cocktail (Barke et al. 2010). In particular, 
Pseudonocardia E4 (renamed P1 in Barke et al. 2010) is shown to produce a 
water-soluble, bioactive compound that structurally resembles, but is not 
identical to, the well-known antifungal nystatin, which shows a poor water-
solubility (Day et al. 2011). We called this new compound nystatin P1. 
Streptomyces E8 (renamed S4 in Barke et al. 2010), another bacterial isolate of 
the same ant colony as Pseudonocardia E4, is found to produce the well-known 
antifungal candicidin. Both compounds belong to the same class of antifungals, 
Chapter 2) Acromyrmex octospinosus ant-associated bacteria
60
polyenes, which bind ergosterol in the fungal membranes, aggregate to pores, 
and increase membrane permeability, leading to fungal death.  
The novelty of nystatin P1 has been discussed by Barke et al. (2010) in 
terms of host-symbiont coevolution. Previously, a Pseudonocardia strain hosted 
by the attine ant Apterostigma dentigerum was also found to produce a novel 
antifungal, called dentigerumycin (Oh et al. 2009). The production of novel 
antibiotic compounds supports the view, originating with Currie et al. (1999b, 
2003), that Pseudonocardia is a long-term, vertically transmitted associate of 
attine ants, which is engaged in a coevolutionary arms race with fungal 
pathogens. Barke et al. (2011) place this idea within mutualism theory as a 
version of partner fidelity feedback (Sachs et al. 2004). Strict vertical 
transmission of a Pseudonocardia lineage by an attine ant lineage aligns the 
fitness interests between host and symbionts. A host-symbiont mutualism, 
however, is disturbed when Escovopsis develops resistance to the antifungal 
produced by the symbiont, leading to colony death. However, variation among 
symbionts in their antifungal biosynthesis genes, and thus their ability to 
produce novel antifungal, is expected to increase the reproductive success of 
some hosts, forming the next generation of host-symbiont combinations. The 
features of the symbionts thus feed back on the fitness of the host, and in 
consequence on their own fitness. 
In contrast, the production of the structurally unmodified candicidin 
molecules by Streptomyces E8 has been discussed to be consistent with 
environmental recruitment of existing actinobacteria from the soil (Barke et al.
2010) because candicidin-producing Streptomyces are widespread in the 
environment (Jørgensen et al. 2009) and because the same compound has also 
been found in an A. octospinosus ant-associated Streptomyces strain isolated 
from a geographically distinct ant colony (Haeder et al. 2009). Furthermore, the 
well-known antifungals antimycins A1-A4, valinomycin, and actinomycin D and 
X2 have been found to be produced by Acromyrmex spp. ant-associated 
Streptomyces strains (Schoenian et al. 2011) that also have been found in non-
ant environments.  
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Environmental recruitment is a form of partner choice (Bull and Rice 
1991), which describes when there is positive assortment (matching) of partners 
that happen to have aligned fitness interests. In other words, by selectively 
recruiting bacteria that already have the capacity to produce antibiotics that kill 
Escovopsis and other parasites, attine colonies increase their own fitness and 
the fitness of the recruited symbionts. In addition, the recruitment of multiple 
antibiotic-producing bacteria can further increase antibiotic efficacy and delay 
the evolution of resistance (Barke et al. 2011). 
Two mechanisms are proposed to be able to bring about partner choice in 
mutualisms: screening and signalling (Archetti et al. 2011a,b). Screening occurs 
when a host couples a demanding environment with a high reward. The 
evolutionary challenge is to set up the demanding environment in such a way 
that only beneficial symbionts are able to live on the host and benefit from the 
hosts rewards. Scheuring and Yu (2012) use screening to show how vertically 
propagated Pseudonocardia symbiont can help attine ants to recruit other 
antibiotic-producing bacteria from the environment. Namely, by providing a 
nutrient-rich cuticular environment, attine ants enable their Pseudonocardia
symbionts to produce abundant antibacterials, and this is the demanding 
environment. Antibiotic-producing bacteria are more likely to be resistant to 
these antibacterials, and are therefore able to colonise the nutrient-rich attine 
cuticle, while non-antibiotic-producing bacteria are less likely to have resistance 
genes and thus are less able to colonise the attine cuticle. In short, antibiotic-
producers are better competitors for the attine niche. Finally, in the attine 
system, the antibiotic-producing bacteria are mostly actinobacteria, which are 
known to produce both antibacterials and antifungals, so a host that recruits 
antibacterial-producing actinobacteria is likely also to recruit in antifungal 
production capacity. 
Thus, competition among bacteria for host resources does not only have to 
reduce the fitness of the host, competition can also help to produce successful 
partner choice. In this context, it would be interesting to ask which ant castes 
are responsible for recruiting bacteria from the environment. Three options 
Chapter 2) Acromyrmex octospinosus ant-associated bacteria
62
would be: the queen recruits diverse bacteria before or during nest initiation and 
passes the bacterial community on to the offspring, including the garden 
workers; in the case of Acromyrmex colonies, older major workers might collect 
bacteria from outside of the nest and pass these on to the young major workers 
in the garden; the young major workers themselves sample bacteria from the 
soil inside the nest. The answer to this question would provide valuable 
information about the overall diversity of antifungal cocktails and how flexible ant 
colonies are in adjusting their cocktails to current parasite attacks. 
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Chapter 3) Antifungals of an Acromyrmex octospinosus ant-
associated Streptomyces strain 
3.1 Introduction 
Since the 1990s, the rate of discovery of new natural product drugs has 
steadily decreased (Li and Vederas 2009); this trend can be attributed to the 
fact that many pharmaceutical companies have closed their natural-product 
research programmes due to re-discovering the same compounds in soil-
collected fungi and actinobacteria, and have switched to the development of 
synthetic drugs. Additionally, the number of antifungals suitable for human use 
is limited by two other factors. Firstly, fungal pathogens are diverse and 
constantly evolving, showing innate and acquired resistances. For example, 
fungi with reduced concentrations of membrane-bound ergosterol are less 
susceptible to polyene drugs (Young et al. 2003). Secondly, mammalian and 
fungal cells are more biochemically similar than are bacteria and human cells, 
so compounds inhibiting and/or killing fungal cells are likely to have adverse 
side-effects on the human host. For example, the polyene antifungal 
amphotericin B, which often is used for treating systemic mycoses, at high 
concentrations also shows affinities to cholesterol in mammalian cells 
(Kaneshiro et al. 2000, Baginski et al. 2002). Hence, research efforts now also 
include soil-unrelated niches to find unknown bacteria and novel antifungal 
metabolites, showing strong bioactivities and less side-effects, increasing the 
medical potential for treating human mycoses.     
During recent years, a new research strategy has been to focus survey 
effort on underexplored niches for natural-product discovery. One increasingly 
important class of underexplored niches is the host-symbiont mutualism, 
including mutualistic associations between bacteria and European beewolf 
Philanthus triangulum (Kroiss et al. 2010), mud dauber wasps Sceliphron 
caementarium and Chalybion californicum (Poulsen et al. 2011), and the 
southern pine beetle Dendroctonus frontalis (Scott et al. 2008). Host-symbiont 
associations, especially those involving bacterial or fungal symbionts, are 
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typically characterised by the exchange of small nutritional and non-nutritional 
molecules (Schmidt 2008), importantly including antibiotics. These antibiotics 
can be used by hosts for defending themselves (Seipke et al. 2011c, Mueller et 
al. 2012), for example when secreted by integumental biofilms of attine ant-
associated bacteria, their offspring (Kaltenpoth et al. 2005, Poulsen et al. 2011), 
and/or other mutualistic partners (e.g. fungal cultivars; Scott et al. 2008, Santos 
et al. 2004, Currie et al. 1999b, Currie et al. 2003, Kost et al. 2007, Haeder et al.
2009, Oh et al. 2009, Sen et al. 2009, Schoenian et al. 2011) from pathogens.  
Because the fitnesses of host and symbiont are, by definition, aligned in 
mutualisms (Weyl et al. 2010, Archetti et al. 2011a), there is and has been 
selection on the host and symbiont to produce beneficial metabolites for the 
other partner. One of the best-studied examples is bacterial symbionts that 
produce antibiotics, which are effective against current pathogens of the host. 
Furthermore, because those antibiotics are applied on the host or on its 
offspring and/or other mutualistic hosts, there is also selection on host and 
symbiont to evolve antibiotics that do not cause harm to the host. 
In consequence, we might expect that symbionts produce antibiotics that 
markedly differ in their metabolic nature from the antibiotics found in soil-
bacteria, resulting in fewer adverse side-effects to the host. As it turns out, the 
structures of a number of symbiont-produced antibiotics have been published, 
some of which indeed possess molecular structures that are novel to science 
(Barke et al. 2010, Kroiss et al. 2010, Poulsen et al. 2011, Scott et al. 2008, 
Haeder et al. 2009, Oh et al. 2009, Schoenian et al. 2011). 
By far the best-studied example of a host-symbiont mutualism in which the 
symbiont produces antibiotics is found in the attine ants (Hymenoptera, 
Formicidae, Attini). Attine ants are known for cultivating mutualistic fungi. The 
two most derived genera in this tribe are Acromyrmex and Atta, collectively 
known as leaf-cutter ants because they cut leaves from live plants and carry 
them to their nests. There, the leaf-material is masticated and fed to the 
symbiotic basidiomycete Leucoagaricus gongylophorus (Agaricales, 
Agaricaceae). In return, the fungus produces nutritious food bodies (gongylidia) 
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that are used to feed the ant larvae and queen. The fitness of attine cultivars is 
endangered by diverse non-cultivar fungi, of which fungi in the genus 
Escovopsis are common, virulent, and specialised (Currie et al. 1999a, 
Rodrigues et al. 2008, Reynolds and Currie 2004, Currie 2001, Gerardo et al.
2006). They can overgrow cultivar gardens, form permanent infections, and feed 
on the cultivar hyphae. However, an array of ant- and cultivar-associated 
bacteria has been suggested, not only to benefit the health of the ants, but also 
to promote the health of the fungal cultivars. For example, from attine workers 
the Gram-positive genera Pseudonocardia, Streptomyces, and Amycolatopsis
have been isolated (Currie et al. 1999b, Currie et al. 2003, Kost et al. 2007, 
Haeder et al. 2009, Sen et al. 2009, Oh et al. 2009). These occur on the 
integument of attine ants and inside their mouth pocket (infrabuccal pocket), 
which serves the collection of infected garden material, where they produce 
antifungal metabolites. Furthermore, bioactive Streptomyces and Gram-negative 
Burkholderia bacteria have also been isolated from the fungal cultivar (Haeder 
et al. 2009, Santos et al. 2004). 
I now briefly review the chemically characterised antibiotics that have been 
isolated from attine-associated bacterial symbionts. Acromyrmex spp. ant- and 
cultivar-associated Streptomyces strains have been reported to produce the 
well-known antifungal candicidin (C59H84N2O18, 1109.57938 amu [M+H]+, 
Haeder et al. 2009). This compound was challenged against the fungal 
mutualist L. gongylophorus and five non-cultivar fungi, including Escovopsis
weberi, E. aspergilloides, Beauveria bassiana, Metarhizium anisopliae, and 
Lecanicillium lecanii. While candicidin inhibited Escovopsis spp., the growth of 
other non-cultivar fungi and fungal mutualist was largely unaffected.  
Furthermore, an Apterostigma dentigerum ant-associated Pseudonocardia
strain has been shown to exhibit inhibitory properties towards Escovopsis sp. 
(Oh et al. 2009). In contrast, the metabolites of this Pseudonocardia strain 
apparently did not reduce the growth of the fungal mutualist. The bioactivity of 
the bacterial strain has been traced back to a novel antibiotic, named 
dentigerumycin (C40H67N9O13, 882.01248 amu, PubChem ID 25181359).  
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Nine Streptomyces, two Pseudonocardia, four Nocardiopsis, and one 
Tsukamurella strain have been isolated from Acromyrmex octospinosus workers 
(Barke et al. 2010). A selection of isolates, including nine Streptomyces (E2-E3, 
E6, E8-E10, E13-E15), two Pseudonocardia (E4, E12), and one Nocardiopsis (E11) 
was tested in colony bioassays against three Escovopsis strains (EWC, EWB, 
EA) and Candida albicans. Most susceptible against the bacterial secretions 
was Escovopsis EWC and C. albicans. In particular, eight Streptomyces (E2-E3, 
E6, E8-E10, E13-E14), one Pseudonocardia (E4), and the Nocardiopsis (E11) strain 
inhibited Escovopsis EWC; three Streptomyces (E6, E8-E9) and one 
Pseudonocardia (E4) strain inhibited C. albicans.  
Pseudonocardia E4 (renamed P1) produces a novel nystatin-like antifungal, 
nystatin P1 (Barke et al. 2010). The genome has been shown to contain 
biosynthesis genes with high amino acid similarities to proteins needed by P. 
autotrophica to produce an antifungal called nystatin-like Pseudonocardia
polyene (NPP, 1129.6 amu [M+H]+), an antifungal that is related to nystatin A1 
of S. noursei. In an LCMS analysis, a methanol extract from a Pseudonocardia
E4 growth culture was analysed alongside a standard of nystatin A1 
(C47H75NO17, 925.5035 amu, KEGG ID C12155). Similar retention times and 
polyene specific UV absorbances indicated analogies between the standard 
(926.5 amu [M+H]+) and a sample ion with a mass of 1088.6 amu [M+H]+, 
confirming the production of a nystatin-like compound. The mass difference 
between both compounds has been suggested to originate from an additional 
hexose molecule, potentially rendering the sample molecule more water-
soluble. The NPP molecule of P. autotrophica, which also contains an additional 
sugar moiety (N-acetyl-glucosamine), has been shown to possess a 300-fold 
higher water solubility than nystatin A1 (Lee et al. 2012).  
In addition, Streptomyces E8 (renamed S4), which was isolated from the 
same ant colony, has been shown to produce the well-known antifungal 
candicidin (Barke et al. 2010). Two candicidin biosynthesis genes were 
discovered in the bacterial genome, and the bacterium was shown to produce 
candicidin (Barke et al. 2010). A liquid growth culture of this strain indeed 
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contained the candicidin mass 1109.6 amu [M+H]+, showing the same MS2
fragmentation and UV absorbance pattern as candicidin identified by Haeder et 
al. (2009).  
Lastly, fourteen Acromyrmex octospinosus, A. echinatior, and A. volcanus
ant- and cultivar-associated Streptomyces strains have been shown to produce 
the well-known antibiotics valinomycin (e.g. C54H90N6O18, 1111.34 amu, CAS: 
14295-14-8); actinomycin D (e.g. C62H86N12O16, 1255.44 amu, Reaxys ID: 
20503753); actinomycin X2 (structurally similar to: C62H84N12O17, 1269.42 amu, 
Reaxys ID: 8386016); as well as antimycin A1 (e.g. C28H40N2O9, 548.634 amu, 
CAS: 116095-18-2), A2 (e.g. C27H38N2O9, 534.607 amu, CAS: 118890-43-0), A3
(e.g. C26H36N2O9, 520.58 amu, CAS: 116095-17-1), and A4 (e.g. C25H34N2O9, 
506.553 amu, CAS: 117603-45-9) (Schoenian et al. 2011). These compounds 
were challenged against diverse test fungi and bacteria. Among others, fungal 
opponents included the fungal mutualist (i.e. L. gongylophorus), garden-
associated non-cultivar fungi (e.g. Escovopsis weberi, CBS 110660), and 
entomopathogens (e.g. Beauveria bassiana). Bacterial opponents, among 
others, included Acromyrmex-isolated Streptomyces and Pseudonocardia
strains as well as Bacillus subtilis. The authors show a complex pattern of fungal 
and bacterial inhibition. For example, valinomycin only inhibited Bacillus, while 
the growth of Escovopsis and L. gongylophorus were unaffected by this 
antibiotic. Actinomycin D inhibited diverse Streptomyces and Pseudonocardia
strains; the compound did not inhibit E. weberi and L. gongylophorus. In 
contrast, antimycins exclusively inhibited the fungal opponents, including 
Escovopsis, and fungal mutualist.   
In conclusion, actinomycete symbionts of attine ant hosts indeed have the 
capacity to produce multiple antibiotic metabolites. Some of these antibiotics 
possess (partly) novel structures (e.g. dentigerumycin and nystatin P1), which is 
consistent with pairwise coevolution (Oh et al. 2009, Barke et al. 2010, Barke et 
al. 2011). Other compounds (candicidin, valinomycin, actinomycin D and X2, 
antimycin A1-A4) are well known from non-symbiotic bacteria, which is 
consistent with environmental recruitment of bacterial species that primarily live 
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in the soil (Haeder et al. 2009, Barke et al. 2010, Barke et al. 2011, Schoenian 
et al. 2011). Mechanisms of action, even for well-known compounds, are often 
unknown or established only with regard to specific and ant system-unrelated 
test organisms and cell lines. However, in some cases, the chemical structure of 
compounds allows suggestions on their molecular targets. For example, 
sceliphrolactam, which was isolated from mud dauber wasp-associated 
(Sceliphron caementarium and Chalybion californicum) Streptomyces (Poulsen 
et al. 2011), is suggested to function as a polyene antifungal due to its 
molecular structure.  
3.2 Aims 
The aim of this chapter is to investigate the full inhibitory potential of a 
single A. octospinosus ant-associated bacterium. Hence, the same highly 
bioactive Streptomyces strain (E8), which has been shown to produce candicidin 
(Barke et al. 2010), was chosen here for follow-up study. Bioassay-guided 
column fractionations, during which bioactive bacterial metabolites become 
separated from non-bioactive compounds of bacterial origin and/or the medium, 
were used to enable mass identifications of non-candicidin antifungals. In 
particular, the butanol extract of a liquid growth culture was purified in bioassay-
guided normal- and reversed-phase column fractionations (Fig. 3.1). This 
allowed a determination of the metabolic features of the bioactive compounds 
by low- and high-resolution LCMS, and a confirmation of mass analogies to a 
known antifungal by comparison to a standard.  
Figure 3.1 Bioassay-guided column fractionation. During multiple purification 
steps, the number of compounds in bioactive fractions was reduced to levels, 
which allow a mass identification of antifungals other than candicidin.
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3.3 Materials and Methods  
3.3.1 Culture supernatants
3.3.1.1 Supernatants  large-scale production  
Sixteen 250 ml flasks, each containing a spring and 100 ml of a mannitol 
soy-flour (MS) broth (Table 3.1), were autoclaved for sterilisation. Fifteen of the 
flasks were inoculated with 50 µl from a Streptomyces E8 glycerol stock. As a 
control, one flask was 
inoculated with an equal 
volume from a S. lividans 
glycerol stock. To 
guarantee strong 
bioassay performance, 
the same Streptomyces
spore/cell material was 
used as for experiments 
carried out in Chapter 2. 
The flasks were 
incubated for 19 days in 
a shaker incubator (30 
oC, 180 rpm). At day 13 of the incubation period, the flasks were heat-shocked 
by placing them in a 50 oC water bath for 45 minutes. The culture supernatants 
were separated from most of the cell material and undissolved components of 
the medium. To do so, the growth cultures were centrifuged twice for 30 minutes 
(4 oC, 4000 rpm). In total, 1250 ml of Streptomyces E8 supernatant and slightly 
less than 100 ml of S. lividans supernatant were harvested; some of the liquid 
was lost due to evaporation and as moisture in the discarded medium. The 
Streptomyces E8 supernatant was sub-divided. 1050 ml were preserved for a 
butanol extraction and a proceeding column fractionation; 200 ml were 
dedicated for bioassays. All of the S. lividans supernatant was reserved for 
bioassays. The supernatants were stored at -20 oC. 
Table 3.1 Media for cultivation of bacteria and 
fungi. 
Medium Ingredients Weight (g),  volume (ml)
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Distilled water 1000 ml
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Agar 15.0 g
Distilled water 1000 ml
Organic soy-flour 20.0 g
Mannitol 20.0 g
Tap water 1000 ml
Organic soy-flour 20.0 g
Mannitol 20.0 g
Agar 20.0 g
Tap water 1000 ml
Mannitol soy-flour (MS) agar 
Mannitol soy-flour (MS) broth 
Lennox broth (LB)
Lennox broth (LB) agar
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3.3.1.2 Supernatants  small-scale production  
In a similar way, further batches of Streptomyces E8 and S. lividans
supernatants were obtained. Two 250 ml flasks, each containing 100 ml of a 
sterile MS broth, were inoculated with 50 µl from the corresponding glycerol 
stocks. The flasks were incubated on a shaker incubator for 12 days (30 oC, 180 
rpm). At day 9 of the incubation period, the flasks were heat-shocked by placing 
them for 30 minutes in a 50 oC water bath. The supernatants were harvested by 
centrifuging the growth cultures for 30 minutes (4 oC, 4000 rpm). The 
supernatants were stored at -20 oC.  
3.3.1.3 Bioassays against Candida  
The Streptomyces E8 supernatant of the large-scale production was 
challenged against human pathogenic yeast Candida spp. A small sub-sample 
of the 200 ml fraction, dedicated for bioassays, was filter-sterilised by passing it 
through a 0.45 µm filter. Then, the sterile supernatant was diluted with sterile 
dH2O to obtain concentrations ranging from 90-10% of the original 
concentration. Additionally, 100% and 
0% concentrations were included in the 
bioassays, consisting of the crude 
supernatant and pure dH2O, 
respectively. These dilutions were 
tested against fourteen Candida strains, 
including Candida albicans CA1-CA11, C. 
tropicalis CA12, C. glabrata CA13 and C. 
dubliniensis CA14 (Table 3.2). The 
yeasts were inoculated from source 
plates into glass containers (universals), 
containing 10 ml of Lennox broth (LB, 
Table 3.1). Then, the universals were 
incubated in a shaker incubator for one 
day (37 oC, 230 rpm). Fourteen LB agar 
Table 3.2 Candida spp. test fungi 
provided by Neil Gow from the 
University of Aberdeen. 
Strain Species Clade
CA1 Candida albicans 1
CA2 Candida albicans 1
CA3 Candida albicans 1
CA4 Candida albicans 2
CA5 Candida albicans 2
CA6 Candida albicans 3
CA7 Candida albicans 3
CA8 Candida albicans 4
CA9 Candida albicans 4
CA10 Candida albicans 11
CA11 Candida albicans 11
CA12 Candida tropicalis -
CA13 Candida glabrata -
CA14 Candida dubliniensis -
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plates (Table 3.1), containing no antibiotics, were coated with 0.5 ml of the yeast 
cultures. When dry, 50 µl of the supernatant dilutions were inoculated on the 
Candida-coated agar plates in such a way that each of the fungal pathogens 
was challenged with any of the eleven dilutions. The presence or absence of 
fungal inhibition was measured after two days of incubation at 26 oC.  
3.3.1.4 Bioassays against Escovopsis  
The Streptomyces E8 and S. lividans supernatants of the large-scale 
production was challenged against Escovopsis. Small sub-samples of the 200 
ml Streptomyces E8 and 100 ml S. lividans supernatants, dedicated for 
bioassays, were filter-sterilised by passing them through a 0.45 µm filter. 500 µl 
of the sterile supernatants were inoculated into the centre of mannitol soy-flour 
(MS) agar plates (Table 3.1), lacking any antibiotics. When dry, Escovopsis 
EWC was point-inoculated to the bioassay plates at a distance of 1 cm from the 
supernatants. The plates were incubated at room temperature until the 
supernatant inocula were either clearly avoided or overgrown by the fungus.  
3.3.2 Butanol-extracts  
3.3.2.1 Butanol extraction  large-scale production  
1050 ml of the Streptomyces E8 supernatant from the large-scale 
production, to be used for column fractionations and antifungal identification, 
were extracted with 3150 ml of butanol. This was done by adding 50-100 ml 
batches of supernatant to a separation funnel and washing them three times 
with the same volumes of butanol. Butanol is an organic solvent, which is more 
apolar than water (polarity index: BuOH=4.0, H2O=9.0). Due to these properties, 
BuOH and water are immiscible and show phase separation. Many antifungals, 
but also non-bioactive metabolites and ingredients of the growth medium, are 
less polar than the aqueous environment in which the bacteria were grown. The 
mixing of aqueous supernatants with BuOH allows such compounds to 
associate with the relatively apolar solvent, and subsequently separate out. The 
organic phases of the washes were harvested and subsequently vacuum 
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concentrated. While the dry residue was stored at -20 oC, the aqueous parts of 
these washes were disposed. 
Similarly, another sub-sample (45 ml) of the 200 ml fraction from the 
Streptomyces E8 large-scale production, dedicated for bioassays, was extracted 
with 150 ml of butanol. The organic phase was evaporated. In contrast to an 
earlier extraction, here the aqueous phase was preserved. Both, residue and 
aqueous phase were stored at -20 oC. 
3.3.2.2 Butanol extraction  small-scale production  
In the same way as above, sub-samples (3 ml) of the 100 ml batches of 
Streptomyces E8 and S. lividans supernatants from the small-scale production 
were BuOH extracted. The supernatants were washed with 9 ml of butanol. The 
organic solvents were evaporated and the residues stored at -20 oC. The 
aqueous phase was disposed.  
3.3.2.3 Bioassays against Candida  
The butanol extract of the 45 ml sub-sample from the Streptomyces E8
large-scale production, obtained above, was challenged against Candida. In 
particular, some of the original supernatant, the BuOH extract (re-dissolved in 
100% MeOH) and the aqueous phase were included in the bioassays, alongside 
100% MeOH and 100% BuOH that served as negative controls. Five paper filter 
disks, with a diameter of 0.9 cm, were inoculated with 200 µl of the test and 
control liquids. Candida CA6 was inoculated into a universal, containing 10 ml 
of Lennox broth, and was grown for 2 days in a shaker incubator (37 oC, 280 
rpm). A 9 cm square Petri dish, containing LB agar and no antibiotics, was 
coated with 800 µl of the Candida culture. When dry, the disks were fixed to the 
Candida lawn with 80 µl of sterile dH2O. The plates were incubated for 2 days at 
room temperature, after which the presence or absence of fungal inhibition was 
scored.     
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3.3.2.4 Bioassays against Escovopsis  
The butanol extract of the 3 ml sub-samples from the Streptomyces E8 and 
S. lividans small-scale productions were challenged against Escovopsis. The 
residues were re-dissolved in 400 µl of 50% aqueous MeOH. The re-dissolved 
extracts were used completely to inoculate two filter disks, with a diameter of 4 
cm. When dry, the disks were attached to MS agar plates, lacking any 
antibiotics, with 200 µl of sterile dH2O. Then, Escovopsis EWC was inoculated 
at the edge of the bioassay plates. The bioassay plates were incubated at room 
temperature until the fungus clearly avoided or overgrew the filters.     
3.3.2.5 Thin layer chromatography of butanol extracts 
The BuOH extract of the 1050 ml sub-sample from the Streptomyces E8
large-scale production, was analysed by thin layer chromatography (TLC). A 
small fraction of the residue was re-dissolved in 50% of aqueous MeOH (HPLC 
grade). The extract was point-inoculated 1 cm from the base of six silica plates. 
Glass containers were prepared, containing six mixtures of methanol (MeOH) 
and ethyl acetate (EtAc), including ratios of 100:0, 90:10, 80:20, 70:30, 60:40, 
and 50:50 (MeOH:EtAc). Paper filters resting in the solvent mixtures saturated 
the internal atmosphere of the closed-up containers. When dry, the TLC plates 
were carefully placed into the solvent mixtures and left in the container until the 
solvent front reached a migration height of 9 cm. Then the TLC plates were 
dried and analysed under short and long wave UV light; the distribution of UV-
active compounds was sketched at a scale of 1:1. Then the plates were stained 
with potassium permanganate. This inorganic chemical is a strongly oxidising 
agent and visualises various functional molecular groups; however, since the 
extract is expected to also contain innumerable oxidisable, but non-bioactive 
compounds, the staining was only used to study the suitability of specific solvent 
mixtures to separate compounds in general. This information has been used for 
the following normal-phase column fractionation.  
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3.3.3 Normal-phase column fractionation 
3.3.3.1 Fractionation  
The remaining residue of the BuOH extract, originating from the 1050 ml of 
Streptomyces E8 large-scale production and previously analysed by TLC, was 
here purified by normal-phase (NP) column fractionation. The residue (2.8 g) 
was dissolved in a 15 ml mixture of MeOH:EtAc (4:11). A small sub-sample of 
this column starter material was preserved for a later TLC analysis. 
Approximately 50 g of silicate are needed for separating compounds per gram 
of extract. Hence, the column was filled with 140 g of silicate. To prevent the 
silicate from being washed out, the base of the glass column was loaded with a 
layer of cotton wool and sand. Under pressure, the column was flushed twice 
with 100% EtAc; this was done to support the settling of the granules. Then, the 
dissolved extract was loaded into a small layer of solvent that was left on top of 
the silicate when closing the column. The sample was carefully run into the 
granule layer by again opening the base of the column and carefully topping it 
up with 100% EtAc. Once the sample disappeared from the surface, the column 
was topped-up with a solvent mixture of MeOH:EtAc in a ratio of 60:40.  
When the compounds of the extract migrated half-way through the column, 
the collection of eluent started. During the collection of fractions 1-50, the 
solvent condition remained unchanged; while collecting fractions 51-66, the 
MeOH:EtAc ratio was changed to 70:30; and during the collection of fractions 
67-85, the polarity of the mobile phase was increased to 100% MeOH. The 
normal-phase fractions were stored in universals at -20 oC.   
3.3.3.2 Bioassays against Candida  
Universals with 10 ml of Lennox broth were inoculated with Candida CA6. 
To ensure abundant fungal growth the cultures were incubated for several days 
in a shaker incubator (37 oC, 280 rpm). LB agar plates, containing no antibiotics, 
were coated with 400 µl of the yeast cultures. Single paper filter disks, with a 
diameter of 0.9 cm, were inoculated with 50 µl of the NP fractions (1-85). Two 
control disks were inoculated with 50 µl of 100% MeOH, another two with 50 µl 
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of 100% EtAc, and one disk remained uninoculated. When dry, the disks were 
attached to Candida-coated agar plates with 50 µl of sterile dH2O. Then, the 
plates were incubated at room temperature for 2 days after which the diameter 
of the inhibition zones was measured. The experiment was repeated three 
times.  
3.3.3.3 Thin layer chromatography  
The NP fractions (1-85), were analysed by TLC in the same way as the 
crude BuOH extract previously. The column starter material was point-
inoculated onto the first lane of each TLC plate, serving as reference, and the 
NP fractions onto any lane thereafter. As mobile phase, a mixture of MeOH 
(HPLC grade):EtAc was used in a ratio of 70:30. The TLC plates were not 
analysed under UV light, but were directly stained with potassium 
permanganate.  
3.3.4 Identification of candicidin 
Sub-samples of the crude BuOH extract and the NP fractions 24 (apolar) 
and 79 (polar), which previously have been shown to contain antifungals with 
differing polarities, were analysed here by low- and high-resolution liquid 
chromatography mass spectrometry (LCMS). The reversed-phase (RP) high-
performance liquid chromatography (HPLC) systems were set up in the 
metabolomics facility at the John Innes Centre (JIC).  
3.3.4.1 Low-resolution LCMS  
Low-resolution LCMS data were generated by running a sub-sample of the 
crude BuOH extract on a surveyor HPLC system that was attached to a Synergi 
PolarRP column (Phenomenex). The column had a length of 150 mm, diameter 
of 2 mm, and particle size of 4 µm. The solvent mixture contained acetonitrile 
(ACN) and water (0.1% formic acid), and was run through the system with a flow 
rate of 260 µl/min and a temperature of 30 oC. At the beginning of the run the 
solvent mixture contained 2% acetonitrile (T0-2). Within 25 minutes, the ACN 
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concentration was gradually increased to 95% (T2-27). After three minutes of 
running the solvent mixture isocratically at 95% ACN (T27-30), meaning that 
solvent ratios remained unchanged, the concentration of acetonitrile was 
reduced to 2% within 30 seconds (T30-30.5).  
Compound masses in the eluent between 100-2000 amu were detected 
with a DecaXPplus ion trap in positive ion mode (+ESI). Furthermore, MS2 data 
were produced with 35% collision energy. The spray chamber conditions 
included the use of 50 units sheath gas, 5 units aux gas, 350 ºC capillary 
temperature, and 5.2 kV spray voltage. UV spectra were collected at 1 Hz from 
200-600 nm.  
3.3.4.2 High-resolution LCMS  
High-resolution LCMS data were obtained by running sub-samples of the 
normal-phase fractions 24 and 79 on a Luna C18 RP column. The column had a 
length of 50 mm, diameter of 2 mm, and particle size of 3 µm. The solvent 
mixture contained MeOH and dH2O (0.1% formic acid) and was run through the 
system at a flow rate of 150 µl/min and a temperature of 30 °C. At the start of 
the run, the solvent mixture contained 5% MeOH (T0-1). Then, the 
concentration of MeOH was increased to 90% within 15 minutes (T1-15). The 
proportion of MeOH was kept isocratically at 90% for two more minutes (T15-
17), before being reduced to 5% within 30 seconds (T17-17.5).  
Compound masses in the eluent between 150-1500 amu were detected 
with an orbitrap mass spectrometer in positive ion mode (+ESI), at a resolution 
of 60,000. MS2 data were produced with 35% collision energy, and were 
detected at low-resolution quality. The spray chamber conditions included the 
use of 32 units sheath gas, 6 units aux gas, 4.4 kV spray voltage, 275 °C 
capillary temperature, and 40 V tube lens. No UV spectra were collected during 
this run. The computer software Xcalibur was used to calculate molecular 
formulae of detected MS ions. 
Chapter 3) Antifungals of an Acromyrmex octospinosus ant-associated Streptomyces
strains 
77
3.3.5 Pooling of normal-phase fractions 
3.3.5.1 Pooling  
Selected normal-phase fractions (1-85) were combined with one another, 
according to their bioactivity, exhibited in figure 3.7. In particular, four groups 
were formed, consisting of fractions 1-21 (A), 22-43 (B), 44-66 (C), and 67-85 
(D). The combined fractions (A-D) then were vacuum-concentrated and, 
depending on their solubilities, re-dissolved in varying concentrations of 
aqueous MeOH (HPLC grade); these were stored at -20 oC.  
To determine the bioactivities of the supernatants and precipitates, which 
apparently have formed during the storing period, the samples were centrifuged 
for 10 minutes (4000 rpm, 4 oC). The combined fractions A showed a 
transparent supernatant and a minuscule pellet; combined fractions B had a 
coloured supernatant and a relatively large pellet; combined fractions C 
contained a slightly coloured supernatant and a small pellet; and combined 
fractions D showed a slightly coloured supernatant and a small pellet. The 
supernatants and precipitates were challenged against Candida. In preparation 
for the bioassays, pellet sub-samples were re-dissolved in 100% DMSO. 
3.3.5.2 Bioassays against Candida  
Paper filter disks, with a diameter of 0.9 cm, were inoculated with 50 µl 
from the supernatants or dissolved pellets. MS agar plates, containing no 
antibiotics, were coated with a 400 µl lawn of a two-day-old Candida CA6
culture, grown in 10 ml of Lennox broth (37 oC, 280 rpm). When dry, the disks 
were attached to the Candida lawn with 50 µl of dH2O. The bioassay plates 
were incubated for two days at 26 oC.   
3.3.6 Reversed-phase column fractionation 
3.3.6.1 Fractionation  
The supernatant and pellet material of the combined fractions B were 
reversed-phase (RP) column fractionated. The remainder of the precipitate was 
re-dissolved in 100% DMSO. The supernatant and re-dissolved pellet was 
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separated on a HPLC system, located at the UEA, which was connected to a 
C18 RP column (Phenomenex). The solvent mixture contained MeOH (HPLC 
grade) and dH2O (0.1% formic acid), and was run through the system with a 
flow rate of 3 ml/min and a temperature of 30 oC. Within 35 minutes, the 
solvents were run in a gradient from 5-95% of aqueous MeOH (T0-35). After 10 
minutes of running the solvents isocratically at 95% methanol (T35-45), the 
MeOH concentration was reduced to 5% within 2.2 minutes (T45-47.2).  
During multiple fractionation runs, 900 µl sub-samples of the supernatant 
or dissolved pellet material were loaded into the system. An autosampler was 
set to collect 80 fractions (1.5 ml) per run for a period of 40 minutes (T10-50). 
Simultaneously, the UV absorbance (200-600 nm) of compounds in the eluent 
was measured by a diode array detector.  
3.3.6.2 Bioassays against Candida  
Paper filter disks, with a diameter of 0.9 cm, were inoculated with 200 µl of 
the RP fractions from the first fractionation run of a supernatant sample. In 
addition, the eluents preceding (T0-5, T5-10) and following (T50-55, T55-60) 
the fraction collection, were bioassayed as well. As negative controls, two disks 
were inoculated with equal volumes of 100% MeOH and dH2O. LB agar plates, 
containing no antibiotics, were coated with 400 µl of a two-day-old Candida CA6
culture, grown in 10 ml of Lennox broth (37 oC, 280 rpm). When dry, the filter 
disks were attached to the Candida lawn with 80 µl of sterile dH2O. Then, the 
plates were incubated for 2 days at 26 oC.  
3.3.6.3 Bioassays of extract and waste  
The double-purified (NP/RP) extract and the waste of the RP column 
fractionation, described above, were challenged against Candida CA6. The 
extract and waste were both vacuum concentrated and the residues re-
dissolved in 500 µl of 100% MeOH. Two paper filter disks, with a diameter of 0.9 
cm, were inoculated with 50 µl of the extract and waste. The colour of both disks 
differed from one another; while the disk with the extract was golden brown, the 
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one with the waste was matte red. As a negative control, a disk was inoculated 
with 95% MeOH. LB agar plates, containing no antibiotics, were inoculated with 
400 µl of a two-day-old Candida CA6 culture, grown in 10 ml of Lennox broth (37 
oC, 280 rpm). The paper disks were attached to the Candida-coated agar plates 
with 60 µl of dH2O. The plates were incubated for two days at 26 oC. 
3.3.7 Identification of antimycin  
The double-purified (NP/RP) combined fractions B were analysed by low- 
and high-resolution LCMS. The HPLC systems, located at the John Innes 
Centre (JIC), were previously used for tracing candicidin. 
3.3.7.1 Low-resolution LCMS  
Low-resolution LCMS data of the double-purified (NP/RP) combined 
fractions B were obtained by running a sub-sample on a surveyor HPLC system 
that was attached to a Luna C8 column (Phenomenex). The column had a 
length of 100 mm, diameter of 2 mm, and particle size of 3 µm. The solvent 
mixture contained acetonitrile and water (0.1% formic acid) and was run through 
the system at a flow rate of 220 µl/min and a temperature of 30 °C. At the start 
of the LCMS run, the solvent mixture contained 2% acetonitrile and was then 
increased to 95% within 15 minutes (T0-15). The acetonitrile concentration was 
kept isocratically at 95% for 2 minutes (T15-17), before being reduced to 5% 
within 30 seconds (T17-17.5).  
Compound masses in the eluent, between 150-1500 amu, were detected 
with a DecaXPplus ion trap in positive ion mode (+ESI). MS2 data were produced 
with 35% collision energy. The spray chamber conditions included the use of 50 
units sheath gas, 5 units aux gas, 3.8 kV spray voltage, and a capillary 
temperature of 350 oC. In addition to MS and MS2 data, UV spectra were 
collected at 1 Hz from 200-600 nm.  
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3.3.7.2 High-resolution LCMS  
High-resolution LCMS data of the double-purified (NP/RP) extract were 
obtained by running a sub-sample on a HPLC system, connected to a Luna C18
column. The column had a length of 50 mm, diameter of 2 mm, and particle size 
of 3 µm. The solvent mixture contained MeOH and water (0.1% formic acid), 
and was run through the system at a flow rate of 150 µl/min and a temperature 
of 30 °C. At the beginning, the solvent composition contained 5% MeOH (T0-1). 
Within 15 minutes, the percentage of MeOH was increased to 90% (T1-15). 
The proportion of MeOH remained isocratically at 90% for 2 more minutes (T15-
17), before being reduced to 5% within 30 seconds (T17-17.5).  
Compound masses in the eluent, between 150-1500 amu, were detected 
with an orbitrap mass spectrometer in positive ion mode (+ESI) and a resolution 
of 60,000. MS2 spectra were produced with 35% collision energy, and were 
detected at a resolution of 30,000. The spray chamber conditions included the 
use of 32 units sheath gas, 6 units aux gas, 4.4 kV spray voltage, 275 °C 
capillary temperature, and a tube-lens voltage of 40 V. The computer software 
Xcalibur was used to calculate molecular formulae of detected MS and MS2
ions.  
3.3.7.3 Database comparison 
The molecular formulae of selected MS parent ions, detected by low- and 
high-resolution LCMS, were matched to the SciFinder 
(https://scifinder.cas.org/scifinder) and Reaxys (www.reaxys.com) databases. 
Whenever formulae for both hydrogen and sodium adducts were available, the 
former were used for compound identification. In addition of finding chemical 
analogies between MS parent ions and database molecules, the molecular 
formulae of MS2 daughter ions were used to determine the accuracy of these 
analogies.  
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3.3.8 Trapping of antimycin  
3.3.8.1 Trapping of multiple antimycin masses  
The double-purified (NP/RP) combined fractions B, here, were fractionated 
by trapping. The trapping system, located at the Institute of Food Research 
(IFR) in Norwich, was connected to a Gemini C18 RP column (Phenomenex). 
The column had a length of 150 mm, diameter of 4.6 mm, and particle size of 5 
µm. The solvent mixture consisted of acetonitrile and water (0.1% formic acid), 
and was run through the system at a flow rate of 1 ml/min. At the start of the 
run, the solvent mixture contained 50% acetonitrile going to a 95% 
concentration within 20 minutes (T0-20). Then, the solvent mixture was kept 
isocratically at 95% for five minutes (T20-25), before the acetonitrile 
concentration was reduced to 50% within one minute (T25-26). The eluent was 
split in a ratio of 19:1; while the smaller part was sent to a Bruker microtof to be 
used for mass spectrometry, the compounds of the larger part were either 
trapped on a Spark Holland Hydrasphere Resin General Purpose filter (10-12 
µm) or directed to the waste. The mass spectrometer was set to detect masses 
in positive ion mode (+ESI). The live detection of masses in the eluent aided the 
trapping of specific compounds and RT intervals. The system was loaded with a 
25 µl sub-sample of the extract and nine RT intervals were trapped, including 
2E7 (T7.0-7.7), 2E8 (T8.0-8.8), 2E9 (T9.2-10.2), 2E10 (T10.7-11.5), 2E12 
(T11.9-13.0), 2F1 (T13.5-14.2), 2F2 (T14.9-15.6), 2F3 (T16.2-16.8), and 2F4 
(T17.0-22.5). When dry, the trapped compounds were re-diluted from the filters 
in 160 µl of deuterated ACN and stored at -20 oC.  
Due to the small loading volume of 25 µl, the fraction material was used 
completely for carrying out bioassays against Candida CA6. Nine paper filter 
disks, with a diameter of 0.9 cm, were inoculated with the trapped fractions. As 
a negative control, another disk was loaded with 100% deuterated ACN. LB 
agar plates, containing no antifungals, were coated with 400 µl of a two-day-old 
Candida growth culture, grown in 10 ml of Lennox broth (37 oC, 280 rpm). When 
dry, the filters were attached to the agar plates with 80 µl of distilled water. 
Then, the plates were incubated for 2 days at 26 oC.  
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3.3.8.2 Trapping of a second set antimycin mass  
The trapping system at the IFR was also used for isolating a larger 
concentration (50 l loading volume) of a second set 535 amu [M+H]+ ion from 
the double-purified (NP/RP) combined fractions B. This molecule was isolated 
for carrying out a follow-up low- and high-resolution LCMS analyses in negative 
ion mode (-ESI). Due to failing ionisation of second set ions in positive ion 
mode, no molecular formulae of these have yet been determined. The same 
chromatography was applied during this LCMS run as for the LCMS run 
described above, with the exception that the mass spectrometer was set to 
detect masses in negative ion mode. The LCMS system was run twice to collect 
compounds in 50 µl of extract. The compounds in the trapped RT area 2G4 
(T14.75-15.2) were accumulated on a Hydrasphere Resin General Purpose 
filter. When dry, the compounds were re-diluted from the filter in 160 µl of 
deuterated acetonitrile and stored at -20 oC.  
With a bioassay the bioactivity of fraction 2G4 was tested against Candida
CA6. The testing procedure was also adopted from the above trapping 
experiment, except that this time smaller filter disks, with a diameter of 4 mm, 
were used. These were inoculated with 20 µl of the eluent; in contrast, the 
remainder of fraction 2G4 was preserved for future low- and high-resolution 
LCMS analyses, described below. LB agar plates, containing no antibiotics, 
were coated with 400 µl of a two-day-old Candida culture, grown in 10 ml of 
Lennox broth (37 oC, 280 rpm). When dry, the inoculated filters were attached to 
the Candida lawn with 60 µl of dH2O and incubated for two days at 26oC.   
3.3.9 LCMS analysis of the second set antimycin mass  
3.3.9.1 Low-resolution LCMS  
Low-resolution LCMS data were obtained by running a sub-sample of 
fraction 2G4 on a Surveyor HPLC system, located at the John Innes Centre 
(JIC), which previously was used for the identification of candicidin and the 
bioactive molecules of the combined fractions B. The system was attached to a 
Luna C18 column; the column had a length of 50 mm, diameter of 2 mm, and 
Chapter 3) Antifungals of an Acromyrmex octospinosus ant-associated Streptomyces
strains 
83
particle size of 3 µm. The solvent mixture contained acetonitrile (0.1% formic 
acid) and water (0.1% formic acid), and was run through the system at a flow 
rate of 150 µl/min and a temperature of 30 oC. At the start of the run, the solvent 
mixture contained 50% acetonitrile increasing to a concentration of 95% within 
seven minutes (T0-7). The concentration of ACN was maintained isocratically 
for one minute (T7-8), before being reduced to 50% within 0.2 minutes (T8-
8.2).  
Compound masses in the eluent, between 150-1500 amu, were detected 
with a DecaXPplus ion trap in negative ion mode (-ESI). MS2 data were produced 
with 35% collision energy. The spray chamber conditions included the use of 50 
units sheath gas, 5 units aux gas, 3.5 kV spray voltage, and a capillary 
temperature of 350 oC. UV spectra were collected from 200-600 nm. 
3.3.9.2 High-resolution LCMS  
High-resolution LCMS data of fraction 2G4 were obtained by running a 
sub-sample on a Surveyor HPLC system, located at the John Innes Centre 
(JIC), which was connected to a Luna C18 column. The column had a length of 
50 mm, diameter of 2 mm, and particle size of 3 µm. The system was run with 
the same chromatography as described for the low-resolution LCMS analysis.  
Compound masses in the eluent between 150-1500 amu, were detected 
with an orbitrap mass spectrometer in negative ion mode (-ESI), at a resolution 
of 60,000. MS2 data were produced with 35% collision energy; daughter ions 
were detected at a resolution of 30,000. The spray chamber conditions included 
the use of 30 units sheath gas, spray voltage of 4.5 kV, capillary temperature of 
300 °C, and a tube-lens voltage of 168 V. Molecular formulae of MS and MS2
masses were calculated using the software Xcalibur, allowing a maximum of 
35xC, 60xH, 10xN, and 15xO atoms.  
3.3.10 Tandem-LCMS analysis of antimycin and an antimycin standard 
Low-resolution LCMS data, of the double-purified (NP/RP) combined 
fractions B and an antimycin A1-A4 standard (Sigma-Aldrich A8674), were 
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obtained by running sub-samples of both in separation, and in combination, of 
one another. The Surveyor HPLC system, set up at the John Innes Centre, was 
attached to a Luna C8 column (Phenomenex). The column had a length of 100 
mm, diameter of 2 mm, and particle size of 3 µm. The solvent mixture contained 
acetonitrile and water (0.1% formic acid), and was run through the system at a 
flow rate of 220 µl/min and a temperature of 30 oC. At the beginning of the run, 
the solvent mixture contained 2% ACN increasing to 95% within 15 minutes (T0-
15). After 2 minutes of isocratic solvent conditions (T15-17), the proportion of 
ACN was reduced to 5% within 30 seconds (T17-17.5).  
Compound masses in the eluent, between 150-1500 amu, were detected 
with a DecaXPplus ion trap in positive ion mode (+ESI). MS2 data were produced 
with 35% collision energy. The spray chamber conditions included the use of 50 
units sheath gas, 5 units aux gas, spray voltage of 3.8 kV, and a capillary 
temperature of 350 oC. UV spectra were detected from 200-600 nm.  
3.4 Results
In this chapter, the hypothesis is tested that the Acromyrmex ant-
associated bacterium Streptomyces E8, in addition to candicidin (Barke et al. 
2010), is able to produce other antifungal compounds. Bioactive compounds, 
extracted from a Streptomyces E8 liquid growth medium, were column-purified 
and mass-identified. Based on the mass data, molecular formulae could be 
calculated that allowed the identification of antifungal compounds.  
Mechanisms of antifungal action can be fungal taxon-specific; this means 
that each test fungus species might be inhibited by only a subset of tested 
antifungals. During the purification of the Streptomyces E8 antifungals, initial 
bioassays made use of two test fungi, namely Escovopsis EWC and Candida 
CA6. Later challenges made use of the faster and more consistently growing 
Candida fungus, facilitating high-volume bioassays. Despite the possibility that 
these test fungi are unaffected by some or many compounds, I was still able to 
detect the presence of multiple antifungal compounds. 
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3.4.1 Culture supernatants  
3.4.1.1 Supernatants  large- and small-scale productions 
Streptomyces E8 and S. lividans supernatants were obtained from 
relatively nutrient-poor culture broths. From a large-scale production, 1250 ml of 
Streptomyces E8 supernatant were obtained. Of those, a majority (1050 ml) was 
dedicated for a BuOH extraction with proceeding column fractionations; a 
minority (200 ml) was used for bioassays. Included in the large-scale production 
was a negative control; in particular, 100 ml of S. lividans supernatant were 
obtained and destined for bioassays. From a small-scale production, 100 ml of 
Streptomyces E8 and S. lividans supernatants were obtained, both dedicated for 
bioassays.  
3.4.1.2 Bioassays against Candida  
The bioactivity of the Streptomyces E8 supernatant, destined for column 
fractionations, was confirmed by bioassaying a small sub-sample of the 200 ml 
fraction from the large-scale production against various Candida strains. Among 
the test fungi were eleven C. albicans strains (CA1-CA11) and three other
Candida species, including C. tropicalis (CA12), C. glabrata (CA13), and C. 
dubliniensis (CA14). The supernatant was diluted with distilled water to obtain 
concentrations between 100% and 10%; the same distilled water was used as 
negative control (0%). The eleven dilutions were applied to Candida (CA1-CA14) 
-coated agar plates and fungal inhibition was measured qualitatively.  
Inhibition zones, ranging from weak to strong, were given scores (Table 
3.3). A score of three was given to zones with complete fungal inhibition (lack of 
fungal growth) and zero was used for zones without fungal inhibition (unaffected 
fungal growth). Intermediate scores (one and two) were attributed to 
intermediate bioassay results. In the table, the dilution factor is set out against 
fungal identity. The more concentrated the supernatant, and/or the less resistant 
a given Candida strain, the higher the inhibition score of a particular dilution. 
Since the applied supernatant concentrations are the same for all test fungi, the 
line totals (last column) display how resistant fungal strains are. For example, 
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Table 3.3 Inhibitory effect of the Streptomyces (E8) growth 
supernatant on fourteen Candida strains. Fungal inhibition is 
scored qualitatively by allocating credits, ranging from three 
(strongest bioactivity and no fungal growth) to zero (no bioactivity 
and unaffected fungal growth). The line totals of the inhibition 
scores show the strength of fungal resistance. Most susceptible to 
the bacterial antifungals are Candida CA3, CA5, CA6, and CA13. 
Candida CA6 was chosen as test fungus for follow-up bioassay-
guided column fractionations. 
Strain 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Total
CA1 3 3 3 3 3 3 3 3 2 1 0 27
CA2 3 3 3 3 3 3 3 3 2 1 0 27
CA3 3 3 3 3 3 3 3 3 3 2 0 29
CA4 3 3 3 3 3 3 3 3 2 2 0 28
CA5 3 3 3 3 3 3 3 3 3 2 0 29
CA6 3 3 3 3 3 3 3 3 3 2 0 29
CA7 3 3 3 3 3 3 3 3 2 1 0 27
CA8 3 3 3 3 3 3 3 2 2 1 0 26
CA9 3 3 3 3 3 3 3 3 2 1 0 27
CA10 3 3 3 3 3 3 3 3 2 1 0 27
CA11 3 3 3 3 3 3 3 2 1 1 0 25
CA12 3 3 3 2 1 1 0 0 0 0 0 13
CA13 3 3 3 3 3 3 3 3 3 2 0 29
CA14 3 3 3 3 3 3 3 3 3 1 0 28
Candida CA3, CA5, CA6, and CA13 show the lowest resistance to the 
Streptomyces E8 supernatant; among those, Candida CA6 is chosen as test 
fungus for high-volume bioassays.     
3.4.1.3 Bioassays against Escovopsis  
The Streptomyces E8 supernatant from the large-scale production, 
destined for bioassays, was also tested against Escovopsis EWC. In contrast to 
other filamentous fungi, such as Escovopsis EWB, this Escovopsis strain 
showed high susceptibilities and a consistent growth during previous colony 
bioassays (Fig. 2.6; Fig. 2.7). The supernatant of S. lividans from the large-scale 
production served as a negative control. The supernatants were added to the 
centre of agar plates and Escovopsis was inoculated in a distance of 1 cm from 
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Figure 3.2 Escovopsis (EWC) supernatant bioassays. (A) Escovopsis EWC is 
challenged against the growth culture supernatant of Streptomyces E8. The test 
fungus avoids overgrowing the centrally inoculated supernatant, showing fungal 
inhibition. (B) As a negative control, the growth culture supernatant of S. 
lividans is included. The test fungus, Escovopsis EWC, overgrows the centrally 
inoculated supernatant.   
the edge of the supernatant. After incubation, the presence or absence of fungal 
inhibition was scored.   
In contrast to the supernatant of S. lividans, the supernatant of 
Streptomyces E8 inhibits the growth of the nest parasite (Fig. 3.2). This effect 
may be attributed to the same or to different antifungals that already inhibited 
Candida.  
3.4.2 Butanol-extracts  
3.4.2.1 Butanol extraction  large- and small-scale productions  
Apolar molecules in the Streptomyces E8 and S. lividans supernatants, 
from the large- and small-scale productions, were extracted with butanol. In 
particular, 1050 ml from the Streptomyces E8 large-scale production, destined 
for column fractionations, were extracted. Also, 45 ml of 200 ml from the 
Streptomyces E8 large-scale production, dedicated for bioassays, were 
extracted. In addition, 3 ml of 100 ml from the Streptomyces E8 and S. lividans
small-scale productions, destined for bioassays, were extracted. Typically, the 
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Figure 3.3 Candida (CA6) bioassays testing the 
bioactivity of the Streptomyces E8 growth 
culture (S), as well as the aqueous (A) and 
organic phase (E) of a BuOH extraction. As 
negative controls, 100% MeOH (M) and 100% 
BuOH (B) are used. The liquids were inoculated 
onto paper filter disks and when dry attached to 
a Candida-coated agar plate. Despite some 
antifungal molecules remained in the aqueous 
phase, sufficient compounds were trapped in 
the organic phase for the Streptomyces E8
antifungals to be extracted by butanol. No 
conclusions can be drawn from the diameters of 
the inhibition zones, since neither the entire 
residue of the organic phase nor the full volume 
of the aqueous phase are used for the 
bioassays. 
aqueous phase of the washes was disposed, except for the 45 ml extraction. 
The BuOH extracts and aqueous phase were challenged against different test 
fungi.  
3.4.2.2 Bioassays against Candida  
The butanol extract, originating from a 45 ml sub-sample of the 
Streptomyces E8 large-scale 
production, was re-dissolved 
in 100% MeOH and 
challenged against Candida
CA6. In addition, the 
bioassays included some of 
the original supernatant, the 
aqueous phase, and two 
negative controls that 
consisted of 100% BuOH 
and 100% MeOH. BuOH has 
been used for extracting the 
supernatants and MeOH has 
been used as holding liquid 
for the residues. All liquids 
were inoculated on paper 
filter disks. When dry, the 
filters were attached with 
distilled water to a Candida-
coated agar plate. After 
incubation, the presence or 
absence of fungal inhibition 
was scored. 
Not only the crude 
supernatant (S) and the 
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Figure 3.4 (A-B) Escovopsis (EWC) bioassays testing the bioactivity of the 
organic phases of Streptomyces E8 and S. lividans BuOH extracts. In contrast 
to the filter of the negative control (B), the test fungus clearly avoids to overgrow 
the filter with the Streptomyces E8 extract (A), showing that the extract contains 
antifungals that not only inhibit Candida (Fig. 3.3) but also Escovopsis.   
extract (E) inhibit the growth of Candida, but also the aqueous phase (A), 
indicating an incomplete absorption of antifungal molecules by the organic 
phase (Fig. 3.3). The size of the inhibition zones cannot be compared with one 
another, as not the entire apolar residue and aqueous phase were used for 
inoculating the filter disks. The results indicate that butanol is suitable for the 
extraction of antifungals from the Streptomyces E8 growth supernatant.  
3.4.2.3 Bioassays against Escovopsis  
The BuOH extracts, obtained from 3 ml sub-samples of the Streptomyces
E8 and S. lividans small-scale productions, were re-dissolved in 50% of aqueous 
MeOH, and challenged against Escovopsis EWC. When dry, the filters were 
attached with distilled water to the centre of the agar plates. Then, the nest 
parasite was inoculated at the edge of the bioassay plates. After incubation, the 
presence or absence of fungal inhibition was scored.   
While the filter with the BuOH extract of S. lividans is completely 
overgrown by the fungus, Escovopsis avoids contacting the disk with the BuOH 
extract of Streptomyces E8 (Fig. 3.4).   
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3.4.2.4 Thin layer chromatography of butanol extracts  
A sub-sample of the BuOH extract, obtained from 1050 ml of the 
Streptomyces E8 large-scale production, was re-dissolved in 50% of aqueous 
MeOH and analysed by thin layer chromatography (TLC). The dissolved residue 
was point-inoculated to the base of six silica plates. Mixtures of methanol 
(MeOH) and ethyl acetate (EtAc) in ratios, ranging from 100:0 to 50:50 
(MeOH:EtAc), served as the mobile phase. The migration rate of compounds 
across TLC plates does not only depend on the polarities of the compounds 
themselves, but also on the polarities of the stationary (silicate) and mobile 
(solvent mixture) phases. The more polar the compounds, the slower their 
migration rate, meaning that relatively apolar compounds will settle relatively 
close to the solvent front.  
Figure 3.5 shows a schematic drawing of the TLC plates under short- 
(bottom left) and long- (bottom right) wave UV light as well as photographs of 
the TLC plates after being stained with the oxidising agent potassium 
permanganate (top). A MeOH:EtAc ratio of 70:30 shows the best separation of 
oxidisable compounds in the BuOH extract. In general, the TLC results may 
indicate that the (non-)bioactive compounds in the BuOH extract are separated 
well by this solvent system.   
3.4.3 Normal-phase column fractionation  
3.4.3.1 Fractionation  
The BuOH extract from a 1050 ml Streptomyces E8 large-scale production, 
previously analysed by TLC, was purified by normal-phase (NP) column 
fractionation. The remaining residue was re-dissolved in a MeOH:EtAc (4:11) 
mixture. A sub-sample of this column starter material was preserved for later 
TLC analysis. The extract was run through a column, containing silica as  
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Figure 3.5 Thin layer chromatography (TLC) analysis on the 
residue of a Streptomyces E8 BuOH extract to determine the 
optimal solvent conditions for a normal-phase column 
fractionation. Sub-samples of the residue are re-dissolved, 
inoculated to the base of TLC plates, and run across plates 
using solvent conditions ranging from relatively polar (100:0 
MeOH:EtAc) to more apolar (50:50 MeOH:EtAc). In the lower 
panel of the figure, the TLC plates are shown under short- (left) 
and long- (right) wave UV light; in the upper panel the same 
plates are shown after being stained with the oxidising agent 
potassium permanganate. The figure shows that the stainable 
(non-)bioactive compounds separate best under solvent 
conditions of 70% MeOH and 30% EtAc.  
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stationary phase, with increasingly polar solvent mixtures (mobile phase) 
spanning MeOH:EtAc ratios of 0:100, 60:40, 70:30, and 100:0. These solvent 
ratios were guided by findings from a previous TLC analysis, described above, 
in which a 70:30 MeOH:EtAc ratio exhibited the best separation of oxidisable 
compounds. The eluent, leaving the column, was captured in a total of 85 
fractions. 
Some normal-phase fractions (12-19, 24-46, 78-80) show a yellow/brown 
colouration (Fig. 3.6), whereas the remainder is transparent. Since early 
fractions eluted under relatively apolar conditions (EtAc>MeOH) and later ones 
under relatively polar conditions (EtAc<MeOH), the fractions should contain 
different molecules.  
3.4.3.2 Bioassays against Candida  
To localise the antifungal molecules in the NP fractions (1-85), bioassays 
were carried out, in which the fractions were tested against Candida CA6. Small 
amounts of each fraction were loaded onto paper filter disks. When dry, the 
filters were attached to Candida-coated agar plates with distilled water. After 
incubation, the diameters of inhibition zones around test filters were measured.  
These bioassays (Fig. 3.7) were carried out in triplicate and the diameters 
of the inhibition zones, averaged across replicate plates, are presented in figure 
3.8. The graph shows a baseline of 0.9 cm, which corresponds to the diameter 
of the filters, and indicates the absence of fungal inhibition. Two sets of 
compounds, including fractions 22-43 and 67-85, show averages above 0.9 cm. 
Due to the polarity difference of the eluents in both sets, this finding reveals that 
Streptomyces E8 produces at least two antifungals.  
3.4.3.3 Thin layer chromatography  
The normal-phase fractions (1-85) were analysed by TLC. As reference, 
the column starter material was point-inoculated onto the first lane of each TLC 
plate, the NP fractions onto any lane thereafter. Since the crude BuOH extract 
separated best under solvent conditions, consisting of a MeOH:EtAc ratio of  
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Figure 3.6 Fractions (1-85) of a normal-phase column fractionation of the 
Streptomyces E8 BuOH extract. As solvent system, changing ratios of EtAc and 
MeOH are used; while initial fractions are relatively apolar, later ones are more 
polar. Fractions 12-19, 24-46, and 78-80 are coloured and the remaining 
fractions are transparent.  
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Figure 3.7 Candida (CA6) bioassays testing the bioactivity of 
normal-phase fractions 1-85 (Fig. 3.6). Paper filter disks, 
inoculated with fraction sub-samples, are attached to Candida-
coated agar plates. As negative controls, one uninoculated filter 
disk (P), two disks with 100% MeOH (M), and two disks with 
100% EtAc (E) were included. Two sets of fractions, namely 
fractions 22-43 and 67-85, are inhibiting the growth of Candida
(red font). Both sets differ too much in their polarity to contain 
the same antifungal compound(s). Analogies between the 
observed bioactivity (22-43, 67-85) and the colouration (12-19, 
24-46, 78-80) of fractions may be linked or, alternatively, 
attributed to different molecules. This experiment is carried out 
in triplicate; average diameters of the inhibition zones are 
shown in figure 3.8. 
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Figure 3.8 Graphical representation of bioassay results on the normal-phase 
fractions 1-85, presented in figure 3.7. The X-axis shows the fraction identity and 
the Y-axis the average diameters (± s.e.) of the inhibition zones around filter disks. 
The baseline of 0.9 cm is formed by the diameter of the filter disks, and values 
above 0.9 cm stem from fungal inhibition. Filters 85-90 are negative controls. Two 
sets of fractions are bioactive, namely fractions 22-43 and 67-85. Due to the 
differences in their polarity, both sets must contain different antifungals. In other 
words, Streptomyces E8 must secrete a minimum of two antifungals into the liquid 
medium.  
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70:30, the same solvent conditions were applied here. The TLC plates were 
stained with the oxidising agent potassium permanganate.  
Only photographs of selected TLC plates are presented in figure 3.9; in 
contrast TLC plates inoculated with non-bioactive or uncoloured fractions, or 
fractions that could not be stained with potassium permanganate, were 
excluded from this selection. Only the relatively apolar fractions 13-15 and 22-
29 could be stained. The stainable fractions 13-15 have previously been shown 
to also possess a colouration (12-19) but no inhibitory effect on Candida. In 
contrast, the oxidisable fractions 22-29 have earlier been shown to possess 
both a colouration (24-46) and an inhibitory effect on the yeast (22-43). Finally, 
no oxidation signal could be detected from the relatively polar fractions 78-80 or 
67-85, which have previously been shown to possess a colouration and an 
inhibitory effect on Candida, respectively. The results confirm the previous 
observation that the applied solvent ratios indeed suited the fractionation of the 
Streptomyces E8 BuOH extract; after all, oxidisable compounds in the column 
starter material indeed have separated into different normal-phase fractions.  
Figure 3.9 Thin layer chromatography (TLC) on the normal-phase fractions (1-
85). The TLC plates are inoculated with sub-samples of the normal-phase 
fractions and the crude BuOH extract that was used as column starter material 
(E, first lane). A solvent mixture of 70% MeOH and 30% EtAc was used as 
mobile phase. Here, only those TLC plates are shown, which were inoculated 
with bioactive (22-43, 67-85) or coloured (12-19, 24-46, 78-80) fractions, or 
which contain fractions that are stainable with potassium permanganate. Three 
TLC plates meet these criteria. (A) Fractions 13-15 are stainable with potassium 
permanganate, showed a colouration (12-19), but did not inhibit Candida. (B) 
Fractions 22-29 and surrounding are oxidisable, showed a colouration (24-46), 
and inhibited Candida (fractions 22-43). (C) Fractions 78-80 showed a 
colouration and fractions 67-85 inhibited Candida; however, none of these 
fractions contained compounds stainable with potassium permanganate.  
Chapter 3) Antifungals of an Acromyrmex octospinosus ant-associated Streptomyces
strains 
97
3.4.4 Identification of candicidin 
To test the hypothesis that Streptomyces E8 produces other antifungals in 
addition to candicidin (Barke et al. 2010), the presence of latter was analysed in 
first place. In particular, the crude BuOH extract and two bioactive normal-phase 
fractions were examined by low- and high-resolution LCMS, respectively. 
Haeder et al. (2009) found candicidin (C59H84N2O18), produced by an 
Acromyrmex cultivar-associated Streptomyces bacterium, to possess an 
accurate ion mass of 1109.57938 amu [M+H]+. The antifungal absorbed UV light 
at maxima of 408 nm, 384 nm, 364 nm, and 344 nm. During a MS2 analysis, the 
authors also showed that the candicidin molecules fragment into daughter ions 
with masses of 1091.56827 amu and 928.48458 amu [M+H]+. Respectively, 
these ions were suggested to represent sub-structures of the candicidin 
molecule, lacking a water molecule [M+H-H2O]+ and a water molecule plus the 
mycosamine subunit [M+H-mycosmine-H2O]+.  
3.4.4.1 Low-resolution LCMS  
During a LCMS analysis, the compounds of the BuOH extract were 
separated on a reversed-phase (RP) column. The masses of the compounds in 
the eluent, accurate to ± 0.1 amu, were detected by a mass spectrometer in 
low-resolution and positive ion mode (+ESI). Also UV absorbance and MS2 data 
were collected.  
The upper part of figure 3.10A-B shows a photodiode array (PDA) trace, 
base peak chromatogram (BPC) for compound masses in between 124-2000 
amu, and mass range for compounds in between 1109.0-1109.9 amu. The PDA 
and BPC signals reveal that the BuOH extract is loaded with innumerable 
molecules, most of which are expected to originate from the medium. In 
contrast, the mass range shows the presence of one dominant peak, eluting 
after 17.83 minutes. In the lower part of figure 3.10A, the full MS of this PDA 
peak is given, which is dominated by an ion mass of 1109.5 amu [M+H]+. To 
verify or falsify that this mass relates to candicidin, its UV absorbance and MS2
pattern are analysed.   
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Figure 3.10 (A-B) Low-resolution reversed-phase LCMS on a Streptomyces E8
BuOH extract, in positive ion mode (+ESI). The goal is to check whether the 
extract contains candicidin. The upper panel of both graphs shows a PDA trace, 
base peak chromatogram (BPC), and mass range for compounds between 
1109.0-1109.9 amu. The latter clearly shows the presence of a single ion peak 
with a retention time of 17.83 minutes. (A) The full MS of this peak (RT=17.83) 
is dominated by an ion with a mass of 1109.5 amu [M+H]+. (B) The UV 
absorbance of the peak (RT=17.83) reveals the presence of four absorbance 
maxima including 406 nm, 383 nm, 362 nm, and 342 nm. Both, mass and UV 
data correspond to the data of candicidin D, presented by Haeder et al. (2009). 
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Figure 3.10 (C-D) Low-resolution reversed-phase LCMS on a Streptomyces E8
BuOH extract, in positive ion mode (+ESI). The fragmentation of the 1109.5 
amu [M+H]+ parent ion, shown above, reveals the presence of at least three 
diagnostic daughter ions with masses of 1091.3 amu, 928.0 amu, and 875.3 
amu [M+H]+. Haeder et al. (2009) suggested the 1091.56827 amu and 
928.48458 amu [M+H]+ daughters to match the parent ion lacking a water 
molecule [M+H-H2O]+ or a water molecule plus the mycosamine sub-unit [M+H-
H2O-mycosamine]+. In addition, the 875.3 amu [M+H]+ daughter may 
correspond to a sub-structure of the parent molecule highlighted teal in figure 
3.10E.
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Figure 3.10B shows the UV absorbance of the eluent with a retention time 
(RT) of 17.83 minutes. Due to the diversity of unrelated absorbances, this and 
no earlier PDA peak was chosen, despite the slight delay between PDA and 
mass detection. The UV signal clearly shows the presence of four absorbance 
maxima at higher wavelengths, including 406 nm, 383 nm, 362 nm, and 342 nm, 
which resemble the maxima found by Haeder et al. (2009). In general, 
corresponding maxima may vary by up to 5 nm, for example, due to slight 
differences in the solvent mixing and/or presence of coeluting contaminants.  
Since molecules tend to fragment at compound-specific locations, MS2
data provide fingerprints of compounds. These sub-structures, as represented 
by diagnostic daughter ions, provide information on the structural constellation 
and identity of the parent molecule. The MS2 fragmentation pattern of the 
1109.5 amu [M+H]+ parent ion is shown in figure 3.10C-D. Daughter ions with 
masses of 875.3 amu and 1091.3 amu [M+H]+ could be detected matching a 
sub-structure of candicidin D (Reaxys ID: 6471601), highlighted teal in figure 
3.10E, and candicidin D lacking a water molecule, respectively. In addition, a 
daughter ion with a mass of 928.0 amu [M+H]+ was detected, suggested to 
match candicidin D lacking a water molecule plus the mycosamine subunit 
(Haeder et al. 2009). In conclusion, both the UV and MS2 data support the 
Exact Mass : 
874.42251
Formula : C45H64NO16
Exact Mass : 
234.14940
Formula : C14H20NO2
Exact Mass : 
1108.57191
Formula : C59H84N2O18
E
Figure 3.10 (E) Low-resolution reversed-phase LCMS on a Streptomyces E8
BuOH extract, in positive ion mode (+ESI). Molecular structure of candicidin D 
(Reaxys ID: 6471601). Above, candicidin is suggested to be present in the 
BuOH extract of the bacterium. The teal colouration indicates a part of the 
molecule, with a mass of 874 amu, which in figure 3.10D has been identified as 
diagnostic daughter ion.  
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suspicion that the 1109.5 amu [M+H]+ parent ion in the Streptomyces E8 BuOH 
extract indeed is candicidin. 
3.4.4.2 High-resolution LCMS  
Low-resolution LCMS has suggested candicidin to be present in the 
Streptomyces E8 BuOH extract. In order to trace the destination of the antifungal 
after normal-phase column fractionation, two bioactive normal-phase fractions, 
including the relatively apolar fraction 24 and the more polar fraction 79 (Fig. 
3.8), were analysed by high-resolution LCMS. The orbitrap mass spectrometer 
was set to detect MS and MS2 masses, accurate to ± 0.00001 amu, in positive 
ion mode (+ESI) that served in calculating molecular formulae.  
The upper panel of figure 3.11A-B shows a BPC for compounds in between 
124-1500 amu and a mass range of 1109.0-1109.9 amu, present in fraction 79. 
The mass range shows an accumulation of 1109 amu [M+H]+ masses with a 
mean retention time of 14.56 minutes. In the lower panel, the full MS is given 
for retention times, ranging from 13.81-15.16 minutes, as well as a simulation of 
the candicidin mass 1109.57919 amu [M+H]+. With a mass difference of only 
0.00131 amu, the simulation matches a sample ion with a mass of 1109.57788 
amu [M+H]+ most closely. Based on the accurate sample mass, a molecular 
formula was calculated, accepting a maximum of 100xN, 100xO, 100xC, 100xH, 
and 1xNa atoms, in case the detected ion is a sodium adduct. Among the 
calculated formulae was C59H85N2O18, which corresponds to the formula of the 
neutral candicidin molecule (C59H84N2O18). Unfortunately, no accurate MS2 data 
of the 1109 amu [M+H]+ parent ion has been generated. 
The upper panel of figure 3.11C-D provides a BPC for compound masses in 
between 50-1500 amu and a mass range of 1109.0-1109.9 amu, present in 
fraction 24. The mass range shows the absence of a dominant 1109 amu 
[M+H]+ peak. In the lower panel, a full MS for retention times is shown, ranging 
from 9.90-22.08 minutes, as well as a simulation of the candicidin mass 
1109.57919 amu [M+H]+.  
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Figure 3.11 (A-B) High-resolution reversed-phase LCMS on normal-phase fraction 
79 (Fig. 3.8), in positive ion mode (+ESI). The upper panel of the graphs shows a 
base peak chromatogram (BPC) and mass range for compounds between 1109.0-
1109.9 amu. The latter reveals the presence of a 1109.57788 amu [M+H]+ ion peak 
eluting at RT=14.56. The lower panel of the graphs shows a simulation on the 
candicidin formula based on which its accurate mass is expected to be 1109.57919 
amu [M+H]+. The mass difference between simulation and sample mass is 0.00131 
amu; however, the molecular formula of the sample ion (C59H85N2O18) matches the 
formula of the neutral candicidin mass (C59H84N2O18). Hence, the candicidin 
molecules detected by low-resolution LCMS in the Streptomyces E8 BuOH extract 
(Fig. 3.10) likely eluted into the relatively polar set of bioactive normal-phase 
fractions.
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Figure 3.11 (C-D) High-resolution reversed-phase LCMS on normal-phase fraction 
24 (Fig. 3.8), in positive ion mode (+ESI). The upper panel of the graphs shows a 
base peak chromatogram (BPC) and mass range for compounds between 1109.0-
1109.9 amu. A strong 1109 amu mass signal, as observed for fraction 79, is absent 
from the mass range of fraction 24. The lower panel of the graphs shows that the 
difference between the simulated candicidin mass (1109.57919 amu [M+H]+) and 
the closest sample masses (1109.52502 amu and 1109.61995 amu [M+H]+) are 
0.05417 amu and 0.04076 amu. These differences are too large to be explained by 
orbitrap measuring errors. For this reason, candicidin can be regarded as absent 
from the more apolar set of bioactive normal-phase fractions.  
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The simulated mass does not match any of the full MS masses; the best 
matching sample masses, 1109.52502 amu and 1109.61995 amu [M+H]+, differ 
from the simulation by 0.05417 amu and 0.04076 amu, respectively. These 
differences are too large to be explained by orbitrap measuring errors and may 
hence indicate the absence of candicidin in fraction 24.  
In conclusion, these results provide further evidence that the 1109 amu 
[M+H]+ ion, which is traced in the Streptomyces E8 BuOH extract, indeed 
corresponds to candicidin. During a normal-phase column fractionation of the 
crude BuOH extract, the antifungal apparently eluted into the relatively polar 
fraction 79; in contrast, candicidin was absent from the more apolar fraction 24.  
3.4.5 Pooling of normal-phase fractions 
3.4.5.1 Pooling   
The normal-phase fractions 1-21 (non-bioactive), 22-43 (bioactive), 44-66 
(non-bioactive), and 67-85 (bioactive) were pooled to increase antifungal 
concentrations. Figure 3.12 shows an overview of the pooled fractions, which in 
the following will be referred to as combined fractions A-D. After evaporating 
the holding liquids, re-dissolving the residues, and temporally storing the 
samples, precipitation accumulated at the bottom of the flasks. Hence, the 
supernatants and precipitates of the combined fractions A-D were challenged 
against Candida separately.  
3.4.5.2 Bioassays against Candida  
For the bioassays, small sub-samples of the pellets were re-dissolved in 
100% DMSO. The supernatants and dissolved pellet materials, alongside two 
negative controls (100% DMSO and 100% MeOH), were inoculated onto paper 
filter disks. Then, the filters were attached with distilled water to Candida-coated 
agar plates and fungal inhibition was recorded. 
Chapter 3) Antifungals of an Acromyrmex octospinosus ant-associated Streptomyces
strains 
105
The supernatants and pellets of the combined fractions B-D were bioactive 
(Fig. 3.13). Sub-lethal antifungal concentrations in fractions 44-66 (Fig. 3.12) are 
responsible for the inhibitory properties of the combined fractions C in this 
experiment; these antifungals must be the same compounds causing bioactivity 
in the combined fractions B and/or D. Also, the results indicate that some of the 
antifungal molecules in the supernatants of the combined fractions B and D 
dropped out of solution.  
Figure 3.12 Pooling of the normal-phase fractions 1-85 into the combined 
fractions 1-21 (A), 22-43 (B), 44-66 (C), and 67-85 (D) according to their 
bioactivity. The combined fractions B and D should contain most of the 
bioactive molecules present in the Streptomyces E8 BuOH extract. Due to 
indications suggesting candicidin to be present in fraction 79 (Fig. 3.11), the 
combined fractions B are used for a follow-up reversed-phase column 
purification. 
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Figure 3.13 (A-D) Bioassays of supernatants and precipitates against Candida CA6. 
Precipitation accumulated at the bottom of the vials holding the combined fractions A-
D. Sub-samples of the precipitates (P), dissolved in DMSO, the remaining 
supernatants (S), and two negative controls, 100% MeOH (M) and 100% DMSO (D), 
were inoculated onto paper filter disks and attached to Candida-coated agar plates. 
The supernatants and pellets of the combined fractions B, C, and D are inhibiting the 
test fungus. The results indicate that some of the antifungal molecules dropped out of 
solution. The inhibition zones of B are relatively small with clear-cut edges and the one 
of D (and C) are relatively large with diffuse edges. This observation may, in addition 
to the polarity differences, indicate that both antifungals differ from one another. 
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3.4.6 Reversed-phase column fractionation 
3.4.6.1 Fractionation  
To determine the identity of the antifungal in the combined fractions B, the 
still highly contaminated sample (Fig. 3.11C-D) was column-purified a second 
time. During multiple HPLC runs, the supernatant and DMSO-dissolved pellet 
were purified by reversed-phase (RP) column fractionation. The solvent 
conditions changed from relatively polar (dH2O>MeOH) to more apolar 
(dH2O<MeOH) conditions. Simultaneously, the UV absorbance of eluting 
compounds was measured; the eluent of each run was sub-divided over 80 
fractions.  
Figure 3.14A shows the UV absorbance signal of the first fractionation run; 
here, the X-axis presents the retention time (minutes), and the Y-axis displays 
the UV absorbance for wavelengths between 200-600 nm. A red colouration 
indicates a strong UV absorbance, whereas a blue colouration displays a weak 
UV absorbance. The graph shows that the chosen chromatography leads to a 
good separation of compounds, and thus a separation of bioactive and non-
bioactive compounds.    
3.4.6.2 Bioassays against Candida  
Sub-samples of the RP fractions, originating from the first fractionation run, 
were inoculated onto filter disks. When dry, the disks were attached with distilled 
water to Candida-coated agar plates and fungal inhibition was recorded. The 
bioactivity clearly localises in the relatively apolar fractions 58-65 (Fig. 3.15). 
This result is expected since the antifungal, which during normal-phase column 
fractionation have eluted under relatively apolar conditions (EtAc>MeOH), also 
eluted under relatively apolar conditions during this reversed-phase column 
fractionation (dH2O<MeOH). Interestingly, the RT area into which the bioactive 
molecules eluted (RT»38.5-42.5), generally shows a relatively poor UV 
absorbance. In contrast, the RT area directly preceding the bioactive area is 
characterised by the presence of four dominant compounds (RT»34.0-37.5).   
Chapter 3) Antifungals of an Acromyrmex octospinosus ant-associated Streptomyces
strains 
108
Figure 3.14 Reversed-phase column fractionation on combined fractions B. The 
bioactive supernatant and dissolved precipitate were fractionated. Per HPLC run, 
80 fractions of eluent were collected. (A) UV absorbance signal from the first 
fractionation run. The Y-axis shows the absorbance from 200-600 nm and the X-
axis the time in minutes. The strength of the signal is presented as a colour gradient 
from blue (relatively weak) to red (relatively strong). The graph indicates that the 
compounds of the extract separated well under the present solvent conditions. 
Challenges between the reversed-phase fractions of the first fractionation run and 
Candida CA6 are given in figure 3.15. The bioassays show that the antifungal 
molecules eluted under relatively apolar conditions (dH2O<MeOH) into fractions 58-
65 (RT=~38.5-42.5). The UV absorbance at the bioactive RT area is fairly weak not 
revealing the presence of any abundant molecules. In contrast, the preceding RT 
area (RT=~34.0-37.5) is characterised by the presence of four dominant 
compounds (white arrows). Due to this observation, follow-up fractionation runs 
combined the eluent of both RT areas. (B) A small sub-sample of the double-
purified (NP/RP) combined fractions B was re-analysed in a final HPLC run. As 
expected, the majority of the pollutants is absent from the sample.  
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Figure 3.15 Bioassays of the reversed-phase fractions from the first HPLC 
run (Fig. 3.14A) against Candida CA6. Sub-samples of the fractions were 
inoculated onto paper filter disks and attached to Candida-coated agar 
plates. The bioassay reveals that the antifungal molecules are eluting under 
relatively apolar conditions (dH2O<MeOH) into fractions 58-65 (red font). 
This corresponds to a retention time of ~38.5-42.5 minutes.  
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Due to the weak UV absorbance in the bioactive RT area and the close 
proximity to the dominant compounds, follow-up fractionation runs combined the 
eluent of both RT areas. 
The purity of the selected eluent, containing the four dominant compounds 
and the bioactive RT area, was analysed in a final HPLC run (Fig. 3.14B) using 
the same chromatography as described above. The graph shows a significant 
reduction of contaminating compounds in the double-purified (NP/RP) combined 
fractions B.  
3.4.6.3 Bioassays of extract and waste  
In bioassays, the double-purified (NP/RP) combined fractions B (E) were 
challenged against Candida
CA6 alongside eluents, which 
during the above reversed-
phase column fractionation, 
were directed to the waste (W). 
This experiment was carried 
out to determine whether 
antifungal molecules had been 
lost to the waste. Sub-samples 
of both liquids were inoculated 
onto paper filter disks. A filter 
inoculated with 100% MeOH 
(C-) served as negative control. 
When dry, the disks were 
attached with water to 
Candida-coated agar plates. 
All bioactive molecules appear 
to have accumulated in the 
extract and no bioactive 
molecules appear to have 
Figure 3.16 Candida (CA6) bioassays testing 
the bioactivity of the double-purified (NP/RP) 
combined fractions B. The selected extract (E) 
and remaining waste (W) of the reversed-
phase column fractionation were inoculated 
onto paper filter disks and attached to 
Candida-coated agar plates. As a negative 
control, a disk with 100% MeOH (C-) was 
included. This test results confirm that no 
antifungal molecules are lost to the waste. 
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been lost to the waste (Fig. 3.16).
3.4.7 Identification of antimycin 
The compound masses of the double-purified (NP/RP) combined fractions 
B were analysed by low- and high resolution LCMS.    
3.4.7.1 Low-resolution LCMS  
MS, MS2, and UV absorbance data of the double-purified (NP/RP) 
combined fractions B were collected during a low-resolution LCMS analysis in 
positive ion mode (+ESI). The detected masses are accurate to ± 0.1 amu. 
Figure 3.17A-B shows a PDA trace of this run, a total ion chromatogram 
(TIC), and a BPC for compounds in between 150-1500 amu. A numerical 
representation and detailed overview of the data are given in table 3.4 and the 
Supplementary Information B1, respectively. The MS data show the presence of 
four major compounds, previously observed during the reversed-phase column 
fractionation, which have masses of 507 amu, 521 amu, 535 amu, and 549 amu 
[M+H]+; these are followed by several minor peaks with masses of 563 amu, 
(805 amu), and 577 amu [M+H]+. In the following, these are referred to as first-
set compounds. The same masses, excluding the 805 amu ion, elute from the 
column a second time under slightly more apolar solvent conditions, and are 
referred to as second-set compounds. In contrast with the retention times of 
the first-set compounds, the retention times of the second-set compounds, 
roughly speaking, match the bioactive RT area defined above. In general, the 
mass signals of the second-set compounds were much weaker than those of 
the first-set compounds. This can be attributed to disadvantageous ionisation 
properties or a low molecular abundance, which also would explain the weak 
absorbance signal experienced during the reversed-phase column fractionation. 
Therefore, the compounds of both sets additionally are visualised in extracted 
ion chromatograms (EIC); these data are presented in table 3.4 and the 
Supplementary Information B2. The masses therein have been identified as 
hydrogen adducts since their sodium counterparts (mass difference of  
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Figure 3.17 (A-B) Low-resolution reversed-phase LCMS of the double-purified 
(NP/RP) combined fractions B in positive ion mode (+ESI). The graphs show a 
PDA, TIC, and BPC trace of the run. A detailed overview of the data is given in 
table 3.4 and the Supplementary Information B1. Six compound masses, 
including the four dominant compounds described earlier (Fig. 3.14), are eluting 
from the column that in the following will be referred to as first-set compounds 
(blue circles). The same six compound masses are eluting from the column 
under slightly more apolar solvent conditions, and will in the following be 
referred to as second-set compounds (red circles). The retention times of the 
second-set compounds may correspond to the retention times of compounds in 
the bioactive RT area (Fig. 3.14). Due to a weak UV absorbance and mass 
signal, the UV, MS, and MS2 data of second-set compounds are incomplete. 
Hence, extracted ion chromatograms (EIC) are presented in the Supplementary 
Information B2 that better visualise the compounds of both compound sets, 
including masses of 507 amu, 521 amu, 535 amu, 549 amu, 563 amu, and 577 
amu [M+H]+. Not only that second-set compounds are more apolar than first-set 
compounds, but also within sets larger compounds are more apolar than 
smaller ones. The results indicate that the bioactivity against Candida CA6 may 
stem from an antifungal complex of six second-set compounds. 
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Table 3.4 Numerical representation of the low-resolution reversed-phase 
LCMS data, shown in figure 3.17. The table shows UV, MS, and MS2 data 
for compounds of the double-purified (NP/RP) combined fractions B in 
positive ion mode (+ESI). Both compound sets contain masses of 507 amu, 
521 amu, 535 amu, 549 amu, 563 amu, and 577 amu [M+H]+. First-set 
compounds tend to fragment into daughter ions with masses of 247 amu 
and 265 amu; also parent-specific daughter ions are generated with masses 
of 243 amu (parent 507 amu), 257 amu (parent 521 amu), 271 amu (parent 
535 amu), 285 amu (parent 549 amu), 299 amu (parent 563 amu), and 313 
amu (parent 577 amu) [M+H]+. In contrast, second-set compounds produce 
daughter ions with masses of 265 amu and 237 amu [M+H]+. Here, no 
parent-specific daughter ions can be detected. The results show that, in 
addition to bioactivity and polarity differences, first- and second-set 
compounds differ in their chemical structures. 
Peak 1 2 3 4 5 6
EIC 507-508 521-522 535-536 549-550 563-564 805-806 577-578
RT 13.49 14.12 14.86 15.48 16.06 16.46 16.71
Parent ion 507.0 521.0 535.0 549.0 563.1 805.2 577.2
Adduct H H H H H H H
RT 13.33 13.97 14.70 15.32 15.90 - 16.50
UV max. 244.0 240.0 244.0 242.0 243.0 - 248.0
UV max. 319.0 321.0 320.0 321.0 323.0 - 324.0
UV max. - 358.0 - - 361.0 - 361.0
UV max. 383.0 383.0 383.0 383.0 383.0 - 383.0
UV max. 405.0 405.0 405.0 405.0 405.0 - 450.0
RT 13.42 14.26 14.66 15.29 15.89 16.42 16.51
Parent ion 507.02 521.21 535.09 549.08 563.09 805.23 577.14
Daughter ion (body) 247.0 247.0 247.0 247.0 247.0 265.0 247.0
Daughter ion (body) 264.9 264.9 264.9 264.9 264.9 435.1 265.0
Daughter ion (tail) 242.9 256.9 271.0 285.0 299.0 522.8 313.0
Daughter ion (body) 219.1 219.1 219.0 219.0 219.0 787.2 219.1
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Adduct - - H H H - H
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Parent ion - - 535.01 549.04 563.17 - 577.22
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21.981945 amu) were consistently present. 
The UV absorbance data of first- and second-set compounds are 
presented in table 3.4 and the Supplementary Information B1. Again, due to the 
relatively low signal/noise ratio, the absorbance data of the second-set 
compounds is incomplete or less accurate. However, an assumption is that first- 
(240-248 nm; 319-324 nm) and second- (241-253 nm; 320-322 nm) set 
compounds absorb at two wavelengths. 
In accordance with the differential polarities, first- and second- set 
compounds show differing MS2 data (Table 3.4.; Supplementary Information B1). 
For example, first-set compounds, except for the 805 amu ion, fragment into 
daughter ions with masses of 247 amu, 265 amu, and 219 amu [M+H]+. In 
addition, the presence of daughter ions with parent specific masses can be 
observed, including 243 amu (parent 507 amu), 257 amu (parent 521 amu), 271 
amu (parent 535 amu), 285 amu (parent 549 amu), 299 amu (parent 563 amu), 
and 313 amu (parent 577 amu) [M+H]+. In contrast, second-set compounds 
consistently fragment into daughters with masses of 265 amu and 237 amu 
[M+H]+; daughter ions with parent specific masses are absent. This suggests 
structural differences between corresponding first- and second-set parent ions 
possessing equal masses. Unfortunately, no MS2 data could be obtained from 
the 507 amu and 521 amu [M+H]+ parent ions of the second set.  
In summary, two sets of compound masses are detected in the double-
purified (NP/RP) combined fractions B. The retention times of the second-set 
compounds may correspond to the retention times of compounds in the 
bioactive RT area, described during reversed-phase column fragmentation (Fig. 
3.14). No bioactivity is observed to originate from first-set compounds, which 
appear to slightly differ in structure from second-set compounds as indicated by 
differential polarities and MS2 fragmentation patterns. The mass similarities 
between both compound sets aided the identification of the bioactive second-set 
compounds, as described below.  
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3.4.7.2 High-resolution LCMS  
MS and MS2 data of the double-purified (NP/RP) combined fractions B 
were collected during high-resolution LCMS in positive ion mode (+ESI). The 
detected masses are accurate to ± 0.00001 amu.  
Figure 3.18A-B shows the TIC and BPC for compounds in between 150-
1500 amu. A numerical representation and detailed overview of these data are 
given in table 3.5 and the Supplementary Information B3, respectively. All 
compounds of the first set, except for the 805 amu [M+H]+ ion, could be 
detected; in contrast, none of the second-set compounds ionised. The accurate 
masses of the first-set compounds are 507.23364 amu, 521.24878 amu, 
535.26483 amu, 549.28027 amu, 563.29529 amu, and 577.31219 amu [M+H]+. 
Interestingly, the compound masses differ by 14 amu, which corresponds to a 
CH2 group. Based on the accurate masses, the molecular formulae of the 
compounds are calculated to be C25H35N2O9, C26H37N2O9, C27H39N2O9, 
C28H41N2O9, C29H43N2O9, and C30H45N2O9. EIC data of the compounds are 
presented in table 3.5 and the Supplementary Information B4.
Except for the largest first-set compound, with a mass of 577.31219 amu, 
accurate MS2 masses were detected for all parent ions (Table 3.5; 
Supplementary Information B3). The fragmentation patterns of all parent ions 
included the daughters 247.071 amu, 265.082 amu, and 219.076 amu [M+H]+; 
their molecular formulae are: C12H11N2O4, C12H13N2O5, and C11H11N2O3, 
respectively. Also, daughter ions with parent specific masses were detected that 
have previously been observed during low-resolution LCMS (Table 3.4). Their 
accurate masses were 243.15884 amu (parent 507 amu), 257.17462 amu 
(parent 521 amu), 271.18994 amu (parent 535 amu), 285.20584 amu (parent 
549 amu), and 299.22144 amu (parent 563 amu) [M+H]+. The molecular 
formulae of these sub-structures are C13H23O4, C14H25O4, C15H27O4, C16H29O4, 
and C17H31O4, respectively. In contrast with the molecular formulae of the 247 
amu, 265 amu, and 219 amu daughters, the molecular formulae of the 
daughters with parent specific masses, do not contain any nitrogen atoms.  
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Figure 3.18 (A-B) High-resolution reversed-phase LCMS on 
the double-purified (NP/RP) combined fractions B in positive 
ion mode (+ESI). During this analysis only first-set ions could 
be detected (blue circles). The accurate MS and MS2 data of 
these ions are shown in table 3.5.  
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Table 3.5 Numerical representation of the high-resolution reversed-phase 
LCMS data, given in figure 3.18. The table shows accurate MS and MS2 data for 
compounds of the double-purified (NP/RP) combined fractions B in positive ion 
mode (+ESI). The second-set compounds, as detected by low-resolution LCMS 
(Table 3.4), did not ionise. Based on the accurate MS data, molecular formulae 
are calculated. The formulae differ between the smallest (507.23364 amu 
[M+H]+; C25H35N2O9) and the largest (577.31219 amu [M+H]+; C30H45N2O9) 
molecule by the stepwise addition of five CH2 groups (14 amu). No MS2 data 
could be obtained from the 577.31219 amu [M+H]+ parent ion. All other 
molecules fragmented into daughters with masses of 247.071 amu 
(C12H11N2O4), 265.082 amu (C12H13N2O5), and 219.076 amu (C11H11N2O3) 
[M+H]+. Interestingly, their molecular formulae all contain two nitrogen atoms. In 
contrast, the parent-specific daughter ions, ranging in mass from 243.15884-
299.22144 amu [M+H]+ (C13-17H23-31O4), do not contain any nitrogen atoms. 
While the parent formulae are used for screening databases of natural products, 
the daughter formulae are used for determining the accuracy of the search hits. 
Peak 1 2 3 4 5 6
EIC 507-508 521-522 535-536 549-550 563-564 577-578
RT 16.02 16.61 17.27 17.84 18.41 19.24
Parent ion 507.23364 521.24878 535.26483 549.28027 563.29529 577.31219
Formula C25H35N2O9 C26H37N2O9 C27H39N2O9 C28H41N2O9 C29H43N2O9 C30H45N2O9
Error -0.132 -1.107 -0.331 -0.705 -1.806 0.403
Adduct H H H H H H
RT 15.94 16.70 17.32 17.69 18.40 -
Parent ion 507.23 521.25 535.27 549.28 563.30 -
Mass 247.07104 247.07109 247.07115 247.07115 247.07112 -
Formula C12H11N2O4 C12H11N2O4 C12H11N2O4 C12H11N2O4 C12H11N2O4 -
Error -1.187 -0.985 -0.742 -0.742 -0.863 -
Mass 265.08154 265.08163 265.08167 265.08160 265.08176 -
Formula C12H13N2O5 C12H13N2O5 C12H13N2O5 C12H13N2O5 C12H13N2O5 -
Error -1.237 -1.011 -0.860 -1.124 -0.521 -
Mass 243.15884 257.17462 271.18994 285.20584 299.22144 -
Formula C13H23O4 C14H25O4 C15H27O4 C16H29O4 C17H31O4 -
Error -1.010 -0.450 -1.644 -0.687 -0.822 -
Mass 219.07617 219.07640 219.07632 219.07623 - -
Formula C11H11N2O3 C11H11N2O3 C11H11N2O3 C11H11N2O3 - -
Error -1.135 -0.085 -0.451 -0.861 - -
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3.4.7.3 Database comparison  
The molecular formulae of the first-set parent ions were matched to 
databases of natural products, including SciFinder and Reaxys. An antifungal 
complex with the name antimycin matches these molecular formulae most 
closely. While the body structures of antimycin molecules are relatively 
conserved, the tail structures are more variable. Most antimycins differ in mass 
and molecular structure by CH2 groups, most commonly being attached to the 
tail. Due to the accumulation of CH2 groups, larger antimycins are more apolar 
than smaller ones. This is in accordance with the finding that the higher-mass 
first-set compounds eluted at more apolar conditions, during low- and high-
resolution LCMS, than the lower-mass compounds. Figure 3.19 shows 
representative antimycin structures, with masses (formulae) of 506.22643 amu 
(C25H34N2O9; Reaxys ID: 1277391), 520.24208 amu (C26H36N2O9; Reaxys ID: 
1277644), 534.25773 amu (C27H38N2O9; Reaxys ID: 8175643), 548.27338 amu 
(C28H40N2O9; Reaxys ID: 6553177), 562.28903 amu (C29H42N2O9; CAS: 
679395-05-2), and 576.30468 amu (C30H44N2O9; CAS: 679395-06-3), 
corresponding to the sample masses and formulae. 
The relatively conserved antimycin body structures, highlighted in teal, 
have an accurate neutral mass of 264.07462 amu (C12H12N2O5) and correspond 
to sample daughter ions with a mass of 265.082 amu [M+H]+ (C12H13N2O5), 
indicated as daughter ion (body) in table 3.5. Due to the presence of nitrogen 
atoms in the molecular formulae of the other sample daughter ions, 247.071 
amu (C12H11N2O4) and 219.076 amu (C11H11N2O3) [M+H]+, these must also be 
sub-structures originating from the antimycin body.  
The more variable antimycin tail structures, highlighted orange in figure 
3.19, have accurate neutral masses of 242.15181 amu (C13H22O4), 256.16746 
amu (C14H24O4), 270.18311 amu (C15H26O4), 284.19876 amu (C16H28O4), 
298.21441 amu (C17H30O4), and 312.23006 (C18H32O4). These sub-structures 
correspond to sample daughter ions with masses of 243.15884 amu (C13H23O4), 
257.17462 amu (C14H25O4), 271.18994 amu (C15H27O4), 285.20584 amu 
(C16H29O4), and 299.22144 amu (C17H31O4) [M+H]+, indicated as daughter ion  
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Exact Mass : 506.22643
Formula : C25H34N2O9
Exact Mass : 242.15181
Formula : C13H22O4
Exact Mass : 264.07462
Formula : C12H12N2O5
Exact Mass : 520.24208
Formula : C26H36N2O9
Exact Mass : 256.16746
Formula : C14H24O4
Exact Mass : 264.07462
Formula : C12H12N2O5
Exact Mass : 534.25773
Formula : C27H38N2O9
Exact Mass : 270.18311
Formula : C15H26O4
Exact Mass : 264.07462
Formula : C12H12N2O5
Exact Mass : 548.27338
Formula : C28H40N2O9
Exact Mass : 284.19876
Formula : C16H28O4
Exact Mass : 264.07462
Formula : C12H12N2O5
Exact Mass : 562.28903
Formula : C29H42N2O9
Exact Mass : 298.21441
Formula : C17H30O4
Exact Mass : 264.07462
Formula : C12H12N2O5
Exact Mass : 576.30468
Formula : C30H44N2O9
Exact Mass : 312.23006
Formula : C18H32O4
Exact Mass : 264.07462
Formula : C12H12N2O5
Figure 3.19 Analogies to antimycin molecules by molecular masses and formulae 
of first-set sample ions, as described in table 3.5. Members of this antifungal 
family often differ in mass and structure by the addition of CH2 groups (14 amu). 
As illustrated by representative chemical structures, these moieties often are 
attached to the tail structure (orange), turning it more variable than the relatively 
conserved body structure (teal). This renders larger molecules also more apolar 
than smaller ones. In particular, the antimycins shown here, have neutral masses 
(formulae) of 506.22643 amu (C25H34N2O9; Reaxys ID: 1277391), 520.24208 amu 
(C26H36N2O9; Reaxys ID: 1277644), 534.25773 amu (C27H38N2O9; Reaxys ID: 
8175643), 548.27338 amu (C28H40N2O9; Reaxys ID: 6553177), 562.28903 amu 
Chapter 3) Antifungals of an Acromyrmex octospinosus ant-associated Streptomyces
strains 
121
(tail) in table 3.5. As mentioned earlier, no MS2 data could be collected for the 
577.31219 amu [M+H]+ sample parent ion. Therefore, the presence of a 312 
amu (C18H32O4) daughter could not be confirmed by high-resolution LCMS; 
however, a corresponding daughter ion (313.0 amu [M+H]+) was detected 
during low-resolution LCMS (Table 3.4). 
Antimycins with the same masses may have different molecular structures 
(and thus varying names), depending on where CH2 groups are attached. For 
example, the 507 amu [M+H]+ parent ion corresponds to antimycin A4 (506 
amu); the 521 amu [M+H]+ parent ion to antimycins A3 and A7 (520 amu); the 
535 amu [M+H]+ parent ion to antimycins A2, A8, A11, and A17 (534 amu); the 549 
amu [M+H]+ parent ion to antimycins A1, A12, and A13 (548 amu); the 563 amu 
[M+H]+ parent ion to antimycins A10, A14, and A15 (562 amu); and the 577 amu 
[M+H]+ parent ion to antimycin A16 (576 amu) (Table 3.6).  
(C29H42N2O9; SciFinder ID: 679395-05-2), and 576.30468 amu (C30H44N2O9; 
SciFinder ID: 679395-06-3). These correspond to the masses (formulae) of the 
hydrogen adducts in the sample, including 507.23364 amu (C25H35N2O9), 
521.24878 amu (C26H37N2O9), 535.26483 amu (C27H39N2O9), 549.28027 amu 
(C28H41N2O9), 563.29529 amu (C29H43N2O9), and 577.31219 amu (C30H45N2O9) 
[M+H]+ (Table 3.5). The MS2 data confirm these analogies. For example, a sub-
structure of the 506.22643 amu antimycin parent, highlighted teal, has a neutral 
mass (formula) of 264.07462 amu (C12H12N2O5). This corresponds to a sub-
structure of the 507.23364 amu [M+H]+ sample ion with a mass (formula) of 
265.08154 amu [M+H]+ (C12H13N2O5) (Table 3.5). Similarly, a sub-structure of the 
506.22643 amu antimycin parent, highlighted orange, has a neutral mass 
(formula) of 242.15181 amu (C13H22O4). This corresponds to a sub-structure of 
the 507.23364 amu [M+H]+ sample ion with a mass (formula) of 243.15884 amu 
[M+H]+ (C13H23O4) (Table 3.5). The same comparison can be made with regard to 
the remaining antimycin tail-structures with neutral masses (formulae) of 
256.16746 amu (C14H24O4), 270.18311 amu (C15H26O4), 284.19876 amu 
(C16H28O4), 298.21441 amu (C17H30O4), and 312.23006 (C18H32O4). No MS2 data 
could be obtained from the 577.31219 amu [M+H]+ sample parent ion and thus 
the presence of expected 247 amu, 265 amu, and 219 amu [M+H]+ daughter ions 
from the body and an expected 313 amu [M+H]+ ion from the tail could not be 
confirmed.
Registry Number: 1222674-31-8  Registry Number: 1058162-14-3  Registry Number: 1177731-89-3  Registry Number: 1262758-07-5  Registry Number: 1059699-16-9  Registry Number: 1060752-54-6
Formula: C25 H34 N2 O9  Formula: C26 H36 N2 O9  Formula: C27 H38 N2 O9  Formula: C28 H40 N2 O9  Formula: C29 H42 N2 O9  Formula: C30 H44 N2 O9
CA Index Name: INDEX NAME NOT YET ASSIGNED CA Index Name: Butanoic acid, 3-methyl-,(2S,3S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-2-methyl-4,9-dioxo-1,5-dioxonan-7-yl ester CA Index Name: INDEX NAME NOT YET ASSIGNED CA Index Name: INDEX NAME NOT YET ASSIGNED CA Index Name: INDEX NAME NOT YET ASSIGNED CA Index Name: INDEX NAME NOT YET ASSIGNED
Molecular Weight 506.55  Molecular Weight 520.57  Molecular Weight 534.6  Molecular Weight 548.63  Molecular Weight 562.65  Molecular Weight 576.68
Registry Number: 1058162-25-6  Registry Number: 1058162-10-9  Registry Number: 1056986-80-1  Registry Number: 1217539-87-1  Registry Number: 959675-72-0  Registry Number: 679395-06-3
Formula: C25 H34 N2 O9  Formula: C26 H36 N2 O9  Formula: C27 H38 N2 O9  Formula: C28 H40 N2 O9  Formula: C29 H42 N2 O9  Formula: C30 H44 N2 O9
CA Index Name: Butanoic acid, 3-methyl-,(3S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-4,9-dioxo-1,5-dioxonan-7-yl ester CA Index Name: Butanoic acid, 3-methyl-,(3S,6S,7R,8R)-8-butyl-3 [[3-(formylamino)-2-methoxybenzoyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl ester CA Index Name: INDEX NAME NOT YET ASSIGNED CA Index Name: INDEX NAME NOT YET ASSIGNED CA Index Name: INDEX NAME NOT YET ASSIGNED CA Index Name: Hexanoic acid, 4-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
Molecular Weight 506.55  Molecular Weight 520.57  Molecular Weight 534.6  Molecular Weight 548.63  Molecular Weight 562.65  Other Names: Antimycin A16
      Molecular Weight 576.68
Registry Number: 871107-10-7  Registry Number: 1058161-86-6  Registry Number: 1026419-62-4  Registry Number: 857196-81-7  Registry Number: 868072-43-9  
Formula: C25 H34 N2 O9  Formula: C26 H36 N2 O9  Formula: C27 H38 N2 O9  Formula: C28 H40 N2 O9  Formula: C29 H42 N2 O9  Registry Number: 561304-91-4
CA Index Name: Butanoic acid, 2(or 3)-methyl-,(2R,3S,6S,7R,8R)-8-ethyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) CA Index Name: Butanoic acid, 3-methyl-,(2R,3S,7R,8R)-8-butyl 3-[[3-(form amino)-2-methoxybe zoyl]amino]-2-methyl-4,9-dioxo-1,5-dioxonan-7-yl ester CA Index Name: INDEX NAME NOT YET ASSIGNED CA Index Name: INDEX NAME NOT YET ASSIGNED CA Index Name: Butanoic acid, 2(or 3)-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-8-(4-methylhexyl)-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Formula: C30 H44 N2 O9
 Molecular Weight 520.57  Molecular Weight 534.6  Other Names: 1,5-Dioxonane-2,6-dione,3-(3-formamidosalicylamido)-7-hexyl-8-hydroxy-4,9-dimethyl-, isovalerate(6CI) Other Names: Antim cin A10  CA Ind x Name: Pentanoic acid,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-8-octyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
Registry Number: 464157-54-8    Molecular Weight 548.63   Molecular Weight 576.68
Formula: C25 H34 N2 O9  Registry Number: 959366-91-7  Registry Number: 877061-67-1    Registry Number: 679395-08-5  
CA Index Name: Butanoic acid, 3-methyl-,(3S,6S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Formula: C26 H36 N2 O9  Formula: C27 H38 N2 O9  Registry Number: 679395-03-0  Formula: C29 H42 N2 O9  Registry Number: 327993-46-4
Molecular Weight 506.55  CA Index Name: INDEX NAME NOT YET ASSIGNED CA Index Name: Butanoic acid, 2-methyl-,3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-8-pentyl-1,5-dioxonan-7-yl ester (9CI) Formula: C28 H40 N2 O9  CA Index Name: Butanoic acid, 3-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-8-(4-methylhexyl)-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Formula: C30 H44 N2 O9
 Molecular Weight 520.57  Other Names: Antimycin A17  CA Index Name: Hexanoic acid, 4-methyl-,(2R,3S,6S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Other Names: SPA 10191-b  CA Index Na : Butanoic acid, 3-methyl-,(2R,3S,6S,7R,8R)-8-hexyl-3-[[2-hydroxy-3-[(1-oxopropyl)amino]benzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
Registry Number: 327993-49-7   Molecular Weight 534.6  Other Names: Antimycin A13  Molecular Weight 562.65  Molecular Weight 576.68
Formula: C25 H34 N2 O9  Registry Number: 622829-22-5   Molecular Weight 548.63    
CA Index Name: Butanoic acid, 3-methyl-,(2R,3S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2-methyl-4,9-dioxo-1,5-dioxonan-7-yl ester Formula: C26 H36 N2 O9  Registry Number: 868862-13-9    Registry Number: 679395-07-4   
Molecular Weight 506.55  CA Index Name: Butanoic acid, 2-methyl-,(2R,3S,6S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, (2R)- (9CI) Formula: C27 H38 N2 O9  Registry Nu ber: 679395-02-9  Formula: C29 H42 N2 O9   
 Other Names: (2'R)-antimycin A3a  CA Index Name: Butanoic acid, 2(or 3)-methyl-,(2R,3S,6S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester Formula: C28 H40 N2 O9  CA Index Name: Butanoic acid, 2-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-8-(4-methylhexyl)-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
Registry Number: 321599-65-9  Molecular Weight 520.57  Other Names: 2-Methoxyantimycin A3  CA Index Name: Pentanoic acid, 4-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-8-(3-methylbutyl)-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Other Names: SPA 10191a   
Formula: C25 H34 N2 O9    Other Names: Antimycin A12  Molecular Weight 562.65   
CA Index Name: Propanoic acid, 2-methyl-,(3S,6S,7R,8R)-8-(cyclopentylmethyl)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) egistry Number: 503291-88-1  Registry Num er: 857839-31-7  Molecular W ight 548.63    
Molecular Weight 506.55  Formula: C26 H36 N2 O9  Formula: C27 H38 N2 O9    Registry Number: 679395-05-2   
 CA Index Name: 2,3(1H)-Isoquinolinedicarboxylic acid,6-[2-(ethoxycarbonyl)-4-nitrophenoxy]octahydro-, 2-(1,1-dimethylethyl)3-ethyl ester, (3S,4aS,6S,8aR)- CA Index Name: INDEX NAME NOT YET ASSIGNED Registry Number: 561304-90-  Formula: C29 H42 N2 O9   
Registry Number: 118890-47-4  Molecular Weight 520.57  Other Names: 1,5-Dioxonane-2,6-dione,3-(3-acetamidosalicylamido)-7-butyl-8-hydroxy-4,9-dimethyl-, isovalerate(6CI) Formul : C28 H40 N2 O9  CA Index Name: Pentanoic acid, 4-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
Formula: C25 H34 N2 O9   Molecular Weight 534.6  CA Index Name: Heptanoic acid,(2R,3S,6S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Other Names: Antimycin A15
CA Index Name: Butanoic acid, 3-methyl-,(2R,3S,6S,7R,8R)-8-ethyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Registry Number: 197791-89-2   Molecular Weight 548.63  Molecular Weight 562.65   
Other Names: 2-O-Methylantimycin A5  Formula: C26 H36 N2 O9  Registry Number: 679395-01-8      
Molecular Weight 506.55  CA Index Name: Butanoic acid,3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-8-(3-methylbutyl)-4,9-dioxo-1,5-dioxonan-7-yl ester, (2R,3S,6S,7R,8R)- (9CI) Formula: C27 H38 N2 O9  Registry Number: 327993-47-5  Registry Number: 679395-04-1   
 Other Names: Antimycin A7b  CA Index Name: Pentanoic acid, 4-methyl-,(2R,3S,6S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Formula: C28 H40 N2 O9  Formula: C2  H42 N2 O9   
Registry Number: 118890-46-3  Molecular Weight 520.57  Other Names: Antimycin A11  CA Index Name: Butanoic acid, 3-methyl-,(2R,3S,6S,7R,8R)-8-butyl-3-[[2-hydroxy-3-[(1-oxopropyl)amino]benzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) CA Index Name: Hexan ic acid, 4-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl] mino]-2,6-dimethyl-8-(3-methylbutyl)-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
Formula: C25 H34 N2 O9   Molecular Weight 534.6  Molecular Weight 548.63  Other Names: Antimycin A14
CA Index Name: Butanoic acid, 2-methyl-,8-ethyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Registr  Number: 197791-88-1     Molecular Weight 562.65   
Other Names: 1,5-Dioxonane, butanoic acid deriv. Formula: C26 H36 N2 O9  Registry Number: 327993-48-6  Registry Number: 118890-41-8    
Molecular Weight 506.55  CA Index Name: Propanoic acid, 2-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-8-(3-methylbutyl)-4,9-dioxo-1,5-dioxonan-7-yl ester Formula: C27 H38 N2 O9  Formula: C28 H40 N2 O9  Registry Number: 561304-93-6   
 Other Names: Antimycin A7a  CA Index Name: Butanoic acid, 3-methyl-,(2R,3S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2-methyl-4,9-dioxo-1,5-dioxonan-7-yl ester CA Index Name: Butanoic acid,3-[[3-(formylamino)-2-methoxybenzoyl]amino]-8 hexyl-2,6 dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, [2R-(2R*,3S*,6S*,7R*,8R*)]- (9CI) Formula: C29 H42 N2 O9   
Registry Number: 117603-45-9  Molecular Weight 520.57  Molecular Weight 534.6  Other Names: 1,5-Dioxonane, butanoic acid deriv. CA Index Name: Pentanoic acid,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-heptyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
Formula: C25 H34 N2 O9    Molecular Weight 548.63  Molecular Weight 562.65   
CA Index Name: Butanoic acid,8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, (2R,3S,6S,7R,8R)- (9CI) Registry Number: 139066-86 7  Registry Number: 197791-91-      
Other Names: Antimycin A4b  Formula: C26 H36 N2 O9  Formula: C27 H38 N2 O9  Registry Number: 118890-40-7  Registry Number: 561304-89-0   
Molecular Weight 506.55  CA Index Name: Butanoic acid, 3-methyl-,(2S,3R,6R,7S,8S)-8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) CA Index Name: Butanoic ac d, 3-methyl-,3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimeth -8-(3-methylbutyl)-4,9-dioxo-1,5-dioxonan-7-yl ester, (2R,3S,6S,7R,8R)- (9CI) Formula: C28 H40 N2 O9  Form la: C29 H42 N2 O9   
 Other Names: Butanoic acid, 3-methyl-,8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, [2S-(2R*,3S*,6S*,7R*,8R*)]-; 1,5-Dioxonane,butanoic acid deriv. Othe  Names: Antim cin A8b  CA Index Name: Propanoic acid, 2-methyl-,3-[[3-(formylamino)-2-meth xyb nzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, [2R-(2R*,3S*,6S*,7R*,8R*)]- (9CI) CA Index Na : Hexan ic cid,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4, -dioxo-1,5-dioxonan-7-yl ester (9CI)
Registry Number: 28068-12-4  Molecular Weight 520.57  Molecular Weight 534.6  Other Names: 1,5-Dioxonane, propanoic acid deriv. Molecular Weight 562.65   
Formula: C25 H34 N2 O9    Molecular Weight 548.63    
CA Index Name: Propanoic acid, 2-methyl-,(2R,3S,6S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester Registry Number: 118890-45-2  Registry Number: 197791-90-5    Registry Number: 118890-39-4   
Other Names: Antimycin A4a  Formula: C26 H36 N2 O9  Formula: C27 H38 N2 O9  Registry Number: 116095-18-2  Formula: C29 H42 N2 O9   
Molecular Weight 506.55  CA Index Name: Butanoic acid,8-butyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, [2R-(2R*,3S*,6S*,7R*,8R*)]- (9CI) CA Index Name: Butanoic acid, 2 methyl-,3-[[3 (f rmylamin )-2-hydroxybenzoyl]amino]-2,6-dimethyl- -(3-methylbutyl)-4,9-dioxo-1,5-dioxonan-7-yl ester, (2R,3S,6S,7R,8R)- (9CI) Formula: C28 H40 N2 O9  CA Index Name: Butanoic acid, 3 m thyl- (2 ,3 ,6 ,7 ,8 )-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
 Other Names: 1,5-Dioxonane, butanoic acid deriv. Other Names: Antimycin A8a  CA Index Name: Butanoic acid, 3-methyl-,3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, [2R-(2R*,3S*,6S*,7R*,8R*)]- (9CI) Other Names: Threonine, N-3-formamido-o-anisoyl-,2-(1,2-dihydroxypropyl)octanoate, h-lactone, isovalerate, L- (6CI);1,5-Dioxonane, butanoic acid deriv.
 Molecular Weight 520.57  Molecular Weight 534.6  Other Names: Antimycin A1b  Molecular Weight 562.65   
   Molecular Weight 548.63    
 Registry Number: 118890-44-1  Registry Number: 125543-39-7    Registry Number: 118890-38-3   
 Formula: C26 H36 N2 O9  Formula: C27 H38 N2 O9  Registry Number: 28068-16-8  Formula: C29 H42 N2 O9   
 CA Index Name: Propanoic acid, 2-methyl-,8-butyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, [2R-(2R*,3S*,6S*,7R*,8R*)]- (9CI) CA Index Name: Threonine, N-(3-acetamidosalicyloyl)-,2-(1,2-dihydroxypr pyl)hexanoate, h-lactone, isovalerate (6CI) Formula: C28 H40 N2 O9  CA Index Name: Butanoic acid, 2-methyl-,3-[[3-(formylamino)-2-methoxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
 Other Names: 1,5-Dioxonane, propanoic acid deriv.  CA Index Name: Butanoic acid, 2-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester Other Names: 1,5-Di xonane, butanoic acid deriv.
 Molecular Weight 520.57  Registry Number: 118890-43-0  Other Names: Antimycin A1a  Molecular Weight 562.65   
  Formula: C27 H38 N2 O9  Molecular Weight 548.63    
 Registry Number: 116095-17-1  CA Index Name: Butanoic acid, 3-methyl-,(2R,3S,6S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester   Registry Numb r: 21788-42   
 Formula: C26 H36 N2 O9  Other Names: Butanoic acid, 3-methyl-,8-butyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, [2R-(2R*,3S*,6S*,7R*,8R*)]-; Threonine,N-3-formamido-o-anisoyl-, 2-(1,2-dihydroxypropyl)hexanoate, h-lactone,isovalerate, L- (6CI); 1,5-Dioxonane, butanoic acid deriv. Registr  Number: 642-15-9  Formula: C29 H42 N2 O9   
 CA Index Name: Butanoic acid, 3-methyl-,(2R,3S,6S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-9-oxo-1,5-dioxonan-7-yl ester Molecular Weight 534.6  Formula: C28 H40 N2 O9  CA Index Name: Butanoic acid, 3-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(acetylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
 Other Names: Antimycin A3b    CA Index Name: Butanoic acid, 2(or 3)-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Other Names: Octanoic acid, 2-(1,2-dihydrox propyl)-, cyclic 2,3'-ester with N-(3-acetamidosalicyloyl)thr onine (8CI)
 Molecular Weight 520.57  Registry Number: 118890-42-9  Other Names: Antimycin A1  Molecular Weight 562.65   
  Formula: C27 H38 N2 O9  Class Identifier: Incompletely Defined Substance     
 Registry Number: 41955-14-0  CA Index Name: Butanoic acid, 2-methyl-,8-butyl-3-[[3-(formylamino)-2-methoxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
 Formula: C26 H36 N2 O9  Other Names: 1,5-Dioxonane, butanoic acid deriv.
 CA Index Name: Butanoic acid, 3-methyl-,8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, [2R-(2R*,3S*,6R*,7S*,8S*)]- (9CI) Molecular Weight 534.6     
 Other Names: 1,5-Dioxonane, butanoic acid deriv.
 Molecular Weight 520.57  Registry Number: 117552-77-9      
  Formula: C27 H38 N2 O9      
 Registry Number: 28068-14-6  CA Index Name: Butanoic acid,3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, [2R-(2R*,3S*,6S*,7R*,8R*)]- (9CI)
 Formula: C26 H36 N2 O9  Other Names: Antimycin A2b
 CA Index Name: Butanoic acid, 2-methyl-,(2R,3S,6S,7R,8R)-8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester, (2S)- (9CI) Molecular Weight 534.6      
 Other Names: Antimycin A3a
 Molecular Weight 520.57  Registry Number: 28068-15-7      
  Formula: C27 H38 N2 O9      
 Registry Number: 22083-60-9  CA Index Name: Propanoic acid, 2-methyl-,(2R,3S,6S,7R,8R)-8-[[3-(formylamino)-2-hydroxybenzoyl]amino]-5-hexyl-2,7-dimethyl-5,9-dioxo-1,5-dioxonan-3-yl ester
 Formula: C26 H36 N2 O9  Other Names: Antimycin A2a
 CA Index Name: Butanoic acid, 2-methyl-,8-butyl-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI) Molecular Weight 534.6      
 Other Names: Isovaleric acid, 8-ester with N-(7-butyl-8-hydroxy-4,9-dimethyl-2,6-dioxo-1,5-dioxonan-3-yl)-3-formamidosalicylamide (7CI,8CI); 1,5-Dioxonane, butanoic acid deriv.
 Molecular Weight 520.57  Registry Number: 21788-41-0      
  Formula: C27 H38 N2 O9      
 Registry Number: 522-70-3  CA Index Name: Butanoic acid, 3-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(acetylamino)-2-hydroxybenzoyl]amino]-8-butyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester (9CI)
 Formula: C26 H36 N2 O9  Other Names: Hexanoic acid, 2-(1,2-dihydroxypropyl)-, cyclic 2,3'-ester with 2-(3-acetamidosalicylamido)-3-hydroxybutyric acid, 1-isovalerate (8CI)
 CA Index Name: Butanoic acid, 2(or 3)-methyl-,(2R,3S,6S,7R,8R)-3-[[3-(formylamino)-2-hydroxybenzoyl]amino]-8-butyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester Molecular Weight 534.6      
 Other Names: Antimycin A3
506 amu 520 amu 534 amu 548 amu 562 amu 576 amu
Table 3.6 Overview of antimycins matching the molecular formulae of the first-set sample ions.
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Taking into account antimycins with CH2 attachments to the body 
structures, increases the number of matching antimycins; for example, 2-O-
Methylantimycin A5 matches the 507 amu [M+H]+ ion and 2-Methoxyantimycin 
A3 matches the 535 amu [M+H]+ ion (Table 3.6). An indication to which 
antimycins, sample molecules relate, may be obtained from the fact that certain 
bacteria are known for producing specific combinations of antimycin molecules.  
3.4.8 Trapping of antimycin  
The antimycin masses of the first and second compound set, which during 
RP column fractionation appeared to differ in bioactivity (bioactive fractions 
eluted after the four dominant compounds of the first compound set, Fig. 3.14), 
were studied by trapping and bioassaying individual ions. In addition, the 
second-set 535 amu [M+H]+ antimycin mass was isolated for a follow-up high-
resolution LCMS analysis.  
3.4.8.1 Trapping of multiple antimycin masses  
The double-purified (NP/RP) combined fractions B were sub-sampled by 
harvesting specific RT ranges from the eluent. While the LCMS system uses a 
minority of the eluent for live mass detection, the remainder can either be 
directed to the waste, or trapped on filters. The mass spectrometer was set to 
detect compound masses in positive ion mode (+ESI). The detected masses are 
accurate to ± 0.001 amu. 
Figure 3.20 displays the trapped RT areas 2E7-2F4, dissection peaks of 
(un)trapped compounds, and the distribution of first- (blue arrows) and second- 
(red arrows) set antimycin masses, with masses of 507 amu, 521 amu, 535 
amu, 549 amu, 563 amu, and 577 amu [M+H]+. Due to an overlap in the 
retention times of compound sets, a low signal/noise ratio, or absent ionisation, 
not all compounds could be trapped (individually). For example, the second-set 
521 amu [M+H]+ ion did not ionise, the second-set 507 amu [M+H]+ ion eluted at 
a retention time between two nearby fractions (2E12 and 2F1), and the second-
set 563 amu and 577 amu [M+H]+ ions were trapped on the same filter.  
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Nonetheless, most compounds were trapped individually, which allowed 
testing their bioactivity against Candida in separation of one another. A 
numerical representation and a detailed overview of the data are given in table 
3.7 and the Supplementary Information B5-6, respectively.  
Figure 3.20 Fractionation of a 25 µl sub-sample from the double-purified 
(NP/RP) combined fractions B by reversed-phase LCMS in positive ion 
mode (+ESI). Sample masses detected in the eluent are displayed as 
numbered dissection peaks; trapped RT ranges (fractions 2E7-2F4) are 
visualised using black bars; and the placement of first- and second-set 
antimycin masses is shown respectively by blue and red arrows (mass, 
dissection peak no.). Despite of overlapping retention times and the fact that 
not all compounds ionised, most antimycin masses could be trapped 
individually making them available for follow-up bioassays. A detailed 
overview on the dissection peaks of fractions 2E9, 2E10, 2F2, and 2F3, and 
extracted ion chromatograms on parent ions with masses of 507 amu, 521 
amu, 535 amu, 549 amu, 563 amu, and 577 amu [M+H]+ are shown in the 
Supplementary Information B5-6.
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Table 3.7 Numerical representation of the trapping data, 
described in figure 3.20. Trapped fractions 2E7-2F4, 
containing first- (blue font) and second- (red font) set 
antimycin masses. 
Fraction RT Dissection peak
2E7 7.0-7.7 18-23 507.236 (20) - -
2E8 8.0-8.8 26-31 521.248 (26) 521.249 (28) -
2E9 9.2-10.2 34-40 535.268 (37) 535.267 (38) -
2E10 10.7-11.5 44-51 549.284 (48) 549.284 (49) -
2E12 11.9-13.0 55-63 563.299 (58) - -
- - 63-68 507.330 (64) 507.330 (65) 507.331 (68)
2F1 13.5-14.2 69-73 577.314 (69) 577.315 (71) -
2F2 14.9-15.6 76-82 535.265 (80) - -
2F3 16.2-16.8 85-90 549.284 (86) 549.284 (89) -
2F4 17.0-22.5 91-129 563.301 (97) 563.554 (100) -
2F4 17.0-22.5 91-129 577.314 (107) 577.313 (110) -
Antimycin masses (dissection peak)
Figure 3.21 (A-C) Bioassays of trapped fractions 2E7-2F4 against Candida
CA6. The compounds, described in figure 3.20, were eluted from the trapping 
filters into fresh holding liquids, inoculated onto filter disks, and placed on 
Candida-coated agar plates. As negative control a filter was included inoculated 
with deuterated ACN (C-), serving as holding liquid for the trapped compounds. 
Despite of their strong ionisation signal, and potentially high molecular 
abundance, none of the fractions holding first-set antimycin masses inhibit 
Candida. In contrast, despite their weak ionisation signal, and potentially low 
molecular abundance, some of the fractions holding second-set antimycin 
masses inhibit Candida. In particular, fractions with the second-set 535 amu and 
549 amu [M+H]+ ions (red arrows) inhibit the pathogen and fractions with the 
corresponding first-set antimycin masses (blue arrows) do not affect its growth. 
Probably, it is due to the small column loading volume of only 25 µl that the 
observed fungal inhibition is generally small and that some second-set fractions 
remain ineffective.
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The trapped fractions were bioassayed against Candida CA6 (Fig. 3.21). 
The compounds were eluted from the trapping filters and inoculated onto fresh 
filter disks. When dry, the disks were attached to Candida-coated agar plates.  
Despite of their strong LCMS signal, and potentially high molecular 
abundance, none of the first-set antimycin masses shows any bioactivity. This 
confirms previous observations, obtained during the RP column fractionation, 
that the four major compounds of the first compound set preceded the bioactive 
RT area (Fig. 3.14); in contrast, despite their weak LCMS signal, and likely low 
molecular abundance, some fractions holding second-set antimycin masses 
show bioactivities. For example, the second-set fractions 2F2 (535 amu [M+H]+) 
and 2F3 (549 amu [M+H]+) are bioactive, whereas the first-set fractions 2E9 
(535 amu [M+H]+) and 2E10 (549 amu [M+H]+) containing corresponding 
compound masses are not bioactive. The reason for not all second-set 
antimycin masses-containing fractions to be bioactive, may be attributed to 
inherent differences in their inhibitory properties towards Candida, or more likely 
to the low column loading volume of 25 l. In combination with polarity 
differences and inconsistencies in their MS2 fragmentation, these results may 
illustrate chemical differences between first- and second-set antimycin masses. 
3.4.8.2 Trapping of a second set antimycin mass  
To determine the molecular formula of a second-set antimycin mass, 
specific RT ranges were trapped containing the second-set 533 amu [M-H]- ion. 
This ion corresponds to the 535 amu [M+H]+ ion detected above in positive ion 
mode (Fig. 3.20). The trapping was carried out with the same chromatography 
as described above; masses, accurate to ± 0.001 amu, were detected in 
negative ion mode (-ESI). In general, the negative ion mode showed stronger 
LCMS signals than the positive ion mode (data not shown). Also, the volume of 
the double-purified (NP/RP) combined fractions B, which was fractionated 
during two HPLC runs, was increased to 50 µl. 
Figure 3.22 displays the trapped RT areas 2G4 (T14.8-15.2) and 2G5 
(T15.2- 16.1), sampled during one of the fractionation runs, dissection peaks of 
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(un)trapped compounds, and localisation of the mass of interest. The filters 
contain multiple, slightly differing, 533 amu [M-H]- masses. Fraction 2G5 
contains ion masses of 533.252 amu, 533.253 amu, and 547.267 amu [M-H]-; 
fraction 2G4 only contains ion masses of 533.211 amu and 533.252 amu [M-H]-. 
A numerical representation and a detailed overview of the mass data are given 
in table 3.8 and the Supplementary Information B7-8, respectively.  
Figure 3.22 Fractionation of a 50 µl sub-sample from the double-
purified (NP/RP) combined fractions B by reversed-phase LCMS in 
negative ion mode (-ESI). The trapping focuses on collecting molecules 
of the second-set 533 amu [M-H]- antimycin mass. The eluent contains 
multiple, slightly differing, second-set 533 amu [M-H]- masses that are 
trapped on two neighbouring filters (2G4 and 2G5). In addition to ion 
masses of 533.252 amu and 533.253 amu [M-H]-, fraction 2G5 also 
contains an ion mass of 547.267 amu [M-H]-. In contrast, fraction 2G4 
only contains ion masses of 533.211 amu and 533.252 amu [M-H]-. Due 
to its purity (Table 3.8) and strong inhibitory properties against Candida
(Fig. 3.23) fraction 2G4 is used for a follow-up LCMS analysis. A 
detailed overview on the dissection peaks of fractions 2G4 and 2G5, 
and extracted ion chromatograms on the 505 amu, 519 amu, 533 amu, 
547 amu, 561 amu, and 575 amu [M-H]- antimycin masses are shown in 
the Supplementary Information B7-8. 
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Fractions 2G4 and 2G5 were challenged against Candida CA6 in the same 
way as described above. The bioassays show that both fractions are bioactive 
(Fig. 3.23). 
Table 3.8 Numerical representation of the trapping data, shown 
in figure 3.22. Masses are detected in negative ion mode. 
Fractions 2G4 and 2G5 both contain the requested 533 amu 
[M-H]- antimycin mass. In addition, fraction 2G5 also contains a 
larger antimycin mass. 
Fraction RT Dissection 
peak
2G4 14.75-15.2 59-64 533.211 (63) 533.252 (64) -
2G5 15.23-16.1 64-70 533.252 (64) 533.253 (66) 547.267 (67)
Anitimycin masses (dissection peak)
Figure 3.23 (A-B) Bioassays of trapped fractions 2G4 and 2G5 against Candida
CA6. The compounds, described in figure 3.22, were eluted from the trapping 
filters into fresh holding liquids, inoculated onto filter disks, and placed on 
Candida-coated agar plates. As negative control a filter was included inoculated 
with deuterated ACN (C-), serving as holding liquid for the trapped compounds. 
Both fractions strongly inhibit the yeast. Since inoculation volumes are equal, 
the size difference of the inhibition zones may suggest that most of the putative 
antimycin molecules eluted into fraction 2G4. 
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3.4.9 LCMS analysis of the second set antimycin mass  
Due to its strong bioactivity (Fig 3.23) and because of not containing any 
larger antimycin masses (Table 3.8), a low- and high-resolution LCMS analysis 
has been carried out on the second-set 533 amu [M-H]- antimycin mass in 
fraction 2G4. During low-resolution LCMS, UV, MS, and MS2 data were 
collected; during high-resolution LCMS, accurate MS and MS2 data were 
generated, serving the calculation of molecular formulae. The system was set to 
detect MS and MS2 masses in negative ion mode (-ESI), accurate to ± 0.1 amu 
and ± 0.00001 amu. 
3.4.9.1 Low-resolution LCMS  
Figure 3.24A shows the low-resolution LCMS data obtained from fraction 
2G4, including a PDA, a BPC for compound masses in between 150-1500 amu, 
and a mass range of 532.7-533.7 amu. The mass range shows the presence of 
a dominant peak (red circle), eluting with a retention time of 10.52 minutes. The 
full MS of this peak is dominated by an ion with a mass of 533.2 amu [M-H]-
(Fig. 3.24B).  
The fragmentation pattern of this second set ion exhibits the presence of 
daughter ions with masses of 245.0 amu and 263.0 amu [M-H]- (Fig. 3.24C). 
These daughters are comparable to daughter ions, 247 amu and 265 amu 
[M+H]+, which previously have been detected in positive ion mode only for first 
set ions (Table 3.4). However, the parent specific 271 amu [M+H]+ analogue 
remained undetected. Despite positive and negative ion mode fragmentations 
cannot be compared to one another, the above findings suggest stronger 
structural analogies between first- and second-set compounds than expected 
based on observations in positive ion mode (Table 3.4).  
The 533.2 amu [M-H]- ion absorbs light at two wavelengths, namely at 
238.0 nm and 319.0 nm (Fig. 3.24D); also antimycin A2 has been shown to 
absorb at two wavelengths, namely at 239.0 nm and 318.0 nm (Supplementary 
Information B9). Since fraction 2G4 contains less contaminants than the double- 
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Figure 3.24 (A-B) Low-resolution reversed-phase LCMS on fraction 2G4 (Fig. 
3.22), in negative ion mode (-ESI). (A) The graph shows a PDA, BPC, and mass 
range for compounds in between 532.7-533.7 amu [M-H]-. The last clearly 
shows an ion peak (red circle) with the required mass at 10.52 minutes. (B) The 
full MS of this peak reveals the presence of a dominant 533.2 amu [M-H]- ion. 
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Figure 3.24 (C-D) Low-resolution reversed-phase LCMS on fraction 2G4 (Fig. 
3.22), in negative ion mode (-ESI). (C) The MS2 data obtained from the 533 amu 
parent, presented above, show daughter ions with masses of 245.0 amu and 
263.0 amu [M-H]-. As expected, the 263.0 amu daughter ion matches a sub-
structure of the antimycin molecule, marked teal in figure 3.19. (D) The UV 
absorbance of the 533 amu [M-H]- parent ion shows two maxima at 238 nm and 
319 nm, which matches the UV absorbance of antimycin.
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purified (NP/RP) combined fractions B, which also exhibited absorbance 
maxima at higher wavelengths (Table 3.4), these may indeed have originated 
from coeluting background molecules.     
3.4.9.2 High-resolution LCMS  
High-resolution LCMS data of fraction 2G4, showing a PDA and a mass 
range of 532.7500-533.7500 amu are presented in figure 3.25A. The mass 
range reveals the presence of a single peak (red circle) eluting with a retention 
time of 8.25 minutes. The full MS of this peak clearly shows the presence of a 
dominant 533.2501 amu [M-H]- ion (Fig. 3.25B); based on the accurate mass, its 
molecular formula is found to be C27H37N2O9. The MS2 data show the presence 
of daughter ions with masses of 245.0563 amu and 263.0667 amu [M-H]-, 
possessing molecular formulae of C12H9N2O4 and C12H11N2O5, respectively (Fig. 
3.25C, Table 3.9). These daughters are analogous to daughter ions, 247.071 
amu (C12H11N2O4) and 265.082 amu (C12H13N2O5) [M+H]+, previously detected 
for first-set ions in positive ion mode (Table 3.5). Since containing nitrogen, the 
daughter ions must correspond to antimycin body structures, as highlighted teal 
in figure 3.19. In conclusion, analogies between the molecular formulae of 
antimycins and first-set antimycin masses, established during an LCMS analysis 
in positive ion mode (Table 3.5), here are shown to also exist between 
antimycins and a bioactive second-set sample ion (533.2501 amu [M-H]-).  
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Figure 3.25 (A-B) High-resolution reversed-phase LCMS on fraction 2G4 (Fig. 
3.22), in negative ion mode (-ESI). (A) The graph shows a BPC trace as well as 
a mass range for compounds between 532.75-533.75 amu [M-H]-. The last 
clearly shows a dominant ion peak (red circle) at 8.25 minutes. (B) Full MS of 
the peak showing an accurate ion mass of 533.2501 amu [M-H]-. The molecular 
formula of this ion is C27H37O9N2 and matches antimycin. 
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Figure 3.25 (C) High-resolution reversed-phase LCMS on fraction 2G4 (Fig. 
3.22), in negative ion mode (-ESI). The fragmentation of the parent molecule, 
shown above, results in daughter ions with masses (formulae) of 245.0563 amu 
(C12H9O4N2) and 263.0667 amu (C12H11O5N2) [M-H]-. As expected, the latter 
matches a sub-structure of the antimycin molecule, marked teal in figure 3.19. 
The data show that the negative ion mode suits well to visualise second-set 
antimycin masses, which failed to ionise during a high-resolution LCMS analysis 
in positive ion mode (Fig. 3.18). The results show that, in addition to first-set 
sample masses, a second-set sample mass also matches antimycin. 
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Table 3.9 Numerical representation of low- and high-
resolution LCMS data on fraction 2G4, presented in figures 
3.24 and 3.25. UV, MS, and MS2 data are obtained by low-
resolution LCMS; MS and MS2 data are generated by high-
resolution LCMS. Compound masses are detected in 
negative ion mode (-ESI). Based on the accurate mass data, 
molecular formulae are calculated for parent and daughter 
ions. In an earlier LCMS analysis in positive ion mode (Table 
3.4), first-set antimycin masses typically produced 265 amu, 
247 amu, and 219 amu [M+H]+ daughter ions, whereas 
second-set ones fragmented into daughters with masses of 
265 amu and 237 amu [M+H]+. Interestingly, here the 
fragmentation of a second-set 533 amu parent (-ESI), 
resulted in daughter ions with masses of 263 amu and 245 
amu [M-H]-, previously found in the MS2 data of first-set 
compounds exclusively. However, no tail structure is 
detected of the 533 amu second-set ion, which is expected to 
be 269 amu [M-H]- in mass. Despite the fact that MS2 data in 
positive and negative ion mode cannot be compared, the 
findings support that the chemical structures of both 
compounds sets are highly similar. 
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3.4.10 Tandem-LCMS analysis of antimycin and an antimycin standard  
As a final test of the hypothesis that the antimycin masses purified from the 
Streptomyces E8 growth culture indeed are antimycins, a tandem-LCMS 
analysis was carried out. In this analysis the double-purified (NP/RP) combined 
fractions B was compared to an antimycin A1-A4 standard. Analogous 
substances must show similar retention times, UV spectra, as well as MS and 
MS2 data. The detector was set to detect masses in positive ion mode (+ESI), 
accurate to ± 0.1 amu. Also, UV spectra of the compounds were generated.  
Table 3.10 shows UV, MS, and MS2 data of the sample compounds and 
antimycin standard; a detailed overview and extracted ion chromatograms of 
them are presented in the Supplementary Information B9-10. The data show that 
the antimycin standard contains five, instead of four, antimycin molecules. In 
addition to ions with masses of 507 amu, 521 amu, 535 amu, and 549 amu 
[M+H]+ (antimycin A1-A4), an antimycin molecule with a mass of 563 amu 
[M+H]+ (e.g. antimycin A10, A14 or A15) is detected in the standard. Also, the data 
show that the compounds of the antimycin standard clearly match in retention 
times the second-set compounds. This means that the standard does not 
correlate to the first compound set, which previously has failed to exhibit 
bioactivity during the RP column fractionation (Fig. 3.14) and trapping (Fig. 
3.21). The compounds of the standard, fragment into daughter ions with masses 
of 265 amu and 237 amu [M+H]+, which are characteristic for the second-set 
compounds (Table 3.4). Due to the low signal/noise ratio of the second-set 
compounds, no accurate UV absorbance data could be collected from the 
double-purified (NP/RP) combined fractions B during this tandem-LCMS run 
(Table 3.10). However, comparing the UV absorbance of the 535 amu [M+H]+ 
(239 nm, 318 nm) ion from the antimycin standard with the one of the second-
set 533 amu [M-H]- (238 nm, 319 nm) ion from fraction 2G4 (Table 3.9), it 
becomes obvious that both share similar maxima. In summary, the tandem-
LCMS results confirm that the second-set antimycin masses indeed are 
antimycins; speculations on the identity of the first-set compounds are given in 
the discussion. 
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Table 3.10 Low-resolution tandem-LCMS analysis on the double-
purified (NP/RP) combined fractions B and an antimycin A1-A4
standard, in positive ion mode (+ESI). The table reveals that the 
standard consists of five, instead of four, compounds. In addition to 
507 amu, 521 amu, 535 amu, and 549 amu [M+H]+ ions, a 563 amu 
ion was detected. The table also shows that the standard matches 
the second, and not the first, compound set. For example, the 
antimycins of the standard share the same retention times as the 
bioactive sample molecules of the second-set. Furthermore, the 
MS2 data of the standard match the fragmentation data obtained 
from the second-set sample molecules. For example, sample and 
standard both produce daughter ions with masses of 265 amu and 
237 amu [M+H]+; also, the standard did not produce any parent-
specific daughters. In summary, the tandem-LCMS data confirm 
that second-set sample molecules are antimycins. In consequence, 
the structurally similar first-set sample molecules must either be 
antimycins, which due to technical reasons or resistances failed to 
inhibit Candida, or they are products in the antimycin biosynthesis 
that share the same masses and similar structures but need 
modifications to become bioactive. 
Peak 1 2 3 4 5 6
EIC 507-508 521-522 535-536 549-550 563-564 577-578
RT - - 17.29 17.93 18.48 19.14
Parent ion - - 535.0 549.1 563.1 577.2
Adduct - - H H H H
RT - - 17.15 17.78 18.33 18.98
UV max. - - 247.0 241.0 249.0 253.0
UV max. - - 322.0 320.0 320.0 322.0
UV max. - - 361.0 359.0 360.0 361.0
UV max. - - 383.0 383.0 383.0 383.0
UV max. - - 405.0 405.0 405.0 405.0
RT - - 17.31 17.89 18.40 19.13
Parent ion - - 535.01 549.04 563.17 577.22
Daughter ion (body) - - 265.0 265.0 265.0 265.0
Daughter ion (body) - - 237.1 237.2 237.1 237.2
Sample set 2
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Peak 1 2 3 4 5 6
EIC 507-508 521-522 535-536 549-550 563-564 577-578
RT 15.91 16.61 17.29 17.96 18.58 -
Parent ion 507.0 521.0 535.0 549.0 563.1 -
Adduct H H H H H -
RT 15.82 16.48 17.17 17.78 - -
UV max. 238.0 240.0 239.0 240.0 - -
UV max. 318.0 318.0 318.0 318.0 - -
RT 15.92 16.51 17.13 17.89 18.39 -
Parent ion 507.02 521.12 535.22 549.04 563.14 -
Daughter ion (body) 265.0 265.0 265.0 265.0 265.0 -
Daughter ion (body) 237.1 237.1 237.0 237.1 237.2 -
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3.5 Discussion 
The Streptomyces E8 supernatant, obtained from a liquid growth culture, 
was tested positive for bioactivity against diverse Candida strains and 
Escovopsis EWC. The antifungal molecules, responsible for fungal growth 
inhibition, were harvested by extracting the supernatant with butanol. In a 
bioassay-guided normal-phase column fractionation on the BuOH extract, two 
sets of normal-phase fractions turned out to inhibit Candida CA6, revealing the 
presence of at least two antifungals. By LCMS, the more polar set of bioactive 
normal-phase fractions, represented by fraction 79, was shown to contain the 
antifungal candicidin. Its presence was confirmed by matching UV and mass 
(MS, MS2) data, which also were used for generating molecular formulae, to 
candicidin identified by Haeder et al. (2009).  
The more apolar set of bioactive normal-phase fractions, represented by 
fraction 24, did not contain candicidin and were recombined; in a follow-up 
bioassay-guided reversed-phase column fractionation these fractions were 
purified a second time. By LCMS, the bioactive reversed-phase fractions were 
shown to contain two sets of six compound masses. Accurate mass data (MS, 
MS2) on first-set masses, which were used for generating molecular formulae, 
revealed analogies to the antifungal antimycin. In contrast, no accurate mass 
data could be collected from any of the second-set masses in this ion mode. 
Bioassays, in which individually trapped first- and second-set antimycin 
masses were challenged against Candida CA6 revealed that only second-set 
masses, which slightly differ in their polarities and MS2 fractionation patterns 
from first-set masses, exhibited fungal inhibition. Using LCMS in a different ion 
mode, UV and mass data (MS, MS2) of a second-set ion could be collected, 
which were used for generating molecular formulae, and these data turned out 
to match the antifungal antimycin as well. Finally, in a tandem-LCMS analysis, 
an antimycin A1-A4 standard was shown to match second-set antimycin masses 
in retention time, UV, MS, and MS2 data confirming that second-set masses 
indeed are antimycins. Further investigations will be needed to reveal the full 
identity of the first-set antimycin masses, which in this study showed no 
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bioactivity against Candida CA6 and had differential polarities and MS2
fragmentation patterns from the second-set antimycin masses and the antimycin 
A1-A4 standard.  
3.5.1 Two sets of antimycin molecules  
The finding that both sets of masses are antimycins has been published by 
Seipke et al. (2011a). The genome of Streptomyces E8 (renamed S4 in Barke 
et al. 2010) has been published by Seipke et al. (2011b). In addition to 
biosynthetic gene clusters encoding non-bioactive secondary metabolites, 
eleven gene clusters have been identified encoding antibiotic, or as yet 
unknown, compounds (Seipke et al. 2011a). These include non-ribosomal 
peptide synthetase (NRPS), polyketide synthase (PKS), and hybrid NRPS/PKS 
gene clusters. Non-ribosomal peptide synthetases and polyketide synthases 
polymerise amino acids and carboxylic acids as substrate to form (antibiotic) 
compounds, respectively.  
In particular, five gene clusters encode antibiotic compounds and show 
sequence analogies to gene clusters that encode candicidin (PKS), 
mannopeptimycin (NRPS), fredericamycin (PKS), gramicidin (NRPS), and 
kendomycin (PKS). Six gene clusters (three NRPS and three NRPS/PKS) show 
no analogies to known antibiotics and therefore potentially could encode novel 
compounds.  
Seipke et al. (2011a) also report on three Streptomyces E8 (deletion) 
knock-out mutants that, respectively, lack a gene (fscC) in the candicidin 
biosynthesis pathway, lack a gene (antC) in one of the three unknown 
NRPS/PKS gene clusters (scaffold06, coordinates 81953106578) that encodes 
a non-ribosomal peptide synthetase, or lack both target genes.  
Alongside the wild-type, the three knock-out mutants were individually 
challenged against Escovopsis EWC and Candida CA6. Interestingly, the 
double-mutant (fscC, antC) lost almost all of its bioactivity against Candida
but still strongly inhibited the growth of Escovopsis. This indicates that 
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Streptomyces E8 must at least produce three antifungals and illustrates the 
value of using multiple test fungi for bioassay-guided column fractionations.  
The deletion of the antC gene disrupts the strains ability to inhibit Candida, 
but not its ability to inhibit Escovopsis. This indicates that in contrast to the gene 
product of the unknown NRPS/PKS gene cluster (scaffold06, coordinates 
81953106578), which is responsible for most of the inhibition of Candida, the 
third unknown antifungal must be ineffective against the yeast. Hence, the 
strong bioactivity of the normal-phase fractions described in this study, 
containing candicidin and antimycin (Fig. 3.12), cannot be attributed to the third 
antifungal.   
Extracts of liquid growth cultures from the wild-type and antC mutant 
were analysed by low-resolution LCMS alongside an antimycin A1-A4 standard 
(Seipke et al. 2011a). Extracted ion chromatograms show that the wild-type 
produces two compound sets with masses of 507 amu, 521 amu, 535 amu, and 
549 amu [M+H]+. The absence of larger antimycin masses, including masses of 
563 amu and 577 amu [M+H]+, can tentatively be attributed to the relatively 
short growth regimes used by the authors. Seipke et al. (2011a) also show that 
the antimycin standard shares the same retention times as the second-set 
compounds, which is consistent with the tandem-LCMS data, presented in this 
chapter (Table 3.10). One important observation is that the growth culture of the 
antC mutant does not contain any second-set antimycin masses, which 
indicates that the unknown NRPS/PKS gene cluster (scaffold06, coordinates 
81953106578) must encode the antimycin biosynthetic pathway.  
Another important finding is that the antC mutant is also unable to 
produce first-set antimycin masses. This indicates that the first-set compounds 
are antimycins too, or inactive precursors of antimycin, which would explain why 
first-set compounds exhibited differential polarities and MS2 fragmentation 
patterns from the second-set compounds (Table 3.4), and displayed no 
bioactivity against Candida CA6 in this chapter (Fig. 3.21). 
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3.5.2 Streptomyces E8 provides multiple antifungals  
In summary, the Acromyrmex ant-associated Streptomyces strain E8 is 
able to produce candicidin, plus two sets of six antimycin molecules, as 
revealed by biochemical analysis, plus a third, so-far unidentified antifungal, as 
revealed by knock-out experiments disrupting candicidin and antimycin 
biosynthesis in the same strain, plus, potentially, a number of other antibiotics, 
as revealed by sequence analysis, some of which might be novel to science 
(Seipke et al. 2011a).  
The antifungals candicidin and antimycin differ in their mechanism of 
action by disrupting different fungal target molecules. The well-known antibiotic 
candicidin is a polyene antifungal, which due to its amphipathic properties, can 
integrate into fungal cell membranes. Its availability to A. octospinosus has been 
published by Haeder et al. (2009) and Barke et al. (2010). Also, the distribution 
of two candicidin biosynthesis genes (fscM and fscP) across selected ant- and 
cultivar-associated bacterial symbionts, described in this study, has been 
analysed in the Supplementary Information C. The data reveal that candicidin 
production may not be limited to bacterial associates of the Acromyrmex system 
in which Streptomyces E8 and E9, originating from two A. octospinosus colonies, 
both possess candicidin biosynthesis genes (Fig. S2). These genes can also be 
found in Streptomyces KY1, a bacterial associate of Tetraponera penzigi
(Chapter 5).  
The antimycin antibiotics were discovered over 60 years ago and their 
molecular structures are well-described (Dunshee et al. 1949, Ortiz-Gómez et 
al. 1995). Antimycins interfere with the electron transport chain and integrity of 
mitochondria. By binding enzyme complex III, antimycins reduce the efflux of 
hydrogen ions (H+) and hence decrease membrane potential, leading to 
inhibition of the adenosine triphosphate (ATP) metabolism. Their availability to 
Acromyrmex spp. has been reported recently by Schoenian et al. (2011) and 
Seipke et al. (2011a). The Supplementary Information C describes the 
phylogenetic relationship of Streptomyces E8 to other antimycin (and/or 
candicidin) producers. The data show that Streptomyces E8 shares a 
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phylogenetic cluster (Fig. S3) with Streptomyces E9 and several candicidin- plus 
antimycin A1-A4-producers, isolated from A. octospinosus and A. volcanus. The 
bacterial associate of T. penzigi, Streptomyces KY1, might possibly produce 
antimycin in addition to candicidin since it is not only genetically related to 
candicidin-producers but also to bacteria in the cluster of candicidin- plus 
antimycin A1-A4-producers.    
It is unknown whether candicidin and antimycin antagonise or synergise in 
their effects against pathogenic fungi. Potentially, an increased permeability of 
fungal cells due to candicidin may increase mitochondrial exposure to 
antimycins. The fact that both compounds are unmodified relative to compounds 
produced by soil-actinobacteria, fits the environmental recruitment hypothesis 
(Barke et al. 2011) in which Acromyrmex ants are proposed to recruit beneficial 
Streptomyces bacteria from the environment. It would not be useful to invest in 
exploring insect niches if this would lead to an isolation of recently acquired 
environmental recruits of attine hosts, and thus to a re-discovery of the same 
antifungal compounds as previously found by pharmaceutical companies 
studying soil-actinobacteria; then, to invest in exploring cryptic pathways, for 
example by the application of chemical inducers or by mining bacterial genomes 
for antibiotic biosynthesis clusters, would be more promising. However, (1) not 
the complete bacterial microbiome of attine ants appears to be recruited; for 
example, Pseudonocardia symbionts seem to be coevolved and produce 
antifungal with novel chemical structures (i.e. nystatin P1 in Barke et al. 2010, 
dentigerumycin in Oh et al. 2009); (2) also, it is unknown whether attine ant-
associated bacteria, other than Pseudonocardia and Streptomyces, are 
coevolved or environmentally recruited. For example, a bioactive Nocardiopsis
strain was isolated from Acromyrmex octospinosus workers during this study, 
which could be coevolved with the ant host; (3) despite attine ants may recruit 
most of their Streptomyces strains from the environment, investing in the 
exploration of host-symbiont systems may nonetheless be profitable since attine 
ants preferentially associate with antibiotic-producing bacteria. This 
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conglomeration of selected bacteria on attine hosts allows an easy access to 
bioactive strains, reducing the costs of prospecting. 
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Chapter 4) Allomerus decemarticulatus and A. octoarticulatus
cultivar-associated bacteria 
4.1 Introduction 
4.1.1 Mutualistic partners 
Mutualistic relationships between plant-ants and ant-plants can be sub-
divided into myrmecophilic and myrmecophytic associations. Plant-ants are 
well-known to protect their plant host against a diversity of herbivores. In return, 
ant-plants provide their ant symbionts with food rewards and with nesting space. 
In particular, both myrmecophilic and myrmecophytic plants provide their ant 
associates with extrafloral nectar, food bodies or indirectly by secreted 
honeydew of hemipteran trophobionts (reviewed in Heil and McKey 2003). 
Myrmecophytic associations, which are less abundant but more persistent, 
provide their ant symbionts additionally with permanent nesting sites, including 
hollow stems, thorns, petioles or leaf pouches (domatia). Some ant species 
enrich the plant-provided diet by making use of host-unrelated food resources, 
including insects, pollen grains, fungal spores and/or detritus (Davidson et al. 
2003, Belin-Depoux and Bastien 2002).  
The focal species here are the two ant species Allomerus decemarticulatus
and A. octoarticulatus (Hymenoptera, Formicidae), which live symbiotically and 
exclusively with the ant-plants Hirtella physophora (Malpighiales, 
Chrysobalanaceae) and Cordia nodosa (Lamiales, Boraginaceae). The host 
plants supply Allomerus (Fig. 4.1) with nectar from extrafloral nectaries and with 
domatia. Hirtella produces pairs of leaf pouches that are attached to single 
leaves (Fig. 4.2), and Cordia produces single-chambered domatia that are 
interconnected to multiple leaves (Fig. 4.3). Typically, host trees are inhabited 
by a single ant colony that occupies most or all the domatia on a plant.  
Smaller worker ants can be found inside of the domatia, which care for the 
brood (pupae, larvae, and eggs), the queen, and the alates; in contrast, larger 
workers patrol leaves, and the largest Allomerus workers build and maintain  
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Figure 4.1 Microscopy photographs of Allomerus ant and fungal trap 
samples. (A-B) Ventral and dorsal side of a worker ant. (C-D) Part of a 
fungal trap gallery, which is built by A. decemarticulatus on the 
myrmecophyte Hirtella physophora and used to capture insects. The traps 
are typically built at the underside of the branches; to better view the trap 
construction, the branch is turned upside-down. (E-F) Close-up of the 
fungal trap, showing that it consists of cut trichomes (tree hairs) and fungal 
material (dark brown). The fungal cultivar Trimmatostroma cordae is 
thought to provide stability to the trap construction.
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Figure 4.2 Host tree Hirtella physophora and ant symbiont Allomerus 
decemarticulatus. (A) H. physophora host tree in the rainforest of French 
Guiana. (B) Branch of the myrmecophytic tree with several domatia (nesting 
sites), each consisting of double-chambered leaf pouches (white arrows). (C-D) 
While the smallest worker ants take care of the brood and queen inside of the 
domatia, larger workers patrol on the leaves, and the largest workers construct 
and maintain trap galleries. The trap galleries are running alongside the 
branches and extend to the trunk; they even interconnect domatia of different 
leaves and branches.  
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galleried traps, which are used to capture visiting arthropods (Dejean et al.
2005) (Fig. 4.4). 
The trap galleries are built along the stem and along the undersides of 
branches and domatia, possibly to avoid rain damage and/or to coincide with 
where travelling arthropods are most likely to land on the host plants. The 
galleries are tunnel shaped constructions gridded with small, circular openings 
(Fig. 4.1) underneath which worker ants wait with opened mandibles for prey to 
Figure 4.3 Host tree Cordia nodosa and ant symbiont Allomerus octoarticulatus. 
(A-B) C. nodosa host tree in the rainforest of French Guiana producing domatia 
with single cavities (white arrow). (C) The trap galleries are built near the 
entrance of domatia and at the trunk.  
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land, at which time the ants grab onto the legs, move in opposite directions to 
stretch the preys legs, and sting the insect to death (Dejean et al. 2005) (Fig. 
4.4). The workers then collectively move the killed prey towards the nearest leaf 
pouches, where the insect is dismantled and consumed.  
The trap galleries are built upon hair-like structures (trichomes) that cover 
the branches and trunk of both Hirtella and Cordia. The ants cut a pathway 
through and interweave trichomes to form the trap scaffold, which is covered 
with carton and frass. The completed trap is then inoculated with a fungus that 
grows over and connects individual trichomes, thereby providing stability (Ruiz-
González et al. 2010). 
Hirtella-hosted A. decemarticulatus ants build extensive trap galleries that 
even interconnect domatia of different branches; here, the fungus covers the 
Figure 4.4 Insect caught by Allomerus decemarticulatus. A foreign ant 
queen has been caught by the ant colony. The largest workers wait 
inside of the trap galleries for insects to land. While some ants 
immobilise prey by clinging to its feet, others overwhelm and sting it to 
death. The insect is dismantled near a domatium. Note that the branch 
is turned upside-down to view the catch.   
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whole trap gallery. In contrast, Cordia-hosted A. octoarticulatus ants build trap 
galleries that cover the entrances of domatia, sometimes extending to the 
underside of branches, and also along the stem. In this symbiosis, apparently 
only parts of the trap galleries are inoculated with the fungus, namely, areas 
near the entrance of domatia containing the queen. It is unknown whether 
differences in trap construction and location reflect differences in hunting 
strategies.  
From trap galleries and foundress-occupied domatia of 108 A. 
decemarticulatus and 31 A. octoarticulatus colonies, Ruiz-González et al. (2010) 
isolated primarily one fungal morphotype. This fungus has been shown, based 
on 114 concatenated full ITS and EF1 sequences, to belong to 16 genetically 
related haplotypes; one of which was dominant, representing more than 75% of 
the sequences (Ruiz-González et al. 2010). The cultivar has been placed, 
based on 124 full ITS sequences, in the ascomycete order Chaetothyriales, 
close to Trimmatostroma cordae (AJ244263) and to fungal collections 
associated with the ant genus Azteca (FJ538958, FJ538959, FJ538960). 
Vertical transmission of the fungal cultivar by new queens is implicated (Lauth et 
al. 2011), which is consistent with the observations that the cultivar is absent 
from unoccupied trees and disappears when ant colonies die. Allomerus ants 
also appear to invest in their association with the cultivar, feeding the fungus 
with prey debris and vegetable material, and manipulating its growth (Ruiz-
González et al. 2010, Lauth et al. 2011). In particular, the ants have been 
proposed to limit the growth of the fungal mutualist to the galleries, to use the 
fungal material for repairing (artificial) damages in the walls of the domatia, and 
to overgrow the stockades that new gynes build to enclose themselves in the 
domatia before the start of reproduction. 
4.1.2 Exploitation control of non-cultivar fungi 
Just as with the fungal cultivar of attine ants, vertical transmission may 
help to ensure that the trap cultivar is available to all new ant colonies and also 
that the fitness interests of ant and fungal cultivar are aligned. However, vertical 
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transmission results in reduced genetic relatedness at the population level, 
which can translate into increased vulnerability to disease and competition 
because the ability of the fungal cultivar to engage in interference competition 
with competitors or to defend against pathogens would be impaired by having 
access to only the same set of fungal metabolites as all neighbouring colonies.  
Trap galleries indeed are subject to fungal and bacterial contamination, 
vectored by water droplets from the overstory, faeces of birds, and/or prey 
insects; fungal traps also receive wind-dispersed fungal spores. Spores from up 
to 44 fungal species have been isolated from the cultivars (Ruiz-González et al.
2010). In vitro, inocula of the slow-growing fungal mutualist are regularly 
overgrown by some of these fast-growing non-cultivar fungi. If invasive fungi 
consume or overgrow the Trimmatostroma cultivar that stabilises the trap 
gallery, the traps could be rendered useless, thereby reducing Allomerus
fitness. Infection zones might also spread to the domatia and infect the ant 
brood. 
In parallel with attine ants, several mechanisms can hypothetically prevent 
non-cultivar fungi and pathogens from infesting fungal traps, and explain the 
widespread occurrence of the fungal cultivar. The ants may (1) physically 
remove non-cultivar fungi or apply metapleural gland secretions. Spores and 
hyphae of non-cultivar fungi indeed are present in the infrabuccal pellets of 
workers as indicated by unpublished data (M. X. Ruiz-Gonzalez 2009); (2) the 
fungal cultivar could defend itself by secreting antibiotics; (3) ant-associated 
bacteria could produce antibiotics that selectively target non-cultivar fungi and 
bacterial pathogens; and/or (4) cultivar-associated bacteria could do the same.  
Seipke et al. (2012) recently presented evidence for the third mechanism, 
demonstrating that an antibiotic-producing microbiome is present on the cuticles 
of A. decemarticulatus and A. octoarticulatus. Six Streptomyces and one 
Amycolatopsis strains were isolated from worker ant cuticles. Both genera have 
previously been reported from attine worker ants (e.g. Haeder et al. 2009, Sen 
et al. 2009). The seven bacterial Allomerus isolates were bioassayed against 
Candida CA6 and two non-cultivar fungi, including Beauveria (F3) and 
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Annulohypoxylon (F5). The Amycolatopsis strain was able to inhibit the growth 
of all fungal opponents in vitro, while the bioactivity of the Streptomyces strains 
was more selective. One Streptomyces strain inhibited Candida and Beauveria 
(F3); another strain inhibited Candida and Annulohypoxylon (F5); and one strain 
inhibited the growth of Candida only.  
4.2 Aims  
In this chapter, the fourth hypothesis is tested that the fungal cultivar itself 
hosts an antibiotic-producing microbiome that is used to attack non-cultivar fungi 
and pathogens. Fungal traps could offer a rich habitat for bacterial symbionts, 
following the findings that bioactive Streptomyces symbionts have been 
reported from the fungal cultivar of Acromyrmex octospinosus (Haeder et al. 
2009) and that bioactive Burkholderia have been isolated from the fungal 
cultivar of Atta sexdens (Santos et al. 2004). From a pharmaceutical point of 
view, this under-explored environmental niche could represent a source of 
putatively coevolved bacteria and novel antifungals.  
4.3 Materials and Methods 
4.3.1 Sampling fungal cultivars  
Worker ants and their fungal cultivar were sampled from Allomerus 
decemarticulatus and A. octoarticulatus colonies, hosted by Hirtella physophora
and Cordia nodosa, respectively. The samples were collected in French Guiana 
from three inland sites and one coastal location (Fig. 4.5). From the inland sites, 
Basevie, Area 9, and Area 24, which all are close to the field station at Barrage 
de Petit Saut, 28 Hirtella-hosted A. decemarticulatus colonies were sampled as 
well as nine Cordia-hosted A. octoarticulatus colonies (Table 4.1). From the 
coastal site, la Montagne des Singes (near Kourou), two Hirtella-hosted A. 
decemarticulatus colonies, but no Cordia-hosted A. octoarticulatus colonies, 
were sampled. Instead, ants and fungal cultivar samples of 20, seemingly rare, 
Hirtella-hosted A. octoarticulatus colonies were sampled. This is the only known 
site to harbour this host symbiont combination. Typically, Hirtella samples  
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Figure 4.5 (A-B) Sampling locations in French Guiana, where Allomerus spp. 
worker ants and their fungal cultivar were sampled. The sampling sites 
include Basevie, Area 24, and Area 9, located near the field station at 
Barrage de Petit Saut, as well as la Montagne des Singes, located near 
Kourou.
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Sampling location Colony Host    tree
Ant 
species
Worker 
ants
Fungal 
cultivar
Preserved 
in
Area 24, French Guiana 53 CN AO 53A,C 53B 2G
Area 24, French Guiana 54 CN AO 54A,C 54B 2G
Area 24, French Guiana 56 CN AO 56A,C 56B 2G
Area 24, French Guiana 51 HP AD 51A,C 51B 2G
Area 24, French Guiana 52 HP AD 52A,C 52B 2G
Area 24, French Guiana 55 HP AD 55A,C 55B 2G
Area 24, French Guiana 57 HP AD 57A,C 57B 2G
Area 24, French Guiana 58 HP AD 58A,C 58B 2G
Area 24, French Guiana 59 HP AD 59A,C 59B 2G
Area 9, French Guiana 42 CN AO 42A,C 42B PBS
Area 9, French Guiana 50 CN AO 50A,C 50B PBS
Area 9, French Guiana 41 HP AD 41A,C 41B PBS
Area 9, French Guiana 43 HP AD 43A,C 43B PBS
Area 9, French Guiana 39 HP AD 39A,C 39B 2G
Area 9, French Guiana 40 HP AD 40A,C 40B 2G
Area 9, French Guiana 44 HP AD 44A,C 44B 2G
Area 9, French Guiana 45 HP AD 45A,C 45B 2G
Area 9, French Guiana 46 HP AD 46A,C 46B 2G
Area 9, French Guiana 47 HP AD 47A,C 47B 2G
Area 9, French Guiana 48 HP AD 48A,C 48B 2G
Area 9, French Guiana 49 HP AD 49A,C 49B 2G
Basevie, French Guiana 6 CN AO 6A,C 6B PBS
Basevie, French Guiana 7 CN AO 7A,C 7B PBS
Basevie, French Guiana 13 CN AO 13A,C 13B PBS
Basevie, French Guiana 16 CN AO 16A,C 16B PBS
Basevie, French Guiana 1 HP AD 1A,C 1B PBS
Basevie, French Guiana 2 HP AD 2A,C 2B PBS
Basevie, French Guiana 3 HP AD 3A,C 3B PBS
Basevie, French Guiana 4 HP AD 4A,C 4B PBS
Basevie, French Guiana 5 HP AD 5A,C 5B PBS
Basevie, French Guiana 8 HP AD 8A,C 8B PBS
Basevie, French Guiana 9 HP AD 9A,C 9B PBS
Basevie, French Guiana 10 HP AD 10A,C 10B PBS
Basevie, French Guiana 11 HP AD 11A,C 11B PBS
Basevie, French Guiana 12 HP AD 12A,C 12B PBS
Basevie, French Guiana 14 HP AD 14A,C 14B PBS
Basevie, French Guiana 15 HP AD 15A,C 15B PBS
La montagne des singes, French Guiana 32 HP AD 32A,C 32B PBS
La montagne des singes, French Guiana 35 HP AD 35A,C 35B PBS
La montagne des singes, French Guiana 17 HP AO 17A,C 17B PBS
La montagne des singes, French Guiana 18 HP AO 18A,C 18B PBS
La montagne des singes, French Guiana 19 HP AO 19A,C 19B PBS
La montagne des singes, French Guiana 20 HP AO 20A,C 20B PBS
La montagne des singes, French Guiana 21 HP AO 21A,C 21B PBS
La montagne des singes, French Guiana 22 HP AO 22A,C 22B PBS
La montagne des singes, French Guiana 23 HP AO 23A,C 23B PBS
La montagne des singes, French Guiana 24 HP AO 24A,C 24B PBS
La montagne des singes, French Guiana 25 HP AO 25A,C 25B PBS
La montagne des singes, French Guiana 26 HP AO 26A,C 26B PBS
La montagne des singes, French Guiana 27 HP AO 27A,C 27B PBS
La montagne des singes, French Guiana 28 HP AO 28A,C 28B PBS
La montagne des singes, French Guiana 29 HP AO 29A,C 29B PBS
La montagne des singes, French Guiana 30 HP AO 30A,C 30B PBS
La montagne des singes, French Guiana 31 HP AO 31A,C 31B PBS
La montagne des singes, French Guiana 33 HP AO 33A,C 33B PBS
La montagne des singes, French Guiana 34 HP AO 34A,C 34B PBS
La montagne des singes, French Guiana 36 HP AO 36A,C 36B PBS
La montagne des singes, French Guiana 37 HP AO 37A,C 37B PBS
La montagne des singes, French Guiana 38 HP AO 38A,C 38B PBS
Table 4.1 Domatia, leaf/leaves, and some of the fungal traps were sampled 
from 28 Hirtella (HP)-hosted A. decemarticulatus (AD) and nine Cordia (CN)-
hosted A. octoarticulatus (AO) colonies nearby Barrage de Petit Saut; two 
Hirtella-hosted A. decemarticulatus and 20 Hirtella-hosted A. octoarticulatus
colonies from la Montagne de Singes. Worker ants (A, C) and their fungal 
cultivar (B) were isolated from the samples, the latter of which was used for 
the bacterial isolations. 
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consisted of a double-chambered domatium, associated leaf, and leaf petiole 
with some of the fungal trap.
Cordia samples consisted of a single-chambered domatium, multiple 
associated leaves and leaf petiole with some of the fungal trap. The samples 
were bagged and brought from the collection sites to the field station, where 
they were stored at 4 oC, until processing. Hirtella-hosted A. decemarticulatus
and A. octoarticulatus colonies, from la Montagne des Singes, were 
distinguished morphologically by counting the number of antennal segments of 
representative worker ants under a stereomicroscope, ten for A. 
decemarticulatus and eight for A. octoarticulatus.  
At the field station of Barrage de Petit Saut, the worker ants were removed 
from the domatia, leaves, and fungal traps under a stereomicroscope. The work 
bench was sterilised with 70% ethanol, the isolation took place nearby an open 
flame, and the insects were picked-up with soft forceps that previously were 
sterilised. The reason for combining workers of different size classes and 
functions was their disrupted functional distribution across leaves, domatia, and 
traps after having been disturbed during collection. The corresponding fungal 
traps were also collected from the plant material. Ants and fungal material were 
preserved in Eppendorf tubes containing 1 ml of phosphate buffered saline 
(PBS) or 1 ml of 20% glycerol (2G). Differing storage media were used to 
reduce the risk of killing bacterial strains due to uncertain and potentially 
unfavourable transport within French Guiana and during transit to the United 
Kingdom.  Before and after their transport, the PBS samples were stored at 4 oC 
and the 2G samples at -20 oC. PBS has been shown to possess good qualities 
as a preservative of bacterial cells (Liao and Shollenberger 2003), and also has 
the advantage that samples can be stored unfrozen. Some samples were stored 
in glycerol since the composition of bacterial species and the presence of 
relatively rare, but possibly important species, is likely more stable at -20 oC; the 
disadvantage here is, that temporarily higher temperatures during transit could 
be lethal to certain bacterial species.   
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4.3.2 Isolation of cultivar-associated bacteria 
Bacterial isolations were carried out in a category 2 microbiological 
laboratory at the University of East Anglia, United Kingdom. Bacteria were 
isolated from the fungal trap sample of 59 A. decemarticulatus or A. 
octoarticulatus colonies (Table 4.1). The samples were vortexed for a minimum 
of 10 seconds. Then the solid particles of the traps were separated from the 
supernatants by briefly centrifuging. The 2G and PBS supernatants were then 
transferred to fresh Eppendorf tubes. Small sub-samples of the supernatants 
were serially diluted (dilution factors: 10-1, 10-2, 10-3, 10-5, 10-7, 10-8) and used 
for inoculating mannitol soy-flour (MS) agar plates (Table 4.2). Fresh agar plates 
were prepared by adding 1 ml of nystatin (5 mg (Sigma N3503-25MU) in 1 ml 
dimethyl sulfoxide (DMSO)) and 1 ml of cycloheximide (5 mg (Fisher 35742-
0050) in 1 ml 100% ethanol) solutions to 100 ml autoclaved agar (50 oC); the 
medium was then sub-divided over four Petri dishes.  
Inoculated agar plates were incubated at 30 oC, and morphotypes of 
Gram-positive and Gram-negative bacteria were purified by repeatedly 
propagating single colonies to fresh MS agar plates. Each morphotype was 
selected once, regardless of colony abundance. In total, 20 bacterial lineages 
(FG1-FG15, FG17-FG21) could be isolated (Table 4.3); most of the strains (85%) 
were isolated from individual traps, and the rest were obtained from pilot 
isolation plates that had been inoculated with combinations of cultivar 
supernatants. The purified strains were stored in 2G, as described for the 
bacterial isolates of the Acromyrmex system (Chapter 2.3.2).  
4.3.3 Aquisition of fungal symbionts 
Ruiz-González et al. (2010) isolated various non-cultivar fungi from fungal 
traps. Sub-cultures of the fungal mutualist (F1) and of four non-cultivar fungi (F2-
F5) were provided by the authors (Table 4.3). The fungal strains were 
maintained on MS, potato dextrose (PDA), and Sabouraud agar (Table 4.2). 
Fresh agar plates were prepared by enriching 100 ml batches of autoclaved 
medium (50 oC) with 1 ml of filter-sterilised carbenicillin (5 mg (Fisher BPE2648- 
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Table 4.2 Media for the cultivation of bacteria and fungi.  
Medium Ingredients Weight (g), volume (ml), percent (%)
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Distilled water 1000 ml
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Agar 15.0 g
Distilled water 1000 ml
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Agar 5.0 g
Distilled water 1000 ml
Organic soy-flour 20.0 g
Mannitol 20.0 g
Agar 20.0 g
(+SB, 150mM sodium butyrate) (16.5 g)
Tap water 1000 ml
Organic soy-flour 20.0 g
Mannitol 20.0 g
(+SB, incl. 150mM sodium butyrate) (16.5 g)
Tap water 1000 ml
Glucose 20.0 g
Instant mashed potato (smash) 5.0 g
Agar 20.0 g
Distilled water 1000 ml
Dextrose 40.0 g
Peptone 10.0 g
Agar 20.0 g
Distilled water 1000 ml
Tryptone soya broth (Oxoid) 30.0 g
Distilled water 1000 ml
Yeast extract 3.0 g
Peptone 5.0 g
Malt extract 3.0 g
Glucose 10.0 g
Distilled water 1000 ml
TSB 50 %
YEME 50 %
TSB/YEME
Sabouraud agar                            
(pH=5.6)
Tryptone soya broth (TSB)
Yeast extract-malt extract 
(YEME)
Mannitol soy-flour (MS) agar 
Mannitol soy-flour (MS) broth 
Potato dextrose agar (PDA) 
Lennox broth (LB)
Lennox broth (LB) agar
Lennox broth (LB) soft agar 
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5) in 1 ml dH2O) and 1 ml of filter-sterilised streptomycin (5 mg (Fisher BPE910-
50) in 1 ml dH2O) solutions. The medium was either equally sub-divided over 
four Petri dishes for short-term usage or added as slopes to cylindrical 
containers (Bijouxs) for long-term storage of strains. The fungal inocula were 
either grown at room temperature or at 30 oC.  
4.3.4 Light microscopy 
Stereomicroscope photographs of the bacterial isolates, a fungal trap, and 
a worker ant were taken in the Henry Wellcome Laboratory for Cell Imaging 
(www.uea.ac.uk/bio/biobmi) with a Zeiss SV11 M2 Bio Quad stereomicroscope 
and an AxioCam HRc CCD camera. Young and thus relatively flat bacterial 
colonies were used, and magnifications were adjusted to suit the size variation 
of bacterial species. Photographs of the bacterial colonies were taken at 
magnifications of 1.0, 1.6, 2.0, 2.5, 3.2, 4.0, 5.0, and 6.6X; photographs of 
Table 4.3 Origin of fungal and bacterial symbionts.  
Sample type Name Sample origin Host type Host colony Host tree
Ant 
species
Fungal cultivar Trimmatostroma cordae  F1 Area 24, Area 9, Basievie, French Guiana - - - -
Non-cultivar fungus F2 Area 24, Area 9, Basievie, French Guiana - - - -
Non-cultivar fungus F3 Area 24, Area 9, Basievie, French Guiana - - - -
Non-cultivar fungus F4 Area 24, Area 9, Basievie, French Guiana - - - -
Non-cultivar fungus F5 Area 24, Area 9, Basievie, French Guiana - - - -
Bacterial isolate FG1 Area 24, French Guiana Cultivar trap 54B CN AO
Bacterial isolate FG2 Area 24, French Guiana Cultivar trap 51B,52B,55B,57B,58B,59B HP AD
Bacterial isolate FG3 Area 24, French Guiana Cultivar trap 52B HP AD
Bacterial isolate FG4 Area 9, French Guiana Cultivar trap 48B HP AD
Bacterial isolate FG5 Area 24, French Guiana Cultivar trap 52B HP AD
Bacterial isolate FG6 Area 24, French Guiana Cultivar trap 53B,54B,56B CN AO
Bacterial isolate FG7 Area 9, French Guiana Cultivar trap 47B HP AD
Bacterial isolate FG8 La Montagne des Singes, French Guiana Cultivar trap 34B HP AO 
Bacterial isolate FG9 Area 24, French Guiana Cultivar trap 53B CN AO
Bacterial isolate FG10 La Montagne des Singes, French Guiana Cultivar trap 37B HP AO
Bacterial isolate FG11 Area 9, French Guiana Cultivar trap 45B HP AD
Bacterial isolate FG12 La Montagne des Singes, French Guiana Cultivar trap 17B HP AO
Bacterial isolate FG13 La Montagne des Singes, French Guiana Cultivar trap 37B HP AO
Bacterial isolate FG14 La Montagne des Singes, French Guiana Cultivar trap 34B HP AO
Bacterial isolate FG15 La Montagne des Singes, French Guiana Cultivar trap 24B HP AO
Bacterial isolate FG16 La Montagne des Singes, French Guiana Worker ants 28A,29A,19A,33A,36A HP AO
Bacterial isolate FG17 Area 24, French Guiana Cultivar trap 54B CN AO
Bacterial isolate FG18 Area 9, French Guiana Cultivar trap 40B HP AD
Bacterial isolate FG19 Basevie, French Guiana Cultivar trap 2B HP AD
Bacterial isolate FG20 La Montagne des Singes, French Guiana Cultivar trap 34B HP AO
Bacterial isolate FG21 Area 24, French Guiana Cultivar trap 53B,54B,56B CN AO
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fungal and ant samples were taken at magnifications of 1.6, 3.2, and 6.6X. 
Scale bars of 1 mm were added to the pictures with AxioVision software (Carl 
Zeiss, Welwyn Garden City, UK).     
4.3.5 Extraction of genomic DNA  
Hyphal material of the fungal strains F1, F2, F3, F4, and F5 (Table 4.3) was 
added to Eppendorf tubes, containing glass beads and 800 µl of ice-cold TGE 
buffer (Table 4.4). DNA extractions were carried out on overnight cultures of the 
bacterial isolates (FG1-FG15, FG17-FG21) (Table 4.3). Glass containers 
(universals), containing 10 ml of TSB/YEME (Table 4.2) and a spring, were 
inoculated with 50 µl from the glycerol stocks or cell material of single plate 
colonies. The universals 
were incubated overnight in 
a shaker incubator (200 
rpm, 30 oC). The bacterial 
cells were harvested by 
centrifugation (4000 rpm, 5 minutes, 4 oC); the supernatants of the samples 
were discarded, whereas the cell pellets were re-suspended in 800 µl of TGE 
buffer and placed into Eppendorf tube containing a small layer of glass beads.  
The fungal and bacterial samples were DNA extracted using a procedure, 
which is summarised below; for a detailed description of the method see 
Chapter 2.3.5. The fungal and bacterial samples were stored on ice for a 
minimum of 5 minutes before, during, and after bead-beating sessions (6x30 
seconds, 6 m/s). Repeatedly, 0.5 ml of phenol:chloroform:isoamyl alcohol 
(25:24:1) was added, vortexed (1 minute), and centrifuged (13,200 rpm, 5 
minutes). The purified supernatants were either washed one time with 0.5 ml 
chloroform:isoamyl alcohol (24:1) or precipitated with 1 ml of 100% ethanol, 
after which the dried DNA pellet was re-suspended in 50 l of sterile dH2O. 
 Table 4.4 Solution for DNA extractions. 
Solution Ingredients Concentration (mM)
Tris 50 mM
EDTA 10 mM
Tris/Glycine/EDTA (TGE) 
buffer (pH=8.0)
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4.3.6 Amplification and purification of diagnostic genes 
Diagnostic genes were amplified from the fungal (ITS region) and bacterial 
(16S rDNA) genomes by polymerase chain reaction (PCR), using sample-
specific primers (ITS1-F-ITS4, 515-1492, Table 4.5) and PCR conditions (Table 
4.6). Selected amplicons were recovered from the gel using a Qiagen Gel 
Extraction Kit and following the manual (www.qiagen.com).  
4.3.7 Sequencing and BLAST-matching  
The cleaned amplicons were sequenced (Table 4.7) using the sample-
specific forward primers (ITS1-F, 515). The sequenced PCR products were 
analysed by The Genome Analysis Centre TGAC (www.jicgenomelab.co.uk) 
Table 4.5 Primer sets for the partial amplification of fungal (ITS region) and 
bacterial (16S SSU) rDNA genes.  
Name Sequence Reference Gene Amplicon length
ITS1-F 5'-CTTGGTCATTTAGAGGAAGTAA-3' Gardens and Bruns (1993)
ITS4 5'-TCCTCCGCTTATTGATATGC-3' White et al . (1990)
515 5'-GTGCCAGCMGCCGCGGTAA-3' Turner et al.  (1999)
1492 5'-GGTTACCTTGTTACGACTT-3' Turner et al. (1999)
18S rDNA ± 600 bp
16S rDNA ± 1000 bp
Table 4.6 (A-B) PCR mixture and thermocycles for the partial amplification of 
fungal (ITS region) and bacterial (16S SSU) rDNA genes. 
A B
PCR mixture Volume
dH2O 23.0 µl
GoTaq buffer (incl. loading buffer) 8.0 µl
GoTaq MgCl (25 mM) 2.4 µl
DMSO (100%) 2.0 µl
Bioline dNTP's (10 mM) 1.0 µl
Forward primer (25 µM) 1.0 µl
Reverse primer (25 µM) 1.0 µl
DNA 1.0 µl
GoTag polymerase 0.6 µl
Total 40.0 µl
Temperature Minutes Temperature Minutes
1 94 oC 4:00 94 oC 12:00
2 95 oC 0:30 94 oC 1:00
3 53 oC 1:00 45 oC 0:45
4 72 oC 1:00 72 oC 1:30
5
6 72 oC 10:00 72 oC 20:00
7 end end
Go 34x to step 2 
Fungi BacteriaStep
Go 29x to step 2 
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using ABI 3730XL sequencers (Life Technologies). The sequences were 
quality-checked and truncated with FinchTV 
(www.geospiza.com/Products/finchtv.shtml). Then the reads were matched to 
the BLAST database of the National Center for Biotechnology Information 
(NCBI, http://blast.ncbi.nlm.nih.gov/Blast.cgi). A BLASTn search compared the 
sample reads to database sequences in the nucleotide collection (nr/nt), 
optimising for highly similar sequences (megablast).     
4.3.8 Colony bioassays  
Selected bacterial isolates of antibiotic-producing genera were tested in 
colony bioassays against Candida albicans (CA6, Table 3.2) and two non-
cultivar fungi (i.e. F3 and F5, Table 4.3). No challenges could be carried out 
against other non-cultivar fungi (i.e. F2 and F4) nor, unfortunately, against the 
fungal mutualist (i.e. F1), since the fungal colonies showed inherently patchy 
growth on agar plates. In total, the bacterial selection included nine of the twenty 
bacterial isolates FG1-FG8 and FG21, which are hereby collectively referred to as 
the NNSPS strains, using the initial letters of the genera Nocardia, 
Nocardiopsis, Streptomyces, Pseudonocardia, and Saccharopolyspora
(Nocardiopsis and Pseudonocardia have been isolated in Chapter 2 from 
Acromyrmex and Saccharopolyspora has been isolated in Chapter 5 from 
Tetraponera).
Table 4.7 (A-B) Reaction mixture and thermocycles for the 
sequencing of PCR amplicons. 
A B
Sequencing mixture Volume
dH2O 5.5 µl
5x sequencing buffer 1.5 µl
Forward primer (3.2 µM) 1.0 µl
DNA 1.0 µl
Enzyme E3.1 1.0 µl
Total 10.0 µl
Step Temperature Minutes
1 96 oC 1:00
2 96 oC 0:10
3 50 oC 0:05
4 60 oC 4:00
5
6 60 oC 0:10
7 end
Go 25x to step 2
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4.3.8.1 Bioassays against Candida  
The selected bacteria were tested in colony bioassays against Candida
CA6. Universals with 10 ml of TSB/YEME and a spring were inoculated with 30 
µl from the bacterial glycerol stocks and grown in a shaker incubator for a 
sufficient accumulation of biomass (280 rpm, 30 oC). The cell material was 
harvested by centrifugation (4000 rpm, 5 min), and the supernatants were 
disposed. The centre of MS agar plates, containing no antibiotics, was point-
inoculated with standardised fractions from the cell pellets. As negative controls, 
one uninoculated plate and one inoculated with cells of Streptomyces lividans
were included.  
The experiment was carried out in duplicate; one set of agar plates 
contained 150 mM of sodium butyrate, which is shown to increase antifungal 
production in certain bacteria (Martin and McDaniel 1976, Moore et al. 2012), 
and one set did not. Inoculated plates were incubated for thirteen days at 21 oC. 
One day before the plates were due to be overlaid with Candida, the yeast was 
grown in 10 ml of Lennox broth (LB) (280 rpm, 37 oC). Then, 1 ml of the culture 
was added to 5 ml of LB soft agar (50 oC) (Table 4.2). The medium was poured 
over the bioassay plates, which were pre-warmed to 30 oC, contacting but not 
overlaying the bacterial colonies. The bioassay plates were incubated for 2 days 
at 26 oC for Candida to grow and become whitish in colour, after which the 
presence or absence of inhibition zones was scored. 
4.3.8.2 Bioassays against non-cultivar fungi F3 and F5
In a second bioassay experiment by Ryan Seipke, the selected bacteria 
were challenged against the non-cultivar fungi F3 and F5, in the absence of 
sodium butyrate. Standardised fractions of cell material from bacterial plate 
colonies were point-inoculated into the centre of MS agar plates, containing no 
antibiotics. As a negative control, mycelia of S. lividans were inoculated onto an 
additional agar plate. The plates were incubated at 30 oC until mature colonies 
had grown. Then the hyphal material of the fungal strains was point-inoculated 
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at the edge of the bioassay plates. The plates were again incubated at 30 oC 
until the fungi clearly overgrew or clearly avoided the bacterial colonies.     
4.3.9 Supernatant bioassays  
Growth cultures of the selected NNSPS strains (FG1-FG8, FG21) were 
challenged against Candida CA6. This test was performed to see whether any of 
these strains secrete bioactive metabolites into a liquid medium, from which 
they could be recovered. No supernatant bioassays were carried out against the 
non-cultivar fungi F3 and F5 because none of the bacterial isolates had been 
shown to inhibit these strains in colony bioassays.  
4.3.9.1 Obtaining supernatants       
Growth cultures of the selected bacteria were obtained by inoculating 50 
ml batches of MS broth (Table 4.2) with 30 µl from the bacterial glycerol stocks. 
As negative controls, one batch of medium was inoculated with spores of S. 
lividans and another batch remained uninoculated. One set of growth media 
contained 150 mM sodium butyrate, and another one did not. Due to the 
relatively low inoculation volume (and possibly a low spore/cell concentration of 
the glycerol stocks), the flasks had to be shaker incubated for a period of 14 
days (30 oC, 250 rpm), before the accumulation of abundant cell material could 
be observed. The supernatants were harvested by pelleting-out and disposing 
much of the cell material and insoluble medium (30 minutes, 4000 rpm, 4 oC). 
For the bioassays, small sub-samples of the supernatants were centrifuged a 
second time with a benchtop centrifuge (5 minutes, 13,200 rpm), before being 
filter-sterilised with 0.2 µm filters.  
4.3.9.2 Bioassays against Candida  
The bacterial supernatants of strains, grown in the presence or absence of 
sodium butyrate, were challenged against Candida CA6. 100 µl of the sterilised 
supernatants were inoculated onto paper filter disks, with a diameter of 0.9 cm. 
As negative controls, two filter disks were inoculated with the control liquids. LB 
Chapter 4) Allomerus decemarticulatus and A. octoarticulatus cultivar-                            
associated bacteria 
163
agar plates were coated with 400 µl of one-day-old Candida growth cultures, 
which were grown in universals containing 10 ml of Lennox broth (Table 4.2). 
When dry, the filters were attached to the agar with 60 µl of dH2O. The bioassay 
plates were incubated for two days at 26 oC; then the presence or absence of 
inhibition zones was scored.  
4.4 Results 
4.4.1 Isolation and microscopy of cultivar-associated bacteria 
In French Guiana, myrmecophytes Hirtella physophora and Cordia nodosa
were sampled for Allomerus decemarticulatus and A. octoarticulatus worker 
ants and their fungal cultivars. These samples originated from 30 Hirtella-hosted
A. decemarticulatus, 9 Cordia-hosted A. octoarticulatus and 20 Hirtella-hosted
A. octoarticulatus ant colonies (Table 4.1). All Hirtella samples included an 
inhabited and double-chambered domatium, the associated leaf, and a part of 
the leaf petiole with some fungal trap; in contrast, all Cordia samples contained 
a single-chambered domatium, associated leaves, and the leaf petiole with 
some fungal trap. The samples were bagged and processed in the field station 
at Barrage de Petit Saut. The worker ants were removed from the leaves, 
domatia, and fungal trap, and were preserved in aliquots of sterile PBS or 2G. 
Thereafter, the fungal cultivars were removed from the plant material and 
preserved in separate aliquots of PBS and 2G. In a culture-dependent way, 
bacteria were isolated from the fungal cultivars in a category 2 microbiological 
laboratory at the University of East Anglia, United Kingdom. For the isolation, 
diluted PBS and 2G holding liquids were inoculated onto agar plates and unique 
morphotypes of Gram-positive and Gram-negative bacteria were purified.  
In total, 20 unique bacterial morphotypes were isolated from the fungal 
traps. Each strain received an ID, consisting of the prefix FG and an individual 
number. Stereomicroscope pictures of the bacterial isolates (FG1-FG15, FG17-
FG21) are presented in figure 4.6 and their origin is shown in table 4.3. 
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4.4.2 Acquisition of fungal symbionts 
Diverse species of non-cultivar fungi were isolated from the 
Trimmatostroma cordae trap fungal cultivar. Sub-samples of the fungal cultivar 
(F1) and four non-cultivar fungi (F2-F5) were provided by Ruiz-González et al.
(2010) (Fig. 4.7; Table 4.3). These strains originated from the same 
myrmecophytes as the fungal cultivars, which are used for the bacterial 
isolations.   
4.4.3 Amplification, purification, sequencing, and BLAST-matching of 
diagnostic genes from genomic DNA extracts 
The morphologically identified fungal cultivar and four non-cultivar fungi 
(Table 4.3) were identified genetically by partially sequencing the ITS region of 
the rDNA gene. The sequences of the fungal cultivar F1 (915 bp), and non-
cultivars F2 (540 bp), F3 (494 bp), F4 (519 bp), and F5 (693 bp), show BLAST 
analogies to rDNA sequences of Trimmatostroma, Penicillium, Beauveria, 
Cladosporium, and Annulohypoxylon/Xylariaceae/Hypoxylon, respectively
(Table 4.8). An overview of the sequencing data is given in the Supplementary 
Information A1.  
Furthermore, a segment of the bacterial 16S rDNA gene was sequenced to 
genetically identify the microbial isolates (Table 4.3). The sequences of the 
bacterial strains FG1-FG15, FG17-FG21 (633-919 bp; mean 883 bp) show BLAST 
analogies to the 16S rDNA of diverse bacterial phyla (Table 4.8). Also, diverse 
actinobacteria in the genus Streptomyces could be isolated from the traps, 
which is interesting because baiting experiments (Yu and Pierce 1998) have 
suggested that Allomerus exclusively completes its life cycle within their host 
trees, and hence might not contact actinobacteria-rich soils. A summary of the 
sequencing data is presented in the Supplementary Information A1.  
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Figure 4.6 Microscopy photographs of 20 bacterial isolates (FG1-FG15, FG17-
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FG21), originating from the fungal cultivar of Allomerus spp. In addition to 
bacteria in the phylum Actinobacteria, bacteria of other phyla were isolated, 
including Gram-positives and Gram-negatives of the phyla Firmicutes, 
Proteobacteria, and Bacterioidetes. An overview of the bacterial origin and 
details on their genetic identity are provided in the tables 4.3 and 4.8, 
respectively. A selection of nine bacterial isolates (FG1-FG8, FG21), belonging to 
antibiotic-producing genera, are referred to as NNSPS strains. Strains FG1, 
FG2, FG4-FG7 and FG21 belong to the genus Streptomyces, strain FG3 to the 
genus Nocardia, and strain FG8 BLASTS to the genera Streptomyces and 
Nocardia, despite morphological analogies to bacteria in the genus 
Streptomyces. 
Figure 4.7 Fungal symbionts of Allomerus spp., provided by Jérôme Orivel and 
Mario Ruiz-González from the University of Toulouse. (A-D) Non-cultivar fungi 
that were isolated from the fungal cultivar of Allomerus spp. In sequence, they 
belong to the genera Penicillium (F2), Beauveria (F3), Cladosporium (F4), and 
Annulohypoxylon/Xylariaceae/Hypoxylon (F5). (E) Fungal cultivar 
Trimmatostroma (F1). While strains B and D spread over agar plates by growing 
hyphae, strains A, C, and E do not spread as readily. Tables 4.3 and 4.8 
provide a detailed overview on the origin and genetic identity of the strains, 
respectively. 
Table 4.8 Genetic identity of fungal and bacterial symbionts. Details on their origin and an overview of the sequencing data are 
presented in table 4.3 and the Supplementary Information A1, respectively. 
Sample type Name PCR                   primers
Sequencing 
primer
Sequence 
length Genus Closest relative (accession)
Max 
score
Total 
score
Query 
coverage E value
Max 
ident
Fungal cultivar Trimmatostroma cordae  F1 ITS1-F  ITS4R ITS1-F 915 bp Trimmatostroma Trimmatostroma cordae  5.8S rRNA gene and internal transcribed spacers 1 and 2 (ITS1, ITS2), strain CBS 418.93 (AJ244263.1) 440 545 42% 7.00E-120 93%
Non-cultivar fungus F2 ITS1-F  ITS4R ITS1-F 540 bp Penicillium Penicillium multicolor  isolate M2 internal transcribed spacer 1, partial sequence (HM595496.1) 990 990 100% 0 99%
Non-cultivar fungus F3 ITS1-F  ITS4R ITS1-F 494 bp Beauveria Beauveria  sp. LA264c 18S ribosomal RNA gene, partial sequence (HQ022490.1) 798 798 94% 0 97%
Non-cultivar fungus F4 ITS1-F  ITS4R ITS1-F 519 bp Cladosporium Cladosporium  sp. F42 18S ribosomal RNA gene, partial sequence (FJ755822.1) 953 953 100% 0 99%
Annulohypoxylon Annulohypoxylon stygium  isolate 2713 18S ribosomal RNA gene, partial sequence (EU272517.1) 1280 1280 100% 0 100%
Xylariaceae Xylariaceae  sp. Vega369 internal transcribed spacer 1 (EF694657.1) 1280 1280 100% 0 100%
Hypoxylon Hypoxylon stygium  18S rRNA gene, partial sequence (AJ390409.1) 1280 1280 100% 0 100%
Bacterial isolate FG1 515F  1492R 515F 908 bp Streptomyces Uncultured Streptomyces  sp. clone OUT1 16S ribosomal RNA gene, partial sequence (EU372800.1) 1677 1677 100% 0 100%
Bacterial isolate FG2 908 bp Streptomyces Uncultured Streptomyces  sp. clone OUT1 16S ribosomal RNA gene, partial sequence (EU372800.1) 1677 1677 100% 0 100%
Bacterial isolate FG3 900 bp Nocardia Nocardia  sp. 30905 16S ribosomal RNA gene, partial sequence (FJ262980.1) 1607 1607 100% 0 98%
Bacterial isolate FG4 515F  1492R 515F 908 bp Streptomyces Streptomyces seoulensis  gene for 16S rRNA, partial sequence, strain: NBRC 16668 (AB249970.1) 1657 1657 99% 0 99%
Bacterial isolate FG5 515F  1492R 515F 888 bp Streptomyces Streptomyces setonensis  strain HBUM174896 16S ribosomal RNA gene, partial sequence (EU841611.1) 1570 1570 99% 0 98%
Bacterial isolate FG6 515F  1492R 515F 905 bp Streptomyces Streptomyces  sp. VAN21 16S ribosomal RNA gene, partial sequence (HM018120.1) 1672 1672 100% 0 100%
Bacterial isolate FG7 515F  1492R 515F 905 bp Streptomyces Streptomyces sp. HB096 16S ribosomal RNA gene, partial sequence (GU213492.1) 1661 1661 100% 0 99%
Streptomyces Streptomyces  sp. HB328 16S ribosomal RNA gene, partial sequence (GQ863929.1) 1683 1683 100% 0 99%
Nocardia Nocardia  sp. JJE-2 16S ribosomal RNA gene, partial sequence (GU132484.1) 1683 1683 100% 0 99%
Bacillus Bacillus  sp. bk_40 16S ribosomal RNA gene, partial sequence (HQ538665.1) 1653 1653 100% 0 100%
Brevibacillus Brevibacillus brevis  strain H2 16S ribosomal RNA gene, partial sequence (HM449127.1) 1653 1653 100% 0 100%
Bacterial isolate FG10 515F  1492R 515F 896 bp Chryseobacterium Chryseobacterium taiwanense  gene for 16S rRNA, partial sequence, strain: LB-B (AB495176.1) 1639 1639 100% 0 99%
Bacterial isolate FG11 515F  1492R 515F 899 bp Tsukamurella Tsukamurella sp. 5-1-47 16S ribosomal RNA gene, partial sequence (GU929204.1) 1655 1655 100% 0 99%
Bacterial isolate FG12 515F  1492R 515F 633 bp Pseudomonas Pseudomonas  sp. E11(2010) 16S ribosomal RNA gene, partial sequence (HQ641264.1) 1170 1170 100% 0 100%
Bacterial isolate FG13 515F  1492R 515F 918 bp Pantoea Pantoea agglomerans  partial 16S rRNA gene, strain WAB1925 (AM184264.1) 1652 1652 100% 0 99%
Bacterial isolate FG14 515F  1492R 515F 859 bp Stenotrophomonas Stenotrophomonas  sp. enrichment culture clone ECC3-1 16S ribosomal RNA gene, partial sequence (GU056297.1) 1581 1581 100% 0 99%
Bacterial isolate FG15 515F  1492R 515F 814 bp Stenotrophomonas Stenotrophomonas maltophilia  strain NK-ST 16S ribosomal RNA gene, partial sequence (EU056836.1) 1498 1498 100% 0 99%
Bacterial isolate FG16 515F  1492R 515F 879 bp Pseudomonas Pseudomonas  sp. IPC3 16S ribosomal RNA gene, partial sequence (HQ108171.1) 1624 1624 100% 0 100%
Microbacterium Microbacterium  sp. HY16(2010) 16S ribosomal RNA gene, partial sequence (HM579807.1) 1652 1652 100% 0 100%
Cellulosimicrobium Cellulosimicrobium cellulans  strain ZFJ-17 16S ribosomal RNA gene, partial sequence (EU931556.1) 1652 1652 100% 0 100%
Bacterial isolate FG18 515F  1492R 515F 897 bp Staphylococcus Staphylococcus  sp. R9-9A 16S ribosomal RNA gene, partial sequence (HQ154574.1) 1657 1657 100% 0 100%
Bacterial isolate FG19 515F  1492R 515F 919 bp Pseudomonas Pseudomonas  sp. HMPB1 16S rRNA gene (AM745260.1) 1653 1653 100% 0 99%
Bacterial isolate FG20 515F  1492R 515F 919 bp Pseudomonas Uncultured Pseudomonas  sp. clone Filt.155 16S ribosomal RNA gene, partial sequence (HM152742.1) 1698 1698 100% 0 100%
Bacterial isolate FG21 515F  1492R 515F 884 bp Streptomyces Uncultured Streptomyces  sp. clone OUT1 16S ribosomal RNA gene, partial sequence (EU372800.1) 1633 1633 100% 0 100%
Non-cultivar fungus F5 ITS1-F  ITS4R ITS1-F 693 bp
515F
FG17Bacterial isolate 894 bp
515F  1492R
515F515F  1492R
FG9Bacterial isolate 895 bp515F515F  1492R
FG8Bacterial isolate 914 bp515F515F  1492R
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4.4.4 Colony bioassays 
In colony bioassays, selected bacterial isolates (NNSPS strains) of well-
known antifungal-producing genera, including Streptomyces (FG1, FG2, FG4, 
FG5, FG6, FG7, FG21), Nocardia (FG3) and Streptomyces/Nocardia (FG8), were 
challenged against Candida CA6 and the non-cultivar fungi Beauveria (F3) and 
Annulohypoxylon/Xylariaceae/Hypoxylon (F5). Due to their patchy growth on 
agar plates, neither the fungal cultivar Trimmatostroma (F1) nor the non-cultivar 
fungi Penicillium (F2) and Cladosporium (F4) were used for the assays.  
4.4.4.1 Bioassays against Candida  
The NNSPS strains were tested against C. albicans on agar plates, some 
containing 150 mM of the chemical inducer sodium butyrate, and were overlaid 
with soft agar containing the yeast. In the absence of sodium butyrate, none of 
the bacteria isolates produced any bioactive metabolites that inhibit the growth 
of Candida (Fig. 4.8A). However, the additive did stimulate Streptomyces FG1
and FG21 to inhibit the yeast (Fig. 4.8B), but only weakly as compared to the 
previously tested Acromyrmex ant-symbionts Streptomyces E8 and E9 (Fig. 
2.5B). 
4.4.4.2 Bioassays against non-cultivar fungi F3 and F5 
The NNSPS isolates were also challenged against the non-cultivar fungi 
Beauveria (F3) and Annulohypoxylon/Xylariaceae/Hypoxylon (F5) in the absence 
of sodium butyrate. The fungi were inoculated at the edge of bioassay plates 
containing the bacterial colonies. All bacterial colonies were overgrown by the 
fungal opponents, indicating the absence of effective antifungals (Fig. 4.9A-B). 
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Figure 4.8 (A) Candida (CA6) colony bioassays of NNSPS isolates (FG1-FG8, 
FG21). As negative controls, an uninoculated agar plate (C- No bacterium) and 
one with a S. lividans colony (C- S. lividans) were included. None of the 
Streptomyces and Nocardia strains is inhibiting Candida.
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Figure 4.8 (B) Candida (CA6) colony bioassays of NNSPS isolates (FG1-FG8, 
FG21). As negative controls, an uninoculated agar plate (C- No bacterium) and 
one with a S. lividans colony (C- S. lividans) were included. In the presence of 
150 mM sodium butyrate, added to the medium, Streptomyces FG1 and FG21
(orange font) are secreting effective antifungals into the surrounding medium 
resulting in small inhibition zones with no or reduced fungal growth. 
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Figure 4.9 (A) Beauveria (F3) colony bioassays of NNSPS isolates (FG1-FG8, 
FG21). An agar plate with a S. lividans colony (C- S. lividans) was included as a 
negative control. None of the bacterial isolates is inhibiting the growth of the test 
fungus on agar plates not containing any sodium butyrate. Ryan Seipke carried 
out the experiment and provided photographs of the bioassay plates.  
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Figure 4.9 (B) Annulohypoxylon/Xylariaceae/Hypoxylon (F5) colony bioassays 
of NNSPS isolates (FG1-FG8, FG21). An agar plate with a S. lividans colony (C-
S. lividans) was included as a negative control. The test fungus is resistant to 
the bacterial secretions when grown on agar plates not containing any sodium 
butyrate. Ryan Seipke carried out the experiment and provided photographs of 
the bioassay plates.  
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4.4.5 Supernatant bioassays 
The NNSPS isolates (FG1-FG8, FG21) were tested for secretion of 
antifungals into a liquid medium via bioassays against Candida CA6. 
Filamentous non-cultivar fungi were not tested because Beauveria (F3) and 
Annulohypoxylon/Xylariaceae/Hypoxylon (F5) were resistant to the bacterial 
isolates on agar plates (Fig. 4.9A-B). 
4.4.5.1 Bioassays against Candida  
The bacterial supernatants, enriched or not enriched with sodium butyrate, 
were sterilised, added to paper filter disks, and attached to Candida-coated agar 
plates. None of the supernatants, lacking the additive, shows bioactivity against 
Candida (Fig. 4.10A-B). This means that the bacteria not inhibiting fungal growth 
on agar plates, in the absence of the inducer sodium butyrate (Fig. 4.8A), also 
did not secrete any effective antifungals into the liquid medium. Furthermore, 
Streptomyces FG1 and FG21, which have exhibited fungal inhibition on sodium 
butyrate-containing agar plates (Fig. 4.8B), also did not secrete any effective 
antifungals into the liquid medium, despite the medium included sodium butyrate 
(Fig. 4.10C-D).  
4.5 Discussion 
The results presented in this chapter show that diverse bacterial genera 
can be found in association to the fungal cultivar of Allomerus decemarticulatus
and A. octoarticulatus. In particular, 20 unique bacterial morphotypes were 
isolated from the fungal traps of the ant species. Nine of the isolates, including 
the Streptomyces and Nocardia species, were tested in colony bioassays 
against the medically important yeast Candida CA6 and two non-cultivar fungi, 
including Beauveria (F3) and Annulohypoxylon/Xylariaceae/Hypoxylon (F5). 
These filamentous fungi were isolated from the same myrmecophytes as some 
of the bacteria. Despite their taxonomic identities, none of the bacterial strains 
inhibited any of the test fungi. The same bacterial isolates were also challenged 
against Candida in the presence of the chemical inducer sodium butyrate, which  
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Figure 4.10 Candida (CA6) supernatant bioassays of NNSPS (FG1-FG8, FG21) 
growth cultures. As negative controls, a growth culture of S. lividans (C- S. 
lividans) and an uninoculated batch of medium (C- No bacterium) were included. 
The experiment was carried out in duplicate; one set of liquid growth cultures 
contained 150 mM of sodium butyrate. The supernatants were inoculated onto 
paper filter disks and attached to Candida-coated agar plates. (A-B) In the 
absence of sodium butyrate, none of the bacterial supernatants is inhibiting 
Candida. (C-D) In the presence of the inducer, also none of the bacterial 
supernatants is inhibiting the fungal growth. Recall that on agar plates, 
containing sodium butyrate, Streptomyces FG1 and FG21 showed their ability to 
produce antifungals (Fig. 4.8B).   
Chapter 4) Allomerus decemarticulatus and A. octoarticulatus cultivar-                            
associated bacteria 
175
is known to stimulate antibiotic production in some actinobacteria. In the 
presence of sodium butyrate, two of the tested Streptomyces isolates inhibited 
the yeast. This result confirms the utility of sodium butyrate as chemical inducer 
and also shows that under some conditions, some cultivar-associated bacteria 
are able to produce antifungals. Since the fungal cultivar or Allomerus ants itself 
might be able to manipulate the chemical environment of the traps in order to 
stimulate antifungal production in bacteria, bacterial associates like 
Streptomyces FG1 and FG21 might be antibiotic-producing symbionts that, in 
combination with worker ant-associated bacteria (Seipke et al. 2012), help to 
defend the fungal traps against competitor and pathogenic fungi. However, the 
overall conclusion is that these results support the interpretation that the main 
source of bacterial antifungals, if bacterial antifungals play a crucial role in the 
defence of the Allomerus-associated cultivar, is more likely to be from a 
microbiome on Allomerus itself (Seipke et al. 2012). 
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Chapter 5) Tetraponera penzigi ant- and cultivar-associated 
bacteria 
5.1 Introduction 
5.1.1 Mutualistic partners  
The overstorey vegetation (most upper canopy layer) of the Kenyan 
Laikipia district is dominated by the swollen-thorn acacia Acacia drepanolobium 
(Fabales, Fabaceae) that in large parts of the area forms a monoculture (Young 
et al. 1997). A. drepanolobium defends itself against herbivory by hosting 
protective ant colonies. The ant species Crematogaster sjostedti, C. mimosae, 
C. nigriceps, and Tetraponera penzigi (Hymenoptera, Formicidae) are 
particularly common (Young et al. 1997, Stanton et al. 2002). The latter three 
ant species only inhabit A. drepanolobium, while C. sjostedti also inhabits the 
co-occurring Acacia seyal (Young et al. 1997).  
A. drepanolobium provides its resident ant colonies with nesting sites 
(domatia) and nutrition. 5-40% of the thorns exhibit swollen and hollow bases 
(Stanton et al. 2002) that are used by three of the ant species for breeding 
purposes and contain queen(s), workers, alates, and brood (pupae, larvae, 
eggs). In contrast, C. sjostedti primarily uses cavities in the stem of A. 
drepanolobium, which are created by cerambycid beetles (Palmer et al. 2008). 
In addition to nesting space, the ant-acacia also feeds its ants directly with 
carbohydrate-rich nectar of extrafloral nectaries, or, in the case of C. sjostedti
and C. mimosae, also indirectly via honeydew-producing scale insects (Young 
et al. 1997). In return, the ants defend their hosts against herbivores. The ant 
investment in this protection service varies across species; C. mimosae and C. 
nigriceps are highly aggressive against herbivores, relative to T. penzigi and C.
sjostedti, showing higher numbers of recruiting workers in response to simulated 
disturbance (Palmer and Brody 2007, Palmer et al. 2010).  
The ant species appear to dominate different life-stages of A. 
drepanolobium. Saplings with a height up to 0.5 m are primarily associated with 
single T. penzigi, C. mimosae, or C. nigriceps colonies; trees taller than 1.0 m 
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are increasingly occupied by C. mimosae and C. sjostedti (Young et al. 1997). 
This niche diversification is likely driven by a competition-colonisation trade-off 
(Stanton et al. 2002). According to the authors, C. sjostedti and C. mimosae
invest in colony size, allowing their colonies to displace other ant colonies from 
neighbouring trees; while the gynes of C. sjostedti mainly remain in their parent 
trees, the gynes of C. mimosae also inhabit neighbouring saplings. In contrast, 
T. penzigi and C. nigriceps colonies are competitively subordinate to colonies of 
the above species; however, they invest in dispersal and produce many gynes 
that are able to disperse to and win saplings and older trees that, for example 
due to low-intensity fires, have lost their ant occupants.  
Naomi E. Pierce and Dino Martins, from Harvard University, observed that 
domatia occupied by T. penzigi (Fig. 5.1) often contained fungal hyphae, and 
unoccupied and closed domatia had no observable hyphal growths (N. E. Pierce 
and D. Martins, unpublished data), suggesting the existence of ant fungiculture. 
In addition, the fungi of different ant nests consistently shared the same 
morphology, all belonging to the ascomycete genus Chaetomonium 
(Sordariales, Chaetomiaceae), suggesting that the fungal growth is a 
monoculture.   
Some support for the hypothesis that T. penzigi cultivates a fungal 
monoculture comes from another African plant-ant that has been shown to 
cultivate ascomycetous fungi in domatia. One example is found in the 
myrmecophyte Leonardoxa africana africana, which can be found in the coastal 
rainforests of Cameroon and surrounding countries, and its ant symbiont 
Petalomyrmex phylax. The ants cultivate a fungus in the ascomycete order 
Chaetothyriales (e.g. EU856528) (Defossez et al. 2009, Blatrix et al. 2009). 95% 
of 961 domatia that were occupied by the ant mutualist also contained the 
fungus; in contrast, none of 108 domatia that were occupied by the parasitic ant 
Cataulacus mckeyi, which uses the trees resources but fails to protect the tree 
against herbivory, showed any fungal growth. The authors also reported P.
phylax worker behaviours that appear to actively maintain the fungus; hyphae 
were chewed, transported, and supplied with detritus and faeces.  
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Furthermore, Blatrix et al. (2012) show that the Chaetothyriales fungi in the 
domatia of Petalomyrmex phylax, Tetraponera aethiops, and Pseudomyrmex 
penetrator that are hosted by Leonardoxa africana africana (Cameroon), 
Barteria fistulosa (Cameroon), and Tachigali sp. (French Guiana), respectively, 
serve as food resource for the developing larvae. Calcofluor- and 15N-labelled 
fungal material was found to be present in the larval gut of the three ant species.  
Figure 5.1 Host tree Acacia drepanolobium and ant symbiont Tetraponera 
penzigi. (A) The myrmecophyte A. drepanolobium defends itself from herbivory 
by producing thorns and housing symbiotic ant colonies. Trees of differing size 
ranges are occupied by four species of ants, including Crematogaster sjostedti, 
C. mimosae, C. nigriceps, and Tetraponera penzigi. (B-C) Ant symbiont T.
penzigi is provided by the tree with housing in the form of single-chambered 
domatia (white arrows) and nectar from extrafloral nectaries. (D) The domatia of 
T. penzigi that are used for breeding purposes appear to consistently contain a 
single fungal morphotype, which belongs to the genus Chaetomonium. 
Photographs A, B, and D are provided by Naomi E. Pierce and Dino Martins 
(Harvard University). 
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5.1.2 Exploitation control of non-cultivar fungi 
Non-cultivar fungi were not observed in either the P. phylax or T. penzigi
systems. However, ant species cultivating a fungal monoculture should be 
under selective pressure to defend their presumed mutualist against any 
unspecialised and/or specialised non-cultivar fungi that may prey on or compete 
with the cultivars. Multiple mechanisms can theoretically prevent non-cultivar 
fungi from successfully attacking and killing the putative fungal cultivar of T. 
penzigi. Analogous to the Allomerus system, (1) T. penzigi worker ants could 
physically remove fungal contaminants or exclude parasitic fungi using bioactive 
metapleural gland secretions; (2) cultivar-secreted antifungals could serve a role 
in its self-defence; (3) ant-associated symbiotic bacteria could produce 
antifungal metabolites that inhibit non-cultivar fungi; and/or (4) cultivar-
associated bacteria could produce antifungals that target non-cultivar fungi to 
which the cultivar itself has evolved resistances.  
5.2 Aims  
In this chapter, the third and fourth hypotheses are tested that ant- and/or 
cultivar-associated bacteria produce antifungals capable of killing non-cultivar 
fungi. As in Allomerus, the worker ants of T. penzigi are not known to have 
specialised morphological structures to support ectosymbiotic bacteria and also 
exhibit no obvious bacterial coatings. Nevertheless, bioactive actinobacteria 
have been isolated from Allomerus spp. worker ants (Seipke et al. 2012) and 
may hence be present on T. penzigi worker ants too.
Actinobacteria were also isolated from the fungal cultivar of Allomerus spp. 
but exhibited no inhibitory properties towards non-cultivar fungi isolated from the 
same ant colonies (Fig. 4.9A-B). However, because bioactive Streptomyces and 
Burkholderia bacteria can be isolated from the fungal gardens of attine ants 
(Santos et al. 2004, Haeder et al. 2009), I also test for bioactive bacterial 
symbionts in the putative fungal cultivar of T. penzigi. Note that the scope of this 
chapter does not include testing whether the fungal cultivar in fact benefits T. 
penzigi. 
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5.3 Materials and Methods 
5.3.1 Ant and cultivar samples 
Acacia drepanolobium samples, including T. penzigi workers and their 
putative fungal cultivar, were provided by Naomi E. Pierce and Dino Martins. 
Sampling sites included Kitengela (S1o23526 E36o49108) and Ngong Hills 
(S1o26946 E36o38358) from southern Kenya (near Nairobi), as well as Mpala 
Ranch and Mpala Road (N0o32 E36o42) from central Kenya (Laikipia district) 
(Fig. 5.2). Multiple occupied domatia were collected from each of 28 ant 
colonies (Table 5.1). In individual containers, the domatia of single 
myrmecophytes were transported to the United States, where they were sub-
sampled twice. The first time, on average five worker ants were collected from 
each colony and were preserved in 1 ml of 20% glycerol (2G); the second time, 
domatia of selected colonies were collected. Between sub-sampling sessions, 
the ants (of single colonies) were free to move in and out of their domatia and 
translocate their fungal cultivar. Hence, the sub-sampled domatia included 
varying numbers of worker ants, and in only three cases some fungal material. 
Bacterial isolations were carried out in a category 2 microbiological laboratory at 
the University of East Anglia, United Kingdom. Worker ants were recovered 
using sterile technique from the domatia with soft forceps, and were placed in 1 
ml of 2G; also, the majority of the cultivar material, found inside the domatia, 
was preserved in 1 ml of 2G. The remainder of the cultivar material was used for 
isolating non-cultivar fungi, as described below.  
5.3.2 Isolation of ant- and cultivar-associated bacteria 
The ant and cultivar samples were vortexed for a minimum of 10 seconds. 
Then, solid particles were removed from the samples by centrifugation. Sub-
samples of the 2G supernatants were serially diluted (dilution factors: 10-2 and 
10-4) and used for inoculating mannitol soy-flour (MS) agar plates (Table 5.2).  
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Figure 5.2 (A-C) Origin of Tetraponera penzigi worker ants and their putative 
fungal cultivar, collected by Naomi E. Pierce and Dino Martins from four 
locations in Kenya. The sampling sites include Kitengela and Ngong Hills from 
the south of the country, as well as Mpala Ranch and Mpala Road from its 
centre.
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Table 5.1 Samples of Tetraponera penzigi
worker ants and their putative fungal cultivar. 
From each of 28 Acacia drepanolobium trees, 
Naomi E. Pierce and Dino Martins collected 
multiple T. penzigi-occupied domatia. These 
were sub-sampled twice; first, for on average 
five worker ants that were provided in glycerol 
solutions (2G) and second, for domatia from 
which worker ants and some fungal material 
were isolated. These samples were stored in 2G 
as well.  
Sampling location Colony Sub-sample Host type
Kitengela, Kenya 1 2G ± 5 Ants
Kitengela, Kenya 2 2G ± 5 Ants
Kitengela, Kenya 3 2G ± 5 Ants
Kitengela, Kenya 4 2G ± 5 Ants
Kitengela, Kenya 6 2G ± 5 Ants
Kitengela, Kenya 8 2G ± 5 Ants
Kitengela, Kenya 17 2G ± 5 Ants
Kitengela, Kenya 27 2G ± 5 Ants
Kitengela, Kenya 29 2G ± 5 Ants
Kitengela, Kenya 30 2G ± 5 Ants
Kitengela, Kenya 4 Domatium 12 Ants
Kitengela, Kenya 4 Domatium Hyphal material
Kitengela, Kenya 17 Domatium 1 Ant
Ngong Hills, Kenya 5 2G ± 5 Ants
Ngong Hills, Kenya 14 2G ± 5 Ants
Ngong Hills, Kenya 19 2G ± 5 Ants
Ngong Hills, Kenya 20 2G ± 5 Ants
Ngong Hills, Kenya 21 2G ± 5 Ants
Ngong Hills, Kenya 25 2G ± 5 Ants
Ngong Hills, Kenya 26 2G ± 5 Ants
Ngong Hills, Kenya 14 Domatium 2 Ants
Ngong Hills, Kenya 14 Domatium Hyphal material
Ngong Hills, Kenya 21 Domatium 1 Ant
Ngong Hills, Kenya 21 Domatium Hyphal material
Mpala Ranch, Kenya 12 2G ± 5 Ants
Mpala Ranch, Kenya 13 2G ± 5 Ants
Mpala Ranch, Kenya 16 2G ± 5 Ants
Mpala Ranch, Kenya 18 2G ± 5 Ants
Mpala Ranch, Kenya 22 2G ± 5 Ants
Mpala Ranch, Kenya 24 2G ± 5 Ants
Mpala Ranch, Kenya 22 Domatium 5 Ants
Mpala Road, Kenya 9 2G ± 5 Ants
Mpala Road, Kenya 10 2G ± 5 Ants
Mpala Road, Kenya 11 2G ± 5 Ants
Mpala Road, Kenya 32 2G ± 5 Ants
Mpala Road, Kenya 31 Domatium 7 Ants
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Fresh agar plates were prepared by inoculating 100 ml batches of 
autoclaved MS agar (50 oC) with 1 ml of nystatin (5 mg (Sigma N3503-25MU) in 
1 ml dimethyl sulfoxide (DMSO)) and 1 ml of cycloheximide (5 mg (Fisher 
35742-0050) in 1 ml 100% ethanol) solutions, and subsequently sub-dividing the 
medium over four Petri dishes. Inoculated agar plates were incubated at 30 oC 
and successfully establishing bacterial morphotypes, both Gram-positives and 
Gram-negatives, were purified by repeatedly propagating single colonies to 
fresh agar plates. Each morphotype was selected once, regardless of its 
abundance.  
In total, 20 bacterial lineages (KY1-KY5, KY7-KY21) could be isolated (Table 
5.3). Glycerol stocks of the purified lineages were prepared as described for the 
bacterial isolates of the Acromyrmex system (Chapter 2.3.2). 
5.3.3 Isolation of fungal symbionts  
Some of the cultivar material, found inside of the domatia, was inoculated 
onto MS, potato dextrose (PDA), and Sabouraud agar plates (Table 5.2). Fresh 
agar plates, here, were prepared by supplementing 100 ml batches of 
autoclaved agar (50 oC) with filter-sterilised solutions of 1 ml carbenicillin (5 mg 
(Fisher BPE2648-5) in 1 ml dH2O) and 1 ml streptomycin (5 mg (Fisher 
BPE910-50) in 1 ml dH2O). The medium was either equally sub-divided over 
four Petri dishes or added as slopes to cylindrical containers (Bijouxs). 
Upcoming non-cultivar fungi were isolated by repeatedly transferring their 
hyphae onto fresh agar plates and incubating the inocula at room temperature 
or 30 oC. In total, five non-cultivar fungi (F1-F4, F6) could be isolated (Table 5.3). 
In addition to worker ants and occupied domatia, Naomi E. Pierce and Dino 
Martins also provided an inoculum of the fungal mutualist (F5). The fungal 
strains were stored in Bijouxs.   
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Table 5.2 Media for the cultivation of bacteria and fungi.  
Medium Ingredients Weight (g), volume (ml), percent (%)
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Distilled water 1000 ml
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Agar 15.0 g
Distilled water 1000 ml
Tryptone 10.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Agar 5.0 g
Distilled water 1000 ml
Organic soy-flour 20.0 g
Mannitol 20.0 g
Agar 20.0 g
(+SB, 150mM sodium butyrate) (16.5 g)
Tap water 1000 ml
Organic soy-flour 20.0 g
Mannitol 20.0 g
(+SB, incl. 150mM sodium butyrate) (16.5 g)
Tap water 1000 ml
Glucose 20.0 g
Instant mashed potato (smash) 5.0 g
Agar 20.0 g
Distilled water 1000 ml
Dextrose 40.0 g
Peptone 10.0 g
Agar 20.0 g
Distilled water 1000 ml
Tryptone soya broth (Oxoid) 30.0 g
Distilled water 1000 ml
Yeast extract 3.0 g
Peptone 5.0 g
Malt extract 3.0 g
Glucose 10.0 g
Distilled water 1000 ml
TSB 50 %
YEME 50 %
TSB/YEME
Sabouraud agar                            
(pH=5.6)
Tryptone soya broth (TSB)
Yeast extract-malt extract 
(YEME)
Mannitol soy-flour (MS) agar 
Mannitol soy-flour (MS) broth 
Potato dextrose agar (PDA) 
Lennox broth (LB)
Lennox broth (LB) agar
Lennox broth (LB) soft agar 
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Table 5.3 Origin of fungal and bacterial symbionts. 
Sample type Name Sample origin Host type Host 
colony
Mutualistic fungus Chaetomonium  F5 Kenya - -
Non-mutualistic fungus F1 Kenya - -
Non-mutualistic fungus F2 Kenya - -
Non-mutualistic fungus F3 Kenya - -
Non-mutualistic fungus F4 Kenya - -
Non-mutualistic fungus F6 Kenya - -
Bacterial isolate KY1 Kitengela, Kenya Worker ants 27
Bacterial isolate KY2 Ngong Hills, Kenya Worker ants 26
Bacterial isolate KY3 Ngong Hills, Kenya Worker ants 14
Bacterial isolate KY4 Ngong Hills, Kenya Worker ants 5
Bacterial isolate KY5 Ngong Hills, Kenya Cultivar 21
Bacterial isolate KY7 Kitengela, Kenya Worker ants 17
Bacterial isolate KY8 Kitengela, Kenya Cultivar 4
Bacterial isolate KY9 Ngong Hills, Kenya Worker ants 25
Bacterial isolate KY10 Ngong Hills, Kenya Worker ants 5
Bacterial isolate KY11 Kitengela, Kenya Worker ants 17
Bacterial isolate KY12 Mpala Road, Kenya Worker ants 31a
Bacterial isolate KY13 Mpala Ranch, Kenya Worker ants 16
Bacterial isolate KY14 Ngong Hills, Kenya Cultivar 14a
Bacterial isolate KY15 Ngong Hills, Kenya Worker ants 21
Bacterial isolate KY16 Ngong Hills, Kenya Cultivar 14a
Bacterial isolate KY17 Kitengla, Kenya Worker ants 4
Bacterial isolate KY18 Ngong Hills, Kenya Cultivar 21
Bacterial isolate KY19 Mpala Road, Kenya Worker ants 9
Bacterial isolate KY20 Mpala Road, Kenya Worker ants 9
Bacterial isolate KY21 Ngong Hills, Kenya Worker ants 14
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5.3.4 Light microscopy 
Stereomicroscope photographs of the bacterial isolates were taken in the 
Henry Wellcome Laboratory for Cell Imaging (www.uea.ac.uk/bio/biobmi) with a 
Zeiss SV11 M2 Bio Quad stereomicroscope and an AxioCam HRc CCD 
camera. Young and thus relatively flat colonies were used, and magnifications 
were adjusted to suit size variances between bacterial species. In particular, 
photographs were taken at magnifications of 2.0, 3.2, 4.0, 5.0, and 6.6X. Scale 
bars of 1 mm were added to the pictures with AxioVision software (Carl Zeiss, 
Welwyn Garden City, UK).    
5.3.5 Extraction of genomic DNA 
The (non-)cultivar fungi, including F1, F2, F3, F4, F5, and F6, were DNA 
extracted (Table 5.3). Hyphal material was added to Eppendorf tubes containing 
glass beads and 800 µl of ice-cold TGE buffer (Table 5.4). In addition, liquid 
cultures of the bacterial isolates, KY1-KY5, KY7-KY21, were DNA extracted 
(Table 5.3). Glass containers (universals), holding 10 ml of TSB/YEME (Table 
5.2) and a spring, were inoculated with 50 µl from the glycerol stocks or cell 
material of single plate 
colonies. The cultures were 
grown overnight in a shaker 
incubator (200 rpm, 30 oC), 
after which they were 
harvested by centrifugation (4000 rpm, 5 minutes, 4 oC). The supernatants were 
discarded and the cell pellets were re-suspended in 800 µl of TGE buffer. The 
solutions were placed into Eppendorf tubes containing a small layer of glass 
beads, and were stored on ice.  
A detailed procedure for extracting DNA from the fungi and bacteria is 
given in Chapter 2.3.5. In short, the fungal and bacterial samples of T. penzigi
were DNA extracted by bead-beating (6x30 seconds, 6 m/s). Before, during, 
and after bead-beating sessions, the samples were stored on ice (>5 minutes). 
The DNA-containing supernatants were repeatedly enriched with 0.5 ml of 
Table 5.4 Solution for DNA extractions. 
Solution Ingredients Concentration (mM)
Tris 50 mM
EDTA 10 mM
Tris/Glycine/EDTA (TGE) 
buffer (pH=8.0)
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phenol:chloroform:isoamyl alcohol (25:24:1), vortexed (1 minute), and benchtop-
centrifuged (13,200 rpm, 5 minutes). The DNA in the aqueous phase of the 
samples was either washed one time with 0.5 ml chloroform:isoamyl alcohol 
(24:1) or precipitated with 1 ml of 100% ethanol. The precipitate was harvested 
by centrifugation, the pellet rinsed with 70% ethanol, dried, and re-suspended in 
50 l of sterile dH2O.  
5.3.6 Amplification and purification of diagnostic genes 
By polymerase chain reaction (PCR), diagnostic genes were amplified 
from the fungal (ITS region) and bacterial (16S rDNA) genomes using the 
sample-specific primers, ITS1-F-ITS4 and 515-1492 (Table 5.5), and PCR 
conditions listed in table 5.6. Selected amplicons were recovered from the gel, 
following the instructions of the Qiagen Gel Extraction Kit manual 
(www.qiagen.com).  
Table 5.5 Primer sets for the partial amplification of fungal (ITS region) and 
bacterial (16S SSU) rDNA genes. 
Name Sequence Reference Gene Amplicon length
ITS1-F 5'-CTTGGTCATTTAGAGGAAGTAA-3' Gardens and Bruns (1993)
ITS4 5'-TCCTCCGCTTATTGATATGC-3' White et al . (1990)
515 5'-GTGCCAGCMGCCGCGGTAA-3' Turner et al.  (1999)
1492 5'-GGTTACCTTGTTACGACTT-3' Turner et al. (1999)
18S rDNA ± 600 bp
16S rDNA ± 1000 bp
Table 5.6 (A-B) PCR mixture and thermocycles for the partial amplification of 
fungal (ITS region) and bacterial (16S SSU) rDNA genes. 
A B
PCR mixture Volume
dH2O 23.0 µl
GoTaq buffer (incl. loading buffer) 8.0 µl
GoTaq MgCl (25 mM) 2.4 µl
DMSO (100%) 2.0 µl
Bioline dNTP's (10 mM) 1.0 µl
Forward primer (25 µM) 1.0 µl
Reverse primer (25 µM) 1.0 µl
DNA 1.0 µl
GoTag polymerase 0.6 µl
Total 40.0 µl
Temperature Minutes Temperature Minutes
1 94 oC 4:00 94 oC 12:00
2 95 oC 0:30 94 oC 1:00
3 53 oC 1:00 45 oC 0:45
4 72 oC 1:00 72 oC 1:30
5
6 72 oC 10:00 72 oC 20:00
7 end end
Go 34x to step 2 
Fungi BacteriaStep
Go 29x to step 2 
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5.3.7 Sequencing and BLAST-matching 
The cleaned amplicons were sequenced (Table 5.7) with the sample-
specific forward primers (ITS1-F, 515). The sequencing reactions were analysed 
by The Genome Analysis Centre TGAC (www.jicgenomelab.co.uk) using ABI 
3730XL sequencers (Life Technologies). The sequences were quality-checked 
and truncated with FinchTV (www.geospiza.com/Products/finchtv.shtml). The 
sequences were then matched to the BLAST database of the National Center 
for Biotechnology Information (NCBI, http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
With a BLASTn search, the fungal and bacterial sequences were compared to 
database reads of the nucleotide collection (nr/nt), optimising for highly similar 
sequences (megablast). 
5.3.9 Colony bioassays  
Selected bacterial isolates of antibiotic-producing genera were tested in 
colony bioassays against Candida albicans (CA6, Table 3.2) and three non-
cultivar fungi (F1, F2, F3). No challenges were carried out against other non-
cultivar fungi (F4, F6), nor against the fungal mutualist (F5), since their hyphae 
did not spread smoothly across agar plates. The bacterial selection included 
seven bacteria, KY1-KY5, KY7 and KY21, which in the following will be referred to 
as NNSPS strains; this acronym is based on the initial letters of the genera 
Nocardia, Nocardiopsis, Streptomyces, Pseudonocardia, and 
Table 5.7 (A-B) Reaction mixture and thermocycles for 
sequencing of PCR amplicons. 
A B
Sequencing mixture Volume
dH2O 5.5 µl
5x sequencing buffer 1.5 µl
Forward primer (3.2 µM) 1.0 µl
DNA 1.0 µl
Enzyme E3.1 1.0 µl
Total 10.0 µl
Step Temperature Minutes
1 96 oC 1:00
2 96 oC 0:10
3 50 oC 0:05
4 60 oC 4:00
5
6 60 oC 0:10
7 end
Go 25x to step 2
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Saccharopolyspora (Pseudonocardia and Nocardiopsis have been isolated from 
Acromyrmex in Chapter 2; Nocardia has been isolated from Allomerus in 
Chapter 4). 
5.3.9.1 Bioassays against Candida  
In colony bioassays, the selected bacteria were tested against Candida
CA6. Universals containing 10 ml of TSB/YEME and a spring were inoculated 
with 30 µl from the bacterial glycerol stocks and were placed in a shaker 
incubator for a sufficient accumulation of biomass (280 rpm, 30 oC). The spring 
was added to increase the oxygen concentration of the medium and to reduce 
cell clustering. The cell material was harvested by centrifugation (4000 rpm, 5 
min); the supernatants were disposed. The bacteria were point-inoculated into 
the centre of MS agar plates, containing no antibiotics, by transferring 
standardised fractions of cell material. As negative controls, one uninoculated 
plate and one inoculated with cell material of S. lividans were included.  
The experiment was carried out in duplicate; one set of agar plates was 
enriched with 150 mM sodium butyrate, which increases antifungal production in 
certain bacteria (Martin and McDaniel 1976, Moore et al. 2012), and the other 
set was not. The inoculated plates were incubated for thirteen days at 21 oC. A 
one-day-old Candida culture was prepared by growing the yeast in 10 ml 
Lennox broth (LB) (280 rpm, 37 oC). Then, 1 ml of the culture was added to 5 ml 
of LB soft agar (50 oC) (Table 5.2). The medium was poured over the bioassay 
plates (30 oC) contacting, but not overlaying, the bacterial colonies. The 
bioassay plates were incubated for 2 days at 26 oC to allow Candida to grow, 
after which the presence or absence of inhibition zones was scored. 
5.3.9.2 Bioassays against non-cultivar fungi F1, F2, and F3
In the absence of sodium butyrate, the selected bacteria were challenged 
against the non-cultivar fungi, F1, F2, and F3 by Ryan Seipke. The bacterial 
isolates were point-inoculated into the centre of MS agar plates, containing no 
antibiotics, by transferring mycelium from bacterial plate colonies. Mycelium of 
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S. lividans was inoculated onto an additional agar plate serving as negative 
control. The agar plates were incubated at 30 oC to obtain maturated colonies; 
then hyphal material of the test fungi was point-inoculated at the edge of the 
plates, which thereafter were incubated (30 oC) until the fungi clearly overgrew 
or clearly avoided the bacterial colonies. 
5.3.10 Supernatant bioassays  
Growth cultures of the selected NNSPS strains (KY1-KY5, KY7, KY21) were 
challenged against Candida CA6 and one of the non-cultivar fungi (F1). This test 
was conducted to indicate whether the bacterial strains are secreting antifungals 
into a liquid medium, from which the metabolites could be extracted. 
5.3.10.1 Obtaining supernatants    
Batches of 50 ml MS broth (Table 5.2) were inoculated with 30 µl from the 
bacterial glycerol stocks. As negative controls, one batch of medium remained 
uninoculated and another was inoculated with S. lividans. Two sets of growth 
cultures were obtained; one set contained 150 mM sodium butyrate, and the 
other one did not. Inoculated flasks were incubated in a shaker incubator for 14 
days (30 oC, 250 rpm). Due to the relatively low inoculation volume (and/or a 
low spore/cell concentration of the glycerol stocks), a relatively long incubation 
period was needed before observing abundant cell growth. The supernatants 
were harvested by pelleting-out the majority of cell material and insoluble 
medium (30 minutes, 4000 rpm, 4 oC). For the bioassays, small sub-samples of 
the supernatants were centrifuged a second time with a benchtop centrifuge (5 
minutes, 13,200 rpm), which then were filter-sterilised with 0.2 µm filters. 
5.3.10.2 Bioassays against Candida   
Challenges were carried out in which the bacterial supernatants, 
containing and not containing sodium butyrate, were tested against Candida 
CA6. Paper filter disks, 0.9 cm in diameter, were inoculated with 100 µl of the 
sterile supernatants and control liquids. LB agar plates were coated with 400 µl 
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of a one-day-old Candida culture, grown in 10 ml Lennox broth. The dry disks 
were attached to the agar plates using 60 µl of dH2O. The presence or absence 
of inhibition zones was scored after incubating the plates for two days at 26 oC. 
5.3.10.2 Bioassays against non-cultivar fungus F1
The supernatants of the bacteria, grown in the absence of sodium 
butyrate, were also challenged against a non-cultivar fungus (F1). Disks with a 
diameter of 4 cm were loaded with 2 ml of the filter-sterilised supernatants. As 
negative control, one filter was inoculated with the same volume of supernatant 
from the uninoculated medium. When dry, the disks were attached with 200 µl of 
dH2O to MS agar plates, containing no antibiotics. Thereafter, hyphal material of 
the fungal strain was point-inoculated at the edge of the bioassay plates. The 
plates were incubated at 26 oC until the filter disks were either contacted by the 
fungi or clearly avoided. 
5.4 Results 
5.4.1 Isolation and microscopy of ant- and cultivar-associated bacteria 
Naomi E. Pierce and Dino Martins sampled multiple domatia containing T. 
penzigi worker ants and their putative fungal cultivar from 28 Kenyan A. 
drepanolobium trees (Fig. 5.2). From the domatia, worker ants and their putative 
fungal cultivar (Table 5.1) were isolated, and stored in glycerol solutions (2G). 
Subsequently, the solutions were diluted and used for inoculating agar plates, 
from which unique morphotypes of Gram-positive and Gram-negative bacteria 
were isolated.  
In total, 20 bacterial lineages were isolated from the worker ants and their 
putative fungal cultivar. Each strain obtained an ID, consisting of the prefix KY 
and an individual number (KY1-KY5, KY7-KY21). Photographs of the bacterial 
isolates, and their origin, are presented in figure 5.3 and table 5.3, respectively.  
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Figure 5.3 Microscopy photographs of 20 bacterial isolates (KY1-KY5, KY7-
KY21). The bacteria were isolated from Tetraponera worker ants and their 
fungal cultivars. In addition to actinobacteria, also Gram-positives and Gram-
negatives of other phyla, including Firmicutes, Proteobacteria, and 
Bacterioidetes, were isolated. An overview of the bacterial origin and details 
on their genetic identity are provided in the tables 5.3 and 5.8, respectively. A 
selection of seven bacteria, KY1-KY5, KY7, and KY21, belonging to antibiotic-
producing genera, will be referred to as NNSPS strains. In particular, strains 
KY1, KY2, KY4, and KY5 belong to the genus Streptomyces and strains KY3, 
KY7, and KY21 belong to the genus Saccharopolyspora.
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5.4.2 Isolation of fungal symbionts 
The remaining cultivar material found inside some domatia, which was not 
used for bacterial extractions, was inoculated onto agar plates for isolating non-
cultivar fungi. Five lineages of non-cultivar fungi were isolated (F1-F4, F6). In 
addition, a separate sample of the putative fungal cultivar (F5) of T. penzigi was 
provided by Naomi E. Pierce and Dino Martins. Photographs of the fungal 
cultivar and non-cultivars, and their origin, are shown in figure 5.4 and table 5.3, 
respectively.  
Figure 5.4 Fungal symbionts of Tetraponera penzigi. (A-E) Non-cultivar fungi 
isolated from the fungal cultivar. In sequence, they belong to the genera 
Acremonium (F1), Fusarium (F2), Alternaria (F3), Penicillium (F4), and Claviceps 
(F6). (F) Fungal cultivar Chaetomonium (F5). Tables 5.3 and 5.8 provide a 
detailed overview on the origin and genetic identity of the strains. Strains A, B, 
and C spread their hyphae across agar plates; whereas strains D, E, and F 
grow locally. 
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5.4.3 Amplification, purification, sequencing, and BLAST-matching of 
diagnostic genes from genomic DNA extracts 
The morphologically identified fungal cultivar (F5) and five non-cultivar 
fungi (F1-F4, F6) (Table 5.3) were identified genetically. The fungi were DNA 
extracted and a fragment of their rDNA gene (ITS region) was sequenced with a 
sample-specific forward primer.  
The sequences of the fungal cultivar F5 (538 bp), as well as the fungal 
non-cultivars F1 (546 bp), F2 (505 bp), F3 (528 bp), F4 (552 bp), and F6 (485 bp), 
show BLAST analogies to rDNA sequences of Chaetomonium, as well as 
Acremonium, Fusarium, Alternaria, Penicillium, and Claviceps, respectively 
(Table 5.8). The sequencing data are given in the Supplementary Information 
A1.  
The bacterial isolates, KY1-KY5, KY7-KY21 (Table 5.3), were identified 
genetically by extracting their DNA and sequencing a segment of the 16S rDNA 
gene with a sample-specific forward primer. The sequences of the bacterial 
strains KY1-KY5, KY7-KY21 (445-886 bp; mean 718 bp) show BLAST analogies 
to 16S rDNA sequences of diverse bacterial genera (Table 5.8). Morphotypes of 
the actinobacterial genera Streptomyces and Saccharopolyspora are relatively 
common in comparison to most other bacterial genera. The sequences are 
displayed in the Supplementary Information A1. 
Table 5.8 Genetic identity of fungal and bacterial symbionts. Details on their origin and an overview of the sequencing data are 
presented in table 5.3 and Supplementary Information A1, respectively. 
Sample type Name PCR                   primers
Sequencing 
primer
Sequence 
length Genus Closest relative (accession)
Max 
score
Total 
score
Query 
coverage E value
Max 
ident
ITS1-F Corynascus Corynascus kuwaitiensis 18S rRNA gene, 5.8S rRNA gene, 26S rRNA gene, ITS1 and ITS2, isolate Kw140 (AJ715483.1) 861 861 100% 0 95%
ITS1-F Chaetomium Chaetomium atrobrunneum strain CGMCC 3.3594 18S ribosomal RNA gene, partial sequence (GU966500.1) 857 857 99% 0 95%
Non-mutualistic fungus F1 ITS1-F  ITS4 ITS1-F 546 bp Acremonium Acremonium implicatum 18S ribosomal RNA gene, partial sequence (AF368810.1) 1009 1009 100% 0 100%
Non-mutualistic fungus F2 ITS1-F  ITS4 ITS1-F 505 bp Fusarium Fusarium polyphialidicum 18S rRNA gene, partial (X94172.1) 933 933 100% 0 100%
Non-mutualistic fungus F3 ITS1-F  ITS4 ITS1-F 528 bp Alternaria Alternaria sp. Ponipodef 07 18S ribosomal RNA gene, partial sequence (HQ731643.1) 976 976 100% 0 100%
Non-mutualistic fungus F4 ITS1-F  ITS4 ITS1-F 552 bp Penicillium Penicillium sizovae strain CBS 115968 18S ribosomal RNA gene, partial sequence (GU944585.1) 1005 1005 98% 0 100%
Non-mutualistic fungus F6 ITS1-F  ITS4 ITS1-F 485 bp Claviceps Claviceps sp. ICMP 16980 internal transcribed spacer 1, partial sequence (EU770250.1) 566 566 84% 6.00E-158 91%
Bacterial isolate KY1 515  1492 515 847 bp Streptomyces Streptomyces  sp. L131D 16S ribosomal RNA gene, partial sequence (HM797397.1) 1565 1565 100% 0 100%
Bacterial isolate KY2 515  1492 515 563 bp Streptomyces Streptomyces  sp. HBUM 49432 16S ribosomal RNA gene, partial sequence (EU158328.1) 1040 1040 100% 0 100%
Bacterial isolate KY3 515  1492 515 767 bp Saccharopolyspora Saccharopolyspora  sp. 8-15 16S ribosomal RNA gene, partial sequence (HQ622522.1) 1411 1411 100% 0 99%
Bacterial isolate KY4 515  1492 515 811 bp Streptomyces Streptomyces  sp. XAS586 16S ribosomal RNA gene, partial sequence (GQ395241.1) 1498 1498 100% 0 100%
Bacterial isolate KY5 515  1492 515 837 bp Streptomyces Streptomyces  sp. CS38 16S ribosomal RNA gene, partial sequence (EF494232.1) 1546 1546 100% 0 100%
Bacterial isolate KY7 515  1492 515 690 bp Saccharopolyspora Saccharopolyspora  sp. 8-15 16S ribosomal RNA gene, partial sequence (HQ622522.1) 1269 1269 100% 0 99%
Bacterial isolate KY8 515  1492 515 445 bp Kocuria Kocuria  sp. M1-36 16S ribosomal RNA gene, partial sequence (HQ425309.1) 822 822 100% 0 100%
Serratia Serratia  sp. PfRB002 gene for 16S rRNA, partial sequence (AB560603.1) 1079 1079 100% 0 100%
Bacillus Bacillus subtilis  strain XJtks46.1 16S ribosomal RNA gene, partial sequence (HQ123474.1) 1079 1079 100% 0 100%
Pseudomonas Pseudomonas  sp. bk_23 16S ribosomal RNA gene, partial sequence (HQ538682.1) 1079 1079 100% 0 100%
Bacterial isolate KY10 515  1492 515 719 bp Chryseobacterium Chryseobacterium daejeonense  strain RB-18 16S ribosomal RNA gene, partial sequence (EF077177.1) 1279 1279 100% 0 98%
Bacterial isolate KY11 515  1492 515 711 bp Staphylococcus Staphylococcus  sp. 2A12S8 16S ribosomal RNA gene, partial sequence (HQ246299.1) 1314 1314 100% 0 100%
Bacterial isolate KY12 515  1492 515 796 bp Pseudomonas Pseudomonas  sp. sk0927 1-3 16S ribosomal RNA gene, partial sequence (FJ751243.1) 1471 1471 100% 0 100%
Bacterial isolate KY13 515  1492 515 628 bp Roseomonas Roseomonas  sp. BZ44 16S ribosomal RNA gene, partial sequence (HQ588850.1) 1160 1160 100% 0 100%
Bacillus Bacillus sp. SG2 16S ribosomal RNA gene, partial sequence (HM057848.1) 1205 1205 100% 0 100%
Brevibacterium Brevibacterium frigoritolerans  strain DSM 8801 16S ribosomal RNA gene, partial sequence (GU252128.1) 1205 1205 100% 0 100%
Serratia Serratia  sp. GmRB009 gene for 16S rRNA, partial sequence (AB560573.1) 1352 1352 100% 0 99%
Bacillus Bacillus subtilis  strain XJtks46.1 16S ribosomal RNA gene, partial sequence (HQ123474.1) 1352 1352 100% 0 99%
Pseudomonas Pseudomonas fluorescens  strain YR20 16S ribosomal RNA gene, partial sequence (HM224401.1) 1352 1352 100% 0 99%
Bacterial isolate KY16 515F  1492R 515 773 bp Gordonia Uncultured Gordonia  sp. clone T0417 16S ribosomal RNA gene, partial sequence (HQ616261.1) 1423 1423 100% 0 99%
Staphylococcus Staphylococcus  sp. 2A12S8 16S ribosomal RNA gene, partial sequence (HQ246299.1) 1631 1631 100% 0 99%
Shewanella Shewanella  sp. S12a partial 16S rRNA gene, strain S12 (FN994186.1) 1631 1631 100% 0 99%
Bacterial isolate KY18 515F  1492R 515 827 bp Arthrobacter Arthrobacter globiformis  partial 16S rRNA gene, strain MA100 (FN908766.1) 1522 1522 100% 0 99%
Stenotrophomonas Stenotrophomonas  sp. TeRB010 gene for 16S rRNA, partial sequence (AB560630.1) 1166 1166 100% 0 100%
Pseudomonas Pseudomonas geniculata  strain NBG2 16S ribosomal RNA gene, partial sequence (HQ256559.1) 1166 1166 100% 0 100%
Xanthomonas Xanthomonas  sp. TE9 16S ribosomal RNA gene, partial sequence (GQ381284.1) 1166 1166 100% 0 100%
Microbacterium Microbacterium  sp. HY16(2010) 16S ribosomal RNA gene, partial sequence (HM579807.1) 1273 1273 100% 0 100%
Cellulosimicrobium Cellulosimicrobium  sp. 6A12S5 16S ribosomal RNA gene, partial sequence (HQ246240.1) 1273 1273 100% 0 100%
Bacterial isolate KY21 515F  1492R 515 772 bp Saccharopolyspora Saccharopolyspora  sp. 8-15 16S ribosomal RNA gene, partial sequence (HQ622522.1) 1415 1415 100% 0 99%
538 bpMutualistic fungus Chaetomonium F5 ITS1-F  ITS4
735 bp
652 bp515515  1492
KY9
515F  1492R 515KY15
KY14
584 bp
515515F  1492R
631 bp515515F  1492RKY19
886 bp515515F  1492R
KY20
Bacterial isolate
Bacterial isolate
Bacterial isolate
Bacterial isolate
Bacterial isolate
Bacterial isolate
KY17
515515  1492
689 bp
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5.4.5 Colony bioassays 
In colony bioassays, selected bacterial isolates of well-known antifungal-
producing genera were challenged against Candida albicans (CA6) and the non-
cultivar fungi Acremonium (F1), Fusarium (F2), and Alternaria (F3). Due to their 
patchy growth, agar plate bioassays did not include the fungal cultivar 
Chaetomonium (F5) nor the non-cultivar fungi Penicillium (F4) or Claviceps (F6). 
The bacterial selection (NNSPS strains) includes Streptomyces KY1, KY2, KY4, 
and KY5 as well as Saccharopolyspora KY3, KY7, and KY21. In particular, the ant 
isolates KY1 and KY7 originate from Kitengela. The ant isolates KY2, KY3, KY4, 
and KY21, as well as the cultivar isolate KY5, originate from Ngong Hills.  
5.4.5.1 Bioassays against Candida  
The selected bacteria were tested against Candida CA6 on agar plates, 
some of which contained 150 mM of the chemical inducer sodium butyrate. The 
bacteria were grown in the centre of agar plates; as negative controls, an 
uninoculated and a S. lividans-containing agar plate, were included. The 
bioassay plates were overlaid with soft agar, containing the yeast. After 
incubation, the presence or absence of fungal inhibition was scored.  
The bacterial strains KY5, KY1, KY2, KY3, KY7, and KY21 successfully 
inhibited the growth of Candida in the absence of sodium butyrate (Fig. 5.5A). In 
the presence of the additive, however, the bioactivity of some strains was 
reduced or disappeared, whereas the bioactivity of others increased (Fig. 5.5B). 
Saccharopolyspora (KY3, KY7, KY21) grew poorly at the applied concentrations 
of sodium butyrate and therefore failed to secrete bioactive metabolites; the 
sizes of the inhibition zones produced by Streptomyces KY2 and KY1 were 
unchanged; and the fungal inhibition of Streptomyces KY5 increased in the 
presence of the inducer. This shows that multiple bacterial isolates are able to 
inhibit Candida; on the other hand, the results also show that sodium butyrate 
influences the bacterial secretion of antifungals. The growth-inhibiting effects of
Streptomyces KY1 and KY5 on Candida are comparable to the bioactivities 
exhibited against the yeast by the Acromyrmex ant-associated Streptomyces
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Figure 5.5 (A) Candida (CA6) colony bioassays of NNSPS isolates (KY1-KY5, 
KY7, KY21). As negative controls, an uninoculated agar plate (C- No bacterium) 
and one with a S. lividans colony (C- S. lividans) were included. The bacteria 
were grown on agar plates, not containing sodium butyrate, which were overlaid 
with soft agar containing the test fungus. Streptomyces KY1 and KY5 are 
exhibiting a relatively strong fungal inhibition; in contrast, Streptomyces KY2 and 
Saccharopolyspora KY3, KY7, and KY21 display a relatively weak inhibitory 
effect. Bioactive strains are highlighted by orange font.  
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Figure 5.5 (B) Candida (CA6) colony bioassays of NNSPS isolates (KY1-KY5, 
KY7, KY21). As negative controls, an uninoculated agar plate (C- No bacterium) 
and one with a S. lividans colony (C- S. lividans) were included. The bacteria 
were grown on agar plates, enriched with 150 mM of sodium butyrate, and 
overlaid with soft agar containing the test fungus. In the presence of the 
chemical inducer, Saccharopolyspora KY3, KY7, and KY21 are not growing well 
and do not produce antifungals. Streptomyces KY5 and KY1 are showing a 
relatively strong fungal inhibition; in contrast, Streptomyces KY2 exhibits a 
relatively weak bioactivity. Bioactive strains are highlighted by orange font.  
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strains E8 and E9 (Fig. 2.5A-B).   
5.4.5.2 Bioassays against non-cultivar fungi F1, F2, and F3
In another bioassay experiment, the selected bacteria were also 
challenged in the absence of sodium butyrate against the non-cultivar fungi 
Acremonium (F1), Fusarium (F2), and Alternaria (F3). The bacteria were grown in 
the centre of agar plates; an agar plate with S. lividans served as negative 
control. The fungi were point-inoculated at the edge of the bioassay plates. After 
incubation, the presence or absence of fungal inhibition was scored.    
The non-cultivar fungus Acremonium (F1) is susceptible to the secretions 
of Streptomyces KY5, as well as to the metabolites of Saccharopolyspora KY3, 
KY7, and KY21 (Fig. 5.6A). In contrast, the other non-cultivar fungi, Fusarium (F2) 
and Alternaria (F3), are not inhibited by any bacteria (Fig. 5.6B-C); even 
Saccharopolyspora colonies, which in the beginning of the experiment managed 
to establish small inhibition zones against Fusarium (F2), were later overgrown.  
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Figure 5.6 (A) Acremonium (F1) colony bioassays of NNSPS isolates (KY1-KY5, 
KY7, KY21). The bacteria were grown in the centre of agar plates, not containing 
sodium butyrate. As a negative control, an agar plate with a S. lividans colony 
(C- S. lividans) was included. The test fungi were introduced at the edge of the 
bioassay plates. Acremonium (F1) is inhibited by Saccharopolyspora KY3, KY7, 
and KY21 as well as by Streptomyces KY5. The colony of Streptomyces KY5
even expanded to almost contact the fungus. Bioactive bacteria are highlighted 
by orange font. Ryan Seipke carried out the experiment and provided 
photographs of the bioassay plates. 
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Figure 5.6 (B) Fusarium (F2) colony bioassays of NNSPS isolates (KY1-KY5, 
KY7, KY21). The bacteria were grown in the centre of agar plates, not containing 
sodium butyrate. The test fungi were introduced at the edge of the bioassay 
plates. None of the bacterial isolates is able to inhibit the growth of Fusarium 
(F2). Even the Saccharopolyspora strains, which initially managed to inhibit the 
test fungus, later became overgrown. Ryan Seipke carried out the experiment 
and provided photographs of the bioassay plates. 
Chapter 5) Tetraponera penzigi ant- and cultivar-associated bacteria
202
Figure 5.6 (C) Alternaria (F3) colony bioassays of NNSPS isolates (KY1-KY5, 
KY7, KY21). The bacteria were grown in the centre of agar plates, not containing 
sodium butyrate. The test fungi were introduced at the edge of the bioassay 
plates. None of the bacterial isolates is able to inhibit the growth of Alternaria
(F3). Ryan Seipke carried out the experiment and provided photographs of the 
bioassay plates. 
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5.4.6 Supernatant bioassays 
The capability of the NNSPS isolates (KY1-KY5, KY7, KY21) was tested to 
secrete antifungals into a liquid medium, some of which contained 150 mM of 
sodium butyrate. Due to the likelihood that a change in growth conditions may 
trigger antifungal production, here also those strains were included that 
previously failed to inhibit fungal strains on agar plates. An uninoculated batch 
of medium and a S. lividans growth culture served as negative control. The 
sterilised supernatants were tested against Candida CA6 and Acremonium (F1). 
No challenges were carried out against Fusarium (F2) and Alternaria (F3) since 
they were found not to be susceptible to any bacteria in colony bioassays (Fig. 
5.6B-C).   
5.4.6.2 Bioassays against Candida  
The sterilised supernatants of the selected bacteria, grown in the presence 
and absence of sodium butyrate, were added to paper filter disks, alongside the 
negative controls. With distilled water, the filters were attached to Candida-
coated agar plates. After incubation, the presence or absence of fungal 
inhibition was scored. 
Only the supernatant of Streptomyces KY1, grown in the absence of 
sodium butyrate, inhibits Candida; the supernatants of all other strains do not 
inhibit the yeast (Fig. 5.7A-C). This result means that only a small fraction of the 
bacterial strains, which inhibited Candida on sodium butyrate-lacking agar 
plates (KY1, KY5, KY7, KY3, KY21, KY2; Fig. 5.5A), secretes antifungals into the 
liquid medium.  
The supernatants of Streptomyces KY5, KY1, and KY2, grown in the 
presence of sodium butyrate, inhibit Candida; all other supernatants proved 
ineffective against the yeast (Fig. 5.7D-F). Streptomyces KY5, KY1, and KY2 also 
inhibited the growth of Candida on sodium butyrate-containing agar plates (Fig. 
5.5B). 
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5.4.6.3 Bioassays against non-cultivar fungus F1
The sterilised supernatants of the selected bacteria, grown in the absence 
of sodium butyrate, were also tested against Acremonium (F1). The 
supernatants were inoculated onto filter disks, which with distilled water were
attached to the centre of agar plates. Acremonium (F1) was point-inoculated at 
the edge of the bioassay plates. After an incubation period, the presence or 
absence of fungal inhibition was scored.  
None of the growth supernatants inhibits Acremonium (F1) (Fig. 5.8). This 
Figure 5.7 Candida (CA6) supernatant bioassays of NNSPS (KY1-KY5, KY7, 
KY21) growth cultures. As negative controls, a growth culture of S. lividans (C- S. 
lividans) and an uninoculated batch of medium (C- No bacterium) were included. 
One set of media contained 150 mM sodium butyrate and another one did not. 
The supernatants were inoculated onto paper filter disks and attached to 
Candida-coated agar plates. (A-C) The supernatant of Streptomyces KY1, 
containing no sodium butyrate, inhibits Candida. The remaining strains 
apparently secreted no, or insufficient amounts of, antifungal molecules into the 
liquid medium. (D-F) The supernatants of Streptomyces KY1, KY2, and KY5, 
containing sodium butyrate, inhibit the yeast. Bioactive strains are highlighted by 
red font.  
Chapter 5) Tetraponera penzigi ant- and cultivar-associated bacteria
205
Figure 5.8 Acremonium (F1) supernatant bioassays of NNSPS (KY1-KY5, KY7, 
KY21) growth cultures. In contrast to Fusarium (F2) and Alternaria (F3), this 
fungus shows susceptibilities to bacteria secretions in colony bioassays (Fig. 
5.6A). As a negative control, the supernatant of an uninoculated batch of 
medium (C- No bacterium) was included. The supernatants, not containing 
sodium butyrate, were inoculated onto paper filter disks and attached to agar 
plates. The test fungus was introduced at the edge of the bioassay plates. None 
of the bacterial supernatants is inhibiting the fungal growth.  
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shows that none of the bacterial strains that inhibited the fungus on sodium 
butyrate-lacking agar plates (KY5, KY3, KY7, KY21; Fig. 5.6A) secreted effective 
antifungals into the liquid medium. However, the observation that the same 
Streptomyces KY1 supernatant, previously inhibited Candida (Fig. 5.7A) and that 
the filamentous fungus was not susceptible to the secretions of this 
Streptomyces strain on agar plates (Fig. 5.6A) suggest that the supernatant 
contains antifungals that selectively affect the yeast but not its filamentous 
counterpart.     
5.5 Discussion 
The data presented in this chapter show that T. penzigi worker ants and 
their fungal cultivars are associated with diverse genera of bioactive bacteria. In 
total, 20 bacterial morphotypes were isolated; seven actinobacteria, including 
several Streptomyces and Saccharopolyspora strains, were tested in colony 
bioassays against the medically important yeast Candida albicans and three 
non-cultivar, filamentous fungi:  Acremonium (F1), Fusarium (F2), and Alternaria
(F3). These three fungal species were isolated from the same Chaetomonium
fungal cultivar material as some of the cultivar-associated bacteria. Three 
Streptomyces (KY1, KY2, KY5) and three Saccharopolyspora (KY3, KY7, KY21) 
strains inhibited the growth of Candida. Also, one of these Streptomyces strains 
(KY5) and all Saccharopolyspora strains inhibited Acremonium (F1). None of the 
bacterial isolates inhibited the other two non-cultivar fungi. Due to the patchy 
growth characteristics of the Chaetomonium fungal cultivar, the Streptomyces
strain (KY5) that inhibited Acremonium could not be tested against 
Chaetomonium; this pairing would have been of particular interest since the 
bacterium was isolated from the fungal cultivar itself.  
Furthermore, sodium butyrate was found to increase or decrease the 
bacterial antifungal production in a strain-specific way. For example, one 
Streptomyces strain (KY5) displayed increased fungal inhibition under the 
influence of the chemical inducer. In contrast, the Saccharopolyspora strains 
(KY3, KY7, KY21) were unable to grow in the presence of the substance and in 
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consequence did not produce antifungals. Potentially, those strains may display 
an increased antifungal production under a lower concentration of sodium 
butyrate.  
Finally, three Streptomyces strains (KY1, KY2, KY5) demonstrated the 
ability to secrete antifungal metabolites into a liquid environment, as shown by 
inhibition of Candida. Here, sodium butyrate clearly promoted antifungal 
production by increasing the number of secreting Streptomyces strains from one 
(KY1) to three.    
In conclusion, the results presented in this chapter indicate that T. penzigi
and its putative fungal cultivar, Chaetomonium, indeed have the opportunity to 
benefit from the bioactive secretions of diverse Streptomyces and 
Saccharopolyspora strains. The ability of some of the isolates to secrete their 
antifungals into liquid medium will enable a straightforward isolation and 
identification of the bioactive metabolites. 
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Chapter 6) General Conclusions 
The central purpose of this thesis was to test the utility of ant-microbe 
associations for discovering bioactive bacteria and antifungal compounds that 
have novel molecular (sub-)structures. Novel antifungals are in demand due to 
the rising prevalence of human mycoses (Slavin et al. 2004) and due to 
problems that accompany currently used antifungal drugs. These problems 
include rising fungal resistance towards specific antifungal compounds, adverse 
side-effects in humans in response to antifungal drugs, and difficulties with the 
application of antifungals, due for example, to the low water-solubility of 
polyenes (Day et al. 2011). Finding compounds with novel (sub-)structures 
displaying reduced side-effects, increased water-solubilities, and strong 
fungicidal and/or fungistatic properties would allow an application of higher and 
thus potentially more effective antifungal doses. In addition, a broader range of 
antifungal compounds per se allows the application of different antifungal drugs 
over time and the application of multiple antifungals simultaneously. All three 
strategies can prevent resistance evolution in fungal pathogens 
Mutualistic symbioses between insects (hosts) and antifungal-producing 
bacteria (symbionts) are of increasing interest to research since some host-
symbiont systems appear to have solved the antibiotic resistance problem, and 
this interest is indicated by the number of recently published studies (Scott et al.
2008, Oh. et al. 2009, Haeder et al. 2009, Kroiss et al. 2010, Barke et al. 2010, 
Poulsen et al. 2011, Schoenian et al. 2011). The antibiotic resistance problem is 
the widespread observation that fungal pathogens evolve and acquire 
resistance against specific antifungals. Host-symbiont systems could (1) teach 
us strategies for reducing resistance evolution in fungal pathogens and (2) 
provide us with bacterial species that, due to their co-evolved association with 
hosts, have evolved antifungals with novel molecular structures.  
The best-studied example of a host-symbiont mutualism in which the 
symbiont produces antibiotics is found in attine ants (Hymenoptera, Formicidae, 
Attini). The mutualism between attine ants, their basidiomycetous fungal cultivar 
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Leucoagaricus gongylophorus (Agaricales, Agaricaceae), and bacterial 
symbionts has existed for over 50 million years (Schultz and Brady 2008). It 
represents a system that apparently has found a solution to successfully defend 
against fungal pathogens, such as Escovopsis spp. (Hypocreales, 
Hypocreaceae) that attack and kill the fungal cultivar, over evolutionary time-
spans. Bacterial mutualists, which inhabit the integument of worker ants and 
also occur inside of their infrabuccal pocket, must adapt to a host that provides 
them with a specific environment and in return demands antifungal molecules 
that target current Escovopsis invaders. Hence, the bacterial symbionts of attine 
ants may phylogenetically differ from their free-living, and potentially well-
explored, counterparts producing antifungals that are novel to science. Some 
antifungals of attine ant-associated bacteria that have been identified so far 
indeed possess novel chemical structures, while others possess unmodified 
chemical structures. For example, the novel antifungal compound 
dentigerumycin (Oh et al. 2009) has been isolated from an Apterostigma ant-
associated Pseudonocardia symbiont. The well-known antifungals candicidin 
(Haeder et al. 2009), as well as antimycin, valinomycin, and actinomycin 
(Schoenian et al. 2011) have been isolated from Acromyrmex ant-associated 
Streptomyces strains.    
In this study, Acromyrmex octospinosus worker ants from Trinidad 
(Chapter 2), the fungal cultivar of Allomerus decemarticulatus and A. 
octoarticulatus from French Guiana (Chapter 4), and Tetraponera penzigi
worker ants and their putative fungal cultivar from Kenya (Chapter 5) were 
examined for associations with bioactive ectosymbiotic bacteria. The three ant 
systems combine the favourable characteristics of (1) being under selection 
pressure to evolve the use of bacterial metabolites in order to protect their 
(putative) fungal cultivars from fungal pathogens and competitors, and (2) 
differing in their ecology and biogeography. The combination of factors 
potentially increases the power to discover novel bacterial symbionts and novel 
antifungal metabolites. 
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As a first step to pursue our goal of finding novel antifungals, microbes 
were isolated from the three ant systems. As illustrated in the Supplementary 
Information C, these isolates belong to four bacterial phyla, including 
Actinobacteria, Firmicutes, Proteobacteria, and Bacteroidetes forming well-
defined phylogenetic clusters (Fig. S1). The phylum Actinobacteria is dominated 
by strains of the genus Streptomyces, which belongs to the sub-order 
Streptomycineae. Streptomyces strains could be isolated from the Acromyrmex, 
Allomerus, and Tetraponera ant systems that were sampled across two 
continents, as well as from both the worker ants and their fungal cultivars. This 
supports the view that Streptomyces is no accidental contaminant but may 
serve a functional role in ant fungicultural systems. Previously, this bacterial 
genus has been shown to serve functional roles in other insect systems such as 
the one of the southern pine beetle Dendroctonus frontalis (Scott et al. 2008) 
and the one of the European beewolf Philanthus triangulum (Kaltenpoth et al. 
2005). A cluster of less common bacterial morphotypes is formed by strains of 
the genera Pseudonocardia and Saccharopolyspora, which are members of the 
sub-order Pseudonocardineae.    
Selected actinobacterial isolates and their growth supernatants were 
challenged against the medically important yeast Candida albicans and diverse 
nest-isolated non-cultivar fungi, in the presence and absence of the chemical 
inducer sodium butyrate. Multiple actinobacteria, isolated from Acromyrmex 
octospinosus worker ants, were found to inhibit Candida and three Escovopsis
strains in agar plate bioassays. Only two of them, Streptomyces E8 and E9, 
secreted antifungals into a liquid medium that inhibited Candida and Escovopsis
EWC, facilitating antifungal purification and identification. Two actinobacteria, 
isolated from the fungal cultivar of Allomerus decemarticulatus and A. 
octoarticulatus, were found to inhibit Candida in agar plate bioassays (in the 
presence of sodium butyrate). In contrast, none of them inhibited the growth of 
two non-cultivar fungi on agar plates and secreted antifungals into a liquid 
medium. Diverse actinobacteria isolated from T. penzigi worker ants and their 
putative fungal cultivar were found to inhibit Candida and one of three non-
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cultivar fungi in agar plate bioassays. Of those, Streptomyces KY1, KY2, and 
KY5 secreted their antifungals into a liquid medium, inhibiting the growth of 
Candida. These results show that ant-microbe associations indeed represent a 
rich source of actinobacteria, allowing the isolation of diverse Pseudonocardia, 
Streptomyces, Nocardiopsis, and Saccharopolyspora strains, and that many of 
the strains produce secondary metabolites with antifungal properties.  
Two bioactive bacteria isolated from worker ants of one Acromyrmex 
octospinosus colony, Pseudonocardia E4 (renamed P1 in Barke et al. 2010) 
and Streptomyces E8 (renamed S4 in Barke et al. 2010), were analysed in 
detail to determine the identity and novelty of their antifungal metabolites. 
Pseudonocardia E4 was shown to produce the partially novel (to science) 
antifungal nystatin P1, suggesting a coevolutionary history with the symbiont 
(Barke et al. 2010). Due to the modified chemical structure of nystatin P1, the 
molecule probably exhibits an increased water-solubility compared to standard 
nystatin A1. The nystatin-like Pseudonocardia polyene (NPP) of P. autotrophica, 
which like nystatin P1 possesses an additional sugar molecule, exhibits a 
strongly increased water solubility as compared to nystatin A1 (Lee et al. 2012). 
Increasing the water-solubility of polyene antifungals, which form pores in the 
membranes of fungal pathogens, may benefit the treatment of systemic 
mycoses by facilitating their application. Streptomyces E8 was shown to produce 
the well-known antifungals candicidin and antimycin, which is consistent with the 
recent recruitment of the bacterium from the environment (Barke et al. 2010, 
Seipke et al. 2011a). The antimycins found in this study are even more 
numerous than those found from a different Streptomyces species isolated by 
Schoenian et al. (2011) from an A. octospinosus ant. These results indicate that 
A. octospinosus has the capacity to use antifungal cocktails to reduce 
resistance evolution in fungal pathogens (Barke et al. 2010) and show that this 
ant-symbiont system provides the opportunity to find novel antibiotics. In 
general, however, the selection pressure for novel antifungals to evolve may be 
reduced by the production of antifungal cocktails in vertically transmitted 
symbionts and/or bacterial consortia. The fitness interests between hosts and 
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symbionts are and, for the time being, will be aligned through the production of 
bioactive metabolites that in combination prevent or limit the evolution of 
resistant pathogens. This again reduces the need to obtain, or the benefit of 
being associated with, bacteria possessing novel antifungal biosynthesis genes.   
A chemical analysis (Chapter 3) of the antimycin metabolites of 
Streptomyces E8 revealed the presence of two compound sets, each consisting 
of six molecules, which differ in the number of attached CH2 groups; the larger 
molecules within sets contain more CH2 groups than the smaller molecules. 
This compound variety and the production of larger, and potentially more costly, 
antimycin molecules may allow Streptomyces E8 to inhibit diverse fungal 
pathogens within the ant system and also to react to pathogen adaptations. This 
hypothesis could be tested by isolating individual antimycins and bioassaying 
them against test fungi that differ or resemble each other in their genetic 
constitution. Despite the fact that both compound sets share the same MS data, 
meaning that they contain the same six antimycin masses, both compound sets 
differ in their polarity, fragmentation pattern, and bioactivity. In bioassays, the 
antimycin molecules of only one compound set inhibited the growth of Candida, 
and revealed tandem-LCMS analogies with an antimycin A1-A4 standard. A 
future study should identify why the other set of antimycin compounds failed to 
inhibit Candida, possibly by including other test fungi is this bioassay analysis.  
Future studies may also investigate how varying concentrations of sodium 
butyrate or other chemical inducers affect antifungal production in the bacterial 
isolates. For example, Saccharopolyspora KY3, KY7, and KY21, which inhibited 
Candida on agar plates containing no sodium butyrate, were unable to grow 
mature colonies and produce antifungals on agar plates containing 150 mM of 
sodium butyrate. However, reducing the concentration of sodium butyrate may 
increase antifungal production in these strains as compared to the antifungal 
production in the absence of the inducer.  
Overall, this study shows that ant-bacteria mutualisms represent a rich 
source of bioactive bacteria and in some cases novel antifungals that could be 
exploited pharmaceutically.  
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Supplementary Information A1) Bacterial and fungal rDNA gene 
sequences 
Partial sequences of the fungal rDNA gene (ITS region) and the bacterial 16S 
rDNA gene. The sequencing data, generated with the sample-specific forward 
primers, are categorised by ant-system (Acromyrmex, Allomerus, and 
Tetraponera). The title of each sequence describes the name of the strain, the 
PCR primer set used, and the length of the sequence. 
Supplementary Information A1
226
Acromyrmex system  
Fungi  
Mutualistic fungus Leucoagaricus gongylophorus, ITS1-FITS4, 280 bp 
GTGCACACCTGTCTTGGACTCTTCTTACTATTCATCCACCCTGTGCACTTCTTGTGGTCTTCTTTCAAGGTCGAAGTG
GGCTTGGTCTTTCTAGGCTCTATGAGGTCTTGAGGAGGGGCATGTTTGCTTTTGTCATAAACAAGTATAGCAGGAAT
GTTTTCTAACGGGCAACCTATGCCTGTGATTTAATATCATACAACTTTCAGCAACGGATCTCTTGGCTCTCGCATCGA
TGAAAAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAAAATTCA 
Non-cultivar fungus Escovopsis weberi EWB, ITS1-FITS4, 604 bp 
CATTACCGAGTTTTCATCAACTCCCTTACCCCATGTGAACGTTACCATACCGTTGCTTCGGCGGTGCGGCCCCGGC
GGCCCGGCTCCCTGCGAGCCGGCGCCTGCCGGGCTCAGGCCCCCGCCGGAGGACCCAAACTCCATGTTTTTTTG
CGAGTCTCTGAGGCGGCCCTGGGCCGATCAAAAAACAAAATGAATCAAAACTTTCAACAACGGATCTCTTGGTTCT
GGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAAC
GCACATTGCGCCCGCCAGCACTCTGGCGGGCATGCCTGTTCGAGCGTCATTTCAACCCTCTGCCGCCCCCCGGGG
CGGCGGGCTCTTGGGGGACGGCCGGCCGCCTAGCGCGGCGGTGCCGCCCCCGAAATCCAGTGGCGACCGAGCC
GCGAACTCCTCTGCGCAGTAGACTTTGAGGCCCCTGCGGCCGAGACGGACTCGCACCGGAGAGCGGATCGGCCC
CGCCGTGAAACCCCCCAACTTCTGAAAGGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCATATCAA
TAA  
Non-cultivar fungus Escovopsis weberi EWC, ITS1-FITS4, 593 bp 
TTACCGAGTTTTTATCAACTCCCTTACCCCATGTGAACGTTACCATACCGTTGCTTCGGCGGTGCGGCCCCGGCGG
CCCGGCTCCCTGCGAGCCGGCGCCTGCCGGGCTCAGGCCCCCGCCGGAGGACCCAAACTCCATGTCTTTTTGCG
AGTCTCTGAGGCGGCCCTGGGCCGATCAAAAAAACAAATGAATCAAAACTTTCAACAACGGATCTCTTGGTTCTGG
CATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGC
ACATTGCGCCCGCCAGCACTCTGGCGGGCATGCCTGTTCGAGCGTCATTTCAACCCTCTGCCGCCCCCCGGGGCG
GCGGGCTCTTGGGGGACGGCCGGCCGCCTCGCGCGGCGGTGCCGCCCCCGAAATGCAGTGGCGACCGAGCCGC
GAACTCCTCTGCGCAGTAGACTTGAGGCCCCTGCGGCCGAACGAGACTCGCACCGGATAGCGGATCGGCCCCGC
CGTGAAACCCCAAACTTCTGAAAGGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCATA  
Non-cultivar fungus Escovopsis aspergilloides EA, ITS1-FITS4, 613 bp 
CATTATCGAGTTTTGAAACGGGTTGTAGCTGGCCTCTCCGGAGGCATGTGCACGCCCTGCTCATCCACTCTACACC
TGTGCACTTACTGTGGGTATCGGAAGGCGTCGCGTCGTTTGCGGCGAGGCGTTAACCGTGCCTACGTCTTACTACA
AACGCTTCAGTATCAGAATGTGTATTGCGATGTAACGCATCTATATACAACTTTCAGCAACGGATCTCTTGGCTCTC
GCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACG
CACCTTGCGCTCCTTGGTATTCCGAGGAGCATGCCTGTTTGAGTGTCATGAAATTCTCAAACCCATAAGTCTTTGCG
GGCTTACGGGCTTTGGACTTGGAGGCTTTGTCGGCGACCGCGAGGTCTGTCGACTCCTCTCAAATGCATTAGCTTG
ATTCCTTGCGGATCGGCTCTCGGTGTGATAATTGTCTACGCCGTGACCGTGAAGCGTTTTGGCGAGCTTCTAATCG
TCTCTTACGAGACAGTTTACATTGACCTCTGACCTCAAATCAGGTAGGACTACCCGCTGAACTTAAGCATATCAATAA 
Bacteria 
Bacterial isolate E2, 5151492, 750 bp 
TTGGGCGTAAGAGCTCGTAGGCGGCTTGTCACGTCGGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCG
ATACGGGCTAGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGG
AACACCGGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGAT
TAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAG
CTAACGCATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCAC
AAGCAGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATATACCGGAAAGCATC
AGAGATGGTGCCCCCCTTGTGGTCGGTATACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGG
TTAAGTCCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCCTTCGGGGTGATGGGGACTCACAGGAG
ACTGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACG
TGCTACAATGGCCGGTACAATGAGCTGCGATGCCGCGAGGCGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGA 
Bacterial isolate E3, 5151492, 708 bp 
AGCTCGTAGGCGGCTTGTCACGTCGGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCGATACGGGCTAG
CTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGG
CGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTG
GTAGTCCACGCCGTAAACGTTGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAGCTAACGCATTAA
GTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCAGCGGAG
CATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATATACCGGAAAGCATCAGAGATGGTGC
CCCCCTTGTGGTCGGTATACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGC
AACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCCTTCGGGGTGATGGGGACTCACAGGAGACTGCCGGGGT
CAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAATGG
CCGGTACAATGAGCTGCGATGCCGCGAGGCGGA 
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Bacterial isolate E4, 5151492, 707 bp 
TTGGGCGTAAGAGCTCGTAGGCGGTGTGTCGCGTCGGCCGTGAAAACTTGGGGCTTAACTCTGAGCGTGCGGTCG
ATACGGGCATCACTTGAGTTCGGCAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAG
GAACACCGGTGGCGAAGGCGGGTCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGG
ATTAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGCGCTAGGTGTGGGGACCATTCCACGGTTTCTGCGCCGC
AGCTAACGCATTAAGCGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCG
CACAAGCGGCGGAGCATGTGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGGTTTGACATGCACAGGATCGC
GGCAGAGATGTCGTTTCCCTTGTGGCCTGTGTGCAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTT
GGGTTAAGTCCCGCAACGAGCGCAACCCTTATTCCATGTTGCCAGCACGTAGTGGTGGGGACTCATGGGAGACTG
CCGGGGTCAACTCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGCCCCTTATGTCCAGGGCTTCACACATGCT
ACAATGGCTCATACAGAGGGCTGCGAGACCGTGA 
Bacterial isolate E5, 5151492, 608 bp 
CGTAAGAGCTCGTAGGCGGCATGTCGCGTCTGCTGTGAAAGACCGGGGCTTAACTCCGGTTCTGCAGTGGATACG
GGCATGCTAGAGGTAGGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACAC
CGGTGGCGAAGGCGGGTCTCTGGGCCTTACCTGACGCTGAGGAGCGAAAGCATGGGGAGCGAACAGGATTAGAT
ACCCTGGTAGTCCATGCCGTAAACGTTGGGCGCTAGGTGTGGGGACTTTCCACGGTTTCCGCGCCGTAGCTAACG
CATTAAGCGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCG
GCGGAGCATGTTGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGTTTGACATCACCCGTGGACCTGTAGAGA
TACAGGGTCATTTAGTTGGTGGGTGACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAG
TCCCGCAACGAGCGCAACCCTTGTTCCATGTTGCCAGCACGTAATGGTGGGGACTCATGGGAGACTGCCGGGGTC
AACTCGGA 
Bacterial isolate E6, 5151492, 725 bp 
TAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGA
AATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAA
GCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCACTAGGTGTGGGCAACATT
CCACGTTGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAG
GAATTGACGGGGGCCCGCACAAGCAGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCT
TGACATACACCGGAAACGGCCAGAGATGGTCGCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAG
CTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTGCCAGCAAGCCCTTCGG
GGTGTTGGGGACTCACGGGAGACCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCC
CTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATACCGCGAGGTGGAGCGAATCTC
AAAAAGCCGGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTC 
Bacterial isolate E7, 5151492, 762 bp 
TTAACCTCGGGCCTGCAGGCGATACGGGCAGACTTGAGTACTGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTG
GAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGGTCTCTGGGCAGTAACTGACGCTGAGGAGCGAA
AGCGTGGGTAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGTACTAGGTGTGGGTTTCCT
TCCACGGGATCCGTGCCGTAGCTAACGCATTAAGTACCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAA
GGAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGGT
TTGACATATAGAGGATCGCCGGAGAGATTCGGTTTGCCTTGTGCCTTCTATACAGGTGGTGCATGGCTGTCGTCAG
CTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCTCATGTTGCCAGCACGTAATGGTGG
GGACTCGTGAGAGACTGCCGGGGTCAACTCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGCCCCTTATGTCC
AGGGCTTCACACATGCTACAATGGCGCGTACAGAGGGCTGCGATACCGTGAGGTGGAGCGAATCCCTTAAAGCGC
GTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTCGGAGTCGCTAGTAATCGCAGATCAGCAACGCTG
CGGTGAATAC 
Bacterial isolate E8, 5151492, 830 bp 
TTGGGCGTAAGAGCTCGTAGGCGGCTTGTCACGTCGGTTGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCG
ATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGG
AACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGAT
TAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCACTAGGTGTGGGCAACATTCCACGTTGTCCGTGCCGCAG
CTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCAC
AAGCGGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATACACCGGAAACGTCT
GGAGACAGGCGCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGG
TTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTGCCAGCAGGCCCTTGTGGTGCTGGGGACTCACGGGAGA
CCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGT
GCTACAATGGCCGGTACAATGAGCTGCGATACCGCGAGGTGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGAT
TGGGGTCTGCAACTCGACCCCATGAAGTCGGAGTCGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTC
CCGG 
Bacterial isolate E9, 5151492, 760 bp 
AGCTCGTAGGCGGCTTGTCACGTCGGTTGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCGATACGGGCAG
GCTAGAGTTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTG
GCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCT
GGTAGTCCACGCCGTAAACGGTGGGCACTAGGTGTGGGCAACATTCCACGTTGTCCGTGCCGCAGCTAACGCATT
AAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGCGG
AGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATACACCGGAAACGTCTGGAGACAGG
CGCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCC
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GCAACGAGCGCAACCCTTGTCCCGTGTTGCCAGCAGGCCCTTGTGGTGCTGGGGACTCACGGGAGACCGCCGGG
GTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAAT
GGCCGGTACAATGAGCTGCGATACCGCGAGGTGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATTGGGGTCT
GCAACTCGACCCC 
Bacterial isolate E10, 5151492, 697 bp 
TAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGA
AATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAA
GCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCACTAGGTGTGGGCAACATT
CCACGTTGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAG
GAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCT
TGACATACACCGGAAACGGCCAGAGATGGTCGCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAG
CTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTGCCAGCAAGCCCCTTCG
GGGGTGTTGGGGACTCACGGGAGACCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGC
CCCTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATACCGCAAGGTGGAGCGAATCT
CAAAAAGCCGGTCTCAGTTCGGA 
Bacterial isolate E11, 5151492, 701 bp 
TTAACCCCGGTTCTGCAGTGGATACGGGCATGCTAGAGGTAGGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTG
AAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGGTCTCTGGGCCTTACCTGACGCTGAGGAGCGAA
AGCATGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCATGCCGTAAACGTTGGGCGCTAGGTGTGGGGACTTT
CCACGGTTTCCGCGCCGTAGCTAACGCATTAAGCGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAG
GAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTTGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGTT
TGACATCACCCGTGGACCTGCAGAGATGTGGGGTCATTTAGTTGGCGGGTGACAGGTGGTGCATGGCTGTCGTCA
GCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTTCCATGTTGCCAGCACGTAATGGTG
GGGACTCATGGGAGACTGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTC
TTGGGCTGCAAACATGCTACAATGGCCGGTACAATGGGCGTGCGATACCGTGAGGTGGAGCGAATCCCTAAAAGC
CGGTCTCAGTTCGGATTGGGGTCTGC 
Bacterial isolate E12, 5151492, 825 bp 
TTGGGCGTAAGAGCTCGTAGGCGGTGTGTCGCGTCGGCCGTGAAAACTTGGGGCTTAACTCTGAGCGTGCGGTCG
ATACGGGCATCACTTGAGTTCGGCAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAG
GAACACCGGTGGCGAAGGCGGGTCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGG
ATTAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGCGCTAGGTGTGGGGACCATTCCACGGTTTCTGTGCCGCA
GCTAACGCATTAAGCGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGC
ACAAGCGGCGGAGCATGTGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGGTTTGACATGCACCAGACATCC
CTAGAGATAGGGCTTCCCTTGTGGTTGGTGTGCAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTG
GGTTAAGTCCCGCAACGAGCGCAACCCTTGTTCCATGTTGCCAGCACGTTATGGTGGGGACTCATGGGAGACTGC
CGGGGTCAACTCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGCCCCTTATGTCCAGGGCTTCACACATGCTA
CAATGGCTCATACAGAGGGCTGCGAGACCGTGAGGTGGAGCGAATCCCTTAAAGTGAGTCTCAGTTCGGATCGGG
GTCTGCAACTCGACCCCGTGAAGTTGGAGTCGCTAGTAATCGCAGATCAGCAACGCTGCGGTGAATACGTTCCCG
G 
Bacterial isolate E13, 5151492, 780 bp 
TTGGGCGTAAGAGCTCGTAGGCGGCTTGTCGCGTCGGTTGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTC
GATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAG
GAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGA
TTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCACTAGGTGTGGGCAACATTCCACGTTGTCCGTGCCGCA
GCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCA
CAAGCGGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATACACCGGAAAGCA
TCAGAGATGGTGCCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTG
GGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTGCCAGCAGGCCCTTGTGGTGCTGGGGACTCACGGGA
GACCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACAC
GTGCTACAATGGCCGGTACAATGAGCTGCGATACCGCAAGGTGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGG
ATTGGGGTCTGCAACTCGACCCCATGAAGTCG 
Bacterial isolate E14, 5151492, 656 bp 
GGTCTGCAGTCGATACGGGCAGGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCA
GATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGG
AGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGAACTAGGTGTTGGCGACATTCCACGTCGT
CGGTGCCGCAGCTAACGCATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACG
GGGGCCCGCACAAGCAGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATACA
CCGGAAAGCATCAGAGATGGTGCCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCG
TGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCCTTCGGGGTGATGGG
GACTCACAGGAGACTGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTT
GGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATGCCGCGAGGCGGA 
Bacterial isolate E15, 5151492, 783 bp 
TTGGGCGTAAGAGCTCGTAGGCGGCTTGTCACGTCGGTTGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCG
ATACGGGCAGGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGG
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AACACCGGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGAT
TAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAG
CTAACGCATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCAC
AAGCAGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATACACCGGAAAGCATC
AGAGATGGTGCCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGG
TTAAGTCCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCCTTCGGGGTGATGGGGACTCACAGGAG
ACTGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACG
TGCTACAATGGCCGGTACAATGAGCTGCGATGCCGCGAGGCGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGA
TTGGGGTCTGCAACTCGACCCCATGAAGTCGGA 
Bacterial isolate E16, 5151492, 897 bp 
TTGGGCGTAAGAGCTCGTAGGCGGCATGTCGCGTCTGCTGTGAAAGACCGGGGCTTAACTCCGGTTCTGCAGTGG
ATACGGGCATGCTAGAGGTAGGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGG
AACACCGGTGGCGAAGGCGGGTCTCTGGGCCTTACCTGACGCTGAGGAGCGAAAGCATGGGGAGCGAACAGGAT
TAGATACCCTGGTAGTCCATGCCGTAAACGTTGGGCGCTAGGTGTGGGGACTTTCCACGGTTTCCGCGCCGTAGC
TAACGCATTAAGCGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACA
AGCGGCGGAGCATGTTGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGTTTGACATCACCCGTGGACCTGTA
GAGATACAGGGTCATTTAGTTGGTGGGTGACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGG
TTAAGTCCCGCAACGAGCGCAACCCTTGTTCCATGTTGCCAGCACGTAATGGTGGGGACTCATGGGAGACTGCCG
GGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCAAACATGCTACA
ATGGCCGGTACAATGGGCGTGCGATACCGTAAGGTGGAGCGAATCCCTTAAAGCCGGTCTCAGTTCGGATTGGGG
TCTGCAACTCGACCCCATGAAGGTGGAGTCGCTAGTAATCGCGGATCAGCAACGCCGCGGTGAATACGTTCCCGG
GCCTTGTACACACCGCCCGTCACGTCATGAAAGTCGGCAACACCCGAAACTTGTGGCCTAACCCTTCGGGGA 
Bacterial isolate E17, 5151492, 817 bp 
GTTCTGCAGTGGATACGGGCATGCTAGAGGTAGGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCA
GATATCAGGAGGAACACCGGTGGCGAAGGCGGGTCTCTGGGCCTTACCTGACGCTGAGGAGCGAAAGCATGGGG
AGCGAACAGGATTAGATACCCTGGTAGTCCATGCCGTAAACGTTGGGCGCTAGGTGTGGGGACTTTCCACGGTTTC
CGCGCCGTAGCTAACGCATTAAGCGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGG
GGGCCCGCACAAGCGGCGGAGCATGTTGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGTTTGACATCACC
CGTGGACCTGTAGAGATACAGGGTCATTTAGTTGGTGGGTGACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCG
TGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTTCCATGTTGCCAGCACGTAATGGTGGGGACTCATG
GGAGACTGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCA
AACATGCTACAATGGCCGGTACAATGGGCGTGCGATACCGTAAGGTGGAGCGAATCCCTTAAAGCCGGTCTCAGTT
CGGATTGGGGTCTGCAACTCGACCCCATGAAGGTGGAGTCGCTAGTAATCGCGGATCAGCAACGCCGCGGTGAAT
ACGTTCCCGGGCCTTGTACACACCGCCCGTCACGTCATGAAAGTCGGCAACACCCGAAACTTGTG 
Allomerus system  
Fungi  
Mutualistic fungus Trimmatostroma cordae F1, ITS1-FITS4, 915 bp 
GCGCTTGCGTCTCGGATAAGTTAATGCATCCTTCTGCAGTGACACTTATTGGAAGCCTTAGATAACCGCCAGAAATG
GTACGGTTCCCGCGACTTTAAACAAGCAGGATCCTAAGGGTTAGTGGTGCCGCCTCTGCTTAATTTATTTAAGCACG
CGGTGCTGCGACACTATCAAATTGCGGGAAGTCCCTTAGAGCCGGCAGTACCGCTCCCTCGTCGAAATGATCGGG
GCAGCACCAGGTTAATGACCTCGGGTATGGTAACAATCTCGCCGGATTGGGTTACCTGCAGCCAAGTCCTCCGCG
GAGGGGTGGTCGTCCACGGGCGGCCGTCTTTCGCGGTCGGATGCAGTTCACAGGCCAAATGGTAGTGGGTGGTC
CCCTTTTGTAAGGGCGATTGCTTAAGATATGGTCGGGCCCCCAGGGAAATCCTGGGGGGTGAGTTCACAAAAGAAT
AAGTAACAAGAACAAACAAAAACGTTCCGTAGGTGAACCTGCGGAAGGATCATTACCGAGTTAGGGTTCTCTCCCG
AGGCCCGACCTCCCAACCCTGTGTCTACCACCTGTGTAACGTGTTGCTTCGGCGGACCGGCAGTCCCCTTACGGG
GGTCCGTCGCCGGGTGTCGCCCCTGGAGAGCGTCCGCCGATGCCCCCAACCAAACAACGCCCAAACCCAAATTAG
CGGACCTAAAACTTCTGAATCAAACCTTTTTGATGTACCAATCAAAAACAAAACTTTCAACAACGGATCTCTTGGTTC
TGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGCGAATTGCAGAATTTCCGTGAGTCATCGAATCTTTGA
ACGCACATTGCGCCCTTTGGCATTCCGAAGGGCATGCCTGTTCGAGCGTCATTATCCTCTCTCAAACCTCGGGTTT
GGTG  
Non-cultivar fungus F2, ITS1-FITS4, 540 bp 
TACTGAGTGAGGGCCCTCCGGGTCCAACCTCCCACCCGTGTTTATTCGTACCTTGTTGCTTCGGCAGGCCCGCCTC
ACGGCCGCCGGGGGGCTTCTGCCCCCGGGCCCGCGCCTGCCGGAGACAATTCTGAACGCTGTCTGAAGAATGCA
GTCTGAGCGATTAGCAAAATTAGTTAAAACTTTCAACAACGGATCTCTTGGTTCCGGCATCGATGAAGAACGCAGCG
AAATGCGATAATTAATGTGAATTGCAGAATTCAGTGAATCATCGAGTCTTTGAACGCACATTGCGCCCCCTGGTATT
CCGGGGGGCATGCCTGTCCGAGCGTCATTGCTGCCCTCAAGCCCGGCTTGTGTGTTGGGCCCTGTTCCCCCGGG
AACAGGCCCGAAAGGCAGTGGCGGCACCGCGTCCGATCCTCGAGCGTATGGGGCTTTGTCACCCGCTCTGTAGG
CCCGGCCGGCGCCCGTCGACCCCCCAACCTTTTTTTTTCAGGTTGACCTCGGATCAGGTAGGGATACCCGCTGAA
CTTAAGCATATCA  
Non-cultivar fungus F3, ITS1-FITS4, 494 bp 
TTGCTTCGGCGGGACCGCCCCGGCGCCCTCAGCGGCCCGGAACCAGGCGCCCGCCGGAGGACCCAAACTCTTG
CTTTGCATAGTGGCATTCTCTGAGTCTCACAAACAAAAATAAATCAAAACTTTCAACAACGGATCTCTTGGCTCTGGC
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ATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCA
CATTGCGCCCGCCAGCACTCTGGCGGGCATGCCTGTTCGAGCGTCATTTCAACCCTCAAGCACCCCTAGGGAGCT
TGGTGTTGGGGACCGGCCCGCCCTCTGCGGCGGCCGCCGCCCCCGAAATGCAGTGGCGACCTCGCCGCAGCCT
CCCCTGCGTAGTAGCACAACCTCGCACCGGAGCGCGGAGACGGTCACGCCGTAAAACGCCCAACTTTCCTAGAGT
TGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCATAT  
Non-cultivar fungus F4, ITS1-FITS4, 519 bp 
TACAAGTTGACCCCGGCCCCCGGGCCGGGATGTTCACAACCCTTTGTTGTCCGACTCTGTTGCCTCCGGGGCGAC
CCTGCCTCCGGGCGGGGGCCCCGGGTGGACACTTCAAAACTCTTGCGTAACTTTGCAGTCTGAGTAAATTTAATTA
ATAAATTAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGT
GAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCCCTGGTATTCCGGGGGGCATGCCTGT
TCGAGCGTCATTTCACCACTCAAGCCTCGCTTGGTATTGGGCGACGCGGTCCGCCGCGCGCCTCAAATCGACCGG
CTGGGTCTTTCGTCCCCTCAGCGTTGTGGAAACTATTCGCTAAAGGGTGCCGCGGGAGGCCACGCCGTAAAACAA
CCCCATTTTCTAAGGTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATATCAATAA  
Non-cultivar fungus F5, ITS1-FITS4, 693 bp 
TACTGAGTTATCAAAAACTCCAACCCTTTGTGAACCTACCTATGTTTCCTCCGGCGTACCGCTTTAGCCTACCCACA
GGGCTCCCCTAAGGGGGGGTTCTGCTGGGGAGGTGCCTGAGTGCTACCTATCCTTCGGGGTACGGTTAGTGCAGT
GAAGGTGCTGACCAAGGCCTCGGCGGCGCCGAGTAGGACCGCTCCAAACTTAAGCACCTAGTGCATCCAACCCCG
CGTTGAACAACTATCGAAAATCTGCTTTTGCTTTTTTTCTTTACGCTAAAACGTCTTTCCCGGTTGGAATTATTGCTCG
AAATAATAATTTCTTTACCCTGCAGTCGTTTGTTTTCAAGCTACAATATCTGCTCGAAAATTGTTCAAAGCTCTGAGG
GGTCTGAATGAATTCATAAAATTGGCAAAAGCCACCTATAAACTACGGTTCTTAGGGGGTGATCAAACCAAGGTTTT
AAAAACCAAATACGTTAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGAT
AAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCATTAGTATTCTAGTGGGC
ATGCCTATTCGAGCGTCATTACAACCCTTAAGCCTTGTAGCTTAGCGTTGGGAATCTACCCCTCACTGAGGGGTAGT
T  
Bacteria
Bacterial isolate FG1, 5151492, 908 bp 
GTAAGAGCTCGTAGGCGGCTTGTCACGTCGGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCGATACGG
GCTAGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACC
GGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATA
CCCTGGTAGTCCACGCCGTAAACGTTGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAGCTAACG
CATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCAG
CGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATATACCGGAAAGCATCAGAGAT
GGTGCCCCCCTTGTGGTCGGTATACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGT
CCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCTTTCGGGGTGATGGGGACTCACAGGAGACTGCC
GGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTAC
AATGGCCGGTACAATGAGCTGCGATGCCGTGAGGCGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATTGGGG
TCTGCAACTCGACCCCATGAAGTCGGAGTTGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGGG
CCTTGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAGCCGGTGGCCCAACCCCTTGTGGGAGGG
AGCTGTC 
Bacterial isolate FG2, 5151492, 908 bp  
GTAAGAGCTCGTAGGCGGCTTGTCACGTCGGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCGATACGG
GCTAGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACC
GGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATA
CCCTGGTAGTCCACGCCGTAAACGTTGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAGCTAACG
CATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCAG
CGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATATACCGGAAAGCATCAGAGAT
GGTGCCCCCCTTGTGGTCGGTATACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGT
CCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCTTTCGGGGTGATGGGGACTCACAGGAGACTGCC
GGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTAC
AATGGCCGGTACAATGAGCTGCGATGCCGTGAGGCGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATTGGGG
TCTGCAACTCGACCCCATGAAGTCGGAGTTGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGGG
CCTTGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAGCCGGTGGCCCAACCCCTTGTGGGAGGG
AGCTGTC 
Bacterial isolate FG3, 5151492, 900 bp  
CGTAAGAGCTTGTAGGCGGTTCGTCGCGTCGTTCGTGAAAACTCGGGGCTCAACCCCGAGCTTGCGGGCGATACG
GGCGGACTAGAGTACTGCAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACAC
CGGTGGCGAAGGCGGGTCTCTGGGCAGTAACTGACGCTGAGAAGCGAAAGCGTGGGTAGCGAACAGGATTAGAT
ACCCTGGTAGTCCACGCCGTAAACGGTGGGCGCTAGGTGTGGGTTTCCTTCCACGGGATCCGTGCCGTAGCTAAC
GCATTAAGCGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGC
GGCGGAGCATGTGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGGTTTGACATACACCAGAAAGCTGTAGAG
ATATGGCCCCCCTTGTGGTTGGTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAG
TCCCGCAACGAGCGCAACCCTTATCTTATGTTGCCAGCGCGTAATGGCGGGGACTCGTGAGAGACTGCCGGGGTC
AACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCCAGGGCTTCACACATGCTACAATGGC
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CGGTACAGAGGGCTGCGATACCGTGAGGTGGAGCGAATCCCTTAAAGCCGGTCTCAGTTCGGATCGGGGTCTGCA
ACTCGACCCCGTGAAGTTGGAGTCGCTAGTAATCGCAGATCAGCAACGCTGCGGTGAATACGTTCCCGGGCCTTG
TACACACCGCCCGTCACGTCATGAAAGTCGGTAACACCCGAAGCCGGTGGCCTAACCCTTGTGGAGGGAGCCGTC 
Bacterial isolate FG4, 5151492, 908 bp  
GTAAGAGCTCGTAGGCGGCTTGTCACGTCGATTGTGAAAGCCCGAGGCTTAACCTCGGGTCTGCAGTCGATACGG
GCTAGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACC
GGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATA
CCCTGGTAGTCCACGCCGTAAACGGTGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAGCTAACG
CATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCAG
CGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATACACCGGAAAGCATCAGAGAT
GGTGCCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGT
CCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCCTTCGGGGTGATGGGGACTCACAGGAGACTGCC
GGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTAC
AATGGCAGGTACAATGAGCTGCGAAACCGTGAGGTAGAGCGAATCTCAAAAAGCCTGTCTCAGTTCGGATTGGGGT
CTGCAACTCGACCCCATGAAGTCGGAGTTGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGGGC
CTTGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAGCCGGTGGCCCAACCCCTTGTGGGAGGGA
GCTGTC 
Bacterial isolate FG5, 5151492, 888 bp  
GTAAGAGCTCGTAGGCGGCTTGTCGCGTCGGGTGTGAAAGACCGGGGCTTAACCCCGGTTCTGCATTCGATACGG
GCAGGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACC
GGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATA
CCCTGGTAGTCCACGCCGTAAACGGTGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAGCTAACG
CATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCAG
CGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATATACCGGAAACGGCCAGAGAT
GGTCGCCCCCTTGTGGTCGGTATACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGT
CCCGCAACGAGCGCAACCCTTGTCCTGTGTTGCCAGCAACACCTTCGGGTGGTTGGGGACTCACAGGAGACCGCC
GGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTAC
AATGGCCGGTACAAAGAGCTGCGAAGCCGTGAGGTGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATTGGGG
TCTGCAACTCGACCCCATGAAGTCGGAGTTGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGGG
CCTTGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAGCCGGTGGCCCAACC 
Bacterial isolate FG6, 5151492, 905 bp  
AGAGCTCGTAGGCGGCTTGTCACGTCGGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCGATACGGGCT
AGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGT
GGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCC
TGGTAGTCCACGCCGTAAACGTTGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAGCTAACGCAT
TAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCAGCG
GAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATATACCGGAAAGCATCAGAGATGG
TGCCCCCCTTGTGGTCGGTATACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCC
GCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCTTTCGGGGTGATGGGGACTCACAGGAGACTGCCGGG
GTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAAT
GGCCGGTACAATGAGCTGCGATGCCGTGAGGCGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATTGGGGTCT
GCAACTCGACCCCATGAAGTCGGAGTTGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGGGCCT
TGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAGCCGGTGGCCCAACCCCTTGTGGGAGGGAG
CTGTC 
Bacterial isolate FG7, 5151492, 905 bp  
GAGCTCGTAGGCGGCTTGTCACGTCGGTTGTGAAAGCCCGAGGCTTAACCTCGGGTCTGCAGTCGATACGGGCAG
GCTAGAGTTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTG
GCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCT
GGTAGTCCACGCCGTAAACGGTGGGCACTAGGTGTGGGCAACATTCCACGTTGTCCGTGCCGCAGCTAACGCATT
AAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGCGG
AGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATACACCGGAAAGCATCAGAGATGGT
GCCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCC
GCAACGAGCGCAACCCTTGTCCCGTGTTGCCAGCAGGCCCTTGTGGTGCTGGGGACTCACGGGAGACCGCCGGG
GTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAAT
GGCCGGTACAATGAGCTGCGATACCGTGAGGTGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATTGGGGTCT
GCAACTCGACCCCATGAAGTCGGAGTCGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGGGCC
TTGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAGCCGGTGGCCCAACCCCCTTGTGGGGAGGG
AGCTGTC 
Bacterial isolate FG8, 5151492, 914 bp  
TTGGGCGTAAGAGCTCGTAGGCGGCTTGTCACGTCGGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCG
ATACGGGCTAGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGG
AACACCGGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGAT
TAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAG
CTAACGCATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCAC
AAGCAGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATATACCGGAAAGCATC
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AGAGATGGTGCCCCCCTTGTGGTCGGTATACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGG
TTAAGTCCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCCTTCGGGGTGATGGGGACTCACAGGAG
ACTGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACG
TGCTACAATGGCCGGTACAATGAGCTGCGATGCCGCGAGGCGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGA
TTGGGGTCTGCAACTCGACCCCATGAAGTCGGAGTTGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTT
CCCGGGCCTTGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAGCCGGTGGCCCAACCCCTTGTG
GGAGGGAGCTGTC 
Bacterial isolate FG9, 5151492, 895 bp  
GCGCGCGCAGGTGGTTTCTTAAGTCTGATGTGAAAGCCCACGGCTCAACCGTGGAGGGTCATTGGAAACTGGGAG
ACTTGAGTGCAGAAGAGGAAAGTGGAATTCCATGTGTAGCGGTGAAATGCGTAGAGATATGGAGGAACACCAGTG
GCGAAGGCGACTTTCTGGTCTGTAACTGACACTGAGGCGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTG
GTAGTCCACGCCGTAAACGATGAGTGCTAAGTGTTAGAGGGTTTCCGCCCTTTAGTGCTGAAGTTAACGCATTAAG
CACTCCGCCTGGGGAGTACGGCCGCAAGGCTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGC
ATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGTCTTGACATCCTCTGAAAACCCTAGAGATAGGGCTTC
TCCTTCGGGAGCAGAGTGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGC
AACGAGCGCAACCCTTGATCTTAGTTGCCATCATTAAGTTGGGCACTCTAAGGTGACTGCCGGTGACAAACCGGAG
GAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGACGGTACAAAG
AGCTGCAAGACCGCGAGGTGGAGCTAATCTCATAAAACCGTTCTCAGTTCGGATTGTAGGCTGCAACTCGCCTACA
TGAAGCTGGAATCGCTAGTAATCGCGGATCAGCATGCCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCC
GTCACACCACGAGAGTTTGTAACACCCGAAGTCGGTGGGGTAACCTTTTTGGAGCCAGCCGCCTA 
Bacterial isolate FG10, 5151492, 896 bp  
TTTAAGGGTCCGTAGGCGGATCTGTAAGTCAGTGGTGAAATCTCACAGCTTAACTGTGAAACTGCCATTGATACTGC
AGGTCTTGAGTAAGGTAGAAGTGGCTGGAATAAGTAGTGTAGCGGTGAAATGCATAGATATTACTTAGAACACCAAT
TGCGAAGGCAGGTCACTATGTCTTAACTGACGCTGATGGACGAAAGCGTGGGGAGCGAACAGGATTAGATACCCT
GGTAGTCCACGCTGTAAACGATGCTAACTCGTTTTTGGGTTTTCGGATTCAGAGACTAAGCGAAAGTGATAAGTTAG
CCACCTGGGGAGTACGAACGCAAGTTTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGATTATGTG
GTTTAATTCGATGATACGCGAGGAACCTTACCAAGGCTTAAATGGGAATTGATCGGTTTAGAAATAGACCTTCCTTC
GGGCAATTTTCAAGGTGCTGCATGGTTGTCGTCAGCTCGTGCCGTGAGGTGTTAGGTTAAGTCCTGCAACGAGCGC
AACCCCTGTTACTAGTTGCTACCATTAAGTTGAGGACTCTAGTAAGACTGCCTACGCAAGTAGAGAGGAAGGTGGG
GATGACGTCAAATCATCACGGCCCTTACGCCTTGGGCCACACACGTAATACAATGGCCGGTACAGAGGGCAGCTA
CACAGCGATGTGATGCAAATCTCGAAAGCCGGTCTCAGTTCGGATTGGAGTCTGCAACTCGACTCTATGAAGCTGG
AATCGCTAGTAATCGCGCATCAGCCATGGCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCAAGCC
ATGGAAGTCTGGGGTACCTGAAGTCGGTGACCGTAAAAGGAGCTGCCTAGGGTAAAACAG 
Bacterial isolate FG11, 5151492, 899 bp  
GAGCTCGTAGGCGGTTTGTCACGTCGTCTGTGAAAACCCGAGGCTTAACCTCGGGCCTGCAGGCGATACGGGCAG
ACTTGAGTACTGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGGAATGCGCAGATATCAGGAGGAACACCGGTG
GCGAAGGCGGGTCTCTGGGCAGTAACTGACGCTGAGGAGCGAAAGCGTGGGTAGCGAACAGGATTAGATACCCT
GGTAGTCCACGCCGTAAACGGTGGGTACTAGGTGTGGGTTTCCTTCCACGGGATCCGTGCCGTAGCTAACGCATT
AAGTACCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGCGG
AGCATGTGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGGTTTGACATATAGAGGATCGCCGCAGAGATGTG
GTTTGCCTTGTGCCTTCTATACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG
CAACGAGCGCAACCCTTGTCTCATGTTGCCAGCACGTAATGGTGGGGACTCGTGAGAGACTGCCGGGGTCAACTC
GGAGGAAGGTGGGGATGACGTCAAGTCATCATGCCCCTTATGTCCAGGGCTTCACACATGCTACAATGGCGCGTA
CAGAGGGCTGCGATACCGTGAGGTGGAGCGAATCCCTTAAAGCGCGTCTCAGTTCGGATTGGGGTCTGCAACTCG
ACCCCATGAAGTCGGAGTCGCTAGTAATCGCAGATCAGCAACGCTGCGGTGAATACGTTCCCGGGCCTTGTACACA
CCGCCCGTCACGTCATGAAAGTCGGTAACACCCGAAGCCGGTGGCCTAACCCCTTGTGGGAGGGAGCTGTCGA 
Bacterial isolate FG12, 5151492, 633 bp  
GAACTGCATCCAAAACTACTGAGCTAGAGTACGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGAAATGCGTAG
ATATAGGAAGGAACACCAGTGGCGAAGGCGACCACCTGGACTGATACTGACACTGAGGTGCGAAAGCGTGGGGAG
CAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGTCGACTAGCCGTTGGGATCCTTGAGATCTTAGT
GGCGCAGCTAACGCGATAAGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGG
CCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCTGGCCTTGACATGCTGAGAA
CTTTCCAGAGATGGATTGGTGCCTTCGGGAACTCAGACACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGA
GATGTTGGGTTAAGTCCCGTAACGAGCGCAACCCTTGTCCTTAGTTACCAGCACCTCGGGTGGGCACTCTAAGGAG
ACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCAGGGCTACACACG
TGCTACAATGGTCGGTACAAAGGGTTGCC 
Bacterial isolate FG13, 5151492, 918 bp  
AAGCGCACGCAGGCGGTCTGTCAAGTCGGATGTGAAATCCCCGGGCTTAACCTGGGAACTGCATTCGAAACTGGC
AGGCTAGAGTCTTGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCGTAGAGATCTGGAGGAATACCGG
TGGCGAAGGCGGCCCCCTGGACAAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACC
CTGGTAGTCCACGCCGTAAACGATGTCGACTTGGAGGTTGTGCCCTTGAGGCGTGGCTTCCGGAGCTAACGCGTT
AAGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAGCGGTGG
AGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTACTCTTGACATCCAGCGAATTTGGTAGAGATACCTT
GGTGCCTTCGGGAACTCTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGTGAAATGTTGGGTTAAGTCCC
GCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGGTCCGGCCGGGAACTCAAAGGAGACTGCCAGTGATAAACT
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GGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGAGTAGGGCTACACACGTGCTACAATGGCGCATA
CAAAGAGAAGCGACCTCGCGAGAGCAAGCGGACCTCATAAAGTGCGTCGTAGTCCGGATTGGAGTCTGCAACTCG
ACTCCATGAAGTCGGAATCGCTAGTAATCGTAGATCAGAATGCTACGGTGAATACGTTCCCGGGCCTTGTACACAC
CGCCCGTCACACCATGGGAGTGGGTTGCAAAAGAAGTATGTAGCTTAACCTTCGGGAGGGCGCTTACCACTTTGTG
ATTCATGACTGGGGT 
Bacterial isolate FG14, 5151492, 859 bp  
AACCTGGGAATTGCGATGGAAACTGGTCGACTAGAGTGTGGCAGAGGGTAGTGGAATTCCTGGTGTAGCAGTGAA
ATGCGTAGAGATCAGGAGGAACATCCGTGGCGAAGGCGACTGCCTGGGCCAACACTGACACTGAGGCACGAAAG
CGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCCTAAACGATGCGAACTGGATGTTGGGTGCAATTT
GGCACGCAGTATCGAAGCTAACGCGTTAAGTTCGCCGCCTGGGGAGTACGGTCGCAAGACTGAAACTCAAAGGAA
TTGACGGGGGCCCGCACAAGCGGTGGAGTATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGCCTTGA
CATGCACGGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACCGTGACACAGGTGCTGCATGGCTGTCGTCAGC
TCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCTTAGTTGCCAGCACGTAATGGTGGG
AACTCTAAGGAGACCGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCA
GGGCTACACACGTACTACAATGGTAGGGACAGAGGGCTGCAAGCCGGCGACGGTGAGCCAATCCCAGAAACCCTA
TCTCAGTCCGGATTGGAGTCTGCAACTCGACTCCATGAAGTCGGAATCGCTAGTAATCGCAGATCAGCATTGCTGC
GGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTTTGTTGCACCAGAAGCAGGTAGCTT
AACCTTCGGGAGGGCGCTTGCCACGGTGTGG 
Bacterial isolate FG15, 5151492, 814 bp  
CTGGGAACTGCAGTGGAAACTGGACGACTAGAATGTGGTAGAGGGTAGCGGAATTCCTGGTGTAGCAGTGAAATG
CGTAGAGATCAGGAGGAACATCCATGGCGAAGGCAGCTACCTGGACCAACATTGACACTGAGGCACGAAAGCGTG
GGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCCTAAACGATGCGAACTGGATGTTGGGTGCAATTTGGCA
CGCAGTATCGAAGCTAACGCGTTAAGTTCGCCGCCTGGGGAGTACGGTCGCAAGACTGAAACTCAAAGGAATTGA
CGGGGGCCCGCACAAGCGGTGGAGTATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGCCTTGACATG
TCGAGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACTCGAACACAGGTGCTGCATGGCTGTCGTCAGCTCGTG
TCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCTTAGTTGCCAGCACGTAATGGTGGGAACTC
TAAGGAGACCGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCAGGGC
TACACACGTACTACAATGGTAGGGACAGAGGGCTGCAAGCCGGCGACGGTAAGCCAATCCCAGAAACCCTATCTC
AGTCCGGATTGGAGTCTGCAACTCGACTCCATGAAGTCGGAATCGCTAGTAATCGCAGATCAGCATTGCTGCGGTG
AATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTTTGTTGCACCAGAA 
Bacterial isolate FG16, 5151492, 879 bp  
GCGCGCGTAGGTGGTTTGTTAAGTTGGATGTGAAAGCCCCGGGCTCAACCTGGGAACTGCATCCAAAACTGGCAA
GCTAGAGTACGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGAAATGCGTAGATATAGGAAGGAACACCAGTG
GCGAAGGCGACCACCTGGACTGATACTGACACTGAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTG
GTAGTCCACGCCGTAAACGATGTCAACTAGCCGTTGGAATCCTTGAGATTTTAGTGGCGCAGCTAACGCATTAAGTT
GACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAGCGGTGGAGCAT
GTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTTGACATGCAGAGAACTTTCCAGAGATGGATTGGTG
CCTTCGGGAACTCTGACACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGTAA
CGAGCGCAACCCTTGTCCTTAGTTACCAGCACGTTATGGTGGGCACTCTAAGGAGACTGCCGGTGACAAACCGGA
GGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCTGGGCTACACACGTGCTACAATGGTCGGTACAG
AGGGTTGCCAAGCCGCGAGGTGGAGCTAATCTCACAAAACCGATCGTAGTCCGGATCGCAGTCTGCAACTCGACT
GCGTGAAGTCGGAATCGCTAGTAATCGCGAATCAGAATGTCGCGGTGAATACGTTCCCGGGCCTTGTACACACCG
CCCGTCACACCATGGGAGTGGGTTGCACCAGAAGTAGCTAGTCTAACCTTC 
Bacterial isolate FG17, 5151492, 894 bp  
GAGCTCGTAGGCGGTCTGTCGCGTCTGCTGTGAAAACCCGAGGCTCAACCTCGGGCCTGCAGTGGGTACGGGCA
GACTAGAGTGCGGTAGGGGAGATTGGAATTCCTGGTGTAGCGGTGGAATGCGCAGATATCAGGAGGAACACCGAT
GGCGAAGGCAGATCTCTGGGCCGTAACTGACGCTGAGGAGCGAAAGGGTGGGGAGCAAACAGGCTTAGATACCC
TGGTAGTCCACCCCGTAAACGTTGGGAACTAGTTGTGGGGTCCATTCCACGGATTCCGTGACGCAGCTAACGCATT
AAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGACCCGCACAAGCGGCGG
AGCATGCGGATTAATTCGATGCAACGCGAAGAACCTTACCAAGGCTTGACATATAGAGGAAACGTCTGGAAACAGT
CGCCCCGCAAGGTCTCTATACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG
CAACGAGCGCAACCCTCGTTCTATGTTGCCAGCACGTAATGGTGGGAACTCATGGGATACTGCCGGGGTCAACTC
GGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGTCTTGGGCTTCACGCATGCTACAATGGCCGGTAC
AAAGGGCTGCAATACCGTGAGGTGGAGCGAATCCCAAAAAGCCGGTCCCAGTTCGGATTGAGGTCTGCAACTCGA
CCTCATGAAGTCGGAGTCGCTAGTAATCGCAGATCAGCAACGCTGCGGTGAATACGTTCCCGGGTCTTGTACACAC
CGCCCGTCAAGTCATGAAAGTCGGTAACACCTGAAGCCGGTGGCCCAACCCTTGTGGAGGGAGCCGTC 
Bacterial isolate FG18, 5151492, 897 bp  
GCGCGCGTAGGCGGTTTCTTAAGTCTGATGTGAAAGCCCACGGCTCAACCGTGGAGGGTCATTGGAAACTGGGAG
ACTTGAGTGCAGAAGAGGAAAGTGGAATTCCATGTGTAGCGGTGAAATGCGCAGAGATATGGAGGAACACCAGTG
GCGAAGGCGACTTTCTGGTCTGTAACTGACGCTGATGTGCGAAAGCGTGGGGATCAAACAGGATTAGATACCCTG
GTAGTCCACGCCGTAAACGATGAGTGCTAAGTGTTAGGGGGTTTCCGCCCCTTAGTGCTGCAGCTAACGCATTAAG
CACTCCGCCTGGGGAGTACGACCGCAAGGTTGAAACTCAAAGGAATTGACGGGGACCCGCACAAGCGGTGGAGC
ATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAAATCTTGACATCCTTTGACCACTCTGGAGACAGAGCTTT
CCCCTTCGGGGGACAAAGTGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCC
GCAACGAGCGCAACCCTTAAGCTTAGTTGCCATCATTAAGTTGGGCACTCTAAGTTGACTGCCGGTGACAAACCGG
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AGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGATTTGGGCTACACACGTGCTACAATGGACAATACAA
AGGGCAGCTAAACCGCGAGGTCATGCAAATCCCATAAAGTTGTTCTCAGTTCGGATTGTAGTCTGCAACTCGACTA
CATGAAGCTGGAATCGCTAGTAATCGTAGATCAGCATGCTACGGTGAATACGTTCCCGGGTCTTGTACACACCGCC
CGTCACACCACGAGAGTTTGTAACACCCGAAGCCGGTGGAGTAACCATTATGGAGCTAGCCGTCGA 
Bacterial isolate FG19, 5151492, 919 bp  
GCGCGCGTAGGTGGTTTGCCAAGTTGAATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATCCAAAACTGGCAG
GCTAGAGTATGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGAAATGCGTAGATATAGGAAGGAACATCAGTGG
CGAAGGCGACCACCTGGACTGATACTGACACTGAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGG
TAGTCCACGCCGTAAACGATGTCAACTAGCCGTTGGGGTCCTTGAGACTTTAGTGGCGCAGCTAACGCATTAAGTT
GACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAGCGGTGGAGCAT
GTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTTGACATGCAGAGAACTTTCCAGAGATGGATTGGTG
CCTTCGGGAACTCTGACACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGTAA
CGAGCGCAACCCTTGTCCTTAGTTACCAGCACGTTAAGGTGGGCACTCTAAGGAGACTGCCGGTGACAAACCGGA
GGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCTGGGCTACACACGTGCTACAATGGTCGGTACAG
AGGGTTGCCAAGCCGCGAGGTGGAGCTAATCTCACAAAACCGATCGTAGTCCGGATCGCAGTCTGCAACTCGACT
GCGTGAAGTCGGAATCGCTAGTAATCGCGAATCAGAATGTCGCGGTGAATACGTTCCCGGGCCTTGTACACACCG
CCCGTCACACCATGGGAGTGGGTTGCACCAGAAGTAGCTAGTCTAACCTTCGGGAGGACGGTTACCACGGTGTGA
TTCATGACTGGGGTGA 
Bacterial isolate FG20, 5151492, 919 bp  
AAGCGCGCGTAGGTGGTTCGTTAAGTTGGATGTGAAAGCCCCGGGCTCAACCTGGGAACTGCATCCAAAACTGGC
GAGCTAGAGTACGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGAAATGCGTAGATATAGGAAGGAACACCAG
TGGCGAAGGCGACCACCTGGACTGATACTGACACTGAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCC
TGGTAGTCCACGCCGTAAACGATGTCAACTAGCCGTTGGAATCCTTGAGATTTTAGTGGCGCAGCTAACGCATTAA
GTTGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAGCGGTGGAG
CATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTTGACATGCAGAGAACTTTCCAGAGATGGATTG
GTGCCTTCGGGAACTCTGACACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCC
GTAACGAGCGCAACCCTTGTCCTTAGTTACCAGCACGTCATGGTGGGCACTCTAAGGAGACTGCCGGTGACAAACC
GGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCTGGGCTACACACGTGCTACAATGGTCGGTA
CAGAGGGTTGCCAAGCCGCGAGGTGGAGCTAATCTCACAAAACCGATCGTAGTCCGGATCGCAGTCTGCAACTCG
ACTGCGTGAAGTCGGAATCGCTAGTAATCGCGAATCAGAATGTCGCGGTGAATACGTTCCCGGGCCTTGTACACAC
CGCCCGTCACACCATGGGAGTGGGTTGCACCAGAAGTAGCTAGTCTAACCTTCGGGAGGACGGTTACCACGGTGT
GATTCATGACTGGGGT 
Bacterial isolate FG21, 5151492, 884 bp  
TTGGGCGTAAGAGCTCGTAGGCGGCTTGTCACGTCGGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCG
ATACGGGCTAGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGG
AACACCGGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGAT
TAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAG
CTAACGCATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCAC
AAGCAGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATATACCGGAAAGCATC
AGAGATGGTGCCCCCCTTGTGGTCGGTATACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGG
TTAAGTCCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCTTTCGGGGTGATGGGGACTCACAGGAG
ACTGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACG
TGCTACAATGGCCGGTACAATGAGCTGCGATGCCGTGAGGCGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGA
TTGGGGTCTGCAACTCGACCCCATGAAGTCGGAGTTGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTT
CCCGGGCCTTGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAGCCGG 
Tetraponera system  
Fungi 
Mutualistic fungus Chaetomonium F5, ITS1-FITS4, 538 bp 
TTACAGAGTTGCAAAACTCCCTAAACCATTGTGAACGTTACCCAAACCGTTGCTTCGGCGGGCGGCGCCCAGTGCG
CCCCCCGGCCCCTCGCGGGGCGCCCGCCGGAGGTACCCCAAACCATTGATACTTTATGGCCTCTCTGAGTCTTCT
GTACTGAATAAGTCAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAA
GTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCCAGTATTCTGGCGGGCAT
GCCTGTTCGAGCGTCATTTCAACCATCAAGCCCCCGGCTTGTGTTGGGGACCTGCGGCTGCCGCAGGCCCTGAAA
AGCAGTGGCGGGCTCGCTGTCACACCGAGCGTAGTAGATCTCATCTCGCTCCGGGCGTGCTGCGGGTTCCGGCC
GTTAAACCACCTTCATAACCCAAGGTTGACCTCGGATCAGGTAGGAAGACCCGCTGAACTTAAGCATATCAATAAGC
GGAGGAA  
Non-cultivar fungus F1, ITS1-FITS4, 546 bp 
ATTACCAGAGTGCCTTTTGGCTCTCCAACCCACTGTGAACATACCTACGTTTCCCTCGGCGGGCTCAGCGCGTTGC
GGTTCTGCCGCCTCGCGTCCGCCGGGGGCACCCAAACTCGAATTTATATCGTGTATCTCTGAGGGGCGAAAGCCC
GTAAAACAAATGAATCAAAACTTTCAACAACGGATCTCTTGGCTCTGGCATCGATGAAGAACGCAGCGAAATGCGAT
AAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCCGGCACTCCGGCGGG
CATGCCTGTCCGAGCGTCATTTCAACCCTCGGGCCCACCCCTCGCGGGGAACGGGCCCGGCGTTGGGGACCGGA
Supplementary Information A1
235
GGCCGCCCCGGCGGCACCCGCCCCCTAAATTCAGTGGCGGTCGCGCCGCAGCCTCCCCTGCGTAGTAGCACACC
TCGCACCGGAGAGCGGCACGGCCACGCCTCGAAACCCCCCAATTTTTCAGGTTGACCTCGGATCAGGTAGGAATA
CCCGCTGAACTTAAGCATA  
Non-cultivar fungus F2, ITS1-FITS4, 505 bp 
TTACCGAGTTTACAACTCCCAAACCCCTGTGAACATACCTATTGTTGCCTCGGCGGATCAGCCCGGCCCCGGTAAA
ACGGGACGGCCCGCCAGAGGACCCCTAAACTCTGTTTTTAGTGTAACTTCTGAGTAAAACAAACAAATAAATCAAAA
CTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCAAAATGCGATAAGTAATGTGAATTGCAGAA
TTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCCAGTATTCTGGCGGGCATGCCTGTTCGAGCGTCAT
TTCAACCCTCAAGCACAGCTTGGTGTTGGGATTCGTGAGGTAAACTCACGGTCCCCAAATTGATTGGCGGTCACGT
CGAGCTTCCATAGCGTAGTAATTACACCTCGTTACTGGTAATCGTCGCGGCCACGCCGTTAAACCCCAACTTCTGAA
TGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAGCATAT  
Non-cultivar fungus F3, ITS1-FITS4, 528 bp 
TTACACAAATATGAAGGCGGGCTGGAACCTCTCGGGGTTACAGCCTTGCTGAATTATTCACCCTTGTCTTTTGCGTA
CTTCTTGTTTCCTTGGTGGGTTCGCCCACCACTAGGACAAACATAAACCTTTTGTAATTGCAATCAGCGTCAGTAAC
AAATTAATAATTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGT
AGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCTTTGGTATTCCAAAGGGCATGC
CTGTTCGAGCGTCATTTGTACCCTCAAGCTTTGCTTGGTGTTGGGCGTCTTGTCTCTAGCTTTGCTGGAGACTCGCC
TTAAAGTAATTGGCAGCCGGCCTACTGGTTTCGGAGCGCAGCACAAGTCGCACTCTCTATCAGCAAAGGTCTAGCA
TCCATTAAGCCTTTTTTTCAACTTTTGACCTCGGATCAGGTAGGGATACCCGCTGAACTTAAGCATA  
Non-cultivar fungus F4, ITS1-FITS4, 552 bp 
TTACCGAGTGAGGGCCCTCTGGGTCCAACCTCCCACCCGTGTTGCACGAACCTGTGTTGCTTCGGCGGGCCCGCC
GCCTAGGCCGCCGGGGGGCATCCGCCCCCGGGCCCGCGCCCGCCGAAGCCCCCCTTCTGAACGCTGTCTGAAG
TTGCAGTCTGAGAAACTAGCTAAATTAGTTAAAACTTTCAACAACGGATCTCTTGGTTCCGGCATCGATGAAGAACG
CAGCGAAATGCGATAACTAATGTGAATTGCAGAATTCAGTGAATCATCGAGTCTTTGAACGCACATTGCGCCCTCTG
GTATTCCGGAGGGCATGCCTGTCCGAGCGTCATTGCTGCCCTCAAGCACGGCTTGTGTGTTGGGCCCCGTCCCCC
CCGCGCCGGGGGGACGGGCCCGAAAGGCAGCGGCGGCACCGCGTCCGGTCCTCGAGCGTATGGGGCTTCGTCA
CCCGCTCTTGTAGGCCCGGCCGGCGCCAGCCGACCCCCAACCTTTATATTTTCTCAGGTTGACCTCGGATCAGGTA
GGGATACCCGCTGAACTTAAGCATAT  
Non-cultivar fungus F6 (KY6), ITS1-FITS4, 485 bp 
TGTTGCTTCGGCGCTGCGTCCCGCGCCCCCTAGGGGGACGGACCCAGGCGCGCGCCGAGGACCCCAAACTCTTG
GTTTTATTTACGAAGTCTGAGTGGCCTTTTGGCAAACAAATGAATCAAAACTTTCAACAACGGATCTCTTGGTTCTGG
CATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGC
ACATTGCGCCCGCCAGTATTCTGGCGGGCATGCCTGTTCGAGCGTCATTTCAACCCTCAAGCCCCGGCTTGGTGTT
GGGGACCGATCGGCTAGATCCGATCGCCCCCGAAATCTAGTGGCGATCCCACCAGCGCGTCCTCTGCGTAGTAAT
ATACCCCGCTCTGGAACGTGGTGTGGTCATGCCGTTAAACCCCCTACTTTTTAAGGTTGACCTCGGATCAGGTAGG
AATACCCGCTGAACTTAAGCATATCAATA  
Bacteria 
Bacterial isolate KY1, 5151492, 847 bp
TAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGA
AATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAA
GCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCACTAGGTGTGGGCAACATT
CCACGTTGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAG
GAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCT
TGACATACACCGGAAACGTCTGGAGACAGGCGCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAG
CTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTGCCAGCAGGCCCTTGTG
GTGCTGGGGACTCACGGGAGACCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCC
TTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATACCGTGAGGTGGAGCGAATCTCAA
AAAGCCGGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTCGGAGTCGCTAGTAATCGCAGATCAG
CATTGCTGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAG
CCGGTGGCCCAACCCCTTGTGGG     
Bacterial isolate KY2, 5151492, 563 bp  
ACCCCGGGTCTGCATTCGATACGGGCAGGCTAGAGTTCGGCAGGGGAGATTGGAATTCCTGGTGTAGCGGTGAAA
TGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGC
GTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGCACTAGGTGTGGGCGGCATTCC
ACGTCGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGA
ATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTG
ACATACACCGGAAAACTCTGGAGACAGGGTCCCCCTTTGGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAGCT
CGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTATCCTGTGTTGCCAGCATGCCTTTCGGGGT
GATGGGGACTCACGGGAGACTGCCGGGGTCAACTCGGA   
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Bacterial isolate KY3, 5151492, 767 bp  
CGTAAGAGCTCGTAGGCGGTTTGTCGCGTCGGCCGTGAAAACCTGCCGCTTAACGGTGGGCGTGCGGTCGATACG
GGCAGACTTGAGTTCGGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACAC
CGGTGGCGAAGGCGGGTCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGAT
ACCCTGGTAGTCCACGCCGTAAACGGTGGGCGCTAGGTGTGGGGACTGTTTCCACGGTTCCTGTGCCGTAGCTAA
CGCATTAAGCGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAG
CGGCGGAGCATGTGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGGTTTGACATGCACAGGATCGCCCCTGA
GAGGGGGTTTCCCTTGTGGCCTGTGTGCAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTA
AGTCCCGCAACGAGCGCAACCCTTGTCCTGTGTTGCCAGCACGTGATGGTGGGGACTCGCAGGAGACTGCCGGG
GTCAACTCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGCCCCTTATGCCCAGGGCTTCACACATGCTACAATG
GCTGGTACAGAGGGTTGCGATACCGTGAGGTGGAGCGAATCCTTAAAGCCGGTCTCAGTTCGGATCGGGGTCTGC
AACTCGACCCCGTGAAGT    
Bacterial isolate KY4, 5151492, 811 bp  
TTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTG
AAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAA
AGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCACTAGGTGTGGGCAACAT
TCCACGTTGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAA
GGAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGG
CTTGACATACACCGGAAAGCATCAGAGATGGTGCCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTC
AGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTGCCAGCAGGCCCTTG
TGGTGCTGGGGACTCACGGGAGACCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCC
CCTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATACCGCAAGGTGGAGCGAATCTC
AAAAAGCCGGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTCGGAGTCGCTAGTAATCGCAGATCA
GCATTGCTGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACGTCACGAAAGTC    
Bacterial isolate KY5, 5151492, 837 bp
CTTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGT
GAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAA
AGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGAACTAGGTGTTGGCGACAT
TCCACGTCGTCGGTGCCGCAGCTAACGCATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAA
GGAATTGACGGGGGCCCGCACAAGCAGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGC
TTGACATATACCGGAAAGCATCAGAGATGGTGCCCCCCTTGTGGTCGGTATACAGGTGGTGCATGGCTGTCGTCAG
CTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCATGCCCTTCGGG
GTGATGGGGACTCACAGGAGACTGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCC
TTATGTCTTGGGCTGCACACGTGCTACAATGGCAGGTACAATGAGCTGCGAAGCCGCGAGGCGGAGCGAATCTCA
AAAAGCCTGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTCGGAGTTGCTAGTAATCGCAGATCAG
CATTGCTGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAG
CCGGTGGCCC     
Bacterial isolate KY7, 5151492, 690 bp  
TTGGGCGTAAGAGCTCGTAGGCGGTTTGTCGCGTCGGCCGTGAAAACCTGCCGCTTAACGGTGGGCGTGCGGTC
GATACGGGCAGACTTGAGTTCGGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAG
GAACACCGGTGGCGAAGGCGGGTCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGG
ATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCGCTAGGTGTGGGGACTGTTTCCACGGTTCCTGTGCCG
TAGCTAACGCATTAAGCGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCG
CACAAGCGGCGGAGCATGTGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGGTTTGACATGCACAGGATCGC
CCCTGAGAGGGGGTTTCCCTTGTGGCCTGTGTGCAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTT
GGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCTGTGTTGCCAGCACGTGATGGTGGGGACTCGCAGGAGACTG
CCGGGGTCAACTCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGCCCCTTATGCCCAGGGCTTCACACATGCT
ACAATGGCTGGTACAGA    
Bacterial isolate KY8, 5151492, 445 bp  
CCCCGGGTGTGCAGTGGGTACGGGCAGACTTGAGTGCAGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAAT
GCGCAGATATCAGGAGGAACACCGATGGCGAAGGCAGGTCTCTGGGCTGTTACTGACGCTGAGGAGCGAAAGCAT
GGGGAGCGAACAGGATTAGATACCCTGGTAGTCCATGCCGTAAACGTTGGGCACTAGGTGTGGGGAACATTCCAC
GTTTTCCGCGCCGTAGCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAAT
TGACGGGGGCCCGCACAAGCGGCGGAGCATGCGGATTAATTCGATGCAACGCGAAGAACCTTACCAAGGCTTGAC
ATACACCGGACCGGGCCAGAGATGGTCTTTCCCCCTTGTGGGGCTGGTGTACAGGTGGTGCATGGTTGTC  
Bacterial isolate KY9, 5151492, 584 bp  
GGGAACTGCATTTGAAACTGGCAAGCTAGAGTCTCGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCG
TAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACGAAGACTGACGCTCAGGTGCGAAAGCGTGG
GGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCTGTAAACGATGTCGATTTGGAGGTTGTGCCCTTGAGGCGT
GGCTTCCGGAGCTAACGCGTTAAATCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACG
GGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTACTCTTGACATCCAG
AGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACTCTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTG
TGAAATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGGTTCGGCCGGGAACTCAAAG
GAGACTGCCAGTGATAAACTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCC    
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Bacterial isolate KY10, 5151492, 719 bp
AAGGGTCCGTAGGCGGATGTGTAAGTCAGTGGTGAAATCTCACAGCTTAACTGTGAAACTGCCATTGATACTGCAT
GTCTTGAGTAAGGTAGAAGTGGCTGGAATAAGTAGTGTAGCGGTGAAATGCATAGATATTACTTAGAACACCAATTG
CGAAGGCAGGTCACTATGTCTTAACTGACGCTGATGGACGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGG
TAGTCCACGCTGTAAACGATGCTTACTCGTTTTTGGGGCTTTTGCTTCAGAGACTAAGCGAAAGTGATAAGTAAGCC
ACCTGGGGAGTACGAACGCAAGTTTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGATTATGTGGT
TTAATTCGATGATACGCGAGGAACCTTACCAAGGCTTAAATGGGAATTGATCGGTTTAGAAATAGACCTTCCTTCGG
GCAATTTTCAAGGTGCTGCATGGTTGTCGTCAGCTCGTGCCGTGAGGTGTTAGGTTAAGTCCTGCAACGAGCGCAA
CCCCTGTCACTAGTTGCCATCATTCAGTTGGGGACTCTAGTGAGACTGCCTACGCAAGTAGAGAGGAAGGTGGGG
ATGACGTCAAATCATCACGGCCCTTACGCCTTGGGCCACACACGTAATACAATGGCCGGTACAGAGGGCAGCTACA
CAGCGATGTGATGCAAATCTCGAAAGCCGGTCTCA     
Bacterial isolate KY11, 5151492, 711 bp 
CAACCGTGGAGGGTCATTGGAAACTGGGAAACTTGAGTGCAGAAGAGGAAAGTGGAATTCCATGTGTAGCGGTGA
AATGCGCAGAGATATGGAGGAACACCAGTGGCGAAGGCGACTTTCTGGTCTGTAACTGACGCTGATGTGCGAAAG
CGTGGGGATCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGAGTGCTAAGTGTTAGGGGGTTTCC
GCCCCTTAGTGCTGCAGCTAACGCATTAAGCACTCCGCCTGGGGAGTACGACCGCAAGGTTGAAACTCAAAGGAAT
TGACGGGGACCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAAATCTTGACA
TCCTTTGAAAACTCTAGAGATAGAGCCTTCCCCTTCGGGGGACAAAGTGACAGGTGGTGCATGGTTGTCGTCAGCT
CGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTAAGCTTAGTTGCCATCATTAAGTTGGGCAC
TCTAGGTTGACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGATTTGGGC
TACACACGTGCTACAATGGACAATACAAAGGGCAGCTAAACCGCGAGGTCATGCAAATCCCATAAAGTTGTTCTCA
GTTCGGATTGTAGTCTGCAACTCGACTAC    
Bacterial isolate KY12, 5151492, 796 bp 
CTGGGCGTAAGCGCGCGTAGGTGGTTTGTTAAGTTGGATGTGAAAGCCCCGGGCTCAACCTGGGAACTGCATCCA
AAACTGGCAAGCTAGAGTACGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGAAATGCGTAGATATAGGAAGGA
ACACCAGTGGCGAAGGCGACCACCTGGACTGATACTGACACTGAGGTGCGAAAGCGTGGGGAGCAAACAGGATTA
GATACCCTGGTAGTCCACGCCGTAAACGATGTCAACTAGCCGTTGGAATCCTTGAGATTTTAGTGGCGCAGCTAAC
GCATTAAGTTGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAGCG
GTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTTGACATGCAGAGAACTTTCCAGAGAT
GGATTGGTGCCTTCGGGAACTCTGACACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAA
GTCCCGTAACGAGCGCAACCCTTGTCCTTAGTTACCAGCACGTTATGGTGGGCACTCTAAGGAGACTGCCGGTGAC
AAACCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCTGGGCTACACACGTGCTACAATGGT
CGGTACAGAGGGTTGCCAAGCCGCGAGGTGGAGCTAATCTCACAAAACCGATCGTAGTCCGGATCGCAGTCTGCA
ACTCGACTGCGTGAAGTCGGAATCGCTAGTAATCGCGAATC    
Bacterial isolate KY13, 5151492, 628 bp 
GGACTGCGCTTGATACTGGGTTGCTTGAGGATGGAAGAGGCTCGTGGAATTCCCAGTGTAGAGGTGAAATTCGTAG
ATATTGGGAAGAACACCGGTGGCGAAGGCGGCGAGCTGGTCCATTACTGACGCTGAGGCGCGACAGCGTGGGGA
GCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGTGCGCTGGATGTTGGGGCCCATAGGGTCTCA
GTGTCGTAGCCAACGCGGTAAGCGCACCGCCTGGGGAGTACGGCCGCAAGGTTGAAACTCAAAGGAATTGACGG
GGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGCAGAACCTTACCAGCCCTTGACATGGTC
ACGACCGGTCCAGAGATGGACTTTCCTAGCAATAGGCGTGATGCACAGGTGCTGCATGGCTGTCGTCAGCTCGTG
TCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTCGCCTCTAGTTGCCAGCATGTTCGGGTGGGCACT
CTAGAGGAACTGCCGGTGACAAGCCGGAGGAAGGTGGGGATGACGTCAAGTCCTCATGGCCCTTATGGGCTGGG
CTACACACGTGCTACAATGGCGGTGACAGA    
Bacterial isolate KY14, 5151492, 652 bp 
AACCGTGGAGGGTCATTGGAAACTGGGGAACTTGAGTGCAGAAGAGGAAAGTGGAATTCCAAGTGTAGCGGTGAA
ATGCGTAGAGATTTGGAGGAACACCAGTGGCGAAGGCGACTTTCTGGTCTGTAACTGACACTGAGGCGCGAAAGC
GTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGAGTGCTAAGTGTTAGAGGGTTTCCG
CCCTTTAGTGCTGCAGCTAACGCATTAAGCACTCCGCCTGGGGAGTACGGCCGCAAGGCTGAAACTCAAAGGAATT
GACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGTCTTGACA
TCCTCTGACAACCCTAGAGATAGGGCTTTCCCCTTCGGGGGACAGAGTGACAGGTGGTGCATGGTTGTCGTCAGC
TCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGATCTTAGTTGCCAGCATTCAGTTGGGCA
CTCTAAGGTGACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGACCTGG
GCTACACACGTGCTACAATGGATGGTACAAAGGGCTGCAAACCTGCGAA    
Bacterial isolate KY15, 5151492, 735 bp 
CTGGGCGTAAGCGCACGCAGGCGGTTTGTTAAGTCAGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATTTG
AAACTGGCAAGCTAGAGTCTCGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCGTAGAGATCTGGAGG
AATACCGGTGGCGAAGGCGGCCCCCTGGACGAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGAT
TAGATACCCTGGTAGTCCACGCTGTAAACGATGTCGATTTGGAGGTTGTGCCCTTGAGGCGTGGCTTCCGGAGCTA
ACGCGTTAAATCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAG
CGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTACTCTTGACATCCAGAGAACTTTCCAGAGA
TGGATTGGTGCCTTCGGGAACTCTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGTGAAATGTTGGGTTA
AGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGGTTCGGCCGGGAACTCAAAGGAGACTGCCAGTGA
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TAAACTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGAGTAGGGCTACACACGTGCTACAATGG
CGTATACAAAGAGAAGCGACCTCGCGAGAGCAAGCGGACCTCATAAAGTACGTCGTA    
Bacterial isolate KY16, 5151492, 773 bp 
CTGGGCGTAAGAGCTCGTAGGCGGTTTGTCGCGTCGTCTGTGAAATTCTGCAACTCAATTGCAGGCGTGCAGGCG
ATACGGGCAGACTTGAGTACTACAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGG
AACACCGGTGGCGAAGGCGGGTCTCTGGGTAGTAACTGACGCTGAGGAGCGAAAGCGTGGGTAGCGAACAGGAT
TAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGTACTAGGTGTGGGTTCCTTTTCACGGGATCCGTGCCGTAGC
TAACGCATTAAGTACCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACA
AGCGGCGGAGCATGTGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGGTTTGACATACACCAGACGCGGCTA
GAGATAGTCGTTCCCTTGTGGTTGGTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTT
AAGTCCCGCAACGAGCGCAACCCTTGTCCTGTATTGCCAGCGGGTTATGCCGGGGACTTGCAGGAGACTGCCGGG
GTCAACTCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGCCCCTTATGTCCAGGGCTTCACACATGCTACAATG
GCTGGTACAGAGGGCTGCGATACCGTGAGGTGGAGCGAATCCCTTAAAGCCAGTCTCAGTTCGGATTGGGGTCTG
CAACTCGACCCCATGAAGTC    
Bacterial isolate KY17, 5151492, 886 bp 
TTGGGCGTAAGCGCGCGTAGGCGGTTTCTTAAGTCTGATGTGAAAGCCCACGGCTCAACCGTGGAGGGTCATTGG
AAACTGGGAAACTTGAGTGCAGAAGAGGAAAGTGGAATTCCATGTGTAGCGGTGAAATGCGCAGAGATATGGAGG
AACACCAGTGGCGAAGGCGACTTTCTGGTCTGTAACTGACGCTGATGTGCGAAAGCGTGGGGATCAAACAGGATTA
GATACCCTGGTAGTCCACGCCGTAAACGATGAGTGCTAAGTGTTAGGGGGTTTCCGCCCCTTAGTGCTGCAGCTAA
CGCATTAAGCACTCCGCCTGGGGAGTACGACCGCAAGGTTGAAACTCAAAGGAATTGACGGGGACCCGCACAAGC
GGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAAATCTTGACATCCTTTGAAAACTCTAGAGAT
AGAGCCTTCCCCTTCGGGGGACAAAGTGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGT
TAAGTCCCGCAACGAGCGCAACCCTTAAGCTTAGTTGCCATCATTAAGTTGGGCACTCTAGGTTGACTGCCGGTGA
CAAACCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGATTTGGGCTACACACGTGCTACAATGGA
CAATACAAAGGGCAGCTAAACCGCGAGGTCATGCAAATCCCATAAAGTTGTTCTCAGTTCGGATTGTAGTCTGCAAC
TCGACTACATGAAGCTGGAATCGCTAGTAATCGTAGATCAGCATGCTACGGTGAATACGTTCCCGGGTCTTGTACA
CACCGCCCGTCACACCACGAGAGTTTGTAACACCCGAAGCCGGTGGAGTAAC    
Bacterial isolate KY18, 5151492, 827 bp 
TTGGGCGTAAGAGCTCGTAGGCGGTTTGTCGCGTCTGCCGTGAAAGTCCGGGGCTCAACTCCGGATCTGCGGTGG
GTACGGGCAGACTAGAGTGATGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGG
AACACCGATGGCGAAGGCAGGTCTCTGGGCATTAACTGACGCTGAGGAGCGAAAGCATGGGGAGCGAACAGGATT
AGATACCCTGGTAGTCCATGCCGTAAACGTTGGGCACTAGGTGTGGGGGACATTCCACGTTTTCCGCGCCGTAGCT
AACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAA
GCGGCGGAGCATGCGGATTAATTCGATGCAACGCGAAGAACCTTACCAAGGCTTGACATGGACCGGATCGCCGCA
GAAATGTGGTTTCTCCTTTGGGGCCGGTTCACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGG
TTAAGTCCCGCAACGAGCGCAACCCTCGTTCCATGTTGCCAGCACGTAGTGGTGGGGACTCATGGGAGACTGCCG
GGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAATCATCATGCCCCTTATGTCTTGGGCTTCACGCATGCTACAA
TGGCCGGTACAAAGGGTTGCGATACTGTGAGGTGGAGCTAATCCCAAAAAGCCGGTCTCAGTTCGGATTGGGGTC
TGCAACTCGACCCCATGAAGTCGGAGTCGCTAGTAATCGCAGATCAGCAACGCTGCGGTGAATACGTTCCCGGG
Bacterial isolate KY19, 5151492, 631 bp 
CTGGGAACTGCAGTGGATACTGGGCGACTAGAATGTGGTAGAGGGTAGCGGAATTCCTGGTGTAGCAGTGAAATG
CGTAGAGATCAGGAGGAACATCCATGGCGAAGGCAGCTACCTGGACCAACATTGACACTGAGGCACGAAAGCGTG
GGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCCTAAACGATGCGAACTGGATGTTGGGTGCAATTTGGCA
CGCAGTATCGAAGCTAACGCGTTAAGTTCGCCGCCTGGGGAGTACGGTCGCAAGACTGAAACTCAAAGGAATTGA
CGGGGGCCCGCACAAGCGGTGGAGTATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGCCTTGACATG
TCGAGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACTCGAACACAGGTGCTGCATGGCTGTCGTCAGCTCGTG
TCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCTTAGTTGCCAGCACGTAATGGTGGGAACTC
TAAGGAGACCGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCAGGGC
TACACACGTACTACAATGGTAGGGACAGA    
Bacterial isolate KY20, 5151492, 689 bp 
AACCTCGGGCCTGCAGTGGGTACGGGCAGACTAGAGTGCGGTAGGGGAGATTGGAATTCCTGGTGTAGCGGTGG
AATGCGCAGATATCAGGAGGAACACCGATGGCGAAGGCAGATCTCTGGGCCGTAACTGACGCTGAGGAGCGAAAG
GGTGGGGAGCAAACAGGCTTAGATACCCTGGTAGTCCACCCCGTAAACGTTGGGAACTAGTTGTGGGGTCCATTC
CACGGATTCCGTGACGCAGCTAACGCATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGG
AATTGACGGGGACCCGCACAAGCGGCGGAGCATGCGGATTAATTCGATGCAACGCGAAGAACCTTACCAAGGCTT
GACATATAGAGGAAACGTCTGGAAACAGTCGCCCCGCAAGGTCTCTATACAGGTGGTGCATGGTTGTCGTCAGCTC
GTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTCGTTCTATGTTGCCAGCACGTAATGGTGGGAA
CTCATGGGATACTGCCGGGGTCAACTCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGTCTTGG
GCTTCACGCATGCTACAATGGCCGGTACAAAGGGCTGCAATACCGTGAGGTGGAGCGAATCCCAAAAAGCCGGTC
CCAGTTCGGATTG    
Bacterial isolate KY21, 5151492, 772 bp 
TTGGGCGTAAGAGCTCGTAGGCGGTTTGTCGCGTCGGCCGTGAAAACCTGCCGCTTAACGGTGGGCGTGCGGTC
GATACGGGCAGACTTGAGTTCGGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAG
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GAACACCGGTGGCGAAGGCGGGTCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGG
ATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCGCTAGGTGTGGGGACTGTTTCCACGGTTCCTGTGCCG
TAGCTAACGCATTAAGCGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCG
CACAAGCGGCGGAGCATGTGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGGTTTGACATGCACAGGATCGC
CCCTGAGAGGGGGTTTCCCTTGTGGCCTGTGTGCAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTT
GGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCTGTGTTGCCAGCACGTGATGGTGGGGACTCGCAGGAGACTG
CCGGGGTCAACTCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGCCCCTTATGCCCAGGGCTTCACACATGCT
ACAATGGCTGGTACAGAGGGTGGCGATACCGTGAGGTGGAGCGAATCCTTAAAGCCGGTCTCAGTTCGGATCGGG
GTCTGCAACTCGACCCCGTGAAGT  
Reference strains  
Bacteria 
Reference strain Streptomyces lividans, 5151492, 812 bp  
TTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTG
AAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAA
AGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCACTAGGTGTGGGCAACAT
TCCACGTTGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAA
GGAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGG
CTTGACATACACCGGAAAGCATCAGAGATGGTGCCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTC
AGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTGCCAGCAAGCCCTTC
GGGGTGTTGGGGACTCACGGGAGACCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGC
CCCTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATACCGCAAGGTGGAGCGAATCT
CAAAAAGCCGGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTCGGAGTCGCTAGTAATCGCAGATC
AGCATTGCTGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACGTCACGAAAGTC 
Reference strain Salmonella enterica, 5151492, 865 bp  
GAACTGCATTCGAAACTGGCAGGCTTGAGTCTTGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCGTA
GAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACAAAGACTGACGCTCAGGTGCGAAAGCGTGGGG
AGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGTCTACTTGGAGGTTGTGCCCTTGAGGCGTGG
CTTCCGGAGCTAACGCGTTAAGTAGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGG
GGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGTCTTGACATCCACAG
AAGAATCCAGAGATGGATTTGTGCCTTCGGGAACTGTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGTG
AAATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGATTAGGTCGGGAACTCAAAGGA
GACTGCCAGTGATAAACTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGACCAGGGCTACACAC
GTGCTACAATGGCGCATACAAAGAGAAGCGACCTCGCGAGAGCAAGCGGACCTCATAAAGTGCGTCGTAGTCCGG
ATTGGAGTCTGCAACTCGACTCCATGAAGTCGGAATCGCTAGTAATCGTGGATCAGAATGCCACGGTGAATACGTT
CCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTGGGTTGCAAAAGAAGTAGGTAGCTTAACCTTCGGGA
GGGCGCTTACCACTTTGTGATTCATGACTGGGGTGA 
Reference strain Escherichia coli, 5151492, 813 bp 
GGGAACTGCATCTGATACTGGCAAGCTTGAGTCTCGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCG
TAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACGAAGACTGACGCTCAGGTGCGAAAGCGTGG
GGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGTCGACTTGGAGGTTGTGCCCTTGAGGCG
TGGCTTCCGGAGCTAACGCGTTAAGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGAC
GGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGTCTTGACATCC
ACGGAAGTTTTCAGAGATGAGAATGTGCCTTCGGGAACCGTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTG
TTGTGAAATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGGTCCGGCCGGGAACTCA
AAGGAGACTGCCAGTGATAAACTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGACCAGGGCTA
CACACGTGCTACAATGGCGCATACAAAGAGAAGCGACCTCGCGAGAGCAAGCGGACCTCATAAAGTGCGTCGTAG
TCCGGATTGGAGTCTGCAACTCGACTCCATGAAGTCGGAATCGCTAGTAATCGTGGATCAGAATGCCACGGTGAAT
ACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTGGGTTGCAAAAGAAGTAG 
Reference strain Bacillus subtilis, 5151492, 826 bp  
GGGTCATTGGAAACTGGGGAACTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGTGAAATGCGTAGA
GATGTGGAGGAACACCAGTGGCGAAGGCGACTCTCTGGTCTGTAACTGACGCTGAGGAGCGAAAGCGTGGGGAG
CGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGAGTGCTAAGTGTTAGGGGGTTTCCGCCCCTTAG
TGCTGCAGCTAACGCATTAAGCACTCCGCCTGGGGAGTACGGTCGCAAGACTGAAACTCAAAGGAATTGACGGGG
GCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGTCTTGACATCCTCTGA
CAATCCTAGAGATAGGACGTCCCCTTCGGGGGCAGAGTGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTG
AGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGATCTTAGTTGCCAGCATTCAGTTGGGCACTCTAAGGTG
ACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACG
TGCTACAATGGACAGAACAAAGGGCAGCGAAACCGCGAGGTTAAGCCAATCCCACAAATCTGTTCTCAGTTCGGAT
CGCAGTCTGCAACTCGACTGCGTGAAGCTGGAATCGCTAGTAATCGCGGATCAGCATGCCGCGGTGAATACGTTC
CCGGGCCTTGTACACACCGCCCGTCACACCACGAGAGTTTGTAACACCCGAAGTCGGTGAGGTAACCTTTTAG 
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Supplementary Information A2) Candicidin gene sequences 
Partial sequences of two bacterial candicidin biosynthesis genes fscM and fscP. 
The sequencing data, generated with the gene-specific forward primers, are 
categorised by ant-system (Acromyrmex and Tetraponera). The title of each 
sequence describes the name of the strain, the PCR primer set used, and the 
length of the sequence. 
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Candicidin biosynthesis gene fscM
Acromyrmex  
Bacterial isolate E8, fscM FR, 898 bp     
AGGTGTACCGCGAGGTCACCCAGTCCTCCCGCTTCAAGGCCCACCGCGCGGTCGTCCGGCAGTCCTACCGGCCC
GCGCTCCAGGCGCGCAAGTACCGCGAGCTGGAGCAGGTCGTCGACGAGGTCCGGCCGGCGCTGATGGTCGTCG
ACTGCGTCGCGGGCTTCGGCGTCGACCTGGCCCTGGCCCGGGGCATCCCGTACGTGCTGAACGTGCCGTTCGTC
GCCAGCAACGTGCTGACCTCGCACAACCCGTTCGGCGCCTCGTACACCCCCAAGAGCTTCCCGGTGCCCAACTCG
GGGCTGCCCGCGCGGATGTCGGTGCGGCAGAAGCTGGCCAACACGCTGTTCAAGTGGCGGACGCTCGGCATGTT
CCTGCACCCGGACATGGCGGCACTGCTGCGCGAGGACGCCGCGATACGCAAGGAGCTGGGCATCGCCCCGCCG
AACGCCATGACCCGGGTCGACGAGGCCGCCGCCGTGGTGTGCTCCTCCGTCGCGGAACTGGACTACCCCTTCGA
CATCCCGGACCGGGTGAGCCTGGTGGGCGCCGTGCTGCCGCCGCTGCCCGAGGCACCGGACGACGACGAGGTC
ACCAGGTGGCTCGACGCGCAGTCGTCGGTGGTCTACATGGGCTTCGGCACCATCACCCGCCTCACCCGCGAGGA
GGTCGCGGCGCTGGTGGAGGTGGCCCGGCGGATGTCCGGCACCCACCAGTTCCTGTGGAAGCTGCCCAAGGAG
CAGCAGCACCTGCTGCCCGAGGCCGGGTCGCTGCCGGACAACCTGCGGGTGGAGAGCTGGGTGCCCTCGCAGC
TCGACGTGCTGGCCCACCCGAACGTCTCCGTCTTCTTCTCGCACGGCGGCGGCAACGCCTACCACGAGGGCGTCT
ACTTCGGTAAGCC 
Bacterial isolate E9, fscM FR, 901 bp     
GCGGTGTACCGCGAGGTCACCCAGTCCTCCCGCTTCAAGGCCCACCGCGCGGTCGTCCGGCAGTCCTACCGGCC
CGCGCTCCAGGCGCGCAAGTACCGCGAGCTGGAGCAGGTCGTCGACGAGGTCCGGCCGGCGCTGATGGTCGTC
GACTGCGTCGCGGGCTTCGGCGTCGACCTGGCCCTGGCCCGGGGCATCCCGTACGTGCTGAACGTGCCGTTCGT
CGCCAGCAACGTCCTGACCTCGCACAACCCGTTCGGCGCCTCGTACACCCCCAAGAGCTTCCCGGTGCCCAACTC
GGGGCTGCCCGCGCGGATGTCGGTGCGGCAGAAGCTGGCCAACACGCTGTTCAAGTGGCGGACGCTCGGCATGT
TCCTGCACCCGGACATGGCGGCACTGCTGCGCGAGGACGCCGCGATACGCAAGGAGCTGGGCATCGCCCCGCC
GAACGCCATGACCCGGGTCGACGAGGCCGCCGCCGTGGTGTGCTCCTCCGTCGCGGAACTGGACTACCCCTTCG
ACATCCCGGACCGGGTGAGCCTGGTGGGCGCCGTGCTGCCGCCGCTGCCCGAGGCACCGGACGACGACGAGGT
CACCAGGTGGCTCGACGCGCAGTCGTCGGTGGTCTACATGGGCTTCGGCACCATCACGCGCCTCACCCGCGAGG
AGGTCGCGGCGCTGGTGGAGGTGGCCCGGCGGATGTCCGGCACCCACCAGTTCCTGTGGAAGCTGCCCAAGGAG
CAGCAGCACCTGCTGCCCGAGGCCGGGTCGCTGCCGGACAACCTGCGGGTGGAGAGCTGGGTGCCCTCGCAGC
TCGACGTGCTGGCCCACCCGAACGTCTCCGTCTTCTTCTCGCACGGCGGCGGCAACGCCTACCACGAGGGCGTCT
ACTTCGGTAAGCCGC 
Bacterial isolate E11, fscM FR, 737 bp      
GCACGGGGCGGTTGCGTCTCATGCCCGTATTGTCGCACCTCCGGGGGGTGGGAGCCAAAAGGCGGGTGGCCGC
GGGCGTGCGCGGGGTTCCAGGGTCAAGGCCTTGACCATCGCCGGTTCGGGCCCGATGCGCGATCGAGATGCCG
GTGCTCTTGGAAATGCGGATCGGCCCGTGTTAATCGGGGTCGCCGCTGGTCGCCGGGTTTCTCCTTCCAGGGGAA
ATGCGTATTTGATTCCCGTCGCCCGGAGTGTGAGGATGTCCCGTGCCCTGCCAGCGGAAAGGCCGGGTGAACTGG
TCGGACCGGGGGCTGGACCGCCGGACGGCCCCGCAAGCGTGAGGATGAGGCCTGGTGTCGTTTCTCGACAGGG
AGAAGAGCGTCGCCCCACCGGGGTACAGCCGCTGGTTCGTGCCGCCCGCGGCTCTCGCGGTGCACTTGTCCATC
GGCCAGGTGTACGCGTTCAGTGTGTTCAAGGCGCCGTTGGTGGAGCGTTTCGATTCGTCGTTGACGGCGATCGGC
GTGGTGTTCAGCATCGCCATTGTCATGCTGGGGCTGTCGGCCGCCTTCGGCGGCAAGTGGGTGGAGGCCAACGG
GCCGCGCAAGGCCATGTTCGTGTCGGGCCTGTGCTGGACGACCGGGTTCGCGGTGGGCTCGCTGGGCGTGGCC
ACCGGGCAGCTGTGGCTGCTGTACCTGGGGTACGGGGTCATCGGCGGCATCAGCCTGACCCTGGACAAGCCG 
Tetraponera 
Bacterial isolate KY1, fscM FR, 844 bp      
TCCTACCGGCCCGCGCTCCAGGCGCGCAAGTACCGCGAGCTGGAGCAGGTCGTCGACGAGGTCCGGCCGGCGC
TGATGGTCGTCGACTGCGTCGCGGGCTTCGGCGTCGACCTGGCCCTGGCCCGGGGCATCCCGTACGTGCTGAAC
GTGCCGTTCGTCGCCAGCAACGTCCTGACCTCGCACAACCCGTTCGGCGCCTCGTACACCCCCAAGAGCTTCCCG
GTGCCCAACTCGGGGCTGCCCGCGCGGATGTCGGTGCGGCAGAAGCTGGCCAACACGCTGTTCAAGTGGCGGAC
GCTCGGCATGTTCCTGCACCCGGACATGGCGGCACTGCTGCGCGAGGACGCCGCGATACGCAAGGAGCTGGGCA
TCGCCCCGCCGAACGCCATGACCCGGGTCGACGAGGCCGCCGCCGTGGTCTGCTCCTCCGTCGCGGAACTGGAC
TACCCCTTCGACATCCCGGACCGGGTGAGCCTGGTGGGCGCCGTGCTGCCGCCGCTGCCCGAGGCACCGGACGA
CGACGAGGTCACCAGGTGGCTCGACGCGCAGTCGTCGGTGGTCTACATGGGCTTCGGCACCATCACCCGCCTCA
CCCGCGAGGAGGTCGCGGCGCTGGTGGAGGTGGCCCGGCGGATGTCCGGCACCCACCAGTTCCTGTGGAAGCT
GCCCAAGGAGCAGCAGCACCTGCTGCCCGAGGCCGGGTCGCTGCCGGACAACCTGCGGGTGGAGAGCTGGGTG
CCCTCGCAGCTCGACGTGCTGGCCCATCCGAACGTCTCCGTCTTCTTCTCGCACGGCGGCGGCAACGCCTACCAC
GAGGGCGTCTACTTCGGTAAGCCGCAGGTCG 
Bacterial isolate KY5, fscM FR, 777 bp      
CCGGGCCGGGGCTTCCTGCCCGCGCCCGGCACCGTCACCGCCTTCGCGCCGCCCTCGGGCCCCGGTGTCCGCC
TGGACGCGGGCGTGGAGTCGGGCTCGGTCATCGGCCCGGCCTGGGACTCGCTCCTGGCCAAGCTGATCGTGACC
GGTGCGACGCGCGAGCAGGCGCTGCAGCGTGCGGCGCGCGCCCTGGACGAGTTCACCGTCGAGGGCATGGCCA
CCGCCATCCCCTTCCACCGCGCAGTGGTCAGGGACCCGGCTTTCGCGCCCGAACTGACCGGCTCCAGCGGCCCG
TTCACCATCTTCACGCGGTGGATCGAGACCGAGTTCGTCAACGAGATCCCGGCCTTCGCCGCGCCCGCGGCGGAC
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GCGGAGACCGATGAGGAGCCGGGCCGCGAGACGGTCGTCGTCGAGGTCGGCGGCAAGCGCCTGGAAGTCTCCC
TGCCGTCCTCCCTCGGCATGACGATCGCGCGGACCGCGGCGGCGGGCGGCGCCCGCCCCAAGCGGCGCGCGG
CCAAGAAGTCCGGCCCCGCCGCCTCCGGCGACACCCTCGCCTCGCCCATGCAGGGCACGATCGTCAAGGTCGCG
GTCGAGGAGGGCCAGGAGGTCAACGAGGGCGACCTGATCGTGGTCCTCGAAGCGATGAAGATGGAACAGCCCCT
CAACGCCCACCGGTCGGGCACGATCAAGGGCCTCACGGCGGAGGTGGGCGCGAGCCTGACCTCCGGTGCGGTC
ATCTGTGAGATCAAGGACTGACTCGGCGACGGGGTTCCCCGG 
Candicidin biosynthesis gene fscP
Acromyrmex  
Bacterial isolate E8, fscP FR, 887 bp      
GGCGCTCGGCGCGCTCCGGGTTGAAGGCGTGCGGGCAGCCGAACGCCTCGGTGTCGTGGTTGGCGGAGGCGAG
CAGCGGCACGATGCCCTCGCCCTTGCGGATGGTCTGGCCGGCGATCTCCACGTCGTCCACGGCGACGCGCAGCG
CCACCATGTCGGCCACCGAGTGCAGGCGCAGCAGCTCCTCCACGAGCCGGTCGTCGCCGATCCACTCCCGGTGC
GAGAGCAGCGTGACGACGCCGAGCCCGATGTTGTTCGCCGTGGTCTCGTGGCCCGCGATCAGCAGGAGCAGCAG
GACACCCGACAGCTCCTCGTCCGAGAGCTTGCCGGTCGACAGCAGGCGGCTGATGAGGTCCTCGCCGCGCCACT
TCTTCTTGATGACGATGAGCCGGTTGATGTACCGCAGGAGCTGCCGGGTGGCCTCGGCGCGCTCCTCGTCGGTCG
AGGTGCGGATGGCGACCAGCGTGCGGGTGCGGGACTCGAAGAAGTCCCGGTCCGCCGACGGCACGCCCAGCAG
CGCGGAGATGACCAGGGACGGCACGGGCAGCGCGAAGTCGTTCACCAGGTCCGCGGTGTTCCCGCCGGCCAGC
ATCGCGTCGATCCGCTCGTCCACGGTCCGTTCGATCGCCGGCCGCAGCTCACGGACGCGGCGCACGGTGAACTC
GGGGATCAGCACCTTGCGGAAACGGTCGTGCTCGGGGGAGTCCAGACCGACGAACCAGCCGGGGATCTGCTCCT
GCTTGGGCACCCCCATCGTCTCGCCGACGTTGGGGAAGCCCTCGTTGCCGGGGTTGGCGCTGATCCGGGGATGG
GTGAGGACCGCGCGCACGTCCTCGTGCCGGGTCACCAGCCAGATCGGCCGGCCGTTCGGCAGGTGCGTCTGGAC
C 
Bacterial isolate E9, fscP FR, 887 bp      
GGCGCTCGGCGCGCTCCGGGTTGAAGGCGTGCGGGCAGCCGAACGCCTCGGTGTCGTGGTTGGCGGAGGCGAG
CAGCGGCACGATGCCCTCGCCCTTGCGGATGGTCTGGCCGGCGATCTCCACGTCGTCCACGGCGACGCGCAGCG
CCACCATGTCGGCCACCGAGTGCAGGCGCAGCAGCTCCTCCACGAGCCGGTCGTCGCCGATCCACTCCCGGTGC
GAGAGCAGCGTGACGACGCCGAGCCCGATGTTGTTCGCCGTGGTCTCGTGGCCCGCGATCAGCAGGAGCAGCAG
GACACCCGACAGCTCCTCGTCCGAGAGCTTGCCGGTCGACAGCAGGCGGCTGATGAGGTCCTCGCCGCGCCACT
TCTTCTTGATGACGATGAGCCGGTTGATGTACCGCAGGAGCTGCCGGGTGGCCTCGGCGCGCTCCTCGTCGGTCG
AGGTGCGGATGGCGACCAGCGTGCGGGTACGGGACTCGAAGAAGTCCCGGTCCGCCGACGGCACGCCCAGCAG
CGCGGAGATGACCAGGGACGGCACGGGCAGCGCGAAGTCGTTCACCAGGTCCGCGGTGTTCCCGCCGGCCAGC
ATCGCGTCGATCCGCTCGTCCACGGTCCGTTCGATCGCCGGCCGCAGCTCACGGACGCGGCGCACGGTGAACTC
GGGGATCAGCACCTTGCGGAAACGGTCGTGCTCGGGGGAGTCCAGACCGACGAACCAGCCGGGGATCTGCTCCT
GCTTGGGCACTCCCATCGTCTCGCCGACGTTGGGGAAGCCCTCGTTGTCGGGGTTGGCGCTGATCCGGGGATGG
GTGAGGACCGCGCGCACGTCCTCGTGCCGGGTCACCAGCCAGATCGGCCGGCCGTTCGGCAGATGCGTCTGGAC
C 
Tetraponera 
Bacterial isolate KY1, fscP FR, 798 bp      
GGAGGCGAGCAGCGGCACGATGCCCTCGCCCTTGCGGATGGTCTGGCCGGCGATTTCCACGTCGTCCACGGCCA
CTCGCAGCGCCACCATGTCGGCCACCGAGTGCAGGCGCAGCAGCTCCTCCACGAGCCGGTCGTTGCCGATCCAC
TCCCGGTGCGAGAGCAGCGTGACGACGCCGAGCCCGATGTTGTTCGCCGTGGTCTCGTGGCCCGCGATCAGCAG
GAGCAGCAGGACCCCCGACAGCTCCTCGTCCGAGAGCTGGCCCGTCGACAGCAGGCGGCTGATGAGGTCCTCGC
CGCGCCACTTCTTCTTGACGACGATGAGCCGGTTGATGTAGCGCAGGAGCTGCCGGGTGGCCTCGGCGCGCTCC
TCGTCGGTCGAGGTGCGGATGGCGACCAGCGTGCGGGTGCGGGACTCGAAGAAGTCCCGGTCCGCCGACGGCA
CGCCCAGCAGCGAGGAGATGACCAGGGACGGCACGGGCAGCGCGAAGTCGGTCACCAGGTCCGCGGTGTTCCC
CCCGGCCAGCATCGCGTCGATCCGCTCGTCCACGGTCCGCTCGATCGCCGGCCGCAGCTCACGGACGCGGCGCA
CGGTGAACTCGGGGATGAGCACCTTGCGGAAACGGTCGTGCTCGGGGGAGTCCAGACCGACGAACCAGCCGGGG
ATCTGCTCCTGCTTGGGCACCCCCATCGTCTCGCCGACGTTGGGGAAGCCCTCGTTGTCGGGATTCGCGCTGATC
CGGGGATGGGTGAGGACCGCGCGCACGTCCTCGTGCCGGGTCACCAGCCAGATCGGCCG 
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Supplementary Information A3) Extended bacterial rDNA gene 
sequences  
Partial sequences of the bacterial 16S rDNA gene. The sequencing data, 
generated with the gene-specific forward primers, are categorised by ant-
system (Acromyrmex and Tetraponera). In particular, the sequences consist of 
two overlapping and merged forward reads of amplicons generated with the 
5151492 and fD216Sr primer sets. The title of each sequence describes the 
name of the strain, the PCR primer sets used, and the length of the sequence. 
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Acromyrmex system  
Bacteria  
Bacterial isolate E2, 5151492 merged with fD216Sr, 1228 bp      
AGTCGACGATGAAGCCGCTTCGGTGGTGGATTAGTGGCGAACGGGTGAGTAACACGTGGGCAATCTGCCCTTCAC
TCTGGGACAAGCCCTGGAAACGGGGTCTAATACCGGATAACACTCTGTCCCGCATGGGACGGGGTTAAAAGCTCC
GGCGGTGAAGGATGAGCCCGCGGCCTATCAGCTTGTTGGTGGGGTAATGGCCTACCAAGGCGACGACGGGTAGC
CGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGA
ATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACGGCCTTCGGGTTGTAAACCTCTT
TCAGCAGGGAAGAAGCGAAAGTGACGGTACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTA
ATACGTAGGGCGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTCACGTCGGATGTGA
AAGCCCGGGGCTTAACCCCGGGTCTGCATTCGATACGGGCTAGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTG
GTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCT
GAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGAACTAGGTG
TTGGCGACATTCCACGTCGTCGGTGCCGCAGCTAACGCATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGCT
AAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCAGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACC
TTACCAAGGCTTGACATATACCGGAAAGCATCAGAGATGGTGCCCCCCTTGTGGTCGGTATACAGGTGGTGCATGG
CTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGCAT
GCCCTTCGGGGTGATGGGGACTCACAGGAGACTGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTC
ATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATGCCGCGAGGCGGA
GCGAATCTCAAAAAGCCGGTCTCAGTTCGGA   
Bacterial isolate E4, 5151492 merged with fD216Sr, 1189 bp      
TGCAGTCGAGCGGTAAGGCCCTTTCGGGGGTACACGAGCGGCGAACGGGTGAGTAACACGTGGGTGACCTGCCC
TCCACTCTGGGATAAGCCCGGGAAACTGGGTCTAATACCGGATAGGACCTCTCAACGCATGTTGGGTGGTGGAAA
GTTTTTTCGGTGGGGGATGGGCCCGCGGCCTATCAGCTTGTTGGTGGGGTGATGGCCTACCAAGGCGGTGACGG
GTAGCCGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGT
GGGGAATATTGCGCAATGGGCGGAAGCCTGACGCAGCGACGCCGCGTGGGGGATGACGGCCTTCGGGTTGTAAA
CCTCTTTCGCCAGGGACGAAGCTTTTGTGACGGTACCTGGAGAAGAAGCACCGGCCAACTACGTGCCAGCAGCCG
CGGTAACACGTAGGGTGCGAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGTGTGTCGCGTCGGC
CGTGAAAACTTGGGGCTTAACTCTGAGCGTGCGGTCGATACGGGCATCACTTGAGTTCGGCAGGGGAGACTGGAA
TTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGGTCTCTGGGCCGATACT
GACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGCG
CTAGGTGTGGGGACCATTCCACGGTTTCTGCGCCGCAGCTAACGCATTAAGCGCCCCGCCTGGGGAGTACGGCC
GCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGATTAATTCGATGCAACGC
GAAGAACCTTACCTGGGTTTGACATGCACAGGATCGCGGCAGAGATGTCGTTTCCCTTGTGGCCTGTGTGCAGGTG
GTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTATTCCATGTT
GCCAGCACGTAGTGGTGGGGACTCATGGGAGACTGCCGGGGTCAACTCGGAGGAAGGTGGGGATGACGTCAAGT
CATCATGCCCCTTATGTCCAGGGCTTCACACATGCTACAATGGCTCATACAGAGGGCTGCGAGACCGTGA   
Bacterial isolate E6, 5151492 merged with fD216Sr, 1262 bp      
TGCAGTCGACGATGAACCGCTTTCGGGCGGGGATTAGTGGCGAACGGGTGAGTAACACGTGGGCAATCTGCCCTG
CACTCTGGGACAAGCCCTGGAAACGGGGTCTAATACCGGATACTCACTGCCTTGGGCATCCTTGGTGGTGGAAAG
CTCCGGCGGTGCAGGATGAGCCCGCGGCCTATCAGCTAGTTGGTGAGGTAATGGCTCACCAAGGCGACGACGGG
TAGCCGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTG
GGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACGGCCTTCGGGTTGTAAACC
TCTTTCAGCAGGGAAGAAGCGAGAGTGACGGTACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGC
GGTAATACGTAGGGCGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTCACGTCGGTT
GTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAAT
TCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTG
ACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCAC
TAGGTGTGGGCAACATTCCACGTTGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGC
AAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCAGCGGAGCATGTGGCTTAATTCGACGCAACGCGA
AGAACCTTACCAAGGCTTGACATACACCGGAAACGGCCAGAGATGGTCGCCCCCTTGTGGTCGGTGTACAGGTGG
TGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTG
CCAGCAAGCCCTTCGGGGTGTTGGGGACTCACGGGAGACCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGAC
GTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATACCGCG
AGGTGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTC 
Bacterial isolate E8, 5151492 merged with fD216Sr, 1312 bp      
TGCAGTCGAACGATGAACCGCTTTCGGGCGGGGATTAGTGGCGAACGGGTGAGTAACACGTGGGCAATCTGCCCT
GCACTCTGGGACAAGCCCTGGAAACGGGGTCTAATACCGGATATGACTGTCCATCGCATGGTGGATGGTGTAAAG
CTCCGGCGGTGCAGGATGAGCCCGCGGCCTATCAGCTTGTTGGTGAGGTAGTGGCTCACCAAGGCGACGACGGG
TAGCCGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTG
GGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACGGCCTTCGGGTTGTAAACC
TCTTTCAGCAGGGAAGAAGCGAAAGTGACGGTACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCG
GTAATACGTAGGGCGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTCACGTCGGTTG
TGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAATTC
CTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGAC
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GCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCACTA
GGTGTGGGCAACATTCCACGTTGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAA
GGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAG
AACCTTACCAAGGCTTGACATACACCGGAAACGTCTGGAGACAGGCGCCCCCTTGTGGTCGGTGTACAGGTGGTG
CATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTGC
CAGCAGGCCCTTGTGGTGCTGGGGACTCACGGGAGACCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGT
CAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATACCGCGAG
GTGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTCGGAGTCGCT
AGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGG   
Bacterial isolate E9, 5151492 merged with fD216Sr, 1249 bp      
AGTCGACGATGAACCGCTTTCGGGCGGGGATTAGTGGCGAACGGGTGAGTAACACGTGGGCAATCTGCCCTGCAC
TCTGGGACAAGCCCTGGAAACGGGGTCTAATACCGGATATGACTGTCCATCGCATGGTGGATGGTGTAAAGCTCC
GGCGGTGCAGGATGAGCCCGCGGCCTATCAGCTTGTTGGTGAGGTAGTGGCTCACCAAGGCGACGACGGGTAGC
CGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGA
ATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACGGCCTTCGGGTTGTAAACCTCTT
TCAGCAGGGAAGAAGCGAAAGTGACGGTACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTA
ATACGTAGGGCGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTCACGTCGGTTGTGA
AAGCCCGGGGCTTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAATTCCT
GGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACG
CTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCACTAG
GTGTGGGCAACATTCCACGTTGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAG
GCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGA
ACCTTACCAAGGCTTGACATACACCGGAAACGTCTGGAGACAGGCGCCCCCTTGTGGTCGGTGTACAGGTGGTGC
ATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTGCCA
GCAGGCCCTTGTGGTGCTGGGGACTCACGGGAGACCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCA
AGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATACCGCGAGGT
GGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCC   
Bacterial isolate E10, 5151492 merged with fD216Sr, 1170 bp      
AATCTGCCCTGCACTCTGGGACAAGCCCTGGAAACGGGGTCTAATACCGGATATTGACCTTCACGGGCATCTGTGA
GGTTCGAAAGCTCCGGCGGTGCAGGATGAGCCCGCGGCCTATCAGCTTGTTGGTGAGGTAATGGCTCACCAAGGC
GACGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAG
GCAGCAGTGGGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACGGCCTTCGG
GTTGTAAACCTCTTTCAGCAGGGAAGAAGCGAAAGTGACGGTACCTGCAGAAGAAGCGCCGGCTAACTACGTGCC
AGCAGCCGCGGTAATACGTAGGGCGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTC
ACGTCGGTTGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTTCGGTAGGGGA
GATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGG
CCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACG
GTGGGCACTAGGTGTGGGCAACATTCCACGTTGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAGT
ACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGCTTAATTCGACG
CAACGCGAAGAACCTTACCAAGGCTTGACATACACCGGAAACGGCCAGAGATGGTCGCCCCCTTGTGGTCGGTGT
ACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGT
CCCGTGTTGCCAGCAAGCCCCTTCGGGGGTGTTGGGGACTCACGGGAGACCGCCGGGGTCAACTCGGAGGAAGG
TGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTG
CGATACCGCAAGGTGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGA   
Bacterial isolate E13, 5151492 merged with fD216Sr, 1198 bp      
AATCTGCCCTGCACTCTGGGACAAGCCCTGGAAACGGGGTCTAATACCGGATACTGACCCTCGCAGGCATCTGCG
AGGTTCGAAAGCTCCGGCGGTGCAGGATGAGCCCGCGGCCTATCAGCTTGTTGGTGAGGTAATGGCTCACCAAGG
CGACGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGA
GGCAGCAGTGGGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACGGCCTTCG
GGTTGTAAACCTCTTTCAGCAGGGAAGAAGCGAAAGTGACGGTACCTGCAGAAGAAGCGCCGGCTAACTACGTGC
CAGCAGCCGCGGTAATACGTAGGGCGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGT
CGCGTCGGTTGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTTCGGTAGGGG
AGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGG
GCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAAC
GGTGGGCACTAGGTGTGGGCAACATTCCACGTTGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGGGAG
TACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGCTTAATTCGAC
GCAACGCGAAGAACCTTACCAAGGCTTGACATACACCGGAAAGCATCAGAGATGGTGCCCCCCTTGTGGTCGGTG
TACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTG
TCCCGTGTTGCCAGCAGGCCCTTGTGGTGCTGGGGACTCACGGGAGACCGCCGGGGTCAACTCGGAGGAAGGTG
GGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGC
GATACCGCAAGGTGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAG
TCG 
Bacterial isolate E14, 5151492 merged with fD216Sr, 1200 bp      
TGCAAGTCGAACGATGAAGCCCTTCGGGGTGGATTAGTGGCGAACGGGTGAGTAACACGTGGGCAATCTGCCCTT
CACTCTGGGACAAGCCCTGGAAACGGGGTCTAATACCGGATAATACTTTCTCCCTCCTGGGAGAAGGTTGAAAGCT
CCGGCGGTGAAGGATGAGCCCGCGGCCTATCAGCTAGTTGGTGGGGTAATGGCCTACCAAGGCGACGACGGGTA
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GCCGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGGG
GAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACGGCCTTCGGGTTGTAAACCTC
TTTCAGCAGGGAAGAAGCGAAAGTGACGGTACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGT
AATACGTAGGGCGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTCACGTCGGTTGTG
AAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTGTGGTAGGGGAGATCGGAATTCCT
GGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGC
TGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGTTGGGAACTAGGT
GTTGGCGACATTCCACGTCGTCGGTGCCGCAGCTAACGCATTAAGTTCCCCGCCTGGGGAGTACGGCCGCAAGGC
TAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCAGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAAC
CTTACCAAGGCTTGACATACACCGGAAAGCATCAGAGATGGTGCCCCCCTTGTGGTCGGTGTACAGGTGGTGCAT
GGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTTCTGTGTTGCCAGC
ATGCCCTTCGGGGTGATGGGGACTCACAGGAGACTGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAG
TCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAATGGCCGGTACAATGAGCTGCGATGCCGCGAGGCG
GA   
Tetraponera system  
Bacteria 
Bacterial isolate KY1, 5151492 merged with fD216Sr, 1349 bp      
TAGTGGCGAACGGGTGAGTAACACGTGGGCAATCTGCCCTGCACTCTGGGACAAGCCCTGGAAACGGGGTCTAAT
ACCGGATATGACTGTCCGCCGCATGGTGGATGGTGTAAAGCTCCGGCGGTGCAGGATGAGCCCGCGGCCTATCA
GCTTGTTGGTGAGGTAGTGGCTCACCAAGGCGACGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACACTGGG
ACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGAAAGCCTGATGCAGC
GACGCCGCGTGAGGGATGACGGCCTTCGGGTTGTAAACCTCTTTCAGCAGGGAAGAAGCGAGAGTGACGGTACCT
GCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGGCGCAAGCGTTGTCCGGAATTATT
GGGCGTAAAGAGCTCGTAGGCGGCTTGTCACGTCGGTTGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCG
ATACGGGCAGGCTAGAGTTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGG
AACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGAT
TAGATACCCTGGTAGTCCACGCCGTAAACGGTGGGCACTAGGTGTGGGCAACATTCCACGTTGTCCGTGCCGCAG
CTAACGCATTAAGTGCCCCGCCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCAC
AAGCGGCGGAGCATGTGGCTTAATTCGACGCAACGCGAAGAACCTTACCAAGGCTTGACATACACCGGAAACGTCT
GGAGACAGGCGCCCCCTTGTGGTCGGTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGG
TTAAGTCCCGCAACGAGCGCAACCCTTGTCCCGTGTTGCCAGCAGGCCCTTGTGGTGCTGGGGACTCACGGGAGA
CCGCCGGGGTCAACTCGGAGGAAGGTGGGGACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGT
GCTACAATGGCCGGTACAATGAGCTGCGATACCGTGAGGTGGAGCGAATCTCAAAAAGCCGGTCTCAGTTCGGATT
GGGGTCTGCAACTCGACCCCATGAAGTCGGAGTCGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCC
CGGGCCTTGTACACACCGCCCGTCACGTCACGAAAGTCGGTAACACCCGAAGCCGGTGGCCCAACCCCTTGTGGG
Bacterial isolate KY2, 5151492 merged with fD216Sr, 1040 bp      
GCAATCTGCCCTGCACTCTGGGACAAGCCCTGGAAACGGGGTCTAATACCGGATATGACCACCGGCCGCATGGTC
TGGTGGTGGAAAGCTCCGGCGGTGCAGGATGAGCCCGCGGCCTATCAGCTTGTTGGTGGGGTGATGGCCTACCA
AGGCGACGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACG
GGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACGGCCT
TCGGGTTGTAAACCTCTTTCAGCAGGGAAGAAGCGCGAGTGACGGTACCTGCAGAAGAAGCACCGGCTAACTACG
TGCCAGCAGCCGCGGTAATACGTAGGGTGCGAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCC
TGTCGCGTCGGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCGATACGGGCAGGCTAGAGTTCGGCAG
GGGAGATTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTC
TGGGCCGATACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTA
AACGTTGGGCACTAGGTGTGGGCGGCATTCCACGTCGTCCGTGCCGCAGCTAACGCATTAAGTGCCCCGCCTGGG
GAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGCGGAGCATGTGGCTTAATTC
GACGCAACGCGAAGAACCTTACCAAGGCTTGACATACACCGGAAAACTCTGGAGACAGGGTCCCCCTTTGGGTCG
GTGTACAGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCC
TTATCCTGTGTTGCCAGCATGCCTTTCGGGGTGATGGGGACTCACGGGAGACTGCCGGGGTCAACTCGGA  
Bacterial isolate KY5, 5151492 merged with fD216Sr, 1307 bp      
AATCTGCCCTTCACTCTGGGACAAGCCCTGGAAACGGGGTCTAATACCGGATAATACCGTCTCTCGCATGGGAGAG
GGTTGAAAGCTCCGGCGGTGAAGGATGAGCCCGCGGCCTATCAGCTTGTTGGTGAGGTAGAAGCTCACCAAGGCG
ACGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGG
CAGCAGTGGGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACGGCCTTCGGG
TTGTAAACCTCTTTCAGCAGGGAAGAAGCGAAAGTGACGGTACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCA
GCAGCCGCGGTAATACGTAGGGCGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTCA
CGTCGGTTGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAGTGTGGTAGGGGAG
ATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAGGAACACCGGTGGCGAAGGCGGATCTCTGGGC
CATTACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGG
TGGGAACTAGGTGTTGGCGACATTCCACGTCGTCGGTGCCGCAGCTAACGCATTAAGTTCCCCGCCTGGGGAGTA
CGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCAGCGGAGCATGTGGCTTAATTCGACGC
AACGCGAAGAACCTTACCAAGGCTTGACATATACCGGAAAGCATCAGAGATGGTGCCCCCCTTGTGGTCGGTATAC
AGGTGGTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTTCT
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GTGTTGCCAGCATGCCCTTCGGGGTGATGGGGACTCACAGGAGACTGCCGGGGTCAACTCGGAGGAAGGTGGGG
ACGACGTCAAGTCATCATGCCCCTTATGTCTTGGGCTGCACACGTGCTACAATGGCAGGTACAATGAGCTGCGAAG
CCGCGAGGCGGAGCGAATCTCAAAAAGCCTGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTCGG
AGTTGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACGTCA
CGAAAGTCGGTAACACCCGAAGCCGGTGGCCC  
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Supplementary Information B1) LCMS on double-purified 
combined fractions B 
Low-resolution LCMS data on the double-purified combined fractions B of 
Streptomyces E8. UV, MS, and MS2 data are presented on ions with masses of 
507 amu, 521 amu, 535 amu, 549 amu, 563 amu, (805 amu), and 577 amu 
[M+H]+. The LCMS system used for generating these data has been located at 
the John Innes Centre and was set to detect ions in positive ion mode (+ESI). 
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Supplementary Information B2) LCMS on double-purified 
combined fractions B 
Low-resolution LCMS data on the double-purified combined fractions B of 
Streptomyces E8. Extracted ion chromatograms are presented on ions with 
masses of 507 amu, 521 amu, 535 amu, 549 amu, 563 amu, (805 amu), and 
577 amu [M+H]+. The LCMS system used for generating these data has been 
located at the John Innes Centre and was set to detect ions in positive ion mode 
(+ESI). 
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Supplementary Information B3) LCMS on double-purified 
combined fractions B 
High-resolution LCMS data on the double-purified combined fractions B of 
Streptomyces E8. MS and MS2 data are presented on ions with masses of 507 
amu, 521 amu, 535 amu, 549 amu, 563 amu, and 577 amu [M+H]+. The LCMS 
system used for generating these data has been located at the John Innes 
Centre and was set to detect ions in positive ion mode (+ESI). 
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Supplementary Information B4) LCMS on double-purified 
combined fractions B 
High-resolution LCMS data on the double-purified combined fractions B of 
Streptomyces E8. Extracted ion chromatograms are presented on ions with 
masses of 507 amu, 521 amu, 535 amu, 549 amu, 563 amu, and 577 amu 
[M+H]+. The LCMS system used for generating these data has been located at 
the John Innes Centre and was set to detect ions in positive ion mode (+ESI). 
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Supplementary Information B5) LCMS on double-purified 
combined fractions B 
High-resolution LCMS data on the double-purified combined fractions B of 
Streptomyces E8. Dissection peaks are presented of fractions 2E9, 2E10, 2F2, 
and 2F3 containing ions with masses of 535 amu and 549 amu [M+H]+ The 
LCMS system used for generating these data has been located at the Institute 
of Food Research and was set to detect ions in positive ion mode (+ESI). 
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Supplementary Information B6) LCMS on double-purified 
combined fractions B 
High-resolution LCMS data on the double-purified combined fractions B of 
Streptomyces E8. Extracted ion chromatograms are presented on ions with 
masses of 507 amu, 521 amu, 535 amu, 549 amu, 563 amu, and 577 amu 
[M+H]+. The LCMS system used for generating these data has been located at 
the Institute of Food Research and was set to detect ions in positive ion mode 
(+ESI). 
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Supplementary Information B7) LCMS on double-purified 
combined fractions B 
High-resolution LCMS data on the double-purified combined fractions B of 
Streptomyces E8. Dissection peaks are presented of fractions 2G4 and 2G5 
containing ions with masses of 533 amu and 547 amu [M-H]-. The LCMS 
system used for generating these data has been located at the Institute of Food 
Research and was set to detect ions in negative ion mode (-ESI). 
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Supplementary Information B8) LCMS on double-purified 
combined fractions B  
High-resolution LCMS data on the double-purified combined fractions B of 
Streptomyces E8. Extracted ions chromatograms are presented on ions with 
masses of 505 amu, 519 amu, 533 amu, 547 amu, 561 amu, and 575 amu [M-
H]-. The LCMS system used for generating these data has been located at the 
Institute of Food Research and was set to detect ions in negative ion mode (-
ESI). 
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Supplementary Information B9) LCMS on antimycin A1-A4
Low-resolution LCMS data on an antimycin A1-A4 standard. UV, MS, and MS2
data on ions with masses of 507 amu (A4), 521 amu (A3), 535 amu (A2), 549 
amu (A1) [M+H]+. The same type of data is presented for an additional antimycin 
mass, 563 amu [M+H]+, detected in the standard. The LCMS system used for 
generating these data has been located at the John Innes Centre and was set to 
detect ions in positive ion mode (+ESI). 
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Supplementary Information B10) Tandem-LCMS on antimycin A1-
A4 and double-purified combined fractions B
Low-resolution tandem-LCMS data on an antimycin A1-A4 standard (507 amu, 
521 amu, 535 amu, 549 amu, 563 amu [M+H]+) and the double-purified 
combined fractions B (507 amu, 521 amu, 535 amu, 549 amu, 563 amu, 805 
amu, and 577 amu [M+H]+). Extracted ion chromatograms are presented on 
ions with masses of 507 amu, 521 amu, 535 amu, 549 amu, 563 amu, (805 
amu), and 577 amu [M+H]+. The LCMS system used for generating these data 
has been located at the John Innes Centre and was set to detect ions in positive 
ion mode (+ESI). 
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Supplementary Information C) Candicidin and antimycin 
producing bacteria 
Distribution of candicidin biosynthesis genes among bacterial isolates and the 
genetic relatedness of bacterial isolates to antimycin producers. 
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Materials and Methods 
Plotting bioactivities 
A Neighbor-Joining (NJ) tree was generated based on 16S rDNA 
sequences of 56 bacterial isolates. In particular, 16 bacteria originated from 
worker ants of Acromyrmex octospinosus (E2-E17), 20 bacteria originated from 
fungal cultivars of Allomerus decemarticulatus and A. octoarticulatus (FG1-FG15, 
FG17-FG21), and 20 bacteria originated from worker ants and their putative 
fungal cultivars of Tetraponera penzigi (KY1-KY5, KY7-KY21). Corresponding 16S 
rDNA sequences of four laboratory organisms, including Streptomyces lividans
(1126), Bacillus subtilis (|A|), Salmonella enterica (SL1344), and Escherichia coli
(DH5), served as phylogenetic references. The DNA extraction, PCR 
amplification, and sequencing of the 16S rDNA have been described in the 
corresponding chapters (Chapters 2, 4, 5), where the reads were used for the 
identification of the bacterial isolates. The truncated sequences of the bacterial 
isolates and reference strains were introduced to BioEdit 
(www.mbio.ncsu.edu/BioEdit/bioedit.html) and aligned with ClustalW (Number of 
Bootstraps: 10000). Using MEGA5 (www.megasoftware.net/), the aligned 
sequences were used to calculate a Neighbor-Joining tree (Number of 
Bootstraps: 10000, pairwise deletion of gaps, Kimura 2-parameter substitution 
model). In the phylogenetic tree, the entries display information about the ant 
system (/ = A. octospinosus, '/ = A. decemarticulatus or A. 
octoarticulatus, / = T. penzigi, à = laboratory strain), the name (e.g. E2, FG2, 
KY2), the host type (A = worker ant, C = fungal cultivar), and the genus (e.g. 
Streptomyces) of the bacteria.  
The phylogenetic tree was used for plotting the bioassay results, in which 
all NNSPS strains (filled symbols) and their culture supernatants, were tested 
against diverse fungi (Chapters 2, 4, 5). Positive bioassay outcomes of strains 
showing fungal inhibition are highlighted with red boxes. The shortages in the 
boxes, including ColEA-, ColEWB-, ColEWC-, ColAcre-, ColCan-/+, 
SupCan-/+, SupEWC-, reveal the nature of the bioassays. Hereby, Col and 
Sup stand for colony and supernatant bioassays; EWB, EA, and EWC refer 
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Table S1 (A-B) PCR mixture and thermocycles for the 
amplification of candicidin biosynthesis genes, fscM and fscP. 
A B
PCR mixture Volume
dH2O 32.00 µl
GoTaq buffer (incl. loading buffer) 10.00 µl
GoTaq MgCl (25 mM) 5.50 µl
Bioline dNTP's (10 mM) 1.50 µl
Forward primer (25 µM) 0.25 µl
Reverse primer (25 µM) 0.25 µl
DNA 0.50 µl
GoTag polymerase 0.50 µl
50.50 µl
Step Temperature Minutes
1 96 oC 10:00
2 96 oC 1:00
3 60 oC 0:45
4 72 oC 1:30
5
6 72 oC 10:00
7 end
Go 40x to step 2
to Escovopsis strains and Acre refers to an Acremonium strain, against which 
Acromyrmex- and Tetraponera-associated NNSPS strains were tested, 
respectively; Can corresponds to the yeast Candida albicans CA6; and +/- 
indicates whether bacterial colonies were grown in the presence/absence of 
sodium butyrate.  
Candicidin gene screen 
The genomes of the NNSPS isolates (E2-E4, E6, E8-E15; FG1-FG8, FG21; 
KY1-KY5, KY7, KY21) were screened by polymerase chain reaction (PCR) for the 
presence of two candicidin biosynthesis genes, fscM (1035 bp) and fscP (1039 
bp). These genes were amplified (Table S1) using the same DNA extracts that 
were used above for the amplification of the 16S rDNA gene, and primers that 
were published by Haeder et al. (2009).  
Amplicons within the correct size range were cleaned with a Qiagen Gel 
Extraction Kit, according to the instructions in the manual, and sequenced 
(Table S2) with the gene-specific forward primers. The sequencing products 
were analysed by The Genome Analysis Centre TGAC 
(www.jicgenomelab.co.uk) using ABI 3730XL sequencers (Life Technologies). 
The sequences were analysed with FinchTV 
(www.geospiza.com/Products/finchtv.shtml), truncated, and matched to the 
NCBI BLAST database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
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Phylogenetic comparison  
Twelve bioactive Streptomyces isolates were placed in a phylogenetic 
context with 52 Streptomyces reference strains that are known to produce 
specific antifungals. In particular, 20 of the 52 reference strains were previously 
used in a phylogenetic analysis by Poulsen et al. (2011); a part of the 
sequences originated from Kaltenpoth et al. (2006) and Scott et al. (2008). In 
addition, 32 of the 52 bacteria were previously used in a phylogenetic analysis 
by Schoenian et al. (2011); the sequences partly originated from Haeder et al. 
(2009). The sequences of the reference strains were downloaded from the NCBI 
database (www.ncbi.nlm.nih.gov/gquery/). 
The twelve selected Streptomyces isolates originated from the worker ants 
of A. octospinosus (E2, E6, E8-E10, E13-E14), fungal cultivars of A. 
decemarticulatus and A. octoarticulatus (FG1, FG21), and worker ants and their 
putative fungal cultivar of T. penzigi (KY1-KY2, KY5). One Pseudonocardia strain 
(E4), originating from the worker ants of A. octospinosus, served as outgroup. 
The phylogenetic resolution was increased by extending the fragment of the 
bacterial 16S rDNA gene that was sequenced. In particular, the previously 
described 515 forward sequences (515-1492, Table 2.6), used for the bacterial 
identification, were merged with newly generated and overlapping fD2 forward 
sequences (fD2-16Sr, Table S3), covering the initial part of the 16S rDNA gene. 
Table S2 (A-B) Reaction mixture and thermocycles for 
the sequencing of candicidin biosynthesis genes. 
A B
Sequencing mixture Volume
dH2O 5.5 µl
5x sequencing buffer 1.5 µl
Forward primer (3.2 µM) 1.0 µl
DNA 1.0 µl
Enzyme E3.1 1.0 µl
Total 10.0 µl
Step Temperature Minutes
1 96 oC 1:00
2 96 oC 0:10
3 50 oC 0:05
4 60 oC 4:00
5
6 60 oC 0:10
7 end
Go 25x to step 2
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The fD2 forward primer resembles the well-known forward primers, 8F (Turner 
et al. 1999) and 27F (Lane et al. 1991), but lacks the first nucleotide; also, it 
shows an A at the position where primer 27F has an M (A+C) and where 
primer 8F has a C. The PCR mixture and thermocycles for generating fD2-16Sr 
amplicons are displayed in table S4.  
Unfortunately, no fD2-16Sr amplicons could be generated for 
Streptomyces FG1 and FG21, leading to their exclusion from the analysis. 
Amplicons of the remaining strains were cleaned with a Qiagen Gel Extraction 
Kit, according to the instructions in the manual, and sequenced with the gene-
specific forward primer (fD2) as described above. The sequencing products 
were analysed by The Genome Analysis Centre TGAC 
(www.jicgenomelab.co.uk), using ABI 3730XL sequencers (Life Technologies), 
truncated in FinchTV (www.geospiza.com/Products/finchtv.shtml), and merged 
with the 515 forward sequences in BioEdit. The merged sequences were 
matched to the NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi) BLAST database. 
Table S3 Primer sequences of fD2 and 16Sr used for the partial 
amplification of the bacterial 16S rDNA gene.  
Name Sequence Reference Gene Amplicon 
length
fD2 5'-GAGTTTGATCATGGCTCAG-3' Bereswill et al . (1995)
16Sr 5'-TTGCGGGACTTAACCCAACAT-3' Aittamaa et al . (2008)
16S rDNA 1400 bp
Table S4 (A-B) PCR mixture and thermocycles for the 
generation of fD2-16Sr amplicons. 
A B
PCR mixture Volume
dH2O 32.00 µl
GoTaq buffer (incl. loading buffer) 10.00 µl
GoTaq MgCl (25 mM) 5.50 µl
Bioline dNTP's (10 mM) 1.50 µl
Forward primer (25 µM) 0.25 µl
Reverse primer (25 µM) 0.25 µl
DNA 0.50 µl
GoTag polymerase 0.50 µl
50.50 µl
Step Temperature Minutes
1 94 oC 5:00
2 94 oC 1:00
3 45 oC 0:45
4 72 oC 1:30
5
6 72 oC 5:00
7 end
Go 34x to step 2
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Then, the sequences of the 52 Streptomyces reference strains, ten 
Streptomyces test strains, and one Pseudonocardia outgroup were aligned in 
BioEdit by ClustalW (Number of Bootstraps: 10000). In MEGA5 
(www.megasoftware.net/) the aligned sequences were used to calculate a 
Neighbor-Joining (NJ) tree (Number of Bootstraps: 10000, pairwise deletion of 
gaps, Kimura 2-parameter substitution model).  
Results 
Plotting bioactivities 
The phylogenetic relationship of 56 bacteria, which have been isolated 
from Acromyrmex (E2-E17), Allomerus (FG1-FG15, FG17-FG21), and Tetraponera
(KY1-KY5, KY7-KY21) worker ants/cultivars, were analysed by generating a 
Neighbor-Joining tree (Fig. S1). The phylogenetic tree is based on fragments of 
the bacterial 16S rDNA gene (mean 791 bp, 445-919 bp). The tree shows that 
the bacterial isolates fall into four overall clusters, representing the bacterial 
phyla Bacterioidetes, Proteobacteria, Firmicutes, and Actinobacteria. While the 
first two phyla contain Gram-negative bacteria, the last two phyla contain Gram-
positive bacteria.  
The outcomes of bioassays, in which 28 actinobacterial isolates (NNSPS 
strains: E2-E4, E6, E8-E15; FG1-FG8, FG21; KY1-KY5, KY7, KY21) were tested 
against diverse fungi, are plotted to the phylogenetic tree. In particular, only 
those bioassay performances, in which bacterial strains showed fungal 
inhibition, are highlighted (red boxes). In other words, bioactively successful 
strains obtain more boxes than bioactively unsuccessful strains of the same ant 
system. The results indicate that the bacterial bioactivity appears to be 
clustered; for example, a clade in the sub-order Streptomycineae, including 
Streptomyces E8 and E9 as well as Streptomyces KY1, was particularly 
bioactive. Strikingly, strains of the typical attine ant-associate Pseudonocardia, 
as represented by the bacterial isolates E4 and E12, are not as successful in 
inhibiting the test fungi as many of the Streptomyces strains. 
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Figure S1 Neighbor-Joining tree of 56 bacterial isolates. The phylogenetic tree is 
based on partial 16S rDNA sequences of bacteria, isolated from the worker ants of 
A. octospinosus (/), fungal cultivar of A. decemarticulatus and A. octoarticulatus
(/), and T. penzigi workers and their putative fungal cultivar (/). As 
phylogenetic references, corresponding sequences of S. lividans, S. enterica, E. 
coli, and B. subtilis are included (à). The phylogenetic tree shows that the bacterial 
isolates belong to four phyla. A selection of 28 actinobacteria (filled symbols), 
NNSPS strains, and their cultivar supernatants are challenged against various 
fungal opponents. Positive bioassay outcomes are highlighted with red boxes. In 
general, it can be said that the more boxes the more bioactively successful strains 
(of the same ant system) are. For example, Streptomyces E8, E9, and KY1 belong to 
the most bioactive bacterial strains. 
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Candicidin gene screen 
The genomes of the NNSPS isolates were PCR-screened for two genes, 
fscM and fscP, in the candicidin biosynthesis pathway. The amplicons were 
analysed on diagnostic electrophoresis gels (Fig. S2), which contain two 
negative controls (S. lividans and sterile dH2O) and one positive control 
(Streptomyces E8). In a chemical analysis, Streptomyces E8 has been shown to 
produce candicidin (Chapter 3). All amplicons within the correct size range 
(framed) have been sequenced, and their reads were matched to the NCBI 
BLAST database. The sequencing information is provided in the Supplementary 
Information A2. 
Amplification of the fscM gene generated relevant amplicons in twelve 
bacterial isolates (E2-E3, E8-E9, E11-E13, FG8, KY1, KY4-KY5, KY21). All 
amplicons, besides the one of KY4, could be sequenced; also, the sequences of 
E12 and KY21 are not matching any sequences of the NCBI database. The 
sequences of E8, E9, and KY1 show strong BLAST analogies to the candicidin 
genes of Streptomyces griseus (yellow frames, Fig. S2; Table S5). The 
sequences of E11 and KY5 show weaker BLAST analogies to candicidin 
(Streptomyces griseus) and oviedomycin/jadomycin (Streptomyces antibioticus/ 
Streptomyces venezuelae) genes, respectively (yellow frames, Fig. S2; Table 
S5). Strains E2, E3, E13, and FG8 show analogies to gene sequences not 
encoding any antifungal compounds. Strong and weak BLAST analogies are 
defined in terms of relatively high and low max scores, as shown in table S5. 
Amplifications of the fscP gene generated amplicons in thirteen bacteria 
(E4, E8-E9, E12, E15, FG1, FG5-FG7, KY1, KY3, KY5, KY7). All amplicons, besides 
the ones of FG6 and KY3, could be sequenced; the sequences of E12, FG5, KY5, 
and KY7 do not match any sequences of the NCBI database. The reads of E4, 
E15, FG1, and FG7 show BLAST analogies to sequences not encoding any 
antifungal compounds, and the sequences of E8, E9, and KY1 show strong 
BLAST analogies, as defined above, to the candicidin genes of Streptomyces 
griseus (yellow frames, Fig. S2; Table S5). 
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Figure S2 Distribution of two candicidin biosynthesis genes, fscM and fscP
among bacterial isolates. FscM (1035 bp, A-D) and fscP (1039 bp, E-H) 
amplicons of the 28 NNSPS isolates within the correct size range (framed), 
are sequenced. Reads with BLAST analogies to antifungal genes are 
highlighted with yellow frames. For example, Streptomyces E8, E9, and KY1
likely possess both candicidin biosynthesis genes.  
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Despite of the weaknesses regarding this screening method (e.g. primer 
incompatibilities), successful amplifications confirm the presence of candicidin 
biosynthesis genes. The data show that the genomes of Streptomyces E8, E9, 
and KY1 contain two candicidin biosynthesis genes, indicating that candicidin-
producing bacteria may not only be associated to A. octospinosus (i.e. 
Streptomyces E8 and E9) but also to non-attine ants such as T. penzigi (i.e. 
Streptomyces KY1). In addition, Nocardiopsis E11 and Streptomyces KY5 may be 
able to produce candicidin- and oviedomycin/jadomycin-like metabolites, 
respectively.  
Name
PCR 
primers
Sequencing 
primer
Sequence 
length
Closest analogies to antifungal genes (accession)
Max 
score
Total 
score
Query 
coverage
E value
Max 
ident
E8 fscM F/R fscM F 898 bp Streptomyces griseus partial ORF1, canA gene, canC gene, canF gene, canT gene, canRA gene and canRB gene (AJ300302.1) 1642 1642 100% 0 99%
E9 fscM F/R fscM F 901 bp Streptomyces griseus  partial ORF1, canA gene, canC gene, canF gene, canT gene, canRA gene and canRB gene (AJ300302.1) 1655 1655 99% 0 99%
E11 fscM F/R fscM F 737 bp Streptomyces griseus  partial ORF1, canA gene, canC gene, canF gene, canT gene, canRA gene and canRB gene (AJ300302.1) 52.8 52.8 3% 0.003 100%
KY1 fscM F/R fscM F 844 bp Streptomyces griseus  partial ORF1, canA gene, canC gene, canF gene, canT gene, canRA gene and canRB gene (AJ300302.1) 1537 1537 100% 0 99%
Streptomyces antibioticus oviedomycin biosynthetic gene cluster, strain ATCC 11891 (AJ632203.2) 627 627 89% 4.00E-176 83%
Streptomyces venezuelae  JadJ (jadJ), jadomycin polyketide synthase cyclase (jadI) (AF126429.1) 573 573 97% 6.00E-160 81%
E8 fscP F/R fscP F 887 bp Streptomyces griseus partial ORF1, canA gene, canC gene, canF gene, canT gene, canRA gene and canRB gene (AJ300302.1) 1605 1605 100% 0 99%
E9 fscP F/R fscP F 887 bp Streptomyces griseus  partial ORF1, canA gene, canC gene, canF gene, canT gene, canRA gene and canRB gene (AJ300302.1) 1594 1594 100% 0 99%
KY1 fscP F/R fscP F 798 bp Streptomyces griseus partial ORF1, canA gene, canC gene, canF gene, canT gene, canRA gene and canRB gene (AJ300302.1) 1369 1369 100% 0 97%
fscM F/RKY5 777 bpfscM F
Table S5 NCBI BLAST analogies of two candicidin biosynthesis genes, fscM and fscP. 
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Phylogenetic comparison 
A Neighbor-Joining (NJ) tree was generated based on the 16S rDNA 
sequences of 52 Streptomyces reference strains (à), known to produce specific 
antifungals, ten bioactive Streptomyces isolates, and a Pseudonocardia (E4) 
isolate that was used as phylogenetic outgroup. The Streptomyces isolates 
originated from worker ants of A. octospinosus ( = E2, E6, E8-E10, E13-E14), 
and worker ants and their putative fungal cultivar of T. penzigi ( = KY1-KY2, 
KY5). The sequencing data (1040-1349 bp, mean of 1228 bp) are presented in 
the Supplementary Information A3 and their BLAST analogies in Table S6.  
The phylogenetic tree (Fig. S3) shows that Tetraponera ant-associated 
Streptomyces strain KY2 as well as a cluster of three Streptomyces philanthi
bacteria (DQ375802, DQ375805, DQ375788) are phylogenetically separated 
from the remaining strains, which can be subdivided into two overall clusters. 
The upper overall cluster includes the bacterial isolates E2, E14, and KY5 as 
well as producers of a vast variety of antifungal compounds, such as 
actinomycin, antimycin, bafilomycin, candicidin, daunomycin, mycangimycin, 
sceliphrolactam, streptazoline, streptazon, and valinomycin. In contrast, the 
lower overall cluster is dominated by candicidin and/or antimycin producers, 
but also valinomycin and mycangimycin producers are represented. This overall 
cluster can be sub-divided into three sub-clusters, one of which contains the 
Acromyrmex ant isolate Streptomyces E6 and Streptomyces symbionts of the 
southern pine beetle Dendroctonus frontalis. One of the D. frontalis isolates has 
been shown to produce the antifungal mycangimycin (Scott et al. 2008). Both, 
Streptomyces E6 and the mycangimycin producer are genetically related to S. 
thermosacchari (Table S6).  This finding suggests that Acromyrmex ants may be 
able to access mycangimycin.  
Table S6 16S rDNA BLAST analogies of eleven bioactive NNSPS strains. The strains included Streptomyces E2, E6, E8-E10, E13-
E14, KY1-KY2, KY5, as well as Pseudonocardia E4, which served as outgroup for a phylogenetic analysis. The data show that 
Streptomyces E8 is genetically related to Streptomyces violascens, Streptomyces E9 to S. flavofungini, Streptomyces E6 to S. 
thermosacchari, Streptomyces KY1 to S. griseus, and Streptomyces KY5 to S. kanamyceticus. 
Sample 
type
Name
PCR                 
primers
Sequencing 
primers
Sequence 
length
Closest relative (accession)
Max 
score
Total 
score
Query 
coverage
E 
value
Max 
identity
Streptomyces acrimycini  strain AS 4.1673 16S ribosomal RNA gene, partial sequence (AY999889.1) 2263 2263 100% 0 99%
Streptomyces albus subsp. albus  gene for 16S rRNA, partial sequence (AB184741.1) 2263 2263 100% 0 99%
Streptomyces baarnensis  gene for 16S rRNA, partial sequence (AB184615.1) 2263 2263 100% 0 99%
Streptomyces caviscabies strain ATCC51928 16S ribosomal RNA gene, partial sequence (AF112160.1) 2263 2263 100% 0 99%
Streptomyces fimicarius gene for 16S rRNA, partial sequence (AB184269.1) 2263 2263 100% 0 99%
Streptomyces flavofuscus  strain 173911 16S ribosomal RNA gene, partial sequence (EU593623.1) 2263 2263 100% 0 99%
Streptomyces setonii  gene for 16S rRNA, partial sequence (AB184300.1) 2263 2263 100% 0 99%
Bacterial 
isolate
E4
fD2-16Sr, 
515-1492
fD2, 515 1189 bp Pseudonocardia ammonioxydans  strain H9 16S ribosomal RNA gene, partial sequence (AY500143.1) 2124 2124 100% 0 98%
Bacterial 
isolate
E6
fD2-16Sr, 
515-1492
fD2, 515 1262 bp Streptomyces thermosacchari  strain LLJ-05 16S ribosomal RNA gene, partial sequence (HQ170508.1) 2289 2289 100% 0 99%
Bacterial 
isolate
E8
fD2-16Sr, 
515-1492
fD2, 515 1312 bp Streptomyces violascens  isolate XSD-115 16S ribosomal RNA gene, partial sequence (EU273550.1) 2423 2423 100% 0 100%
Bacterial 
isolate
E9
fD2-16Sr, 
515-1492
fD2, 515 1249 bp Streptomyces flavofungini isolate XSD-104 16S ribosomal RNA gene, partial sequence (EU273540.1) 2307 2307 100% 0 100%
Streptomyces carnosus  strain HBUM174871 16S ribosomal RNA gene, partial sequence (FJ486392.1) 2161 2161 100% 0 100%
Streptomyces litmocidini strain RT-13 16S ribosomal RNA gene, partial sequence (HQ909754.1) 2161 2161 100% 0 100%
Bacterial 
isolate
E13
fD2-16Sr, 
515-1492
fD2, 515 1198 bp Streptomyces collinus  subsp. albescens  gene for 16S rRNA, partial sequence (AB184101.2) 2213 2213 100% 0 100%
Bacterial 
isolate
E14
fD2-16Sr, 
515-1492
fD2, 515 1200 bp Streptomyces drozdowiczii partial 16S rRNA gene (AM921646.1) 2211 2211 100% 0 99%
Bacterial 
isolate
KY1
fD2-16Sr, 
515-1492
fD2, 515 1349 bp Streptomyces griseus subsp. griseus  gene for 16S rRNA (AB045867.1) 2486 2486 100% 0 99%
Streptomyces cacaoi  subsp. cacaoi  gene for 16S rRNA, partial sequence (AB184183.1) 1921 1921 100% 0 100%
Streptomyces violaceoruber  strain HBUM49432 16S ribosomal RNA gene, partial sequence (GQ163473.1) 1921 1921 100% 0 100%
Bacterial 
isolate
KY5
fD2-16Sr, 
515-1492
fD2, 515 1307 bp Streptomyces kanamyceticus gene for 16S rRNA, partial sequence (AB184388.1) 2405 2405 100% 0 99%
Bacterial 
isolate
Bacterial 
isolate
Bacterial 
isolate
E2 1228 bp
KY2 1040 bp
1170 bpE10
fD2-16Sr, 
515-1492
fD2, 515
fD2-16Sr, 
515-1492
fD2, 515
fD2-16Sr, 
515-1492
fD2, 515
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The second sub-cluster includes the Acromyrmex ant isolates 
Streptomyces E10 and E13 along with valinomycin- and candicidin-producing 
reference strains. The third sub-cluster contains Acromyrmex ant isolates 
Streptomyces E8 and E9 as well as Tetraponera ant isolate Streptomyces KY1. 
Various candicidin and/or antimycin producers dominate this sub-cluster. 
Interestingly, the distribution of candicidin plus antimycin producers appears to 
be limited to this sub-cluster. This finding is analogous to the chemical (Chapter 
3) and genetic (Supplementary Information C) data presented earlier, showing 
that Streptomyces E8 is able to produce candicidin and antimycin.  
This phylogenetic analysis provides a straightforward and useful approach 
to obtain indications of what antifungals bacterial isolates may produce. 
Unfortunately, these data have been unavailable when the antimycin 
metabolites of Streptomyces E8 were chemically identified. 
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Figure S3 Neighbor-Joining tree of 52 bacterial reference strains (à), known for 
producing specific antifungals (Poulsen et al. 2011, Kaltenpoth et al. 2006, Scott 
et al. 2008, Schoenian et al. 2011, Haeder et al. 2009), and eleven bioactive 
NNSPS isolates. In particular, partial 16S rDNA sequences were included of 
Streptomyces E2, E6, E8-E10, E13-E14 (), and Streptomyces KY1-KY2, KY5 (). 
Pseudonocardia E4 served as phylogenetic outgroup. A 50% threshold for the 
bootstrap values is handled. The data indicate that Streptomyces E8 and E9, and 
possibly Streptomyces KY1, are able to produce candicidin and antimycin. 
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 Streptomyces sp. MP15-36 (EU263060); Candicidin (S26)
 Streptomyces sp. MP47-06 (EU263062); Candicidin (S25)
 Streptomyces albidoflavus (DQ978978.1); Antimycin A1-A4 (S34)
 Streptomyces sp. Ae 32 2 (FJ490544); Antimycin A1-A4, Candicidin (S41)
 E8 A Streptomyces
 E9 A Streptomyces
 Streptomyces sp. Ao 10 (FJ490543); Antimycin A1-A4, Candicidin (S40)
 Streptomyces sp. Av28 3 (FJ490540); Antimycin A1-A4, Candicidin (S37)
 Streptomyces sp. Av26 5 (FJ490538); Antimycin A1-A4, Candicidin (S35)
 Streptomyces sp. Av25 1 (FJ490532); Antimycin A1-A4, Candicidin (S36)
 Streptomyces sp. (DQ375802); Unknown (P31) 
 Streptomyces sp. (DQ375805); Unknown (P29) 
 Streptomyces sp. (DQ375788); Unknown (P30)  
 KY2 A Streptomyces
 E4 A Pseudonocardia
100
100
99
99
57
99
99
50
50
67
58
68
97
78
95
83
94
94
83
88
84
83
98
53
73
73
52
65
84
74
65
62
96
99
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